Understanding Neuropsychiatric Disorders

Insights from Neuroimaging

Understanding Neuropsychiatric Disorders

An informative and comprehensive review from the leading researchers in the field, this book provides a complete one-stop guide to neuroimaging techniques and their application to a wide range of neuropsychiatric disorders. For each disorder or group of disorders, separate chapters review the most up-to-date findings from structural imaging, functional imaging and/or molecular imaging. Each section ends with an overview from a internationally-renowned luminary in the field, addressing the question of ‘What do we know and where are we going?' Richly illustrated throughout, each chapter includes a ‘summary box', providing readers with explicit take-home messages. This is an essential resource for clinicians, researchers and trainees who want to learn how neuroimaging tools lead to new discoveries about brain and behaviour associations in neuropsychiatric disorders.

Reference Title: References

Reference Type: reference-list

Agartz I , Andersson J L and Skare S. 2001. Abnormal brain white matter in schizophrenia: a diffusion tensor imaging study. Neuroreport 12, 2251–4.
Andreasen N C. 1999. A unitary model of schizophrenia: Bleuler's “fragmented phrene” as schizencephaly. Arch Gen Psychiatry 56, 781–7.
Ardekani B A , Nierenberg J , Hoptman M J , Javitt D C and Lim K O. 2003. MRI study of white matter diffusion anisotropy in schizophrenia Neuroreport 14, 2025–9.
Ashtari M , Cottone J , Ardekani B , et al. 2007. Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography. Arch Gen Psychiatry 64, 1270–80.
Bartzokis G. 2002. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27, 672–83.
Baumann N and Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81, 871–927.
Beaulieu C and Allen P. 1994. Determinants of anisotropic water diffusion in nerves. Mag Res Med 31, 394–400.
Bleuler E. 1911. Dementia Praecox or the Group of Schizophrenias. New York, NY: International Universities Press.
Borgwardt S , Riecher-Rössler A , Dazzan P , et al. 2007. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61, 1148–56.
Bourgeois J P and Rakic P. 1993. Changes of synaptic density in the primary visual cortex of the macaque monkey from fetal to adult stage. J Neurosci 13, 2801–20.
Brambilla P , Cerini R , Gasparini A , et al. 2005. Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophr Res 79, 201–10.
Buchsbaum M , Tang C , Peled S , et al. 1998. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9, 425–30.
Buchsbaum M S , Friedman J , Buchsbaum B R , et al. 2006. Diffusion tensor imaging in schizophrenia. Biol Psychiatry 60, 1181–7.
Burns J , Job D , Bastin M E , et al. 2003. Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry 182, 439–43.
Butler P , Hoptman M , Nierenberg J , Foxe J , Javitt D and Lim K. 2006. Visual white matter integrity in schizophrenia. Am J Psychiatry 163, 2011–3.
Cahn W , Pol H E , Lems E B , et al. 2002. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 59, 1002–10.
Cheung V , Cheung C , McAlonan G , et al. 2008. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychol Med 38, 877–85.
Crow T. 1998. Schizophrenia as a transcallosal misconnection syndrome. Schizophr Res 30, 111–4.
Davatzikos C. 2004. Why voxel-based morphometric analysis should be used with great caution when characterizing group differences. Neuroimage 23, 17–20.
De Bellis M , Keshavan M , Beers S , et al. 2001. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex 11, 552–7.
Douaud G , Smith S , Jenkinson M , et al. 2007. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 130, 2375–86.
Ellison-Wright I , Glahn D , Laird A , Thelen S and Bullmore E. 2008. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 165, 1015–23.
Ennis D and Kindlmann G. 2006. Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med 55, 136–46.
Federspiel A , Begré S , Kiefer C , Schroth G , Strik W and Dierks T. 2006. Alterations of white matter connectivity in first episode schizophrenia. Neurobiol Dis 22, 702–9.
Feinberg I. 1978. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr Bull 4, 636–40.
Feinberg I. 1982. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17, 319–34.
Fields R. 2004. The other half of the brain. Sci Am 290, 54–61.
Fields R. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31, 361–70.
Foong J , Maier M , Clark C A , Barker G J , Miller D H and Ron M A. 2000. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 68, 242–4.
Foong J , Symms M R , Barker G J , Maier M , Miller D H and Ron M A. 2002. Investigating regional white matter in schizophrenia using diffusion tensor imaging. Neuroreport 13, 333–6.
Ford J M , Mathalon D H , Heinks T , Kalba S , Faustman W O and Roth W T. 2001. Neurophysiological evidence of corollary discharge dysfunction in schizophrenia. Am J Psychiatry 158, 2069–71.
Friedman J , Tang C , Carpenter D , et al. 2008. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry 165, 1024–32.
Friston K. 1999. Schizophrenia and the disconnection hypothesis. Acta Psychiatr Scand Suppl 395, 68–79.
Frith C D. 1992. The Cognitive Neuropsychology of Schizophrenia. Hove, UK: Lawrence Erlbaum Associates.
Frith C D , Blakemore S and Wolpert D M. 2000. Explaining the symptoms of schizophrenia: abnormalities in the awareness of action. Brain Res Rev 31, 357–63.
Frith C D and Done D J. 1989. Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action. Psychol Med 19, 359–63.
Fujiwara H , Namiki C , Hirao K , et al. 2007. Anterior and posterior cingulum abnormalities and their association with psychopathology in schizophrenia: a diffusion tensor imaging study. Schizophr Res 95, 215–22.
Garner B , Pariante C , Wood S , et al. 2005. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 58, 417–23.
Glahn D , Laird A , Ellison-Wright I , et al. 2008. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64, 774–81.
Gur R E , Cowell P , Turetsky B I , et al. 1998. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 55, 145–52.
Gurrera R , Nakamura M , Kubicki M , et al. 2007. The uncinate fasciculus and extraversion in schizotypal personality disorder: a diffusion tensor imaging study. Schizophr Res 90, 360–2.
Hao Y , Liu Z , Jiang T , et al. 2006. White matter integrity of the whole brain is disrupted in first-episode schizophrenia. Neuroreport 17, 23–6.
Hirayasu Y , Tanaka S , Shenton M E , et al. 2001. Prefrontal gray matter volume reduction in first episode schizophrenia. Cerebral Cortex 11, 374–81.
Honea R , Crow T J , Passingham D and Mackay C E. 2005. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162, 2233–45.
Hubl D , Koenig T , Strik W , et al. 2004. Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry 61, 658–68.
Jahanshahi M and Frith C. 1998. Willed action and its impairments. Cogn Neuropsychol 15, 483.
Jones D K , Catani M , Pierpaoli C , et al. 2006. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp 27, 230–8.
Kanaan R A , Kim J S , Kaufmann W E , Pearlson G D , Barker G J and McGuire P K. 2005. Diffusion tensor imaging in schizophrenia. Biol Psychiatry 58, 921–9.
Kanaan R A , Shergill S S , Barker G J , et al. 2006. Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Res 146, 73–82.
Karlsgodt K , van Erp T , Poldrack R , Bearden C , Nuechterlein K and Cannon T. 2008. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry 63, 512–8.
Kasai K , Shenton M E , Salisbury D F , et al. 2003. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 60, 766–75.
Kawashima T , Nakamura M , Boiux S , et al. 2009. Uncinate fasciculus abnormalities in recent onset schizophrenia and affective psychosis: a diffusion tensor imaging study. Schiz Res 110, 119–26.
Kendi M , Kendi A , Lehericy S , et al. 2008. Structural and diffusion tensor imaging of the fornix in childhood- and adolescent-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 47, 826–32.
Keshavan M S , Anderson S and Pettegrew J W. 1994. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 28, 239–65.
Konopaske G , Dorph-Petersen K , Sweet R , et al. 2008. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 63, 759–65.
Kraepelin E , ed. 1907. Textbook of Psychiatry. London: Macmillan.
Kubicki M , McCarley R , Westin C F , et al. 2007. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res 41, 15–30.
Kubicki M , Park H , Westin C F , et al. 2005. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 26, 1109–18.
Kubicki M , Westin C F , Maier S E , et al. 2002. Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry 159, 813–20.
Kubicki M , Westin C F , Nestor P G , et al. 2003. Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol Psychiatry 54, 1171–80.
Kumra S , Ashtari M , Cervellione K , et al. 2005. White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study. J Am Acad Child Adolesc Psychiatry 44, 934–41.
Kumra S , Ashtari M , McMeniman M , et al. 2004. Reduced frontal white matter integrity in early-onset schizophrenia: a preliminary study. Biol Psychiatry 55, 1138–45.
Kuroki N , Kubicki M , Nestor P G , et al. 2006. Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry 60, 22–31.
Kyriakopoulos M , Vyas N , Barker G , Chitnis X and Frangou S . 2008. A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol Psychiatry 63, 519–23.
Lawrie S M , Buechel C , Whalley H C , Frith C D , Friston K J and Johnstone E C. 2002. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biological Psychiatry 51, 1008–11.
Lim K O , Hedehus M , Moseley M , de Crespigny A , Sullivan E V and Pfefferbaum A. 1999. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56, 367–74.
Manoach D , Ketwaroo G , Polli F , et al. 2007. Reduced microstructural integrity of the white matter underlying anterior cingulate cortex is associated with increased saccadic latency in schizophrenia. Neuroimage 37, 599–610.
McIntosh A M , Maniega S M , Lymer G K S , et al. 2008. White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry 64, 1088–92.
Minami T , Nobuhara K , Okugawa G , et al. 2003. Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology 47, 141–5.
Mitelman S , Torosjan Y , Newmark R , et al. 2007. Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr Res 92, 211–24.
Miyata J , Hirao K , Namiki C , et al. 2007. Interfrontal commissural abnormality in schizophrenia: tractography-assisted callosal parcellation. Schizophr Res 97, 236–41.
Mori T , Ohnishi T , Hashimoto R , et al. 2007. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res 154, 133–45.
Nestor P , Kubicki M , Niznikiewicz M , Gurrera R , McCarley R and Shenton M. 2008. Neuropsychological disturbance in schizophrenia: a diffusion tensor imaging study. Neuropsychology 22, 246–54.
O'Daly O , Frangou S , Chitnis X and Shergill S. 2007. Brain structural changes in schizophrenia patients with persistent hallucinations. Psychiatry Res 156, 15–21.
Pakkenberg B. 1993. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical dissectors. Biol Psychiatry 34, 768–72.
Pantelis C , Velakoulis D , McGorry P D , et al. 2003. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361, 281–8.
Park H J , Westin C F , Kubicki M , et al. 2004. White matter hemisphere asymmetries in healthy subjects and in schizophrenia: a diffusion tensor MRI study. Neuroimage 23, 213–23.
Pearlson G D and Marsh L. 1999. Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry 46, 627–49.
Pekny M and Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50, 427–34.
Pfefferbaum A , Mathalon D H , Sullivan E V , Rawles J M , Zipursky R B and Lim K O . 1994. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51, 874–87.
Pfefferbaum A and Sullivan E V. 2003. Increased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn Reson Med 49, 953–61.
Price G , Bagary M S , Cercignani M , Altmann D R and Ron M A. 2005. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 76, 585–7.
Price G , Cercignani M , Bagary M , et al. 2006. A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophr Res 87, 100–08.
Price G , Cercignani M , Parker G , et al. 2008. White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage 39, 949–55.
Price G , Cercignani M , Parker G J , et al. 2007. Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage 35, 458–66.
Purves D and Lichtman J W. 1980. Elimination of synapses in the developing nervous system. Science 210, 153–7.
Roberts G , Colter N , Lofthouse R , Bogerts B , Zech M and Crow T. 1986. Gliosis in schizophrenia: a survey. Biol Psychiatry 21, 1043–50.
Rosenberger G , Kubicki M , Nestor P , et al. 2008. Age-related deficits in fronto-temporal connections in schizophrenia: a diffusion tensor imaging study. Schizophr Res 102, 181–8.
Rotarska-Jagiela A and Linden D. 2008. The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions. Neuroimage 39, 1522–32.
Roy K , Murtie J , El-Khodor B , et al. 2007. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci U S A 104, 8131–6.
Salisbury D , Kuroki N , Kasai K , Shenton M and McCarley R. 2007. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 64, 521–9.
Scherk H and Falkai P. 2006. Effects of antipsychotics on brain structure. Curr Opin Psychiatry 19, 145–50.
Schlösser R , Nenadic I , Wagner G , et al. 2007. White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study. Schizophr Res 89, 1–11.
Schneiderman J S , Buchsbaum M S , Haznedar M , et al. 2009. Age and diffusion anisotropy in adolescent and adult patients with schizophrenia. Neuroimage 45, 662–71.
Seal M , Yücel M , Fornito A , et al. 2008. Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity. Schizophr Res 101, 106–10.
Seeman P and Kapur S. 2000. Schizophrenia: more dopamine, more D2 receptors. Proc Natl Acad Sci U S A 97, 7673–5.
Selemon L D and Goldman-Rakic P S. 1999. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45, 17–25.
Seok J , Park H , Chun J , et al. 2007. White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Psychiatry Res 156, 93–104.
Shenton M , Dickey C , Frumin M and McCarley R. 2001. A review of MRI findings in schizophrenia. Schizophr Res 49, 1–52.
Shergill S , Kanaan R , Chitnis X , et al. 2007. A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry 164, 467–73.
Song S , Sun S , Ju W , Lin S , Cross A and Neufeld A. 2003. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20, 1714–22.
Song S , Sun S , Ramsbottom M , Chang C , Russell J and Cross A. 2002. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17, 1429–36.
Stangel M. 2004. Remyelinating and neuroprotective treatments in multiple sclerosis. Expert Opin Investig Drugs 13, 331–47.
Steen R , Mull C , McClure R , Hamer R and Lieberman J. 2006. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188, 510–8.
Steen R G , Ogg R J , Reddick W E and Kingsley P B. 1997. Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence. Am J Neuroradiol 18, 819–28.
Sun D , Stuart G , Jenkinson M , et al. 2009. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 14, 976–86.
Sun Z , Wang F , Cui L , et al. 2003. Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study. Neuroreport 14, 1833–6.
Szeszko P , Robinson D , Ashtari M , et al. 2008. Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 33, 976–84.
Takei K , Yamasue H , Abe O , et al. 2008. Disrupted integrity of the fornix is associated with impaired memory organization in schizophrenia. Schizophr Res 103, 52–61.
Thompson C. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–62.
Uranova N , Vostrikov V , Vikhreva O , Zimina I , Kolomeets N and Orlovskaya D. 2007. The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol 10, 537–45.
van Haren N , Hulshoff Pol H , Schnack H , et al. 2008. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry 63, 106–13.
Vita A , De Peri L , Silenzi C and Dieci M. 2006. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82, 75–88.
Walterfang M , Wood S , Velakoulis D , Copolov D and Pantelis C. 2005. Diseases of white matter and schizophrenia-like psychosis. Aust N Z J Psychiatry 39, 746–56.
Wang F , Sun Z , Cui L , et al. 2004. Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. Am J Psychiatry 161, 573–5.
White T , Kendi A , Lehéricy S , et al. 2007. Disruption of hippocampal connectivity in children and adolescents with schizophrenia – a voxel-based diffusion tensor imaging study. Schizophr Res 90, 302–7.
Whitford T J , Grieve S M , Farrow T F , et al. 2006. Progressive grey matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. NeuroImage 32, 511–9.
Whitford T J , Grieve S M , Farrow T F , et al. 2007a. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry 164, 1082–9.
Whitford T J , Kubicki M and Shenton M E , in press. Diffusion tensor imaging (DTI), schizophrenia and discrete brain regions. US Psychiatric Rev.
Whitford T J , Rennie C J , Grieve S M , Clark C R , Gordon E and Williams L M. 2007b. Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Human Brain Mapp 28, 228–37.
Wolkin A , Choi S , Szilagyi S , Sanfilipo M , Rotrosen J and Lim K. 2003. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am J Psychiatry 160, 572–4.
Wood S , Pantelis C , Velakoulis D , Yücel M , Fornito A and McGorry P. 2008. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull 34, 322–9.
Yakovlev P , Lecours A and Minkowski A. 1967. Regional development of the brain early in life. Boston, MA: Blackwell Scientific Publications, pp. 3–70.
Yücel M , Wood S , Phillips L , et al. 2003. Morphology of the anterior cingulate cortex in young men at ultra-high risk of developing a psychotic illness. Br J Psychiatry 182, 518–24.
Zahajszky J , Dickey C , McCarley R , et al. 2001. A quantitative MR measure of the fornix in schizophrenia. Schizophr Res 47, 87–97.
Zhou Y , Shu N , Liu Y , et al. 2008. Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia. Schizophr Res 100, 120–32.
Zou L , Xie J , Yuan H , Pei X , Dong W and Liu P. 2008. Diffusion tensor imaging study of the anterior limb of internal capsules in neuroleptic-naive schizophrenia. Acad Radiol 15, 285–9.

Reference Title: References

Reference Type: reference-list

Aleman A , Kahn R S . 2005. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 77, 283–98.
Allen A J , Griss M E , Folley B S , Hawkins K A and Pearlson G D . 2009. Endophenotypes in schizophrenia: A selective review. Schizophr Res 109, 24–37.
Arfanakis K , Cordes D , Haughton V M , et al. 2000. Combining independent component analysis and correlation analysis to probe interregional connectivity in fMRI task activation datasets. Magn Reson Imaging 18, 921–30.
Assaf M , Rivkin P R , Kuzu C H , et al. 2006. Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia. Biol Psychiatry 59, 452–9.
Assaf M , Jagannathan K , et al. 2009. Temporal sequence of hemispheric network activation during semantic processing: a functional network connectivity analysis. Brain Cogn 70, 238–46.
Astur R S , St Germain S A , Baker E K , et al. 2005. fMRI hippocampal activity during a virtual radial arm maze. Appl Psychophysiol Biofeedback 30, 307–17.
Baas D , Aleman A , Vink M , et al. 2008. Evidence of altered cortical and amygdala activation during social decision-making in schizophrenia. Neuroimage 40, 719–27.
Baddeley A . 1992. Working memory. Science 255, 556–9.
Barch D M , Berman M G , Engle R , et al. 2009. CNTRICS final task selection: working memory. Schizophr Bull 35, 136–52.
Barch D M , Braver T S , Cohen A L , et al. 1998. Context processing deficits in schizophrenia. Arch Gen Psychiatry 50, 280–8.
Barch D M , Carter C S , Braver T S , et al. 2001. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58, 280–8.
Barch D M , and Smith E . 2008. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol Psychiatry 64, 11–7.
Barta P E , Pearlson G D , Powers R E , et al. 1990. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147, 1457–62.
Beckmann C F , DeLuca M , Devlin J T , et al. 2005. Investigations into resting-state connectivity using independent component analysis. Phil Trans R Soc Lond B Biol Sci 360, 1001–13.
Biswal B B , Van Kylen J and Hyde J S . 1997. Simultaneous assessment of flow and BOLD signals in resting-state functional connectivity maps. NMR Biomed 10, 165–70.
Bluhm R L , Miller J , Lanius R A , et al. 2007. Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. Schizophr Bull 33, 1004–12.
Broyd S J , Demanuele C , Debener S , et al. 2009. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev 33, 279–96.
Calhoun V D , Adali T , Giuliani N R , et al. 2006a. Method for multimodal analysis of independent source differences in schizophrenia: combining gray matter structural and auditory oddball functional data. Hum Brain Mapp 27, 47–62.
Calhoun V D , Adali T , Kiehl K A , et al. 2006b. A method for multitask fMRI data fusion applied to schizophrenia. Hum Brain Mapp 27, 598–610.
Calhoun V D , Adali T , Pearlson G D , et al. 2006c. Neuronal chronometry of target detection: fusion of hemodynamic and event-related potential data. Neuroimage 30, 544–53.
Calhoun V D , Kiehl K A , Liddle P F , et al. 2004. Aberrant localization of synchronous hemodynamic activity in auditory cortex reliably characterizes schizophrenia. Biol Psychiatry 55, 842–9.
Calhoun V D , Kiehl K A and Pearlson G D . 2008. Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks. Hum Brain Mapp 29, 828–38.
Callicott J H , Bertolino A , Mattay V S , et al. 2000. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10, 1078–92.
Callicott J H , Egan M F , Mattay V S , et al. 2003a. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160, 709–19.
Callicott J H , Mattay V S , Bertolino A , et al. 1999. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9, 20–6.
Callicott J H , Mattay V S , Verchinski V A , et al. 2003b. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 160, 2209–15.
Callicott J H , Ramsey N F , Tallent K , et al. 1998. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 18, 186–96.
Callicott J H , Straub R E , Pezawas L , et al. 2005. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 102, 8627–32.
Carvalho K N , Pearlson G D , Astur R S , et al. 2006. Simulated driving and brain imaging: combining behavior, brain activity, and virtual reality. CNS Spectr 11, 52–62.
Cohen J D , Braver T S , O'Reilly R C , et al. 1996. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges. Phil Trans R Soc Lond B Biol Sci 351, 1515–27.
Cordes D , Haughton V M , Arfanakis K , et al. 2001. Frequencies contributing to functional connectivity in the cerebral cortex in “resting-state” data. Am J Neuroradiol 22, 1326–33.
Damoiseaux J S , Rombouts S A , Barkhof F , et al. 2006. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A 103, 13 848–53.
De Luca M , Smith S , De Stefano N , et al. 2005. Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res 167, 587–94.
Demirci O , Stevens M C , Andresen N C , et al. 2009. Investigation of relationships between fMRI brain networks in the spectral domain using ICA and Granger causality reveals distinct differences between schizophrenia patients and healthy controls. Neuroimage 46, 419–31.
D'Esposito M , Postle B R , Ballard D , et al. 1999. Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cogn 41, 66–86.
Di Giorgio A , Blasi G , Sambataro F , et al. 2008. Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci 28, 2129–36.
Dosenbach N U , Fair D A , Miezin F M , et al. 2007. Distinct brain networks for adaptive and stable task control in humans. Proc Natl Acad Sci U S A 104, 11 073–8.
Driesen N R , Leung H C , Calhoun V D , et al. 2008. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry 64, 1026–34.
Egan M F , Goldberg T E , Kolachana B S , et al. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98, 6917–22.
Foley B S , Astur R, Jagannathan K , et al. 2010. Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage 49, 3373–84.
Ford J M , Gray M , Whitfield S L , et al. 2004. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 61, 119–29.
Ford J M , Roach B J , Jorgensen K W , et al. 2009. Tuning in to the voices: a multisite FMRI study of auditory hallucinations. Schizophr Bull 35, 58–66.
Fransson P. 2006. How default is the default mode of brain function? Further evidence from intrinsic BOLD signal fluctuations. Neuropsychologia 44, 2836–45.
Friedman H R and Goldman-Rakic P S . 1994. Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey. J Neurosci 14, 2775–88.
Fuster J M . 2006. The cognit: a network model of cortical representation. Int J Psychophysiol 60, 125–32.
Garrity A G , Pearlson G D , McKiernan K , et al. 2007. Aberrant “default mode” functional connectivity in schizophrenia. Am J Psychiatry 164, 450–7.
Glahn D C , Ragland J D , Abramoff A , et al. 2005. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25, 60–9.
Goldberg T E , Patterson K J , Taqqu Y , et al. 1998. Capacity limitations in short-term memory in schizophrenia: tests of competing hypotheses. Psychol Med 28, 665–73.
Goldberg T E and Weinberger D R . 2004. Genes and the parsing of cognitive processes. Trends Cogn Sci 8, 325–35.
Green M F . 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153, 321–30.
Greicius M D , Srivastava G , Reiss A L , et al. 2004. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101, 4637–42.
Gusnard D A , Akbudak E , Shulman G L , et al. 2001. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci U S A 98, 4259–64.
Hall J. , Harris J M , Sprengelmeyer R , et al. 2004. Social cognition and face processing in schizophrenia. Br J Psychiatry 185, 169–70.
Harvey P D and Keefe R S. 2001. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158, 176–84.
Heckers S , Weiss A P , Deckersbach T , et al. 2004. Anterior cingulate cortex activation during cognitive interference in schizophrenia. Am J Psychiatry 161, 707–15.
Henik A , Carter C S , Salo R , et al. 2002. Attentional control and word inhibition in schizophrenia. Psychiatry Res 110, 137–49.
Hoffman R E , Anderson A W , Varanko M , et al. 2008. Time course of regional brain activation associated with onset of auditory/verbal hallucinations. Br J Psychiatry 193, 424–5.
Holt D J , Kunkel L , Weiss A P , et al. 2006. Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr Res 82, 153–62.
Jafri M J , Pearlson G D , Stevens M , et al. 2008. A method for functional network connectivity among spatially independent resting-state components in schizophrenia. Neuroimage 39, 1666–81.
Jansma J M , Ramsey N F , van der Wee M J , et al. 2004. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res 68, 159–71.
Johnson M R , Morris N A , Astur R S , et al. 2006. A functional magnetic resonance imaging study of working memory abnormalities in schizophrenia. Biol Psychiatry 60, 11–21.
Karlsgodt K H , Sun D , Jimenez A M , et al. 2008. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 20, 1297–327.
Kerns J G , Cohen J D , MacDonald A W III, et al. 2005. Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia. Am J Psychiatry 162, 1833–9.
Kiehl K A , Stevens M C , Laurens K R , et al. 2005. An adaptive reflexive processing model of neurocognitive function: supporting evidence from a large scale (n = 100) fMRI study of an auditory oddball task. Neuroimage 25, 899–915.
Laurens K R , Kiehl K A , Ngan E T , et al. 2005. Attention orienting dysfunction during salient novel stimulus processing in schizophrenia. Schizophr Res 75, 159–71.
Liu J , Kiehl K A , Pearlson G , et al. 2009a. Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. Neuroimage 46, 809–16.
Liu J , Pearlson G , Windemuth A , et al. 2009b. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum Brain Mapp 30, 241–55.
Lowe M J , Mock B J and Sorensen J A. 1998. Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage 7, 119–32.
Manoach D S. 2003. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 60, 285–98.
Manoach D S , Gollub R L , Benson E S , et al. 2000. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48, 99–109.
Manoach D S , Greve D N , Lindgren K A , et al. 2003. Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI. Neuroimage 20, 1670–84.
Manoach D S , Schlaug G , Siewert B , et al. 1997. Prefrontal cortex fMRI signal changes are correlated with working memory load. Neuroreport 8, 545–9.
Marwick K and Hall J . 2008. Social cognition in schizophrenia: a review of face processing. Br Med Bull 88, 43–58.
McDonald C , Marshall N , Sham P C , et al. 2006. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 163, 478–87.
McKeown M J and Sejnowski T J. 1998. Independent component analysis of fMRI data: examining the assumptions. Hum Brain Mapp 6, 368–72.
McKiernan K A , D'Angelo B R , Kaufman J N and Binder J R . 2006. I nterrupting the “stream of consciousness”: An fMRI investigation. Neuroimage 29, 1185–9.
McKiernan K A , Kaufman J N , Kucera-Thomson J , et al. 2003. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J Cogn Neurosci 15, 394–408.
Meda S A , Bhattarai M , Morris N A , et al. 2008. An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients. Schizophr Res 104, 85–95.
Mesulam M M . 1998. From sensation to cognition. Brain 121, 1013–52.
Meyer-Lindenberg A , Poline J B , Kohn P D , et al. 2001. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158, 1809–17.
Meyer-Lindenberg A and Weinberger D R . 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7, 818–27.
Miller E K , Erickson C A , Desimone R , et al. 1996. Neural mechanisms of visual working memory in prefrontal cortex of the macaque. J Neurosci 16, 5154–67.
Minzenberg M J , Laird A R , Thelen S , et al. 2009. Meta-analysis of 41 functional neuroimaging studies of executive function reveals dysfunction in a general-purpose cognitive control system in schizophrenia. Arch Gen Psychiatry 66, 811–22.
Park S and Holzman P S . 1992. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49, 975–82.
Park S , Puschel J , Sauter B H , et al. 1999. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biol Psychiatry 46, 392–400.
Pearlson G. 2009. Multisite collaborations and large databases in psychiatric neuroimaging: Advantages, problems, and challenges. Schizophr Bull 35, 1–2.
Pearlson G D and Folley B S . 2008a. Endophenotypes, dimensions, risks: is psychosis analogous to common inherited medical illnesses? Clin EEG Neurosci 39, 73–7.
Pearlson G D and Folley B S . 2008b. Schizophrenia, psychiatric genetics, and Darwinian psychiatry: An evolutionary framework. Schizophr Bull 34, 722–33.
Perlstein W M , Carter C S , Noll D C , et al. 2001. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 158, 1105–13.
Petrides M. 1995. Impairments on nonspatial self-ordered and externally ordered working memory tasks after lesions of the mid-dorsal part of the lateral frontal cortex in the monkey. J Neurosci 15, 359–75.
Pezawas L , Verchinski B A , Mattay V S , et al. 2004. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24, 10 099–102.
Quintana J , Wong T , Ortiz-Portillo E , et al. 2003. Right lateral fusiform gyrus dysfunction during facial information processing in schizophrenia. Biol Psychiatry 53, 1099–112.
Ragland J D , Yoon J , Minzenberg M J , et al. 2007. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism. Int Rev Psychiatry 19, 417–27.
Raichle M E , MacLeod A M , Snyder A Z , et al. 2001. A default mode of brain function. Proc Natl Acad Sci USA 98, 676–82.
Rubia K , Russell T , Bullmore E T , et al. 2001. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res 52, 47–55.
Rypma B and D'Esposito M . 1999. The roles of prefrontal brain regions in components of working memory: effects of memory load and individual differences. Proc Natl Acad Sci U S A 96, 6558–63.
Seeley W W , Menon V , Schtazberg A F , et al. 2007. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27, 2349–56.
Servan-Schreiber D , Cohen J D and Steingard S . 1996. Schizophrenic deficits in the processing of context. A test of a theoretical model. Arch Gen Psychiatry 53, 1105–12.
Silver H , Feldman P , Bilker W , et al. 2003. Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am J Psychiatry 160, 1809–16.
Sommer I E , Diederen K M , Blom J D , et al. 2008. Auditory verbal hallucinations predominantly activate the right inferior frontal area. Brain 131, 3169–77.
Sternberg S. 1966. High-speed scanning in human memory. Science 153, 652–4.
Sui J , Adali T , Pearlson G D , et al. 2009. An ICA-based method for the identification of optimal FMRI features and components using combined group-discriminative techniques. Neuroimage 46, 73–86.
Surguladze S , Russell T , Kucharska-Pietura K , et al. 2006. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol Psychiatry 60, 423–31.
Tan H Y , Callicott J H and Weinberger D R . 2007. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex 17, i171–81.
Veltman D J , Rombouts S A and Dolan R J . 2003. Maintenance versus manipulation in verbal working memory revisited: an fMRI study. Neuroimage 18, 247–56.
Wexler B E , Stevens A A , Bowers A A , et al. 1998. Word and tone working memory deficits in schizophrenia. Arch Gen Psychiatry 55, 1093–6.
Wible C G , Lee K , Molina I , et al. 2009. fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull 35, 47–57.
Winterer G , Coppola R , Egan M F , et al. 2003. Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biol Psychiatry 54, 1181–92.
Yurgelun-Todd D A , Waternaux C M , Cohen B M , et al. 1996. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 153, 200–5.

Reference Title: References

Reference Type: reference-list

Abbott C and Bustillo J . 2006. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr Opin Psychiatry 19, 135–9.
Aydin K , Ucok A and Cakir S. 2007. Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection. Am J Neuroradiol 28, 1968–74.
Barany M and Glonek T. 1984. Identification of diseased states by phosphorus-31 NMR. In Gorenstein D G (Ed.) Phosphorus-31 NMR, Principles and Applications. New York, NY: Academic Press, pp. 511–5.
Baslow M H. 2003. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28, 941–53.
Bhakoo K K , Craig T J and Styles P. 2001. Developmental and regional distribution of aspartoacylase in rat brain tissue. J Neurochem 79, 211–20.
Birken D L and Oldendorf W H. 1989. N-Acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13, 23–31.
Bustillo J R , Rowland L M , Jung R , et al. 2008. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. Crit Rev Neurobiol 33, 2456–66.
Cerdan S , Subramanian V H , Hilberman M , et al. 1986. 31P NMR detection of mobile dog brain phospholipids. Magn Reson Med 3, 432–9.
Chandrakumar N and Subramanian S. 1987. Coherence transfer. In Modern Techniques in High Resolution FT-NMR. New York, NY: Springer-Verlag New York Inc.
Chang L , Friedman J , Ernst T , Zhong K , Tsopelas N D and Davis K. 2007. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry 62, 1396–404.
Creese I and Hess E J. 1986. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia. Clin Neuropharmacol 9 (Suppl 4), 14–6.
Dager S R , Corrigan N M , Richards T L and Posse S. 2008. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 19, 81–96.
de Kruijff B , Rietveld A and Cullis P R. 1980. 31P-NMR studies on membrane phospholipids in microsomes, rat liver slices and intact perfused rat liver. Biochim Biophys Acta 600, 343–57.
de Kruijff B , Verkley A J , van Echteld C J , et al. 1979. The occurrence of lipidic particles in lipid bilayers as seen by 31P NMR and freeze–fracture electron-microscopy. Biochim Biophys Acta 555, 200–09.
Delamillieure P , Constans J M , Fernandez J , Brazo P and Dollfus S. 2004. Relationship between performance on the Stroop test and N-acetylaspartate in the medial prefrontal cortex in deficit and nondeficit schizophrenia: preliminary results. Psychiatry Res 132, 87–9.
Eeg-Olofsson O , Kristensson K , Sourander P and Svennerholm L. 1966. Tay-Sach's Disease. A generalized metabolic disorder. Acta Paed Scand 55, 546–62.
Ende G , Hubrich P , Walter S , et al. 2005. Further evidence for altered cerebellar neuronal integrity in schizophrenia. Am J Psychiatry 162, 790–2.
Erecinska M and Silver I A. 1990. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 35, 245–96.
Evans J S and Chan S I. 1994. Phosphophoryn, a biomineralization template protein: pH-dependent protein folding experiments. Biopolymers 34, 507–27.
Fleysher R , Fleysher L , Liu S and Gonen O. 2009. On the voxel size and magnetic field strength dependence of spectral resolution in magnetic resonance spectroscopy. Magn Reson Imaging 27, 222–32.
Frahm J , Michaelis T , Merboldt K D , Hanicke W , Gyngell M L and Bruhn H. 1991. On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo . NMR Biomed 4, 201–04.
Fukuzako H. 2001. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J Biol Psychiatry 2, 70–82.
Fukuzako H , Fukuzako T , Hashiguchi T , Kodama S , Takigawa M and Fujimoto T. 1999. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am J Psychiatry 156, 1205–08.
Fukuzako H , Fukuzako T , Takeuchi K , et al. 1996. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 20, 629–40.
Gangadhar B N , Jayakumar P N , Venkatasubramanian G , Janakiramaiah N and Keshavan M S. 2006. Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 30, 910–3.
Geddes J W , Panchalingam K , Keller J N and Pettegrew J W. 1997. Elevated phosphocholine and phosphatidyl choline following rat entorhinal cortex lesions. Neurobiol Aging 18, 305–08.
Glonek T , Kopp S J , Kot E , Pettegrew J W , Harrison W H and Cohen M M. 1982. P-31 nuclear magnetic resonance analysis of brain: the perchloric acid extract spectrum. J Neurochem 39, 1210–9.
Goldberg N D and O'Toole A G. 1969. The properties of glycogen synthetase and regulation of glycogen biosynthesis in rat brain. J Biol Chem 244, 3053–61.
Goldstein F B. 1959. Biosynthesis of N-acetyl-l-aspartic acid. J Biol Chem 234, 2702–06.
Goldstein F B. 1969. The enzymatic synthesis of N-acetyl-L-aspartic acid by subcellular preparations. J Biol Chem 244, 4257–60.
Goldstein G , Panchalingam K , McClure R J , et al. 2009. Molecular neurodevelopment: An in vivo 31P–1H MRSI study. J Int Neuropsychol Soc 15, 671–83.
Gonen O , Gruber S , Li B S , Mlynarik V and Moser E. 2001. Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. Am J Neuroradiol 22, 1727–31.
Gonzalez-Mendez R , Litt L , Koretsky A P , von Colditz J , Weiner M W and James T L. 1984. Comparison of 31P NMR spectra of in vivo rat brain using convolution difference and saturation with a surface coil. Source of the broad component in the brain spectrum. J Magn Reson 57, 526–33.
Hess H H , Bass N H , Thalheimer C and Devarakonda R. 1976. Gangliosides and the architecture of human frontal and rat somatosensory isocortex. J Neurochem 26, 1115–21.
Hoult D I and Lauterbur P C. 1979. The sensitiivty of the zeugmatographic experiment involving human samples. J Magn Reson 34, 425–33.
Jakary A , Vinogradov S , Feiwell R and Deicken R F. 2005. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI. Schizophr Res 76, 173–85.
Jansson S E , Harkonen M H and Helve H. 1979. Metabolic properties of nerve endings isolated from rat brain. Acta Physiol Scand 107, 205–12.
Jayakumar P N , Gangadhar B N , Subbakrishna D K , Janakiramaiah N , Srinivas J S and Keshavan M S. 2003. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biol Psychiatry 54, 491–4.
Jayakumar P N , Venkatasubramanian G , Keshavan M S , Srinivas J S and Gangadhar B N. 2006. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naive schizophrenia. Acta Psychiatr Scand 114, 346–51.
Jensen J E , Al Semaan Y M , Williamson P C , et al. 2002a. Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia: (31)P-MRS study at 4.0 Tesla. Br J Psychiatry 180, 39–44.
Jensen J E , Drost D J , Menon R S and Williamson P C. 2002b. In vivo brain 31P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR Biomed 15, 338–47.
Jensen J E , Miller J , Williamson P C , et al. 2004. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry 184, 409–15.
Jensen J E , Miller J , Williamson P C , et al. 2006. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Psychiatry Res 146, 127–35.
Kennedy C and Sokoloff L. 1957. An adaptation of the nitrous oxide method to the study of the cerebral circulation in children; normal values for cerebral blood flow and cerebral metabolic rate in childhood. J Clin Invest 36, 1130–7.
Keshavan M S , Pettegrew J W , Panchalingam K S , Kaplan D and Bozik E. 1991. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Arch Gen Psychiatry 48, 1112–3.
Keshavan M S , Stanley J A , Montrose D M , Minshew N J and Pettegrew J W. 2003. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol Psychiatry 8, 316–23.
Keshavan M S , Stanley J A and Pettegrew J W. 2000. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings – Part II. Biol Psychiatry 48, 369–80.
Kilby P M , Bolas N M and Radda G K. 1991. 31P-NMR study of brain phospholipid structures in vivo. Biochim Biophys Acta 1085, 257–64.
King M M , Huang C Y , Chock P B , et al. 1984. Mammalian brain phosphoproteins as substrates for calcineurin. J Biol Chem 259, 8080–3.
Klemm S , Rzanny R , Riehemann S , et al. 2001. Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia. Am J Psychiatry 158, 958–60.
Klunk W E , Xu C , Panchalingam K , McClure R J and Pettegrew J W. 1996. Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging 17, 349–57.
Klunk W E , Xu C J , Panchalingam K , McClure R J and Pettegrew J W. 1994. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units. Neurobiol Aging 15, 133–40.
Knizley H. 1967. The enzymatic synthesis of N-acetyl-L-aspartic acid by a water-insoluble preparation of a cat brain acetone powder. J Biol Chem 242, 4619–22.
Koller K J , Zaczek R and Coyle J. 1984. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 43, 1136–42.
Li C W , Negendank W G , Murphy-Boesch J , Padavic-Shaller K and Brown T R. 1996. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9, 141–55.
Lowden J A and Wolfe L S. 1964. Studies on brain gangliosides. III Evidence for the location of gangliosides specifically in neurones. Can J Biochem 42, 1587–94.
Makar T K , Cooper A J , Tofel-Grehl B , Thaler H T and Blass J P. 1995. Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem Res 20, 705–11.
Marenco S , Steele S U , Egan M F , et al. 2006. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. Am J Psychiatry 163, 740–2.
Mason R P , Trumbore M W and Pettegrew J W. 1995. Membrane interactions of a phosphomonoester elevated early in Alzheimer's disease. Neurobiol Aging 16, 531–9.
McCandless D W and Wiggins R C . 1981. Cerebral energy metabolism during the onset and recovery from halothane anesthesia. Neurochem Res 6, 1319–26.
McClure R J , Keshavan M S and Pettegrew J W. 1998. Chemical and physiologic brain imaging in schizophrenia. In Buckley P F (Ed.) The Psychiatric Clinics of North America Schizophrenia, Philadelphia: W.B. Saunders, pp. 93–122.
McIlwain H and Bachelard H S. 1985. Biochemistry and the Central Nervous System. Edinburgh: Churchill Livingstone.
McNamara R , Arias-Mendoza F and Brown T R. 1994. Investigation of broad resonances in 31P NMR spectra of the human brain in vivo . NMR Biomed 7, 237–42.
Merrill A H J and Sandhoff K. 2002. Sphingolipids: metabolism and cell signaling. In Vance D E and Vance J E (Eds) Biochemistry of Lipids, Lipoproteins and Membranes. New York, NY: Elsevier, pp. 390–407.
Miller B L. 1991. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4, 47–52.
Miyaoka T , Yasukawa R , Mizuno S , et al. 2005. Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Psychiatr Res 39, 29–34.
Molina V , Sanchez J , Sanz J , et al. 2007. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry J Assoc Eur Psychiatrists 22, 505–12.
Murphy-Boesch J , Stoyanova R , Srinivasan R , et al. 1993. Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed 6, 173–80.
Murphy E J , Bates T E , Williams S R , et al. 1992. Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengths. Biochim Biophys Acta 1111, 51–8.
Murphy E J , Rajagopalan B , Brindle K M and Radda G K. 1989. Phospholipid bilayer contribution to 31P NMR spectra in vivo . Magn Reson Med 12, 282–9.
Nadler J V and Cooper J R. 1972. N-acetyl-L-aspartic acid content of human neural humours and bovine peripheral nervous tissues. J Neurochem 19, 313–9.
O'Neill J , Levitt J , Caplan R , et al. 2004. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage 21, 1781–9.
Ohrmann P , Siegmund A , Suslow T , et al. 2007. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res 41, 625–34.
Ohrmann P , Siegmund A , Suslow T , et al. 2005. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 73, 153–7.
Ongur D , Jensen J E , Prescot A P , et al. 2008. Abnormal glutamatergic neurotransmission and neuronal–glial interactions in acute mania. Biol Psychiatry 64, 718–26.
Ongur D , Prescot A P , Jensen J E , Cohen B M and Renshaw P F. 2009. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res 172, 44–8.
Paz R D , Tardito S , Atzori M and Tseng K Y. 2008. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol 18, 773–86.
Pelupessy P , Rennella E and Bodenhausen G. 2009. High-resolution NMR in magnetic fields with unknown spatiotemporal variations. Science 324, 1693–7.
Perry T L , Hansen S , Berry K , Mok C and Lesk D. 1971. Free amino acids and related compounds in biopsies of human brain. J Neurochem 18, 521–8.
Petroff O A C , Prichard J W , Behar K L , Alger J R , den Hollander J A and Shulman R G. 1985. Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology 35, 781–8.
Pettegrew J W , Keshavan M S , Panchalingam K , et al. 1991. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48, 563–8.
Pettegrew J W , Panchalingam K , Klunk W E , McClure R J and Muenz L R. 1994. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol Aging 15, 117–32.
Pettegrew J W , Panchalingam K , Withers G , McKeag D and Strychor S. 1990. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J Neuropathol Exp Neurol 49, 237–49.
Pettegrew J W , Withers G , Panchalingam K and Post J F. 1988. Considerations for brain pH assessment by 31P NMR. Magn Reson Imaging 6, 135–42.
Potwarka J J , Drost D J , Williamson P C , et al. 1999. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biol Psychiatry 45, 687–93.
Pouwels P J and Frahm J. 1997. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 10, 73–8.
Purdon S E , Valiakalayil A , Hanstock C C , Seres P and Tibbo P. 2008. Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia. Schizophr Res 99, 218–24.
Puri B K , Counsell S J , Hamilton G , et al. 2004. Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study. Prostag Leukotri and Ess Fatty Acids 70, 409–11.
Puri B K , Counsell S J , Hamilton G , Bustos M and Treasaden I H. 2008. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended. Prog Neuropsychopharmacol Biol Psychiatry 32, 751–4.
Riehemann S , Hubner G , Smesny S , Volz H P and Sauer H. 2002. Do neuroleptics alter the cerebral intracellular pH value in schizophrenics? A (31)P-MRS study on three different patient groups. Psychiatry Res 114, 113–7.
Rothermundt M , Ohrmann P , Abel S , et al. 2007. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog Neuropsychopharmacol Biol Psychiatry 31, 361–4.
Rowland L M , Bustillo J R , Mullins P G , et al. 2005. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry 162, 394–6.
Rzanny R , Klemm S , Reichenbach J R , et al. 2003. 31P-MR spectroscopy in children and adolescents with a familial risk of schizophrenia. Eur Radiol 13, 763–70.
Scherk H , Backens M , Zill P , et al. 2008. SNAP-25 genotype influences NAA/Cho in left hippocampus. J Neural Transm 115, 1513–8.
Seelig J. 1978. 31P nuclear magnetic resonance and the head group structure of phospholipids in membranes. Biochim Biophys Acta 515, 105–40.
Seeman P. 2002. Atypical antipsychotics: mechanism of action. Can J Psychiatry – Rev Can Psychiatrie 47, 27–38.
Shedd S F , Lutz N W and Hull W E. 1993. The influence of medium formulation on phosphomonoester and UDP-hexose levels in cultured human colon tumor cells as observed by 31P NMR spectroscopy. NMR Biomed 6, 254–63.
Shenton M E , Dickey C C , Frumin M and McCarley R W. 2001. A review of MRI findings in schizophrenia. Schizophr Res 49, 1–52.
Shimizu E , Hashimoto K , Ochi S , et al. 2007. Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits. J Psychiatr Res 41, 49–56.
Shirayama Y , Yano T , Takahashi K , Takahashi S and Ogino T. 2004. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest. Eur J Neurosci 20, 749–56.
Simmons M L , Frondoza C G and Coyle J T. 1991. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37–45.
Smesny S , Rosburg T , Nenadic I , et al. 2007. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia. Neuroimage 35, 729–37.
Sokoloff L. 1991. Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain. Adv Exp Med Biol 291, 21–42.
Sokoloff L. 1993. Function-related changes in energy metabolism in the nervous system: localization and mechanisms. Keio J Med 42, 95–103.
Stanley J A. 2002. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can J Psychiatry 47, 315–26.
Stanley J A and Pettegrew J W. 2001. Post-processing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo 31-P brain spectra. Magn Reson Med 45, 390–6.
Stanley J A , Pettegrew J W and Keshavan M S. 2000. Magnetic resonance spectroscopy in schizophrenia: methodological issues and fIndings – Part I. Biol Psychiatry 48, 357–68.
Stanley J A , Vemulapalli M , Nutche J , et al. 2007. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res 93, 23–32.
Stanley J A , Williamson P C , Drost D J , et al. 1994. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study. Schizophr Res 13, 209–15.
Steen R G , Hamer R M and Lieberman J A. 2005. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Crit Rev Neurobiol 30, 1949–62.
Suzuki K. 1966. The pattern of mammalian brain gangliosides III. Regional and developmental differences. J Neurochem 12, 969–79.
Szulc A , Galinska B , Tarasow E , et al. 2005. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Pharmacopsychiatry 38, 214–9.
Tallan H H. 1957. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem 224, 41–5.
Tallan H H , Moore S and Stein W H. 1956. N-acetyl-L-aspartic acid in brain. J Biol Chem 219, 257–64.
Tanaka Y , Obata T , Sassa T , et al. 2006. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psychiatry and Clin Neurosci 60, 365–72.
Tang C Y , Friedman J , Shungu D , et al. 2007. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry 7, 25.
Terpstra M , Vaughan T J , Ugurbil K , Lim K O , Schulz S C and Gruetter R. 2005. Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. Magma 18, 276–82.
Theberge J , Al Semaan Y , Drost D J , et al. 2004a. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Res 131, 107–14.
Theberge J , Al Semaan Y , Jensen J E , et al. 2004b. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla. Psychiatry Res 132, 33–9.
Theberge J , Williamson K E , Aoyama N , et al. 2007. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry 191, 325–34.
Tibbo P , Hanstock C , Valiakalayil A and Allen P. 2004. 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. Am J Psychiatry 161, 1116–8.
Truckenmiller M E , Namboodiri M A A , Brownstein M J and Neale J H. 1985. N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 45, 1658–62.
Ugurbil K , Adriany G , Andersen P , et al. 2003. Ultrahigh field magnetic resonance imaging and spectroscopy. Magn Reson Imaging 21, 1263–81.
Ulrich M , Wokrina T , Ende G , Lang M and Bachert P. 2007. 31P-{1H} Echo-planar spectroscopic imaging of the human brain in vivo. Magn Reson Med 57, 784–90.
Urenjak J , Williams S R , Gadian D G and Noble M. 1993. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13, 981–9.
Van Elst L T , Valerius G , Buchert M , et al. 2005. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 58, 724–30.
Vance D E. 1991. Phospholipid metabolism and cell signalling in eucaryotes. In Vance D E and Vance J E (Eds) Biochemistry of Lipids, Lipoproteins and Membranes, Volume 20. New York, NY: Elsevier, pp. 205–40.
Vance J E. 1988. Compartmentalization of phospholipids for lipoprotein assembly on the basis of molecular species and biosynthetic origin. Biochim Biophys Acta 963, 70–81.
Vaughan J T , Garwood M , Collins C M , et al. 2001. 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med 46, 24–30.
Volz H R , Riehemann S , Maurer I , et al. 2000. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47, 954–61.
Weickert C S and Kleinman J E. 1998. The neuroanatomy and neurochemistry of schizophrenia. In Buckley P F (Ed.) The Psychiatric Clinics of North America Schizophrenia. Philadelphia: W.B. Saunders, pp. 57–75.
Whittaker V P. 1966. Some properties of synaptic membranes isolated from the central nervous system. Ann N Y Acad Sci 137, 982–98.
Wiegandt H. 1967. The subcellular localization of gangliosides in the brain. J Neurochem 14, 671–4.
Wood S J , Berger G E , Lambert M , et al. 2006. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 63, 969–76.
Wood S J , Berger G E , Wellard R M , et al. 2008. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naive and early-treated first episode psychosis. Schizophr Res 102, 163–70.
Wood S J , Yucel M , Wellard R M , et al. 2007. Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. Schizophr Res 94, 328–31.
Yacubian J , de Castro C C , Ometto M , et al. 2002. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res 58, 117–22.

Reference Title: References

Reference Type: reference-list

Abi-Dargham A , Kegeles L S , Zea-Ponce Y , et al. 2004. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry 55, 1001–06.
Abi-Dargham A , Rodenhiser J , Printz D , et al. 2000. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 97, 8104–09.
Adams B W , Bradberry C W and Moghaddam B . 2002. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse 43, 12–8.
Breier A , Su T P , Saunders R , et al. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 94, 2569–74.
Buchsbaum M S , Christian B T , Lehrer D S , et al. 2006. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res 85, 232–44.
Carlsson A. 1999. Birth of neuropsychopharmacology – impact on brain research. Brain Res Bull 50, 363.
Carlsson A , Waters N and and Carlsson M L. 1999. Neurotransmitter interactions in schizophrenia – therapeutic implications. Biol Psychiatry 46, 1388–95.
Carson R E , Breier A , de Bartolomeis A , et al. 1997. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cerebr Blood Flow and Metab 17, 437–47.
Davidson L L and Heinrichs R W . 2003. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res 122, 69–87.
Erritzoe D , Rasmussen H , Kristiansen K , et al. 2006. Serotonin 2A binding in neuroleptics-naïve schizophrenic patients and healthy controls using PET and [18-F]altanserin. NeuroImage 31, T44–186 [Abstract].
Erritzoe D , Rasmussen H , Kristiansen K T , et al. 2008. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients. Neuropsychopharmacology 33, 2435–41.
Farde L , Hall H , Ehrin E and Sedvall G. 1986. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231, 258–61.
Farde L , Wiesel F A , Halldin C and Sedvall G . 1988. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45, 71–6.
Farde L , Wiesel F A , Stone-Elander S , et al. 1990. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Arch Gen Psychiatry 47, 213–9.
Frankle W G , Narendran R , Huang Y , et al. 2005. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry 57, 1510–6.
Grace A A. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24.
Gründer G , Carlsson A and Wong D F . 2003. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 60, 974–7.
Gründer G , Fellows C , Janouschek H , et al. 2008. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: An [18F]fallypride PET study. Am J Psychiatry 165, 988–95.
Hurlemann R , Boy C , Meyer P T , et al. 2005. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia. Anat Embryol (Berl) 210, 519–23.
Innis R B , Cunningham V J , Delforge J , et al. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27, 1533–9.
Joyce J N , Shane A , Lexow N , Winokur A , Casanova M F and Kleinman J E. 1993. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315–36.
Krystal J H , Abi-Saab W , Perry E , et al. 2005. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) 179, 303–9.
Laruelle M. 1998. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 42, 211–21.
Laruelle M , Abi-Dargham A , Casanova M F , Toti R , Weinberger D R and Kleinman J E. 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study. Arch Gen Psychiatry 50, 810–8.
Laruelle M , Abi-Dargham A , van Dyck C H , Gil R and D'Souza C D. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 93, 9235–40.
Laruelle M , Abi-Dargham A , van Dyck C , et al. 2000. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biol Psychiatry 47, 371–9.
Martinez D , Gelernter J , Abi-Dargham A , et al. 2001. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24, 553–60.
Matusch A , Hurlemann R , Rota Kops E , et al. 2007. Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans. J Neural Transm 114, 1433–42.
Mukherjee J , Christian B T , Dunigan K A , et al. 2002. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies and preliminary assessment of sensitivity to aging effects on dopamine D2/D3 receptors. Synapse, 46, 170–88.
Mukherjee J , Christian B T , Narayanan T K , Shi B and Collins D. 2005. Measurement of d-amphetamine-induced effects on the binding of dopamine D2/D3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non human primates using PET. Brain Res 1032, 77–84.
Mukherjee J , Christain B T , Narayanan T K , Shi B and Mantil J. 2001. Evaluation of dopamine D2 receptor occupancy by clozapine, risperidone and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology, 25, 476–88.
Mukherjee J , Shi B , Christian B T , Chattopadhyay S , and Narayanan T K . 2004. 11C-fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain. Bioorg Med Chem 12, 95–102.
Munro C A , McCaul M E , Oswald L M , et al. 2006a. Striatal dopamine release and family history of alcoholism. Alcohol Clin Exp Res 30, 1143–51.
Munro C A , McCaul M E , Wong D F , et al. 2006b. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59, 966–74.
Nozaki S , Kato M , Takano H , et al. 2009. Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET. Schizophr Res 108, 78–84.
Nyberg S , Olsson H , Nilsson U , Maehlum E , Halldin C and and Farde L. 2002. Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole. Psychopharmacology (Berl) 162, 37–41.
Oswald L M , Wong D F , McCaul M , et al. 2005. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 30, 821–32.
Rasmussen H , Erritzoe D , Andersen R , et al. 2010. Decreased frontal serotonin 2A receptor binding in antipsychotic-naïve patients with first-episode schizophrenia. Arch Gen Psychiatry 67, 9–16.
Reith J , Benkelfat C , Sherwin A , et al. 1994. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A 91, 11 651–4.
Singer H S , Szymanski S , Guiliano J , et al. 2002. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry 159, 1329–36.
Talvik-Lotfi M , Nyberg S , Nordström A L , et al. 2000. High 5HT2A receptor occupancy in M100907-treated schizophrenic patients. Psychopharmacology (Berl) 148, 400–03.
Wagner H N , Jr, Burns H D , Dannals R F , et al. 1983. Imaging dopamine receptors in the human brain by positron tomography. Science 221, 1264–6.
Wong D F. 2002a. In vivo imaging of D2 dopamine receptors in schizophrenia: the ups and downs of neuroimaging research. Arch Gen Psychiatry 59, 31–4.
Wong D F. 2002b. [Erratum] In vivo imaging of D2 dopamine receptors in schizophrenia: the ups and downs of neuroimaging research. Arch Gen Psychiatry 59, 440.
Wong D F , Potter W Z and Brašić J R. 2002. Proof of concept: functional models for drug development in humans. In Davis K L , Charney D , Coyle J T and Nemeroff C (Eds) Neuropsychopharmacology: The Fifth Generation of Progress. Baltimore, MD: Lippincott Williams and Wilkins, pp. 457–73.
Wong D F and Brašić J R. 2005. Progress in the neuropsychiatry of schizophrenia. Psychiatric Times 22(3), 57–60.
Wong D F , Gjedde A , Wagner H N, Jr, et al. 1986. Quantification of neuroreceptors in the living human brain. II. inhibition studies of receptor density and affinity. J Cerebr Blood Flow Metab 6, 147–53.
Wong D F , Kuwabara H , Schretlen D J , et al. 2006. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31, 2716–27. Erratum in: Neuropsychopharmacology 2007; 32, 256.
Wong D F , Brašić J R , Singer H S , et al. 2008. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette Syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33, 1239–51.
Wong D F , Maini A , Rousset O G and Brašić J R. 2003. Positron emission tomography: a tool for identifying the effects of alcohol dependence on the brain. Alcohol Res Health 27, 161–73.
Wong D F , Tauscher J and Gründer G. 2009. The role of imaging in proof of concept for CNS drug discovery and development. Neuropsychopharmacology, 34, 187–203.
Wong D F , Wagner H N Jr , Dannals R F , et al. 1984. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226, 1393–6.
Yasuno F , Suhara T , Okubo Y , et al. 2004. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia. Am J Psychiatry 161, 1016–22.
Yokoi F , Gründer G , Biziere K , et al. 2002. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27, 248–59.
Zanardi R , Artigas F , Moresco R , et al. 2001. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 21, 53–8.

Reference Title: References

Reference Type: reference-list

Andreasen N C , Arndt S , Cizadlo T , et al. 1996. Sample size and statistical power in 15O H2O studies of human cognition. Journal of Cerebral Blood Flow and Metabolism 16, 804–16.
Andreasen N C , Cohen G C , Harris G , Parkkinen J , Rezai K and Swayze V W. 1992. Image processing for the study of brain structure and function: Problems and programs. Journal of Neuropsychiatry and Clinical Neuroscience 4, 125–33.
Andreasen N C , Nasrallah H A , Dunn V , et al. 1986. Structural abnormalities in the frontal system in schizophrenia: A magnetic resonance imaging study. Archives of General Psychiatry 43, 136–44.
Andreasen N C , O'Leary D S , Cizadlo T, A et al. 1995. Remembering the past: Two facets of episodic memory explored with positron emission tomography. American Journal of Psychiatry 152, 1576–85.
Andreasen N C , Olsen S A , Dennert J W and Smith M R. 1982. Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. American Journal of Psychiatry 139, 297–302.
Arndt S , Cizadlo T , Andreasen N C , Heckel D , Gold S and O'Leary D . 1996. Tests for comparing images based on randomization and permutation methods. Journal of Cerebral Blood Flow and Metabolism 16, 1271–9.
Cahn W , Hulshoff Pol H E , Lems E B , et al. 2002. Brain volume changes in first-episode schizophrenia: A 1-year follow-up study. Archives of General Psychiatry 59, 1002–10.
Cizadlo T , Harris G , Heckel D , et al. 1997. An automated method to quantify the area, depth, and convolutions of the cerebral cortex from MR data: (BRAINSURF). Neuroimage 5, 402.
Cohen G , Andreasen N C , Alliger R , et al. 1992. Segmentation techniques for the classification of brain tissue using magnetic resonance imaging. Psychiatric Research: Neuroimaging 45, 33–51.
DeLisi L E . 2008. The concept of progressive brain change in schizophrenia: Implications for understanding schizophrenia. Schizophrenia Bulletin 34, 312–21.
Feinberg I. 1982. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research 17, 319–34.
Dorph-Petersen K A , Pierri J N , Perel J M , Sun Z , Sampson A R , and Lewis D A . 2005. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30, 1649–61.
Gold S , Christiansen B , Arndt S , et al. 1998. Functional MRI statistical software packages: A comparative analysis. Human Brain Mapping 6, 73–84.
Johnstone E C , Frith C D , Crow T J , Husband J and Kreel L. 1976. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2, 924–6.
Lieberman J A , Tollefson G D , Charles C , et al. 2005. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62, 361–70.
Miller D D , Andreasen N C , O'Leary D S , Watkins G L , Boles Ponto L L and Hichwa R D . 2001. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological Psychiatry 49, 704–15.
Shenton M E , Kikinis R , Jolesz F A , et al. 1992. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. New England Journal of Medicine 327, 604–12.
Sowell E R , Thompson P M , Tessner K D and Toga A W. 2001. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. Journal of Neuroscience 21, 8819–29.
Weinberger D R , Cannon-spoor E , Potkin S G and Wyatt R J . 1980. Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia. American Journal of Psychiatry 137, 1410–3.
Whitford T J , Grieve S M , Farrow T F , et al. 2006. Progressive grey matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: A tensor-based morphometry study. Neuroimage 32, 511–9.
Worsley K , Evans A , Marrett S , and Neelin P. 1992. A three-dimensional statistical analysis for CBF activation studies in human brain. Journal of Cerebral Blood Flow and Metabolism 12, 900–18.

Reference Title: References

Reference Type: reference-list

Adler C M , Adams J , DelBello M P , et al. 2006b. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: A diffusion tensor imaging study. Am J Psychiatry 163, 322–4.
Adler C M , DelBello M P , Jarvis K , Levine A , Adams J and Strakowski S M . 2007. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 61, 776–81.
Adler C M , DelBello M P and Strakowski S M . 2006a. Brain network dysfunction in bipolar disorder. CNS Spectrums 11, 312–20.
Adler C M , Holland S K , Schmithorst V , et al. 2004. Abnormal frontal white matter tracts in bipolar disorder: A diffusion tensor imaging study. Bipolar Disord 6, 197–203.
Adler C M , Levine A D , DelBello M P , Strakowski S M . 2005. Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 58, 151–7.
Adolphs R . 2008. Fear, faces, and the human amygdala. Curr Opin Neurobiol 18, 166–72.
Ahn M S , Breeze J L , Makris N , et al. 2007. Anatomic brain magnetic resonance imaging of the 4 basal ganglia in pediatric bipolar disorder. J Affect Disord 104, 147–54.
Altshuler L L , Bartzokis G , Grieder T , Curran J and Mintz J . 1998. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: An MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry 55, 663–4.
Altshuler L L , Bartzokis G , Grieder T , et al. 2000. An MRI study of temporal lobe structures in men with bipolar disorder and schizophrenia. Biol Psychiatry 48, 147–62.
Angst J . 1998. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50, 143–51.
Angst J and Sellaro R . 2000. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 48, 445–57.
Arnone D , McIntosh A M , Chandra P and Ebmeier K P . 2008. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in bipolar disorder. Acta Psychiatr Scand 118, 357–62.
Aylward E H , Roberts-Twillie J V , Barta P E , et al. 1994. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. AmJ Psychiatry 151, 687–93.
Bearden C E , Hoffman K M , Cannon T D . 2001. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disord 3, 106–50.
Beyer J L , Taylor W D , MacFall J R , et al. 2005. Cortical white matter microstructural abnormalities in bipolar disorder. Neuropsychopharmacology 30, 2225–9.
Blumberg H P , Krystal J H , Bansal R , et al. 2006. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: A cross-sectional study. BiolPsychiatry 59, 611–8.
Bonelli R M , Kapfhammer H P , Pillay S S and Yurgelun-Todd D A . 2006. Basal ganglia volumetric studies in affective disorder: What did we learn in the last 15 years? J Neural Transmission 113, 255–68.
Brambilla P , Glahn D C , Balestrieri M and Soares J C . 2005. Magnetic resonance findings in bipolar disorder. Psychiatr Clin North Am 28, 443–67.
Brambilla P , Harenski K , Nicoletti M , et al. 2001a. Differential effects of age on brain gray matter in bipolar patients and healthy individuals. Neuropsychobiology 43, 242–7.
Brambilla P , Harenski K , Nicoletti M A , et al. 2001b. Anatomical MRI study of basal ganglia in bipolar disorder patients. Psychiatry Res 106, 65–80.
Brambilla P , Harenski K , Nicoletti M , et al. 2001c. MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res 35, 313–22.
Brambilla P , Nicoletti M A , Harenski K , et al. 2002. Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology 27, 792–9.
Bruno S , Cercignani M and Ron M A . 2008. White matter abnormalities in bipolar disorder: A voxel-based diffusion tensor imaging study. Bipolar Disord 10, 460–8.
Chang K , Barnea-Goraly N , Karchemskiy A , Simeonova D I , et al. 2005. Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder. Biol Psychiatry 58, 197–203.
Chen B K , Sassi R , Axelson D , et al. 2004. Cross-sectional study of abnormal amygdala development in adolsecents and young adults with bipolar disorder. Biol Psychiatry 56, 399–405.
Chakos M H , Lieberman J A , Bilder R M , et al. 1994. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151, 1430–6.
Chepenik L G , Fredericks C , Papademetris X , et al. 2009. Effects of the brain-derived neurotrophic growth factor Val66Met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 34, 944–51.
Chiu S , Widjaja F , Bates M E , et al. 2008. Anterior cingulate volume in pediatric bipolar disorder and autism. J Affect Disord 105, 93–9.
Coffman J A , Bornstein R A , Olson S C , Schwarzkopf S B and Nasrallah H A . 1990. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 27, 1188–96.
DelBello M P , Strakowski S M , Zimmerman M E , Hawkins J M and Sax K W . 1999. MRI analysis of the cerebellum in bipolar disorder: A pilot study. Neuropsychopharmacology 21, 63–8.
DelBello M P , Zimmerman M E , Mills N P , Getz G E and Strakowski S M . 2004. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord 6, 43–52.
Devinsky O , Morrell M J and Vogt B A . 1995. Contributions of anterior cingulate cortex to behaviour. Brain 118, 279–306.
Dickstein D P , Milham M P , Nugent A C , et al. 2005. Frontotemporal alterations in pediatric bipolar disorder: Results of a voxel-based morphometry study. Arch Gen Psychiatry 62, 734–41.
Doty T J , Payne M E , Steffens D C , Beyer J L , Krishnan K R and LaBar K S . 2008. Age-dependent reduction of amygdala volume in bipolar disorder. Psychiatry Res 163, 84–94.
Drevets W C , Price J L , Simpson J R Jr, et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824–7.
Farrow T F , Whitford T J , Williams L M , Gomes L and Harris A W . 2005. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58, 713–23.
Foland L C , Altshuler L L , Sugar C A , et al. 2008. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport 19, 221–4.
Fornito A , Malhi G S , Lagopoulos J , et al. 2008. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res 162, 123–32.
Frangou S . 2005. The Maudsley Bipolar Disorder Project. Epilepsia 46 (Suppl 4), 19–25.
Frangou S , Hadjulis M , Chitnis X , Baster D , Donaldson S and Raymont V . 2002. The Maudsley Bipolar Disorder Project: Brain structural changes in bipolar I disorder. Bipolar Disor 4(Suppl 1), 123–4.
Frazier J A , Breeze J L , Papdimitriou G , et al. 2007. White matter abnormalities in children with and at risk for bipolar disorder. Bipolar Disord 9, 799–809.
Geller B , Harms M P , Wang L , et al. 2009. Effects of age, sex, and independent life events on amygdala and nucleus accumbens volumes in child bipolar I disorder. Biol Psychiatry 65, 432–7.
Haber S and McFarland N R . 2001. The place of the thalamus in frontal cortical–basal ganglia circuits. Neuroscientist 7, 315–24.
Hajek T , Kozeny J , Kopecek M , Alda M and Höschl C . 2008. Reduced subgenual cingulate volumes in mood disorders: A meta-analysis. J Psychiatry Neurosci 33, 91–9.
Haldane M , Cunningham G , Androutsos C and Frangou S . 2008. Structural brain correlates of response inhibition in Bipolar Disorder I. J Psychopharmacol 22, 138–43.
Haznedar M M , Roversi F , Pallanti S , et al. 2005. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry 57, 733–42.
Hirayasu Y , Shenton M E , Salisbury D F , et al. 1999. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156, 1091–3.
Honea R , Crow T J , Passingham D and Mackay C E . 2005. Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162, 2233–45.
Houenou J , Wessa M , Douaud G , et al. 2007. Increased white matter connectivity in euthymic bipolar patients: Diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry 12, 1001–10.
Hwang J , Lyoo I K , Dager S R , et al. 2006. Basal ganglia shape alterations in bipolar disorder. Am J Psychiatry 163, 276–85.
Javadapour A , Malhi G S , Ivanovski B , Chen X , Wen W and Sachdev P . 2007. Increased anterior cingulate cortex volume in bipolar I disorder. Aust N Z J Psychiatry 41, 910–6.
Jueptner M and Weiller C . 1998. A review of differences between basal ganglia and cerebellar control of movements as revealed by functional imaging studies. Brain 121, 1437–49.
Kaur S , Sassi R B , Axelson D , et al. 2005. Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry 162, 1637–43.
Kempton M J , Gedes J R , Ettinger U , Williams S C R and Grasby P M . 2008. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 65, 1017–32.
Konarski J Z , McIntyre R S , Kennedy S H , Rafi-Tari S , Soczynska J K and Ketter T A . 2008. Volumetric neuroimaging investigations in mood disorder: Bipolar disorder versus major depressive disorder. Bipolar Disord 10, 1–37.
Koo M S , Levitt J J , Salisbury D F , Nakamura M , Shenton M E and McCarley R W . 2008. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 65, 746–60.
Kraepelin E . 1921. Manic-Depressive Insanity and Paranoia (transl. R M Barclay ), G M Robertson , Ed. Edinburgh: E . and S. Livingstone ; reproduced in the series “The Classic of Psychiatry and Behavioral Sciences Library”, E T Carlson , Ed. Birmingham, AL: Gryphon Editions, Inc., p. 138.
Lochhead R A , Parsey R V , Oquendo M A and Mann J J . 2004. Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry. Biol Psychiatry 55, 1154–62.
Lopez-Larson M P , DelBello M P , Zimmerman M E , Schwiers M L and Strakowski S M . 2002. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 52, 93–100.
Lyoo I K , Kim M J , Stoll A L , et al. 2004. Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry 55, 648–51.
Lyoo I K , Sung Y H , Dager S R , et al. 2006. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 8, 65–74.
Mayberg H S , Liotti M , Brannan S K , et al. 1999. Reciprocal limbic–cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry 156, 675–82.
McDonald C , Zanelli J , Rabe-Hesketh S , et al. 2004. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 56, 411–7.
McIntosh A M , Forrester A , Lawrie S M , et al. 2001. A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology. Psychol Med 31, 159–71.
McIntosh A M , Job D E , Moorhead T W , et al. 2004. Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol Psychiatry 56, 544–52.
McIntosh A M , Maniega S M , Lymer G K , et al. 2008. White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry 64, 1088–92.
Mega M S , Cummings J L , Salloway S and Malloy P . 1997. The limbic system: An anatomic, phylogenetic, and clinical perspective. J Neuropsychiatr Clin Neurosci 9, 315–30.
Mills N P , Delbello M P , Adler C M and Strakowski S M . 2005. MRI analysis of cerebellar vermal abnormalities in bipolar disorder. Am J Psychiatry 162, 1530–2.
Monkul E S , Hatch J P , Sassi R B , et al. 2008. MRI study of the cerebellum in young bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 32, 613–9.
Moorhead T W , McKirdy J , Sussmann J E , et al. 2007. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 62, 894–900.
Murray C J L and Lopez A D . 1996. The Global Burden of Disease: Summary. Cambridge, MA, Harvard School of Public Health Monograph.
Narrow W E , Rae D S , Robins L N and Regier D A . 2002. Revised prevalence estimates of mental disorders in the United States: Using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 59, 115–23.
Noga J T , Vladar K and Torrey E F . 2001. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 106, 25–34.
Nugent A C , Milham M P , Bain E E , et al. 2006. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30, 485–97.
Ongür D and Price J L . 2000. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys, and humans. Cerebral Cortex 10, 206–19.
Pfeiffer J C , Welge J , Strakowski S M , Adler C M and DelBello M P . 2008. Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 47, 1290–9.
Posse S , Fitzgerald D , Gao K , et al. 2003. Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage 18, 760–8.
Roy-Byrne P P , Post R M , Uhde T W , Porcu T and Davis D . 1985. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand 71 (suppl 317), 1–34.
Sacchetti B , Scelfo B and Strata P . 2005. The cerebellum: Synaptic changes and fear conditioning. Neuroscientist 11, 217–27.
Sanches M , Sassi R B , Axelson D , et al. 2005. Subgenual prefrontal cortex of child and adolescent bipolar patients: A morphometric magnetic resonance imaging study. Psychiatry Res 138, 43–9.
Sassi R B , Brambilla P , Hatch J P , et al. 2004. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 56, 467–75.
Sax K W , Strakowski S M , Zimmerman M E , et al. 1999. Frontosubcortical neuroanatomy and the Continuous Performance Test in mania. Am J Psychiatry 156, 139–41.
Schlaepfer T E , Harris G J , Tien A Y , et al. 1994. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 151, 842–8.
Schmahmann J D . 2004. Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 16, 367–78.
Schmahmann J D , Weilburg J B and Sherman J C . 2007. The neuropsychiatry of the cerebellum – insights from the clinic. Cerebellum 6, 254–67.
Sharma V , Menon R , Carr T J , Densmore M , Mazmanian D and Williamson P C . 2003. An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. J Affect Disord 77, 167–71.
Singh M K , Delbello M P , Adler C M , Stanford K E and Strakowski S M . 2008. Neuroanatomical characterization of child offspring of bipolar parents. J Am Acad Child Adolesc Psychiatry 47, 526–31.
Strakowski S M. 2002. Differential brain mechanisms in bipolar and unipolar disorders: Considerations from brain imaging. In Soares J C (Ed) Brain Imaging in Affective Disorders. New York, NY: Marcel Dekker, Inc.
Strakowski S M , Wilson D R , Tohen M , Woods B T , Douglass A W and Stoll A L . 1993. Structural brain abnormalities in first-episode mania. Biol Psychiatry 33, 602–09.
Strakowski S M , DelBello M P , Sax K W , et al. 1999. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 56, 254–60.
Strakowski S M , DelBello M P , Zimmerman M E , et al. 2002a. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159, 1841–7.
Strakowski S M , Adler C and DelBello M P . 2002b. Comparison of morphometric magnetic resonance imaging findings in bipolar disorder and unipolar depression. Bipolar Disorders 4, 80–8.
Strakowski S M , Adler C M , Holland S K , Mills N P and DelBello M P . 2004. A preliminary fMRI study of sustained attention in unmedicated, euthymic bipolar disorder. Neuropsychopharmacology 29, 1734–40.
Strakowski S M , DelBello M P and Adler C M . 2005. The functional neuroanatomy of bipolar disorder. Molecular Psychiatry 10, 105–16.
Strakowski S M , Adler C M and DelBello M P . 2007. Metabolic dysfunction within the anterior limbic network in bipolar disorder: A model for studying new treatments. Neuropsychiatria i Neuropsychologia (Neuropsychiatry and Neuropsychology; Poland) 1, 5–14.
Tekins S and Cummings J L . 2002. Frontal–subcortical neuronal circuits and clinical neuropsychiatry: An update. J Psychosom Res 53, 647–54.
Versace A , Almeida J R , Hassel S , et al. 2008. Elevated left and reducted right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry 65, 1041–52.
Voorn P , Vanderschuren L J M J , Groenewegen H J , Robbins T W and Pennartz C M A . 2004. Putting a spin on the dorsal–ventral divide of the striatum. Trends Neurosci 27, 468–74.
Wang F , Jackowski M , Kalmar J H , et al. 2008a. Abnormal anterior cingulum integrity in bipolar disorder determined through diffusion tensor imaging. Br J Psychiatry 192, 126–9.
Wang F , Kalmar J H , Edmiston E , et al. 2008b. Abnormal corpus callosum integrity in bipolar disorder: A diffusion tensor imaging study. Biol Psychiatry 64, 730–3.
Wilke M , Kowatch R A , DelBello M P , Mills N P and Holland S K . 2004. Voxel-based morphometry in adolescents with bipolar disorder: First results. Psychiatry Res 131, 57–69.
Yamasaki H , LaBar K S and McCarthy G . 2002. Dissociable prefrontal brain systems for attention and emotion. Proc Natl Acad Sci U S A 99, 11 447–51.
Yatham L N , Lyoo I K , Liddle P , et al. 2007. A magnetic resonance imaging study of mood stabilizer- and neuroleptic-naïve first-episode mania. Bipolar Disord 9, 693–7.
Yelnik J . 2002. Functional anatomy of the basal ganglia. Movement Disord 17, S15–21.
Yurgelun-Todd D A , Silveri M M , Gruber S A , Rohan M L and Pimentel P J . 2007. White matter abnormalities observed in bipolar disorder: A diffusion tensor imaging study. Bipolar Disord 9, 504–12.

Reference Title: References

Reference Type: reference-list

Adler C M , Delbello M P , Mills N P , Schmithorst V , Holland S and Strakowski S M . 2005. Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task. Bipolar Disord 7, 577–88.
Adler C M , Holland S K , Schmithorst V , Tuchfarber M J and Strakowski S M . 2004. Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disord 6, 540–9.
Altshuler L L , Bookheimer S Y , Townsend J , et al. 2005. Blunted activation in orbitofrontal cortex during mania: A functional magnetic resonance imaging study. Biol Psychiatry 58, 763–9.
Altshuler L , Bookheimer S , Townsend J , et al. 2008. Regional brain changes in bipolar I depression: A functional magnetic resonance imaging study. Bipolar Disord 10, 708–17.
Baxter L R Jr, Schwartz J M , Phelps M E , et al. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46, 243–50.
Benabarre A , Vieta E , Martin F , et al. 2004. Clinical value of 99mTc-HMPAO SPECT in depressed bipolar I patients. Psychiatry Res 132, 285–9.
Benabarre A , Vieta E , Martinez-Aran A , et al. 2005. Neuropsychological disturbances and cerebral blood flow in bipolar disorder. Aust N Z J Psychiatry 39, 227–34.
Benedetti F , Bernasconi A , Blasi V , et al. 2007. Neural and genetic correlates of antidepressant response to sleep deprivation: A functional magnetic resonance imaging study of moral valence decision in bipolar depression. Arch Gen Psychiatry 64, 179–87.
Berns G S , Martin M and Proper S M . 2002. Limbic hyperreactivity in bipolar II disorder. Am J Psychiatry 159, 304–06.
Blumberg H P , Leung H C , Skudlarski P , et al. 2003a. A functional magnetic resonance imaging study of bipolar disorder: State- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 60, 601–09.
Blumberg H P , Martin A , Kaufman J , et al. 2003b. Frontostriatal abnormalities in adolescents with bipolar disorder: Preliminary observations from functional MRI. Am J Psychiatry 160, 1345–7.
Blumberg H P , Stern E , Martinez D , et al. 2000. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 48, 1045–52.
Blumberg H P , Stern E , Ricketts S , et al. 1999. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry 156, 1986–8.
Caligiuri M P , Brown G G , Meloy M J , et al. 2003. An fMRI study of affective state and medication on cortical and subcortical brain regions during motor performance in bipolar disorder. Psychiatry Res 123, 171–82.
Caligiuri M P , Brown G G , Meloy M J , et al. 2004. A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder. Bipolar Disord 6, 183–96.
Caligiuri M P , Brown G G , Meloy M J , et al. 2006. Striatopallidal regulation of affect in bipolar disorder. J Affect Disord 91, 235–42.
Chang K , Adleman N E , Dienes K , Simeonova D I , Menon V and Reiss A . 2004. Anomalous prefrontal–subcortical activation in familial pediatric bipolar disorder: A functional magnetic resonance imaging investigation. Arch Gen Psychiatry 61, 781–92.
Chang K D , Wagner C , Garrett A , Howe M and Reiss A . 2008. A preliminary functional magnetic resonance imaging study of prefrontal–amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine. Bipolar Disord 10, 426–31.
Chen C H , Lennox B , Jacob R , et al. 2006. Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: A functional magnetic resonance imaging study. Biol Psychiatry 59, 31–9.
Culha A F , Osman O , Dogangun Y , et al. 2008. Changes in regional cerebral blood flow demonstrated by 99mTc-HMPAO SPECT in euthymic bipolar patients. Eur Arch Psychiatry Clin Neurosci 258, 144–51.
Curtis V A , Dixon T A , Morris R G , et al. 2001. Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J Affect Disord 66, 111–21.
Davidson R J . 1998. Anterior electrophysiological asymmetries, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology 35, 607–14.
Dickstein D P , Rich B A , Roberson-Nay R , et al. 2007. Neural activation during encoding of emotional faces in pediatric bipolar disorder. Bipolar Disord 9, 679–92.
Drapier D , Surguladze S , Marshall N , et al. 2008. Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task. Biol Psychiatry 64, 513–20.
Drevets W C , Price J L , Bardgett M E , Reich T , Todd R D and Raichle M E . 2002. Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 71, 431–47.
Dunn R T , Kimbrell T A , Ketter T A , et al. 2002. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 51, 387–99.
Dye S M , Spence S A , Bench C J , et al. 1999. No evidence for left superior temporal dysfunction in asymptomatic schizophrenia and bipolar disorder. PET study of verbal fluency. Br J Psychiatry 175, 367–74.
Elliott R , Ogilvie A , Rubinsztein J S , Calderon G , Dolan R J and Sahakian B J . 2004. Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol Psychiatry 55, 1163–70.
Foland L C , Altshuler L L , Bookheimer S Y , Eisenberger N , Townsend J and Thompson P M . 2008. Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res 162, 27–37.
Frangou S . 2005. The Maudsley Bipolar Disorder Project. Epilepsia 46 (Suppl 4), 19–25.
Frangou S , Kington J , Raymont V and Shergill S S . 2008. Examining ventral and dorsal prefrontal function in bipolar disorder: A functional magnetic resonance imaging study. Eur Psychiatry 23, 300–08.
Goel V and Dolan R J . 2003. Reciprocal neural response within lateral and ventral medial prefrontal cortex during hot and cold reasoning. Neuroimage 20, 2314–21.
Goodwin G M , Cavanagh J T , Glabus M F , Kehoe R F , O'Carroll R E and Ebmeier K P . 1997. Uptake of 99mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: Associations with mania. Br J Psychiatry 170, 426–30.
Gruber S A , Rogowska J and Yurgelun-Todd D A . 2004. Decreased activation of the anterior cingulate in bipolar patients: An fMRI study. J Affect Disord 82, 191–201.
Gyulai L , Alavi A , Broich K , Reilley J , Ball W B and Whybrow P C . 1997. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: A clinical study. Biol Psychiatry 41, 152–61.
Haldane M , Jogia J , Cobb A , Kozuch E , Kumari V and Frangou S . 2008. Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol 18, 48–54.
Hariri A R , Mattay V S , Tessitore A , Fera F and Weinberger D R . 2003. Neocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry 53, 494–501.
Ito H , Kawashima R , Awata S , et al. 1996. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med 37, 410–4.
Jogia J , Haldane, M. , Cobb, A. , Kumari, V. and Frangou S . 2008. Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder. Br J Psychiatry 192, 197–201.
Ketter T A , Kimbrell T A , George M S , et al. 2001. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49, 97–109.
Killgore W D , Gruber S A and Yurgelun-Todd D A . 2008. Abnormal corticostriatal activity during fear perception in bipolar disorder. Neuroreport 19, 1523–7.
Lagopoulos J , Ivanovski B and Malhi G S . 2007. An event-related functional MRI study of working memory in euthymic bipolar disorder. J Psychiatry Neurosci 32, 174–84.
Lagopoulos J and Malhi G S . 2007. A functional magnetic resonance imaging study of emotional Stroop in euthymic bipolar disorder. Neuroreport 18, 1583–7.
Lawrence N S , Williams A M , Surguladze S , et al. 2004. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 55, 578–87.
Lennox B R , Jacob R , Calder A J , Lupson V and Bullmore E T . 2004. Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania. Psychol Med 34, 795–802.
Levesque J , Eugene F , Joanette Y , et al. 2003. Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 53, 502–10.
Liotti M , Mayberg H S , Brannan S K , Mcginnis S , Jerabek P and Fox P T . 2000. Differential limbic–cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry 48, 30–42.
Malhi G S , Lagopoulos J , Owen A M , Ivanovski B , Shnier R and Sachdev P . 2007a. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord 97, 109–22.
Malhi G S , Lagopoulos J , Sachdev P S , Ivanovski B and Shnier R . 2005. An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disord 7 (Suppl 5), 58–69.
Malhi G S , Lagopoulos J , Sachdev P S , Ivanovski B , Shnier R and Ketter T . 2007b. Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients. Bipolar Disord 9, 345–57.
Malhi G S , Lagopoulos J , Sachdev P , Mitchell P B , Ivanovski B and Parker G B . 2004a. Cognitive generation of affect in hypomania: An fMRI study. Bipolar Disord 6, 271–85.
Malhi G S , Lagopoulos J , Ward P B , et al. 2004b. Cognitive generation of affect in bipolar depression: An fMRI study. Eur J Neurosci 19, 741–54.
Marchand W R , Lee J N , Thatcher G W , et al. 2007a. A functional MRI study of a paced motor activation task to evaluate frontal–subcortical circuit function in bipolar depression. Psychiatry Res 155, 221–30.
Marchand W R , Lee J N , Thatcher J , Thatcher G W , Jensen C and Starr J . 2007b. A preliminary longitudinal fMRI study of frontal–subcortical circuits in bipolar disorder using a paced motor activation paradigm. J Affect Disord 103, 237–41.
Matsuo K , Kouno T , Hatch J P , et al. 2007. A near-infrared spectroscopy study of prefrontal cortex activation during a verbal fluency task and carbon dioxide inhalation in individuals with bipolar disorder. Bipolar Disord 9, 876–83.
Mayberg H S . 1997. Limbic–cortical dysregulation: A proposed model of depression. J Neuropsychiatry Clin Neurosci 9, 471–81.
Mcintosh A M , Whalley H C , Mckirdy J , et al. 2008. Prefrontal function and activation in bipolar disorder and schizophrenia. Am J Psychiatry 165, 378–84.
Migliorelli R , Starkstein SE , Teson A , et al. 1993. SPECT findings in patients with primary mania. J Neuropsychiatry Clin Neurosci 5, 379–83.
Mitchell R L , Elliott R , Barry M , Cruttenden A and Woodruff P W . 2004. Neural response to emotional prosody in schizophrenia and in bipolar affective disorder. Br J Psychiatry 184, 223–30.
Monks P J , Thompson J M , Bullmore E T , et al. 2004. A functional MRI study of working memory task in euthymic bipolar disorder: Evidence for task-specific dysfunction. Bipolar Disord 6, 550–64.
Nelson E E , Vinton D T , Berghorst L , et al. 2007. Brain systems underlying response flexibility in healthy and bipolar adolescents: An event-related fMRI study. Bipolar Disord 9, 810–9.
Nestler E J , Barrot M , Dileone R J , Eisch A J , Gold S J and Monteggia L M . 2002. Neurobiology of depression. Neuron 34, 13–25.
O'Connell R A , Van Heertum R L , Luck D , et al. 1995. Single-photon emission computed tomography of the brain in acute mania and schizophrenia. J Neuroimaging 5, 101–04.
Pavuluri M N , O'Connor M M , Harral E M and Sweeney J A . 2008. An fMRI study of the interface between affective and cognitive neural circuitry in pediatric bipolar disorder. Psychiatry Res 162, 244–55.
Phillips M L , Drevets W C , Rauch S L and Lane R . 2003. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry 54, 504–14.
Rich B A , Fromm S J , Berghorst L H , et al. 2008. Neural connectivity in children with bipolar disorder: Impairment in the face emotion processing circuit. J Child Psychol Psychiatry 49, 88–96.
Ridderinkhof K R , Ullsperger M , Crone E A and Nieuwenhuis S . 2004. The role of the medial frontal cortex in cognitive control. Science 306, 443–7.
Roth R M , Koven N S , Randolph J J , et al. 2006. Functional magnetic resonance imaging of executive control in bipolar disorder. Neuroreport 17, 1085–9.
Rubin E , Sackeim H A , Prohovnik I , Moeller J R , Schnur D B and Mukherjee S . 1995. Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiatry Res 61, 1–10.
Salamone J D . 2007. Functions of mesolimbic dopamine: Changing concepts and shifting paradigms. Psychopharmacology (Berl) 191, 389.
Silverstone P H , Bell E C , Willson M C , Dave S and Wilman A H . 2005. Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: An fMRI study. Ann Gen Psychiatry 4, 14.
Stern C E , Owen A M , Tracey I , Look R B , Rosen B R and Petrides M . 2000. Activity in ventrolateral and mid-dorsolateral prefrontal cortex during nonspatial visual working memory processing: Evidence from functional magnetic resonance imaging. Neuroimage 11, 392–9.
Strakowski S M , Adler C M , Holland S K , Mills N and Delbello M P . 2004. A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 29, 1734–40.
Strakowski S M , Adler C M , Holland S K , Mills N P , Delbello M P and Eliassen J C . 2005. Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. Am J Psychiatry 162, 1697–705.
Yurgelun-Todd D A , Gruber S A , Kanayama G , Killgore W D , Baird A A and Young A D . 2000. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2, 237–48.
Yurgelun-Todd D A , and Ross A J . 2006. Functional magnetic resonance imaging studies in bipolar disorder [review]. CNS Spectr 11, 287–97.

Reference Title: References

Reference Type: reference-list

Adler C M , DelBello M P and Strakowski S M . 2006. Brain network dysfunction in bipolar disorder. CNS Spectr 11, 312–20.
Agam G , Shamir A , Shaltiel G and Greenberg M L . 2002. Myo-inositol-1-phosphate (MIP) synthase: A possible new target for antibipolar drugs. Bipolar Disord 4 Suppl 1, 15–20.
Alexander G E , Crutcher M D and DeLong M R . 1990. Basal ganglia–thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res 85, 119–46.
Amaral J A , Tamada R S , Issler C K , et al. 2006. A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients. Hum Psychopharmacol 21, 215–20.
Amsterdam J D and Newberg A B . 2007. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology 55, 167–70.
Benes F M , Todtenkopf M S , Logiotatos P and Williams M . 2000. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat 20, 259–69.
Bertolino A , Frye M , Callicott J H , et al. 2003. Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53, 906–13.
Blasi G , Bertolino A , Brudaglio F , et al. 2004. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: A proton magnetic resonance spectroscopic imaging study. Psychiatry Res 131, 95–105.
Brambilla P , Stanley J A , Nicoletti M A , et al. 2005. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 86, 61–7.
Brambilla P , Stanley J A , Sassi R B , et al. 2004. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 29, 1918–24.
Brooks J O , Hoblyn J C and Ketter T A . 2010. Metabolic evidence of corticolimbic dysregulation in bipolar mania. Psychiatry Res 181, 136–40.
Brooks J O , Hoblyn J C , Woodard S A , Rosen A C and Ketter T A . 2009a. Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. J Psychiatr Res 94, 32–7.
Brooks J O , Wang P W , Bonner J C , et al. 2009b. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. J Psychiatr Res 43, 181–8.
Cannon D M , Ichise M , Fromm S J , et al. 2006. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry 60, 207–17.
Castillo M , Kwock L , Courvoisie H and Hooper S R . 2000. Proton MR spectroscopy in children with bipolar affective disorder: Preliminary observations. Am J Neuroradiol 21, 832–8.
Cecil K M , DelBello M P , Morey R and Strakowski S M . 2002. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4, 357–65.
Cecil K M , DelBello M P , Sellars M C and Strakowski S M . 2003. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol 13, 545–55.
Chang K , Adleman N , Dienes K , Barnea-Goraly N , Reiss A and Ketter T . 2003. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 53, 1059–65.
Dager S R , Friedman S D , Parow A , et al. 2004. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61, 450–8.
Davanzo P , Thomas M A , Yue K , et al. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24, 359–69.
Dean B , Pavey G , McLeod M , Opeskin K , Keks N and Copolov D . 2001. A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder. J Affect Disord 66, 147–58.
Dechent P , Pouwels P J , Wilken B , Hanefeld F and Frahm J . 1999. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol 277, R698–704.
Deicken R F , Eliaz Y , Feiwell R and Schuff N . 2001. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res 106, 35–45.
Deicken R F , Fein G and Weiner M W . 1995a. Abnormal frontal lobe phosphorus metabolism in bipolar disorder. Am J Psychiatry 152, 915–8.
Deicken R F , Pegues M P , Anzalone S , Feiwell R and Soher B . 2003. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 160, 873–82.
Deicken R F , Weiner M W and Fein G . 1995b. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 33, 195–9.
Drevets W C , Frank E , Price J C , et al. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46, 1375–87.
Drevets W C , Price J L , Simpson J R , et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824–7.
Ebert D , Feistel H , Kaschka W , Barocka A and Pirner A . 1994. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation – Preliminary results. Biol Psychiatry 35, 880–5.
Frey B N , Andreazza A C , Nery F G , et al. 2007a. The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 18, 419–30.
Frey B N , Stanley J A , Nery F G , et al. 2007b. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: An in vivo 1H MRS study. Bipolar Disord 9 Suppl 1, 119–27.
Friedman S D , Dager S R , Parow A , et al. 2004. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 56, 340–8.
Frye M A , Thomas M A , Yue K , et al. 2007a. Reduced concentrations of N-acetylaspartate (NAA) and the NAA–creatine ratio in the basal ganglia in bipolar disorder: A study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Res 154, 259–65.
Frye M A , Watzl J , Banakar S , et al. 2007b. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32, 2490–9.
Goodwin F K and Jamison K R . 2007. Manic-Depressive Illness (2nd ed.). New York, NY: Oxford University Press.
Gyulai L , Bolinger L , Leigh J S , Barlow C and Chance B . 1984. Phosphorylethanolamine – The major constituent of the phosphomonoester peak observed by 31P-NMR on developing dog brain. FEBS Lett 178, 137–42.
Hajek T , Bernier D , Slaney C , et al. 2008. A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. J Psychiatry Neurosci 33, 531–40.
Hallcher L M and Sherman W R . 1980. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 255, 10 896–901.
Hamakawa H , Kato T , Murashita J and Kato N . 1998. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 248, 53–8.
Hamakawa H , Kato T , Shioiri T , Inubushi T and Kato N . 1999. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 29, 639–44.
Kato T , Hamakawa H , Shioiri T , et al. 1996. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 21, 248–54.
Kato T , Murashita J , Kamiya A , Shioiri T , Kato N and Inubushi T . 1998. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: A confirmation in drug-free patients and correlation with white matter hyperintensity. Eur Arch Psychiatry Clin Neurosci 248, 301–6.
Kato T , Shioiri T , Murashita J , Hamakawa H , Inubushi T and Takahashi S . 1994a. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res 55, 41–50.
Kato T , Shioiri T , Murashita J , et al. 1995. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 25, 557–66.
Kato T , Shioiri T , Takahashi S and Inubushi T . 1991. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS. J Affect Disord 22, 185–90.
Kato T , Takahashi S and Inubushi T . 1992. Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res 45, 53–63.
Kato T , Takahashi S , Shioiri T and Inubushi T . 1993. Alterations in brain phosphorus metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 27, 53–9.
Kato T , Takahashi S , Shioiri T , Murashita J , Hamakawa H and Inubushi T . 1994b. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 31, 125–33.
Ketter T A , Kimbrell T A , George M S , et al. 2001. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49, 97–109.
Ketter T A and Wang P W . 2003. The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders. J Clin Psychiatry 64 Suppl 3, 15–20.
Malhi G S , Ivanovski B , Wen W , Lagopoulos J , Moss K and Sachdev P . 2007. Measuring mania metabolites: A longitudinal proton spectroscopy study of hypomania. Acta Psychiatr Scand 434(Suppl), 57–66.
Manji H K and Lenox R H . 2000. Signaling: Cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 48, 518–30.
Marazziti D , Lenzi A , Raffaelli S , Falcone M F , Aglietti M and Cassano G B . 1993. A single electroconvulsive treatment affects platelet serotonin uptake in bipolar I patients. Eur Neuropsychopharmacol 3, 33–6.
Mayberg H S . 1997. Limbic–cortical dysregulation: A proposed model of depression. J Neuropsychiatry Clin Neurosci 9, 471–81.
Mega M S and Cummings J L . 1994. Frontal–subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 6, 358–70.
Meyer J H , Kapur S , Houle S , et al. 1999. Prefrontal cortex 5-HT2 receptors in depression: An [18F]setoperone PET imaging study. Am J Psychiatry 156, 1029–34.
Michael N , Erfurth A , Ohrmann P , et al. 2003. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl) 168, 344–6.
Molina V , Sánchez J , Sanz J , et al. 2007. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry 22, 505–12.
Moore C M , Breeze J L , Gruber S A , et al. 2000a. Choline, myo-inositol and mood in bipolar disorder: A proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2, 207–16.
Moore G J , Bebchuk J M , Hasanat K , et al. 2000b. Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48, 1–8.
Moore G J , Bebchuk J M , Parrish J K , et al. 1999. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156, 1902–08.
Ng W X , Lau I Y , Graham S and Sim K. 2009. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: A review and synthesis. Neurosci Biobehav Rev 33, 336–54.
Nudmamud S , Reynolds L M and Reynolds G P . 2003. N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: A postmortem study. Biol Psychiatry 53, 1138–41.
Ohara K , Isoda H , Suzuki Y , et al. 1998. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res 84, 55–60.
Olvera R L , Caetano S C , Fonseca M , et al. 2007. Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol 17, 461–73.
Ongür D , Jensen J E , Prescot A P , et al. 2008. Abnormal glutamatergic neurotransmission and neuronal–glial interactions in acute mania. Biol Psychiatry 64, 718–26.
Oquendo M A , Bongiovi-Garcia M E , Galfalvy H , et al. 2007. Sex differences in clinical predictors of suicidal acts after major depression: A prospective study. Am J Psychiatry 164, 134–41.
Pearlson G D , Wong D F , Tune L E , et al. 1995. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry 52, 471–7.
Port J D , Unal S S , Mrazek D A and Marcus S M . 2008. Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatry Res 162, 113–21.
Renshaw P F , Yurgelun-Todd D A , Tohen M , Gruber S and Cohen B M . 1995. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry 152, 444–6.
Sassi R B , Stanley J A , Axelson D , et al. 2005. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry 162, 2109–15.
Scherk H , Backens M , Schneider-Axmann T , et al. 2007. Cortical neurochemistry in euthymic patients with bipolar I disorder. World J Biol Psychiatry 1–10.
Sharma R , Venkatasubramanian P N , Bárány M and Davis J M . 1992. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res 8, 43–9.
Silverstone P H , Hanstock C C , Fabian J , Staab R and Allen P S . 1996. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biol Psychiatry 40, 235–46.
Silverstone P H , Hanstock C C and Rotzinger S . 1999. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. J Psychiatry Neurosci 24, 222–6.
Silverstone P H , Wu R H , O'Donnell T , Ulrich M , Asghar S J and Hanstock C C . 2002. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Hum Psychopharmacol 17, 321–7.
Stahl S M , Woo D J , Mefford I N , Berger P A and Ciaranello R D . 1983. Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am J Psychiatry 140, 26–30.
Strakowski S M , Delbello M P and Adler C M . 2005. The functional neuroanatomy of bipolar disorder: A review of neuroimaging findings. Mol Psychiatry 10, 105–16.
Suhara T , Nakayama K , Inoue O , et al. 1992. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berl) 106, 14–8.
Wang P W , Sailasuta N , Chandler R A and Ketter T A . 2006. Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. Acta Neuropsychiatrica 18, 120–6.
Watanabe A , Kato N and Kato T . 2002. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 42, 279–85.
Winsberg M E , Sachs N , Tate D L , Adalsteinsson E , Spielman D and Ketter T A . 2000. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 47, 475–81.
Wu R H , O'Donnell T , Ulrich M , Asghar S J , Hanstock C C and Silverstone P H . 2004. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Ann Gen Hosp Psychiatry 3, 13.
Yildiz A , Sachs G S , Dorer D J and Renshaw P F . 2001. 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: A meta-analysis. Psychiatry Res 106, 181–91.
Young L T , Warsh J J , Kish S J , Shannak K and Hornykeiwicz O . 1994. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 35, 121–7.
Zubieta J K , Huguelet P , Ohl L E , et al. 2000. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: Sex differences and cognitive correlates. Am J Psychiatry 157, 1619–28.
Zubieta J K , Taylor S F , Huguelet P , Koeppe R A , Kilbourn M R and Frey K A . 2001. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry 49, 110–6.

Reference Title: References

Reference Type: reference-list

Agid R , Levin T , Gomori J M , Lerer B and Bonne O . 2003. T2-weighted image hyperintensities in major depression: Focus on the basal ganglia. Int J Neuropsychopharmacol 6, 215–24.
Alexopoulos G S , Kiosses D N , Choi S J , Murphy C F and Lim K O . 2002. Frontal white matter microstructure and treatment response of late-life depression: A preliminary study. Am J Psychiatry 159, 1929–32.
Alexopoulos G S , Murphy C F , Gunning-Dixon F M , et al. 2008. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 165, 238–44.
Andreescu C , Butters M A , Begley A , et al. 2008. Gray matter changes in late life depression – A structural MRI analysis. Neuropsychopharmacology 33, 2566–72.
Bae J N , MacFall J R , Krishnan K R , Payne M E , Steffens D C and Taylor W D . 2006. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry 60, 1356–63.
Ballmaier M , Narr K L , Toga A W , et al. 2007. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry 165, 229–37.
Ballmaier M , Sowell E R , Thompson P M , et al. 2004a. Mapping brain size and cortical gray matter changes in elderly depression. Biol Psychiatry 55, 382–9.
Ballmaier M , Toga A W , Blanton R E , et al. 2004b. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: An MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 161, 99–108.
Barbosa S , Blumhardt L D , Roberts N , Lock T and Edwards R H . 1994. Magnetic resonance relaxation time mapping in multiple sclerosis: Normal appearing white matter and the “invisible” lesion load. Magn Reson Imaging 12, 33–42.
Bjartmar C , Yin X and Trapp B D . 1999. Axonal pathology in myelin disorders. J Neurocytol 28, 383–95.
Butters M A , Aizenstein H J , Hayashi K M , et al. 2008. Three-dimensional surface mapping of the caudate nucleus in late-life depression. Am J Geriatr Psychiatry 17, 4–12.
Coffey C E , Figiel G S , Djang W T , Cress M , Saunders W B and Weiner R D . 1988. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 24, 143–61.
Coffey C E , Figiel G S , Djang W T and Weiner R D . 1990. Subcortical hyperintensity on magnetic resonance imaging: A comparison of normal and depressed elderly subjects. Am J Psychiatry 147, 187–9.
Ehrlich S , Noam G G , Lyoo I K , Kwon B J , Clark M A and Renshaw P F . 2004. White matter hyperintensities and their associations with suicidality in psychiatrically hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 43, 770–6.
Eng J , Ceckler T L and Balaban R S . 1991. Quantitative 1H magnetization transfer imaging in vivo. Magn Reson Med 17, 304–14.
Figiel G S , Krishnan K R , Doraiswamy P M , Rao V P , Nemeroff C B and Boyko O B . 1991. Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 12, 245–7.
Firbank M J , Lloyd A J , Ferrier N and O' Brien J T . 2004. A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatry 12, 606–12.
Frodl T , Meisenzahl E , Zetzsche T , et al. 2002. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 51, 708–14.
Frodl T , Meisenzahl E M , Zetzsche T , et al. 2004. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 65, 492–9.
Frodl T , Schaub A , Banac S , et al. 2006. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 31, 316–23.
Frodl T , Zill P , Baghai T , et al. 2008a. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. Am J Med Genet B Neuropsychiatr Genet 147B, 1003–07.
Frodl T S , Koutsouleris N , Bottlender R , et al. 2008b. Depression-related variation in brain morphology over 3 years: Effects of stress? Arch Gen Psychiatry 65, 1156–65.
Godin O , Dufouil C , Maillard P , et al. 2008. White matter lesions as a predictor of depression in the elderly: The 3C-Dijon study. Biol Psychiatry 63, 663–9.
Greenwald B S , Kramer-Ginsberg E , Krishnan K R , Ashtari M , Auerbach C and Patel M . 1998. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 29, 613–7.
Greenwald B S , Kramer-Ginsberg E , Krishnan K R , et al. 2001. A controlled study of MRI signal hyperintensities in older depressed patients with and without hypertension. J Am Geriatr Soc 49, 1218–25.
Grossman R I . 1994. Magnetization transfer in multiple sclerosis. Ann Neurol 36 Suppl, S97–9.
Gunning-Dixon F M , Hoptman M J , Lim K O , et al. 2008. Macromolecular white matter abnormalities in geriatric depression: A magnetization transfer imaging study. Am J Geriatr Psychiatry 16, 255–62.
Hamilton J P , Siemer M and Gotlib I H . 2008. Amygdala volume in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Mol Psychiatry 13, 993–1000.
Hastings R S , Parsey R V , Oquendo M A , Arango V and Mann J J . 2004. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 29, 952–9.
Heiden A , Kettenbach J , Fischer P , et al. 2005. White matter hyperintensities and chronicity of depression. J Psychiatr Res 39, 285–93.
Henkelman R M , Stanisz G J and Graham S J . 2001. Magnetization transfer in MRI: A review. NMR Biomed 14, 57–64.
Hickie I , Naismith S , Ward P B , et al. 2005a. Vascular risk and low serum B12 predict white matter lesions in patients with major depression. J Affect Disord 85, 327–32.
Hickie I , Naismith S , Ward P B , et al. 2005b. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry 186, 197–202.
Hickie I , Scott E , Mitchell P , Wilhelm K , Austin M P and Bennett B . 1995. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37, 151–60.
Hickie I , Scott E , Wilhelm K and Brodaty H . 1997. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression – A longitudinal evaluation. Biol Psychiatry 42, 367–74.
Hickie I B , Naismith S L , Ward P B , et al. 2007. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord 98, 137–42.
Hoptman M J , Gunning-Dixon F M , Murphy C F , et al. 2008. Blood pressure and white matter integrity in geriatric depression. J Affect Disord 115, 171–6.
Husain M M , McDonald W M , Doraiswamy P M , et al. 1991. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res 40, 95–9.
Iosifescu D V , Renshaw P F , Lyoo I K , et al. 2006. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry 188, 180–5.
Jenkins M , Malloy P , Salloway S , et al. 1998. Memory processes in depressed geriatric patients with and without subcortical hyperintensities on MRI. J Neuroimaging 8, 20–6.
Kim M J , Hamilton J P and Gotlib I H . 2008. Reduced caudate gray matter volume in women with major depressive disorder. Psychiatry Res 164, 114–22.
Kramer-Ginsberg E , Greenwald B S , Krishnan K R , et al. 1999. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry 156, 438–44.
Kronmuller K T , Pantel J , Kohler S , et al. 2008. Hippocampal volume and 2-year outcome in depression. Br J Psychiatry 192, 472–3.
Kumar A , Bilker W , Jin Z and Udupa J . 2000a. Atrophy and high intensity lesions: Complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 22, 264–74.
Kumar A , Bilker W , Lavretsky H and Gottlieb G . 2000b. Volumetric asymmetries in late-onset mood disorders: An attenuation of frontal asymmetry with depression severity. Psychiatry Res 100, 41–7.
Kumar A , Gupta R C , Albert T M , Alger J , Wyckoff N and Hwang S . 2004. Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer. Psychiatry Res 130, 131–40.
Kumar A , Mintz J , Bilker W and Gottlieb G . 2002. Autonomous neurobiological pathways to late-life major depressive disorder: Clinical and pathophysiological implications. Neuropsychopharmacology 26, 229–36.
Lacerda A L , Nicoletti M A , Brambilla P , et al. 2003. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 124, 129–40.
Lai T , Payne M E , Byrum C E , Steffens D C and Krishnan K R . 2000. Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry 48, 971–5.
Lampe I K , Hulshoff Pol H E , Janssen J , Schnack H G , Kahn R S and Heeren T J . 2003. Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder. Am J Psychiatry 160, 2052–4.
Lange C and Irle E . 2004. Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychol Med 34, 1059–64.
Lavretsky H , Ballmaier M , Pham D , Toga A and Kumar A . 2007. Neuroanatomical characteristics of geriatric apathy and depression: A magnetic resonance imaging study. Am J Geriatr Psychiatry 15, 386–94.
Lavretsky H , Kurbanyan K , Ballmaier M , Mintz J , Toga A and Kumar A . 2004. Sex differences in brain structure in geriatric depression. Am J Geriatr Psychiatry 12, 653–7.
Lavretsky H , Lesser I M , Wohl M , Miller B L , Mehringer C M and Vinters H V . 2000. Apolipoprotein-E and white-matter hyperintensities in late-life depression. Am J Geriatr Psychiatry 8, 257–61.
Lee S H , Payne M E , Steffens D C , et al. 2003. Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. Biol Psychiatry 54, 529–33.
Lenze E , Cross D , McKeel D , Neuman R J and Sheline Y I . 1999. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 156, 1602–7.
Lenze E J and Sheline Y I . 1999. Absence of striatal volume differences between depressed subjects with no comorbid medical illness and matched comparison subjects. Am J Psychiatry 156, 1989–91.
Lesser I M , Boone K B , Mehringer C M , Wohl M A , Miller B L and Berman N G . 1996. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 153, 1280–7.
Levy R M , Steffens D C , McQuoid D R , Provenzale J M , MacFall J R and Krishnan K R . 2003. MRI lesion severity and mortality in geriatric depression. Am J Geriatr Psychiatry 11, 678–82.
Li L , Ma N , Li Z , et al. 2007. Prefrontal white matter abnormalities in young adult with major depressive disorder: A diffusion tensor imaging study. Brain Res 1168, 124–8.
Ma N , Li L , Shu N , et al. 2007. White matter abnormalities in first-episode, treatment-naive young adults with major depressive disorder. Am J Psychiatry 164, 823–6.
MacQueen G M , Campbell S , McEwen B S , et al. 2003. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 100, 1387–92.
Maller J J , Daskalakis Z J and Fitzgerald P B . 2007. Hippocampal volumetrics in depression: The importance of the posterior tail. Hippocampus 17, 1023–7.
Matsuo K , Rosenberg D R , Easter P C , et al. 2008. Striatal volume abnormalities in treatment-naive patients diagnosed with pediatric major depressive disorder. J Child Adolesc Psychopharmacol 18, 121–31.
Mervaala E , Fohr J , Kononen M , et al. 2000. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 30, 117–25.
Murata T , Kimura H , Omori M , et al. 2001. MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: A comparison of early- and late-onset cases. Int J Geriatr Psychiatry 16, 1129–35.
Murphy C F , Gunning-Dixon F M , Hoptman M J , et al. 2007. White-matter integrity predicts stroop performance in patients with geriatric depression. Biol Psychiatry 61, 1007–10.
Naismith S , Hickie I , Ward P B , et al. 2002. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry 159, 2096–8.
Nebes R D , Reynolds C F, III, Boada F , et al. 2002. Longitudinal increase in the volume of white matter hyperintensities in late-onset depression. Int J Geriatr Psychiatry 17, 526–30.
Neumeister A , Wood S , Bonne O , et al. 2005. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry 57, 935–7.
Nobuhara K , Okugawa G , Minami T , et al. 2004. Effects of electroconvulsive therapy on frontal white matter in late-life depression: A diffusion tensor imaging study. Neuropsychobiology 50, 48–53.
Nobuhara K , Okugawa G , Sugimoto T , et al. 2006. Frontal white matter anisotropy and symptom severity of late-life depression: A magnetic resonance diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 77, 120–2.
O'Brien J , Ames D , Chiu E , Schweitzer I , Desmond P and Tress B . 1998. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow up study. BMJ 317, 982–4.
O'Brien T J , Lloyd A , McKeith I , Gholkar A and Ferrier N . 2004. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161, 2081–90.
Parashos I A , Tupler L A , Blitchington T and Krishnan K R . 1998. Magnetic-resonance morphometry in patients with major depression. Psychiatry Res 84, 7–15.
Pillay S S , Renshaw P F , Bonello C M , Lafer B C , Fava M and Yurgelun-Todd D . 1998. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity. Psychiatry Res 84, 61–74.
Pillay S S , Yurgelun-Todd D A , Bonello C M , Lafer B , Fava M and Renshaw P F . 1997. A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity. Biol Psychiatry 42, 79–84.
Pompili M , Innamorati M , Mann J J , et al. 2008. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry 32, 1501–07.
Posener J A , Wang L , Price J L , et al. 2003. High-dimensional mapping of the hippocampus in depression. Am J Psychiatry 160, 83–9.
Rabins P V , Pearlson G D , Aylward E , Kumar A J and Dowell K . 1991. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 148, 617–20.
Rosso I M , Cintron C M , Steingard R J , Renshaw P F , Young A D and Yurgelun-Todd D A . 2005. Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry 57, 21–6.
Salloway S , Boyle P A , Correia S , et al. 2002. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry 10, 107–11.
Salloway S , Malloy P , Kohn R , et al. 1996. MRI and neuropsychological differences in early and late-onset geriatric depression. Neurology 46, 1567–74.
Sheline Y I , Gado M H and Kraemer H C . 2003. Untreated depression and hippocampal volume loss. Am J Psychiatry 160, 1516–8.
Sheline Y I , Gado M H and Price J L . 1998. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9, 2023–8.
Sheline Y I , Price J L , Vaishnavi S N , et al. 2008. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry 165, 524–32.
Sheline Y I , Wang P W , Gado M H , Csernansky J G and Vannier M W . 1996. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93, 3908–13.
Siegle G J , Konecky R O , Thase M E and Carter C S . 2003. Relationships between amygdala volume and activity during emotional information processing tasks in depressed and never-depressed individuals: An fMRI investigation. Ann N Y Acad Sci 985, 481–4.
Simpson S W , Baldwin R C , Burns A and Jackson A . 2001. Regional cerebral volume measurements in late-life depression: Relationship to clinical correlates, neuropsychological impairment and response to treatment. Int J Geriatr Psychiatry 16, 469–76.
Simpson S , Baldwin R C , Jackson A and Burns A S . 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 28, 1015–26.
Simpson S W , Jackson A , Baldwin R C and Burns A . 1997. 1997 IPA/Bayer Research Awards in Psychogeriatrics. Subcortical hyperintensities in late-life depression: Acute response to treatment and neuropsychological impairment. Int Psychogeriatr 9, 257–75.
Sonohara K , Kozaki K , Akishita M , et al. 2008. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly. Geriatr Gerontol Int 8, 93–100.
Steffens D C , Bosworth H B , Provenzale J M and Macfall J R . 2002. Subcortical white matter lesions and functional impairment in geriatric depression. Depress Anxiety 15, 23–8.
Steffens D C , Byrum C E , McQuoid D R , et al. 2000. Hippocampal volume in geriatric depression. Biol Psychiatry 48, 301–09.
Steffens D C , Conway C R , Dombeck C B , Wagner H R , Tupler L A and Weiner R D . 2001. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. J ECT 17, 45–9.
Steffens D C , Potter G G , McQuoid D R , et al. 2007. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry 15, 839–49.
Steffens D C , Taylor W D , McQuoid D R and Krishnan K R . 2008. Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatric depression. Int J Geriatr Psychiatry 23, 244–8.
Steffens D C , Trost W T , Payne M E , Hybels C F and MacFall J R . 2003. Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. Biol Psychiatry 54, 674–81.
Taylor W D , Kuchibhatla M , Payne M E , et al. 2008a. Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS ONE 3, e3267.
Taylor W D , MacFall J R , Steffens D C , Payne M E , Provenzale J M and Krishnan K R . 2003a. Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuropsychopharmacol Biol Psychiatry 27, 539–44.
Taylor W D , Payne M E , Krishnan K R , et al. 2001. Evidence of white matter tract disruption in MRI hyperintensities. Biol Psychiatry 50, 179–83.
Taylor W D , Steffens D C , MacFall J R , et al. 2003b. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 60, 1090–6.
Taylor W D , Steffens D C , McQuoid D R , et al. 2003c. Smaller orbital frontal cortex volumes associated with functional disability in depressed elders. Biol Psychiatry 53, 144–9.
Taylor W D , Zuchner S , McQuoid D R , et al. 2008b. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry 16, 263–71.
Thomas A J , O'Brien J T , Barber R , McMeekin W and Perry R . 2003. A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord 76, 49–54.
Thomas A J , Perry R , Barber R , Kalaria R N and O' Brien J T . 2002. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci 977, 333–9.
Tupler L A , Krishnan K R , McDonald W M , Dombeck C B , D'Souza S and Steffens D C . 2002. Anatomic location and laterality of MRI signal hyperintensities in late-life depression. J Psychosom Res 53, 665–76.
van Eijndhoven P , van Wingen G , van Oijen K , et al. 2008. Amygdala volume marks the acute state in the early course of depression. Biol Psychiatry 65, 812–8.
van Waesberghe J H , Kamphorst W , De Groot C J , et al. 1999. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability. Ann Neurol 46, 747–54.
von Gunten A , Fox N C , Cipolotti L and Ron M A , 2000. A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J Neuropsychiatry Clin Neurosci 12, 493–8.
Yang Q , Huang X , Hong N and Yu X . 2007. White matter microstructural abnormalities in late-life depression. Int Psychogeriatr 19, 757–66.
Yuan Y , Zhang Z , Bai F , et al. 2007. White matter integrity of the whole brain is disrupted in first-episode remitted geriatric depression. Neuroreport 18, 1845–9.
Zhao Z , Taylor W D , Styner M , Steffens D C , Krishnan K R and Macfall J R . 2008. Hippocampus shape analysis and late-life depression. PLoS ONE 3, e1837.
Zou K , Huang X , Li T , et al. 2008. Alterations of white matter integrity in adults with major depressive disorder: A magnetic resonance imaging study. J Psychiatry Neurosci 33, 525–30.

Reference Title: References

Reference Type: reference-list

Abercrombie H C , Schaefer S M , Larson C L , et al. 1998. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 9, 3301–7.
Aizenstein H J , Butters M A , Figurski J L , Stenger V A , Reynolds C F , III and Carter C S. 2005. Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry 58, 290–6.
Alexopoulos G S. 2002. Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr. Psychiatry 10, 687–95.
Alexopoulos G S , Meyers B S , Young R C , Campbell S , Silbersweig D and Charlson M. 1997. “Vascular depression” hypothesis. Arch Gen Psychiatry 54, 915–22.
Anand A , Li Y , Wang Y , et al. 2005a. Activity and connectivity of brain mood regulating circuit in depression: A functional magnetic resonance study. Biol Psychiatry 57, 1079–88.
Anand A , Li Y , Wang Y , et al. 2005b. Antidepressant effect on connectivity of the mood-regulating circuit: An fMRI study. Neuropsychopharmacology 30, 1334–44.
Anand A , Li Y , Wang Y , Gardner K and Lowe M J. 2007. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: An fMRI study. J Neuropsychiatry Clin Neurosci 19, 274–82.
Audenaert K , Goethals I , Van Laere K , et al. 2002. SPECT neuropsychological activation procedure with the Verbal Fluency Test in attempted suicide patients. Nucl Med Commun 23, 907–16.
Austin M-P , Ross M , Murray C , O'Carroll R E , Ebmeier K P and Goodwin G M. 1992. Cognitive functions in major depression. J Affect Disord 25, 21–30.
Ballmaier M , Toga A W , Blanton R E , et al. 2004. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: An MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 161, 99–108.
Barch D M , Sheline Y I , Csernansky J G and Snyder A Z. 2003. Working memory and prefrontal cortex dysfunction: Specificity to schizophrenia compared with major depression. Biol Psychiatry 53, 376–84.
Baxter L R , Schwartz J M , Phelps M E , et al. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46, 243–50.
Baxter L R , Phelps M E , Mazziotta J C , et al. 1985. Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 42, 441–7.
Beats B C , Sahakian B J and Levy R. 1996. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 26, 591–603.
Beck A T , Rush A J , Shaw B F and Emery G. 1979. Cognitive Therapy of Depression. New York, NY: Guilford.
Bhagwagar Z , Cowen P J , Goodwin G M and Harmer C J. 2004. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry 161, 166–8.
Biswal B , Yetkin F Z , Haughton V and Hyde J S. 1995. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Res Med 34, 537–41.
Biver F , Goldman S , Delvenne V , et al. 1994. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 36, 381–8.
Booij L , Van der D W , Benkelfat C , et al. 2002. Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 27, 852–61.
Bouhuys A L , Geerts E and Gordijn M C M. 1999. Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: A longitudinal study. J Nerv Mental Dis 187, 595–602.
Brassen S , Kalisch R , Weber-Fahr W , Braus D F and Buchel C. 2008. Ventromedial prefrontal cortex processing during emotional evaluation in late-life depression: A longitudinal functional magnetic resonance imaging study. Biol Psychiatry 64, 349–55.
Brody A L , Saxena S , Stoessel P , et al. 2001. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Arch Gen Psychiatry 58, 631–40.
Calder A J , Lawrence A D and Young A W. 2001. Neuropsychology of fear and loathing. Nat Rev Neurosci 2, 352–63.
Canli T , Cooney R E , Goldin P , et al. 2005. Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport 16, 1267–70.
Charney D S and Babich K S. 2002. Foundation for the NIMH strategic plan for mood disorders research. Biol Psychiatry 52, 455–6.
Chen C H , Suckling J , Ooi C , et al. 2008. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 33, 1909–18.
Dalla B G , Parlato V , Iavarone A and Boller F. 1995. Anosognosia, intrusions and “frontal” functions in Alzheimer's disease and depression. Neuropsychologia 33, 247–59.
Davidson R J , Irwin W , Anderle M J and Kalin N H. 2003. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160, 64–75.
Drevets W C. 1999. Prefrontal cortical–amygdalar metabolism in major depression. Ann N Y Acad Sci 877, 614–37.
Drevets W C , Bogers W and Raichle M E. 2002. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12, 527–44.
Drevets W C , Price J L and Furey M L. 2008. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213, 93–118.
Drevets W C , Price J L , Simpson J R, Jr, et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824–7.
Drevets W C , Videen T O , Price J L , Preskorn S H , Carmichael S T and Raichle M E. 1992. A functional anatomical study of unipolar depression. J Neurosci 12, 3628–41.
Ebmeier K P , Glabus M F , Prentice N , Ryman A and Goodwin G M. 1998. A voxel-based analysis of cerebral perfusion in dementia and depression of old age. Neuroimage 7, 199–208.
Elliott R , Baker S C , Rogers R D , et al. 1997. Prefrontal dysfunction in depressed patients performing a complex planning task: A study using positron emission tomography. Psychol Med 27, 931–42.
Elliott R , Sahakian B J , Michael A , Paykel E S and Dolan R J. 1998. Abnormal neural response to feedback on planning and guessing tasks in patients with unipolar depression. Psychol Med 28, 559–71.
Elliott R , Rubinsztein J S , Sahakian B J and Dolan R J. 2002. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry 59, 597–604.
Epstein J , Pan H , Kocsis J H , et al. 2006. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 163, 1784–90.
Fava M. 2003. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53, 649–59.
Fitzgerald P. 2008. Brain stimulation techniques for the treatment of depression and other psychiatric disorders. Austral Psychiatry 16, 183–90.
Fitzgerald P B , Laird A R , Maller J and Daskalakis Z J. 2008a. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 29, 683–95.
Fitzgerald P B , Srithiran A , Benitez J , et al. 2008b. An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Hum Brain Mapp 29, 490–501.
Forbes E E , Christopher M J , Siegle G J , et al. 2006. Reward-related decision-making in pediatric major depressive disorder: An fMRI study. J Child Psychol Psychiatry 47, 1031–40.
Fu C H , Mourao-Miranda J , Costafreda S G , et al. 2008a. Pattern classification of sad facial processing: Toward the development of neurobiological markers in depression. Biol Psychiatry 63, 656–62.
Fu C H , Williams S C , Cleare A J , et al. 2004. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61, 877–89.
Fu C H Y , Williams S C R , Brammer M J , et al. 2007. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry 164, 599–607.
Fu C H Y , Williams S C R , Cleare A J , et al. 2008b. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 64, 505–12.
George M S , Ketter T A , Parekh P I , Rosinsky N , Ring H A and Pazzaglia P J. 1997. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci 9, 55–63.
Gonul A S , Kula M , Bilgin A G , Tutus A and Oguz A. 2004. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuropsychopharmacol Biol Psychiatry 28, 1015–21.
Gotlib I H and Hamilton J P. 2008. Neuroimaging and depression: Current status and unresolved issues. Curr Dir Psychol Sci 17, 159–63.
Gotlib I H and Whiffen V E. 1989. Depression and marital functioning: An examination of specificity of gender differences. J Abnorm Psychol 98, 23–30.
Greicius M D , Flores B H , Menon V , et al. 2007. Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 62, 429–37.
Gur R C , Erwin R J , Gur R E , Zwil A S , Heimberg C and Kraemer H C. 1992. Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res 42, 241–51.
Gusnard D A , Akbudak E , Shulman G L and Raichle M E . 2001. Medial prefrontal cortex and self-referential mental activity: Relation to a default mode of brain function. Proc Natl Acad Sci U S A 98, 4259–64.
Hariri A R , Tessitore A , Mattay V S , Fera F and Weinberger D R . 2002. The amygdala response to emotional stimuli: A comparison of faces and scenes. Neuroimage 17, 317–23.
Hasler G , Drevets W C , Gould T D , Gottesman I I and Manji H K. 2006. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 60, 93–105.
Hasler G , Drevets W C , Manji H K and Charney D S. 2004. Discovering endophenotypes for major depression. Neuropsychopharmacology 29, 1765–81.
Hasler G , Fromm S , Carlson P J , et al. 2008. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65, 521–31.
Haxby J V , Hoffman E A and Gobbini M I. 2000. The distributed human neural system for face perception. Trends Cognit Sci 4, 223–33.
Hickie I , Scott E , Mitchell P , Wilhelm K , Austin M P and Bennett B. 1995. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37, 151–60.
Keedwell P , Drapier D , Surguladze S , Giampietro V , Brammer M and Phillips M. 2009. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J Psychopharmacol 23, 775–88.
Keedwell P A , Andrew C , Williams S C , Brammer M J and Phillips M L. 2005a. A double dissociation of ventromedial prefrontal cortical responses to sad and happy stimuli in depressed and healthy individuals. Biol Psychiatry 58, 495–503.
Keedwell P A , Andrew C , Williams S C , Brammer M J and Phillips M L. 2005b. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 58, 843–53.
Kennedy S H , Konarski J Z , Segal Z V , et al. 2007. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 164, 778–88.
Kessler R C , Berglund P , Demler O , et al. 2003. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–105.
Kimbrell T A , Ketter T A , George M S , et al. 2002. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51, 237–52.
Kimura M , Shimoda K , Mizumura S , et al. 2003. Regional cerebral blood flow in vascular depression assessed by 123I-IMP SPECT. J Nippon Med Sch 70, 321–6.
Knutson B , Bhanji J P , Cooney R E , Atlas L Y and Gotlib I H. 2008. Neural responses to monetary incentives in major depression. Biol Psychiatry 63, 686–92.
Koschack J , Hoschel K and Irle E. 2003. Differential impairments of facial affect priming in subjects with acute or partially remitted major depressive episodes. J NervMental Dis 191, 175–81.
Kraemer H C , Gullion C M , Rush A J , Frank E and Kupfer D J. 1994. Can state and trait variables be disentangled? A methodological framework for psychiatric disorders. Psychiatry Res 52, 55–69.
Kraemer H C , Schultz S K and Arndt S. 2002. Biomarkers in psychiatry: methodological issues. Am J Geriatr Psychiatry 10, 653–9.
Kumari V , Mitterschiffthaler M T , Teasdale J D , et al. 2003. Neural abnormalities during cognitive generation of affect in treatment-resistant depression. Biol Psychiatry 54, 777–91.
Lang P J , Bradley M M and Cuthbert B N. 2001. International Affective Picture System (IAPS): Instruction Manual and Affective Ratings. Technical Report A-5 The Center for Research in Psychophysiology, University of Florida.
Lawrence N S , Williams A M , Surguladze S A , et al. 2004. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 55, 578–87.
Libet J and Lewinson P. 1973. Concept of social skills with special reference to the behavior of depressed persons. J Consult Clin Psychol 40, 304–13.
Liotti M , Mayberg H S , McGinnis S , Brannan S L and Jerabek P. 2002. Unmasking disease-specific cerebral blood flow abnormalities: Mood challenge in patients with remitted unipolar depression. Am J Psychiatry 159, 1830–40.
Lozano A M , Mayberg H S , Giacobbe P , Hamani C , Craddock R C and Kennedy S H. 2008. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64, 461–7.
Mannie Z N , Norbury R , Murphy S E , Inkster B , Harmer C J and Cowen P J. 2008. Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br J Psychiatry 192, 356–61.
Martin S D , Martin E , Rai S S , Richardson M A and Royall R. 2001. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Arch Gen Psychiatry 58, 641–8.
Martinot J L , Hardy P , Feline A , et al. 1990. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatry 147, 1313–7.
Masurier M L , Cowen P J and Harmer C J. 2007. Emotional bias and waking salivary cortisol in relatives of patients with major depression. Psychol Med 37, 403–10.
Matsuo K , Glahn D C , Peluso M A , et al. 2007. Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder. Mol Psychiatry 12, 158–66.
Mayberg H S. 1997. Limbic–cortical dysregulation: A proposed model of depression. J Neuropsychiatry Clin Neurosci 9, 471–81.
Mayberg H S , Brannan S K , Mahurin R K , et al. 1997. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8, 1057–61.
Mayberg H S , Liotti M , Brannan S K , McGinnis B S , Mahurin R K and Jerabek P A. 1999. Reciprocal limbic–cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry 156, 675–82.
Mayberg H S , Lozano A M , Voon V , et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–60.
McKiernan K A , Kaufman J N , Kucera-Thompson J and Binder J R. 2003. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J Cognit Neurosci 15, 394–408.
Monchi O , Petrides M , Petre V , Worsley K and Dagher A. 2001. Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21, 7733–41.
Monk C S , Klein R G , Telzer E H , et al. 2008. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 165, 90–8.
Moreaud O , Naegele B , Chabannes J P , Roulin J L , Garbolino B and Pellat J. 1996. Frontal lobe dysfunction and depression: Relation with the endogenous nature of the depression. Encephale 22, 47–51.
Mueller T I , Leon A C , Keller M B , et al. 1999. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 156, 1000–6.
Navarro V , Gasto C , Lomena F , et al. 2004. Prognostic value of frontal functional neuroimaging in late-onset severe major depression. Br J Psychiatry 184, 306–11.
Neumeister A , Nugent A C , Waldeck T , et al. 2004. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 61, 765–73.
Nofzinger E A , Nichols T E , Meltzer C C , et al. 1999. Changes in forebrain function from waking to REM sleep in depression: Preliminary analyses of [18F]FDG PET studies. Psychiatry Res 91, 59–78.
Okada G , Okamoto Y , Morinobu S , Yamawaki S and Yokota N. 2003. Attenuated left prefrontal activation during a verbal fluency task in patients with depression. Neuropsychobiology 47, 21–6.
Perico C A M , Skaf C R , Yamada A , et al. 2005. Relationship between regional cerebral blood flow and separate symptom clusters of major depression: A single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett 384, 265–70.
Persad S and Polivy J. 1993. Differences between depressed and nondepressed individuals in the recognition of and response to facial cues. J Abnorm Psychol 102, 358–68.
Phillips M L , Drevets W C , Rauch S L and Lane R. 2003a. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry 54, 504–14.
Phillips M L , Drevets W C , Rauch S L and Lane R. 2003b. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54, 515–28.
Phillips M L and Frank E. 2006. Redefining bipolar disorder: Toward DSM-V. Am J Psychiatry 163, 1135–6.
Phillips M L , Ladouceur C D and Drevets W C. 2008. A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 13, 833–57.
Phillips M L , Young A W , Senior C , et al. 1997. A specific neural substrate for perceiving facial expressions of disgust. Nature 389, 495–8.
Pochon J B , Levy R , Fossati P , et al. 2002. The neural system that bridges reward and cognition in humans: An fMRI study. Proc Natl Acad Sci U S A 99, 5669–74.
Raichle M E , MacLeod A M , Snyder A Z , Powers W J , Gusnard D A and Shulman G L. 2001. Inaugural Article: A default mode of brain function. Proc Natl Acad Sci U S A 98, 676–82.
Raz N , Gunning F M , Head D , et al. 1997. Selective aging of the human cerebral cortex observed in vivo: Differential vulnerability of the prefrontal gray matter. Cerebral Cortex 7, 268–82.
Roberson-Nay R , McClure E B , Monk C S , et al. 2006. Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: An fMRI study. Biol Psychiatry 60, 966–73.
Rose E J , Simonotto E and Ebmeier K P. 2006. Limbic over-activity in depression during preserved performance on the n-back task. Neuroimage 29, 203–15.
Salloway S , Malloy P , Kohn R , et al. 1996. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 46, 1567–74.
Schlaepfer T E , Cohen M X , Frick C , et al. 2008. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33, 368–77.
Sheline Y I , Barch D M , Donnelly J M , Ollinger J M , Snyder A Z and Mintun M A. 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry 50, 651–8.
Siegle G J , Steinhauer S R , Thase M E , Stenger V A and Carter C S. 2002. Can't shake that feeling: Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 51, 693–707.
Siegle G J , Carter C S and Thase M E. 2006. Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 163, 735–8.
Siegle G J , Thompson W , Carter C S , Steinhauer S R and Thase M E. 2007. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: Related and independent features. Biol Psychiatry 61, 198–209.
Solomon D A , Keller M B , Leon A C , et al. 1997. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 54, 1001–06.
Sprengelmeyer R , Rausch M , Eysel U T and Przuntek H. 1998. Neural structures associated with recognition of facial expressions of basic emotions. Proc R Soc Lond B Biol Sci 265, 1927–31.
Stuss D T and Levine B. 2002. Adult clinical neuropsychology: Lessons from studies of the frontal lobes. Annu Rev Psychol 53, 401–33.
Surguladze S A , Brammer M J , Keedwell P , et al. 2005. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 57, 201–09.
Surguladze S A , Brammer M J , Young A W , et al. 2003. A preferential increase in the extrastriate response to signals of danger. Neuroimage 19, 1317–28.
Surguladze S A , Young A W , Senior C , Brebion G , Travis M J and Phillips M L. 2004. Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology 18, 212–8.
Suslow T , Junghanns K and Arolt V. 2001. Detection of facial expressions of emotions in depression. Percept Motor Skills 92, 857–68.
Teasdale J D. 1988. Cognitive vulnerability to persistent depression. Cogn Emot 2, 247–74.
Thomas K M , Drevets W C , Dahl R E , et al. 2001. Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 58, 1057–63.
Tremblay L K , Naranjo C A , Graham S J , et al. 2005. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62, 1228–36.
Üstün B T and Chatterji S. 2001. Global burden of depressive disorders and future projections. In Dawson A and Tylee A (Eds.) Depression: Social and Economic Timebomb. London: BMJ, pp. 31–43.
Vaishnavi S and Taylor W D. 2006. Neuroimaging in late-life depression. Int Rev Psychiatry 18, 443–51.
Veiel H O F. 1997. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 19, 587–603.
Videbech P , Ravnkilde B , Pedersen T H , et al. 2002. The Danish PET/depression project: Clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 106, 35–44.
Walsh N D , Williams S C R , Brammer M J , et al. 2007. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry 62, 1236–43.
World Health Organization . 1999. The World Health Report 1999: Making a Difference. Geneva: World Health Organization.
Yao Z , Wang L , Lu Q , Liu H and Teng G. 2008. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: A resting-state fMRI study. J Affect Disord 115, 430–8.
Zakzanis K K , Leach L and Kaplan E. 1998. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry, Neuropsychol Behav Neurol 11, 111–9.
Zang Y , Jiang T , Lu Y , He Y and Tian L. 2004. Regional homogeneity approach to fMRI data analysis. NeuroImage 22, 394–400.
Zola-Morgan S , Squire L R , varez-Royo P and Clower R P. 1991. Independence of memory functions and emotional behavior: Separate contributions of the hippocampal formation and the amygdala. Hippocampus 1, 207–20.

Reference Title: References

Reference Type: reference-list

Abas M A , Sahakian B J and Levy R. 1990. Neuropsychological deficits and CT scan changes in elderly depressives. Psychol Med 20, 507–20.
Abi-Dargham A , Laruelle M , Lipska B , et al. 1993. Serotonin 5-HT3 receptors in schizophrenia: A postmortem study of the amygdala. Brain Res 616, 53–7.
Agid Y , Buzsáki G , Diamond D M , et al. 2007. How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6, 189–201.
Agren H and Reibring L. 1994. PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27, 2–6.
Agren H , Reibring L , Hartvig P , et al. 1991. Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: A positron emission tomography study on patients and healthy volunteers. Acta Psychiatr Scand 83, 449–55.
Alexopoulos G S , Meyers B S , Young R C , et al. 2000. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 57, 285–90.
Alexopoulos G S , Vrontou C , Kakuma T , et al. 1996. Disability in geriatric depression. Am J Psychiatry 153, 877–85.
Allard P and Norlen M. 2001. Caudate nucleus dopamine D(2) receptors in depressed suicide victims. Neuropsychobiology 44, 70–3.
Anand A , Verhoeff P , Seneca N , et al. 2000. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 157, 1108–14.
Arango V , Underwood M D , Gubbi A V and Mann J J. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688, 121–33.
Arango V , Underwood M D and Mann J J . 2002. Serotonin brain circuits involved in major depression and suicide. Progr Brain Res 136, 443–53.
Arango V , Underwood M D and Mann J J. 1997. Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann N Y Acad Sci 836, 269–87.
Arnett C D , Wolf A P , Shiue C Y , et al. 1986. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. J Nucl Med 27, 1878–82.
Beekman A T , Copeland J R and Prince M J. 1999. Review of community prevalence of depression in later life. Br J Psychiatry 174, 307–11.
Beekman A T , Geerlings S W , Deeg D J , et al. 2002. The natural history of late-life depression: A 6-year prospective study in the community. Arch Gen Psychiatry 59, 605–11.
Bergstrom M , Westerberg G , Kihlberg T and Langstrom B. 1997a. Synthesis of some 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain. Nucl Med Biol 24, 381–8.
Bergstrom M , Westerberg G and Langstrom B. 1997b. 11C-harmine as a tracer for monoamine oxidase A (MAO-A): In vitro and in vivo studies. Nucl Med Biol 24, 287–93.
Bhagwagar Z , Hinz R , Taylor M , Fancy S , Cowen P and Grasby P. 2006. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [(11)C]MDL 100,907. Am J Psychiatry 163, 1580–7.
Bhagwagar Z , Murthy N , Selvaraj S , et al. 2007. 5-HTT binding in recovered depressed patients and healthy volunteers: A positron emission tomography study with [11C]DASB. Am J Psychiatry 164, 1858–65.
Biegon A , Kargman S , Snyder L and McEwen B S. 1986. Characterization and localization ofserotonin receptors in human brain postmortem. Brain Res 363, 91–8.
Biver F , Wikler D , Lotstra F , Damhaut P , Goldman S and Mendlewicz J. 1997. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex. Br J Psychiatry 171, 444–8.
Blakely R D , Ramamoorthy S , Schroeter S , et al. 1998. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44, 169–78.
Blier P , de Montigny C and Chaput Y. 1990. A role for the serotonin system in the mechanism of action of antidepressant treatments: Preclinical evidence. J Clin Psychiatry 51 (Suppl), 14–20; discussion 21.
Blin J , Denis A , Yamaguchi T , Crouzel C , MacKenzie E T and Baron J C. 1991. PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand. Neurosci Lett 121, 183–6.
Blin J , Sette G , Fiorelli M , et al. 1990. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. J Neurochem 54, 1744–54.
Bowden C , Theodorou A E , Cheetham S C , et al. 1997. Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 752, 227–33.
Bowden C L , Seleshi E and Javors M A. 1989. Mania associated with high percentage of inhibition of monoamine oxidase. Am J Psychiatry 146, 121.
Brown A K , Kimura Y , Zoghbi S S , et al. 2008. Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET. J Nucl Med 49, 2042–8.
Brown A S and Gershon S. 1993. Dopamine and depression. J Neural Transm 91, 75–109.
Bruce M L and Leaf P J. 1989. Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Hlth 79, 727–30.
Brücke T , Kornhuber J , Angelberger P , Asenbaum S , Frassine H , and Podreka I . 1993. SPECT imaging of dopamine and serotosin transporters with [123I]beta-CIT. Binding kinetics in the human brain. J Neurol Transm Gen Sect 94, 137–46.
Buck A , Gucker P M , Schonbachler R D , et al. 2000. Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: Assessment of methods. J Cerebr Blood Flow Metab 20, 253–62.
Camps M , Cortés R , Gueye B , Probst A and Palacios J M. 1989. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites. Neuroscience 28, 275–90.
Cannon D M , Ichise M , Fromm S J , et al. 2006. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry 60, 207–17.
Cannon D M , Ichise M , Rollis D , et al. 2007. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry 62, 870–7.
Cannon D M , Klaver J M , Peck S A , Rallis-Voak D , Erickson K and Drevets W C. 2009. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology, 5, 1277–87.
Carson R E , Kiesewetter D O , Jagoda E , Der M G , Herscovitch P and Eckelman W C. 1998. Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: Control and competition studies. J Cereb Blood Flow Metab 18, 1130–42.
Caspi A , Sugden K , Moffitt T E , et al. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301, 386–9.
Castren E. 2004. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol Neurobiol 29, 289–302.
Catafau A M , Perez V , Plaza P , et al. 2006. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: A 123I-ADAM SPECT study. Psychopharmacology (Berl) 189, 145–53.
Chaly T , Dhawan V , Kazumata K , et al. 1996. Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol 23, 999–1004.
Chauveau F , Boutin H , Van Camp N , Dollé F and Tavitian B. 2008. Nuclear imaging of neuroinflammation: A comprehensive review of [(11)C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35, 2304–19.
Ciliax B J , Drash G W , Staley J K , et al. 1999. Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409, 38–56.
Cole M G , Bellavance F and Mansour A. 1999. Prognosis of depression in elderly community and primary care populations: A systematic review and meta-analysis. Am J Psychiatry 156, 1182–9.
Comley R , Parker C , Wishart M , Martarello L , Jakobsen S and Gunn R. 2006. In vivo evaluation and quantification of the 5-HT4 receptor PET ligand [11C]SB-207145. Neuroimage 31, T23.
Conwell Y , Duberstein P R , Cox C , Herrmann J H , Forbes N T and Caine E D. 1996. Relationships of age and axis I diagnoses in victims of completed suicide: A psychological autopsy study. Am J Psychiatry 153, 1001–08.
Cortes R , Soriano E , Pazos A , Probst A and Palacios J M. 1988. Autoradiography of antidepressant binding sites in the human brain: Localization using [3H]imipramine and [3H]paroxetine. Neuroscience 27, 473–96.
Cowen P J. 1996. Advances in psychopharmacology: Mood disorders and dementia. Br Med Bull 52, 539–55.
DaSilva J N , Lourenco C M , Meyer J H , Hussey D , Potter W Z and Houle S. 2002. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[(11)C]rolipram and positron emission tomography. Eur J Nucl Med Mol Imag 29, 1680–3.
David S P , Murthy N V , Rabiner E A , et al. 2005. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25, 2586–90.
Davis M R , Votaw J R , Bremner J D , et al. 2003. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT. J Nucl Med 44, 855–61.
Dewey S L , MacGregor R R , Brodie J D , et al. 1990. Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine. Synapse 5, 213–23.
Dewey S L , Smith G , Logan J , Brodie J D , Fowler J S and Wolf A P. 1993. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13, 350–6.
Dilsaver S C. 1986. Cholinergic mechanisms in depression. Brain Res 396, 285–316.
Ding Y S , Lin K S and Logan J. 2006. PET imaging of norepinephrine transporters. Curr Pharm Des 12, 3831–45.
Drevets W C , Frank E , Price J C , et al. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46, 1375–87.
Drevets W C , Frank E , Price J C , Kupfer D J , Greer P J and Mathis C. 2000. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27, 499–507.
Duman R S , Heninger G R and Nestler E J. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54, 597–606.
Ebert D , Feistel H , Kaschka W , Barocka A and Pirner A. 1994. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation – Preliminary results. Biol Psychiatry 35, 880–5.
Eckelman W C. 2001. Radiolabeled muscarinic radioligands for in vivo studies. Nucl Med Biol 28, 485–91.
Eckelman W C , Reba R C , Rzeszotarski W J , et al. 1984. External imaging of cerebral muscarinic acetylcholine receptors. Science 223, 291–3.
Efange S M. 2000. In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter. Faseb J 14, 2401–13.
Erlandsson K , Sivananthan T , Lui D , et al. 2005. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: A SPECT validation study. Eur J Nucl Med Mol Imaging 32, 1329–36.
Farde L , Ehrin E , Eriksson L , et al. 1985. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82, 3863–7.
Farde L , Ito H , Swahn C G , Pike V W and Halldin C. 1998. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. J Nucl Med 39, 1965–71.
Ferrarese C , Guidotti A , Costa E , et al. 1991. In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine, a possible ligand for positron emission tomography. Neuropharmacology 30, 899–905.
First M , Spitzer R , Williams J and Gibbon M. 1995. Structured Clinical Interview for DSM-IV-Non-Patient Edition (SCID-NP, Version 1.0)., Washington, D.C.: American Psychiatric Press.
Fowler J S , MacGregor R R , Wolf A P , et al. 1987. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 235, 481–5.
Francis P T , Pangalos M N , Stephens P H , et al. 1993. Antemortem measurements of neurotransmission: Possible implications for pharmacotherapy of Alzheimer's disease and depression. J Neurol Neurosurg Psychiatry 56, 80–4.
Frankle W G , Lombardo I , New A S , et al. 2005. Brain serotonin transporter distribution in subjects with impulsive aggressivity: A positron emission study with [11C]McN 5652. Am J Psychiatry 162, 915–23.
Frankle W G , Slifstein M , Gunn R N , et al. 2006. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: Reproducibility and comparison of methods. J Nucl Med 47, 815–26.
Frey K A , Koeppe R A , Kilbourn M R , et al. 1996. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 40, 873–84.
Frokjaer V G , Mortensen E L , Nielsen F A , et al. 2008. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry 63, 569–76.
Frost J J. 2001. PET imaging of the opioid receptor: The early years. Nucl Med Biol 28, 509–13.
Frost J J , Rosier A J , Reich S G , et al. 1993. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 34, 423–31.
Frost J J , Wagner H N Jr, Dannals R F , et al. 1985. Imaging opiate receptors in the human brain by positron tomography. J Comp Assist Tomog 9, 231–6.
Fujita M , Imaizumi M , Zoghbi S S , et al. 2008. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 40, 43–52.
Furey M L and Drevets W C. 2006. Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63, 1121–9.
Garnett E S , Firnau G and Nahmias C. 1983. Dopamine visualized in the basal ganglia of living man. Nature 305, 137–8.
George T P , Sacco K A , Vessicchio J C , Weinberger A H and Shytle R D. 2008. Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: A preliminary study. J Clin Psychopharmacol 28, 340–4.
Ginovart N , Meyer J H , Boovariwala A et al. 2006. Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain. J Cereb Blood Flow Metab 26, 330–44.
Ginovart N , Wilson A A , Meyer J H , Hussey D and Houle S. 2001. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: Modeling strategies. J Cereb Blood Flow Metab 21, 1342–53.
Giovacchini G , Chang M C , Channing M A , et al. 2002. Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J Cereb Blood Flow Metab 22, 1453–62.
Hall H , Halldin C , Farde L and Sedvall G. 1998. Whole hemisphere autoradiography of the postmortem human brain. Nucl Med Biol 25, 715–9.
Halldin C , Farde L , Hogberg T , et al. 1995. Carbon-11-FLB 457: A radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 36, 1275–81.
Halldin C , Foged C , Chou Y H , et al. 1998. Carbon-11-NNC 112: A radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med 39, 2061–8.
Hargreaves R. 2002. Imaging substance P receptors (NK1) in the living human brain using positron emission tomography. J Clin Psychiatry 63, 18–24.
Hariri A R , Mattay V S , Tessitore A , et al. 2002. Serotonin in transporter genetic variation and the response of the human amygdala. Science 297, 400–3.
Hartvig P , Agren H , Reibring L , et al. 1991. Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography. J Neural Transm Gen Sect 86, 25–41.
Hashimoto K , Nishiyama S , Ohba H , et al. 2008. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: A PET study in conscious monkeys. PLoS ONE 3, e3231.
Heiss W D. 2009. The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging 36(Suppl 1), S105–12.
Heiss W D and Herholz K. 2006. Brain receptor imaging. J Nucl Med 47, 302–12.
Henriksson M M , Marttunen M J , Isometsa E T , et al. 1995. Mental disorders in elderly suicide. Int Psychogeriatr 7, 275–86.
Hirvonen J , Aalto S , Hagelberg N , et al. 2009. Measurement of central micro-opioid receptor binding in vivo with PET and [(11)C]carfentanil: A test–retest study in healthy subjects. Eur J Nucl Med Mol Imaging 36, 275–86.
Hirvonen J , Karlsson H , Kajander J , et al. 2008. Striatal dopamine D2 receptors in medication-naïve patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl) 197, 581–90.
Holsboer F. 2000. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477–501.
Horti A G , Chefer S I , Mukhin A G , et al. 2000. 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci 67, 463–9.
Houle S , Ginovart N , Hussey D , Meyer J H and Wilson A A. 2000. Imaging the serotonin transporter with positron emission tomography: Initial human studies with [11C]DAPP and [11C]DASB. Eur J Nucl Med 27, 1719–22.
Hoyer D , Pazos A , Probst A and Palacios J M. 1986a. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376, 85–96.
Hoyer D , Pazos A , Probst A and Palacios J M. 1986b. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376, 97–107.
Huang Y , Kegeles L S , Bae S , et al. 2001. Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands. Bioorg Med Chem Lett 11, 1375–7.
Hwang D R , Kegeles L S and Laruelle M. 2000. (–)-N-[(11)C]propyl-norapomorphine: A positron-labeled dopamine agonist for PET imaging of D(2) receptors. Nucl Med Biol 27, 533–9.
Ichimiya T , Suhara T , Sudo Y , et al. 2002. Serotonin transporter binding in patients with mood disorders: A PET study with [11C](+)McN5652. Biol Psychiatry 51, 715–22.
Ikoma Y , Suhara T , Toyama H , et al. 2002. Quantitative analysis for estimating binding potential of the brain serotonin transporter with [11 C]McN5652. J Cereb Blood Flow Metab 22, 490–501.
Ito H , Nyberg S , Halldin C , Lundkvist C and Farde L. 1998. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. J Nucl Med 39, 208–14.
Junck L , Olson J M , Ciliax B J , et al. 1989. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 26, 752–8.
Kapur S and Mann J J. 1992. Role of the dopaminergic system in depression. Biol Psychiatry 32, 1–17.
Kato M and Serretti A . 2010. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15, 473–500.
Keller J , Schatzberg A F and Maj M. 2007. Current issues in the classification of psychotic major depression. Schizophr Bull 33, 877–85.
Kessler R C , Chiu W T , Demler O , Merikangas K R and Walters E E. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62, 617–27.
Kessler R M , Mason N S , Votaw J R , et al. 1992. Visualization of extrastriatal dopamine D2 receptors in the human brain. Eur J Pharmacol 223, 105–7.
Kilts C D. 1994. Recent pharmacologic advances in antidepressant therapy. Am J Med 97, 3S–12S.
Klein N , Sacher J , Geiss-Granadia T , et al. 2006. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology (Berl) 188, 263–72.
Klein N , Sacher J , Geiss-Granadia T , et al. 2007. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: An [123I]ADAM SPECT study. Psychopharmacology (Berl) 191, 333–9.
Klimek V , Schenck J E , Han H , Stockmeier C A and Ordway G A. 2002. Dopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem study. Biol Psychiatry 52, 740–8.
Klimke A , Larisch R , Janz A , Vosberg H , Muller-Gartner H W and Gaebel W. 1999. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90, 91–101.
Koeppe R A , Frey K A , Snyder S E , Meyer P , Kilbourn M R and Kuhl D E. 1999. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: Alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J Cereb Blood Flow Metab 19, 1150–63.
Koeppe R A , Holthoff V A , Frey K A , Kilbourn M R and Kuhl D E. 1991. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11, 735–44.
Krishnan V and Nestler E J. 2008. The molecular neurobiology of depression. Nature 455, 894–902.
Kugaya A , Sanacora G , Staley J K , et al. 2004. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biol Psychiatry 56, 497–502.
Kugaya A , Seneca N M , Snyder P J , et al. 2003. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28, 413–20.
Kuhl D E , Koeppe R A , Fessler J A , et al. 1994. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 35, 405–10.
Kung H F , Alavi A , Chang W , et al. 1990. In vivo SPECT imaging of CNS D-2 dopamine receptors: Initial studies with iodine-123-IBZM in humans. J Nucl Med 31, 573–9.
Kung M P , Hou C , Oya S , Mu M , Acton P D and Kung H F. 1999. Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters. Eur J Nucl Med 26, 844–53.
Laruelle M , van Dyck C , Abi-Dargham A , et al. 1994. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. J Nucl Med 35, 743–54.
Leopoldo M , Berardi F , Colabufo N A , et al. 2002. Structure–affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands. J Med Chem 45, 5727–35.
Lesch K P , Bengel D , Heils A , et al. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–31.
Leysen J E. 1990. Gaps and peculiarities in 5-HT2 receptor studies. Neuropsychopharmacology 3, 361–9.
Lopez J F , Chalmers D T , Little K Y and Watson S J. 1998. A.E. Bennett research award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biol Psychiatry 43, 547–73.
Lu B and Gottschalk W. 2000. Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Progr Brain Res 128, 231–41.
Lundkvist C , Halldin C , Ginovart N , et al. 1996. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography. Life Sci 58, PL 187–92.
Maes M and Meltzer H. 1995. The serotonin hypothesis of major depression. In Bloom Kupfer F (ed.) Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press, pp. 933–44.
Malison R T , Price L H , Berman R , et al. 1998. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44, 1090–8.
Mann J J. 1999. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21, 99S–105S.
Mann J J , Huang Y Y , Underwood M D , et al. 2000. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57, 729–38.
Marek G J and Aghajanian G K. 1998. The electrophysiology of prefrontal serotonin systems: Therapeutic implications for mood and psychosis. Biol Psychiatry 44, 1118–27.
Marner L , Gillings N , Gunn R , et al. 2007. Quantification of 11C-SB207145-PET for 5-HT4 receptors in the human brain: Preliminary results. J Nucl Med Meeting Abstracts 48, 159P.
Martarello L , Kilts C D , Ely T , et al. 2001. Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor. Nucl Med Biol 28, 187–95.
Massou J M , Trichard C , Attar-Levy D , et al. 1997. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 133, 99–101.
Mathew S J , Manji H K and Charney D S. 2008. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 33, 2080–92.
Mathis C A , Wang Y , Holt D P , Huang G F , Debnath M L and Klunk W E. 2003. Synthesis and evaluation of (11)C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46, 2740–54.
Mayberg H S . 2003. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65, 193–207.
Meador-Woodruff J H , Mansour A , Bunzow J R , Van Tol H H , Watson S J Jr and Civelli O . 1989. Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 86, 7625–8.
Meltzer C C , Price J C , Mathis C A , et al. 1999. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 156, 1871–8.
Meltzer C C , Price J C , Mathis C A , et al. 2004. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29, 2258–65.
Meltzer C C , Smith G , DeKosky S T , et al. 1998. Serotonin in aging, late-life depression, and alzheimer's disease: The emerging role of functional imaging. Neuropsychopharmacology 18, 407–30.
Mengod G , Pompeiano M , Martínez-Mir M I and Palacios J M. 1990. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524, 139–43.
Merikangas K R , Akiskal H S , Angst J , et al. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry 64, 543–52.
Mervaala E , Könönen M , Föhr J , et al. 2001. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord 66, 47–58.
Messa C , Colombo C , Moresco R M , et al. 2003. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: A PET study. Psychopharmacology 167, 72–8.
Meyer J H. 2007. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 32, 86–102.
Meyer J H , Cho R , Kennedy S and Kapur S. 1999a. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET. Psychopharmacology 144, 279–81.
Meyer J H , Ginovart N , Boovariwala A , et al. 2006. Elevated monoamine oxidase a levels in the brain: An explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63, 1209–16.
Meyer J H , Houle S , Sagrati S , et al. 2004. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61, 1271–9.
Meyer J H , Kapur S , Houle S , et al. 1999b. Prefrontal cortex 5-HT2 receptors in depression: An [18F]setoperone PET imaging study. Am J Psychiatry 156, 1029–34.
Meyer J H , Kruger S , Wilson A A , et al. 2001a. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12, 4121–5.
Meyer J H , McMain S , Kennedy S H , et al. 2003. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry 160, 90–9.
Meyer J H , Wilson A A , Ginovart N , et al. 2001b. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [(11)C]DASB PET imaging study. Am J Psychiatry 158, 1843–9.
Milak M S , Severance A J , Ogden R T , et al. 2008. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET. J Nucl Med 49, 587–96.
Miller J M , Oquendo M A , Ogden R T , Mann J J and Parsey R V. 2008. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. J Psychiatric Res 42, 1137–44.
Montgomery A J , Thielemans K , Mehta M A , Turkheimer F , Mustafovic S and Grasby P M. 2006. Correction of head movement on PET studies: Comparison of methods. J Nucl Med 47, 1936–44.
Moresco R M , Colombo C , Fazio F , et al. 2000. Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: A PET study. Neuroimage 12, 452–65.
Moses-Kolko E L , Wisner K L , Price J C , et al. 2008. Serotonin 1A receptor reductions in postpartum depression: A positron emission tomography study. Fertil Steril 89, 685–92.
Mukherjee J , Christian B T , Dunigan K A , et al. 2002. Brain imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test–retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46, 170–88.
Muller-Gartner H W , Wilson A A , Dannals R F , Wagner H N Jr and Frost J J. 1992. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide. J Cereb Blood Flow Metab 12, 562–70.
Mullins D , Adham N , Hesk D , et al. 2008. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y(5) receptor and development of a novel Y(5)-selective radioligand. Eur J Pharmacol 601, 1–7.
Murray C. 1996. Rethinking DALYs. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard School of Public Health.
Myers R and Hume S. 2002. Small animal PET. Eur Neuropsychopharmacol 12, 545–55.
Nestler E J and Carlezon W A Jr. 2006. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59, 1151–9.
Newberg A B , Amsterdam J D , Wintering N , et al. 2005. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: A preliminary study. J Nucl Med 46, 973–7.
Nobler M S , Mann J J and Sackeim H A. 1999a. Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging. Brain Res 30, 250–63.
Nobler M S , Pelton G H and Sackeim H A. 1999b. Cerebral blood flow and metabolism in late-life depression and dementia. J Geriatric Psychiatry Neurol 12, 118–27.
Nomura M and Nomura Y. 2006. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann N Y Acad Sci 1086, 134–43.
Nordberg A , Lundqvist H , Hartvig P , Lilja A and Langstrom B. 1995. Kinetic analysis of regional (S) (–)11C-nicotine binding in normal and Alzheimer brains – in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9, 21–7.
Ohayon M M and Schatzberg A F. 2002. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 159, 1855–61.
Okazawa H , Leyton M , Benkelfat C , Mzengeza S and Diksic M. 2000. Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and alpha-[11C]methyl-L-tryptophan. J Psychiatry Neurosci 5, 359–70.
Oquendo M A , Hastings R S , Huang Y Y , et al. 2007. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry 64, 201–08.
Owens M J and Nemeroff C B. 1994. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40, 288–95.
Pappata S , Tavitian B , Traykov L , et al. 1996. In vivo imaging of human cerebral acetylcholinesterase. J Neurochem 67, 876–9.
Parker C A , Cunningham V J , Martarello L , et al. 2008. Evaluation of the novel 5-HT6 receptor radioligand, [11C]GSK-215083 in human. Neuroimage 41, T20.
Parsey R V , Hastings R S , Oquendo M A , et al. 2006a. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163, 52–8.
Parsey R V , Kegeles L S , Hwang D R , et al. 2000. In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. J Nucl Med 41, 1465–77.
Parsey R V , Kent J M , Oquendo M A , et al. 2006b. Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol Psychiatry 59, 821–8.
Parsey R V , Oquendo M A , Ogden R T , et al. 2006c. Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59, 106–13.
Parsey R V , Oquendo M A , Simpson N R , et al. 2002. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954, 173–82.
Parsey R V , Oquendo M A , Zea-Ponce Y , et al. 2001. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry 50, 313–22.
Pazos A , Probst A and Palacios J M. 1987. Serotonin receptors in the human brain – III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21, 97–122.
Pearlson G D , Wong D F , Tune L E , et al. 1995. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry 52, 471–7.
Peroutka S J. 1995. 5-HT receptors: Past, present and future. Trends Neurosci 18, 68–9.
Pierson M E , Andersson J , Nyberg S , et al. 2008. [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Neuroimage 41, 1075–85.
Pifferi F , Tremblay S , Plourde M , Tremblay-Mercier J , Bentourkia M and Cunnane S C. 2008. Ketones and brain function: Possible link to polyunsaturated fatty acids and availability of a new brain PET tracer, 11C-acetoacetate. Epilepsia 49 (Suppl 8), 76–9.
Pike V W , Halldin C , Nobuhara K , et al. 2003. Radioiodinated SB 207710 as a radioligand in vivo: Imaging of brain 5-HT4 receptors with SPET. Eur J Nucl Med Mol Imaging 30, 1520–8.
Pike V W , McCarron J A , Lammertsma A A , et al. 1996. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. Eur J Pharmacol 301, R5–7.
Pirker W , Asenbaum S , Hauk M , et al. 2000. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: Binding kinetics and effects of normal aging. J Nucl Med 41, 36–44.
Podruchny T A , Connolly C , Bokde A , et al. 2003. In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers. Synapse 48, 39–44.
Pogarell O , Koch W , Pöpperl G , et al. 2007. Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine. Psychiatry Res 156, 251–5.
Price J C , Kelley D E , Ryan C M , et al. 2002. Evidence of increased serotonin-1A receptor binding in type 2 diabetes: A positron emission tomography study. Brain Res 927, 97–103.
Psychiatric GWAS Consortium Steering Committee . 2009. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 14, 10–7.
Rahmim A , Dinelle K , Cheng J C , et al. 2008. Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events. IEEE Trans Med Imaging 27, 1018–33.
Raison C L , Capuron L and Miller A H. 2006. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27, 24–31.
Rapoport S I. 2008. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostagland Leukot Essen Fatty Acids 79, 153–6.
Rausch J L , Stahl S M and Hauger R L. 1990. Cortisol and growth hormone responses to the 5-HT1A agonist gepirone in depressed patients. Biol Psychiatry 28, 73–8.
Reid A E , Ding Y S , Eckelman W C , et al. 2008. Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. Nucl Med Biol 35, 287–98.
Reimold M , Batra A , Knobel A , et al. 2008. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: A [11C]DASB PET study. Mol Psychiatry 13, 606–13, 557.
Ressler K J and Mayberg H S. 2007. Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nature Neurosci 10, 1116–24.
Riccardi P , Li R , Ansari M S , et al. 2006. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 31, 1016–26.
Riemann B , Schafers K P , Schober O and Schafers M. 2008. Small animal PET in preclinical studies: Opportunities and challenges. Q J Nucl Med Mol Imaging 52, 215–21.
Rosa-Neto P , Diksic M , Okazawa H , et al. 2004. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry 61, 556–63.
Rousset O G , Collins D L , Rahmim A and Wong D F. 2008. Design and implementation of an automated partial volume correction in PET: Application to dopamine receptor quantification in the normal human striatum. J Nucl Med 49, 1097–106.
Rowland D J and Cherry S R. 2008. Small-animal preclinical nuclear medicine instrumentation and methodology. Semin Nucl Med 38, 209–22.
Sacher J , Asenbaum S , Klein N , et al. 2007. Binding kinetics of 123I[ADAM] in healthy controls: A selective SERT radioligand. Int J Neuropsychopharmacol 10, 211–8.
Sargent P A , Kjaer K H , Bench C J , et al. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment. Arch Gen Psychiatry 57, 174–80.
Satyamurthy N , Barrio J R , Bida G T , Huang S C , Mazziotta J C and Phelps M E. 1990. 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. Int J Radiat App Instrument – Part A, Appl Radiat Isotopes 41, 113–29.
Saudou F and Hen R. 1994. 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem Int 25, 503–32.
Schatzberg A F. 2002. Brain imaging in affective disorders: More questions about causes versus effects. Am J Psychiatry 159, 1807–8.
Schotte A , Maloteaux J M and Laduron P M. 1983. Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 276, 231–5.
Schou M , Pike V W and Halldin C. 2007. Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography. Curr Top Med Chem 7, 1806–16.
Sen S , Nesse R M , Stoltenberg S F , et al. 2003. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28, 397–401.
Shank R P , Vaught J L , Pelley K A , Setler P E , McComsey D F and Maryanoff B E. 1988. McN-5652: A highly potent inhibitor of serotonin uptake. J Pharmacol Exp Therap 247, 1032–8.
Shidahara M , Tsoumpas C , Hammers A , et al. 2009. Functional and structural synergy for resolution recovery and partial volume correction in brain PET. Neuroimage 44, 340–8.
Shioe K , Ichimiya T , Suhara T , et al. 2003. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48, 184–8.
Shiue C Y , Shiue G G , Mozley P D , et al. 1997a. P-[18F]-MPPF: A potential radioligand for PET studies of 5-HT1A receptors in humans. Synapse 25, 147–54.
Shiue C Y , Vallabhahosula S , Wolf A P , et al. 1997b. Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons. Nucl Med Biol 24, 145–50.
Shoghi-Jadid K , Small G W , Agdeppa E D , et al. 2002. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriat Psychiatry 10, 24–35.
Simpson S , Talbot P R , Snowden J S and Neary D. 1997. Subcortical vascular disease in elderly patients with treatment resistant depression. J Neurol Neurosurg Psychiatry 62, 196–7.
Smith G , Dewey S L , Brodie J D , et al. 1997. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Am J Psychiatry 154, 490–6.
Smith G , Kahn A , Hanratty K , et al. 2008. Serotonin transporter occupancy by citalopram treatment in geriatric depression. Neuroimage 41, T168.
Smith G , Kramer E , Hermann C , et al. 2009a. Serotonin modulation of cerebral glucose metabolism in geriatric depression. Biol Psychiatry 66, 259–66.
Smith G , Kramer E , Hermann C , et al. 2009b. The functional neuroanatomy of geriatric depression. Int J Geriatric Psychiatry 24, 798–808.
Smith G , Lotrich F , Malhotra A , et al. 2004. The effect of serotonin transporter polymorphisms on serotonin function. Neuropsychopharmacology 29, 2226–34.
Smith G , Price J C , Lopresti B J , et al. 1998. Test–retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse 30, 380–92.
Smith G S , Gunning-Dixon F M , Lotrich F E , Taylor W D and Evans J D. 2007. Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology 32, 1857–75.
Smith G S , Ma Y , Dhawan V , Chaly T and Eidelberg D. 2009. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography. Synapse 63, 1–6.
Smith J S , Zubieta J K , Price J C , et al. 1999. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography. J Cereb Blood Flow Metab 19, 956–66.
Smolka M N , Schumann G , Wrase J , et al. 2005. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25, 836–42.
Sokoloff P , Giros B , Martres M P , Bouthenet M L and Schwartz J C. 1990. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146–51.
Sorger D , Scheunemann M , Grossmann U , et al. 2008. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter. Nucl Med Biol 35, 185–95.
Sotelo C , Cholley B , El Mestikawy S , Gozlan H and Hamon M. 1990. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2, 1144–54.
Staley J K , van Dyck C H , Weinzimmer D , et al. 2005. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: Feasibility and reproducibility. J Nucl Med 46, 1466–72.
Steiniger B , Kniess T , Bergmann R , Pietzsch J and Wuest F R. 2008. Radiolabeled glucocorticoids as molecular probes for imaging brain glucocorticoid receptors by means of positron emission tomography (PET). Mini Rev Med Chem 8, 728–39.
Stephenson K A , van Oosten E M , Wilson A A , Meyer J H , Houle S and Vasdev N. 2008. Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-exaprolol for imaging cerebral beta-adrenergic receptors with PET. Neurochem Int 53, 173–9.
Stockmeier C A. 2003. Involvement of serotonin in depression: Evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatric Res 37, 357–73.
Stockmeier C A , Shapiro L A , Haycock J W , Thompson P A and Lowy M T. 1996. Quantitative subregional distribution of serotonin1A receptors and serotonin transporters in the human dorsal raphe. Brain Res 727, 1–12.
Strafella A P , Paus T , Fraraccio M and Dagher A. 2003. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 126, 2609–15.
Strome E M , Clark C M , Zis A P and Doudet D J. 2005. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: An in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry 57, 1004–10.
Suehiro M , Scheffel U , Dannals R F , Ravert H T , Ricaurte G A and Wagner N H Jr. 1993. A PET radiotracer for studying serotonin uptake sites: Carbon-11-McN-5652Z. J Nucl Med 34, 120–7.
Suhara T , Fukuda H , Inoue O , et al. 1991. Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology 103, 41–5.
Suhara T , Higuchi M and Miyoshi M. 2008. Neuroimaging in dementia: In vivo amyloid imaging. Tohoku J Exp Med 215, 119–24.
Suhara T , Inoue O , Kobayashi K , Suzuki K and Tateno Y. 1993. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett 149, 225–8.
Suhara T , Nakayama K , Inoue O , et al. 1992. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology 106, 14–8.
Sullivan G M , Parsey R V , Kumar J S , et al. 2007. PET imaging of CRF1 with [11C]R121920 and [11C]DMP696: Is the target of sufficient density? Nucl Med Biol 34, 353–61.
Syvanen S , Eriksson J , Genchel T , Lindhe O , Antoni G and Langstrom B. 2007. Synthesis of two potential NK1-receptor ligands using [1–11C]ethyl iodide and [1–11C]propyl iodide and initial PET-imaging. BMC Med Imaging 7, 6.
Szabo Z , Kao P F , Scheffel U , et al. 1995. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652. Synapse 20, 37–43.
Szabo Z , McCann U D , Wilson A A , et al. 2002. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med 43, 678–92.
Takano A , Arakawa R , Hayashi M , Takahashi H , Ito H and Suhara T. 2007. Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry 62, 588–92.
Takano A , Gulyas B , Varrone A , et al. 2008. Imaging the norepinephrine transporter with positron emission tomography: Initial human studies with (S,S)-[(18)F]FMeNER-D (2). Eur J Nucl Med Mol Imaging 35, 153–7.
Tauscher J , Bagby R M , Javanmard M , Christensen B K , Kasper S and Kapur S. 2001. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: A [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 158, 1326–8.
Tiihonen J , Kuoppamäki M , Någren K , et al. 1996. Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology (Berl) 126, 277–80.
Tweedie D J and Burke M D. 1987. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites. Drug Metab Disposition: Biol Fate Chem 15, 74–81.
van Heeringen C , Audenaert K , Van Laere K , et al. 2003. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord 74, 149–58.
Van Tol H H , Bunzow J R , Guan H C , et al. 1991. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610–4.
Varnas K , Halldin C and Hall H. 2004. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Human Brain Mapp 22, 246–60.
Vasdev N , LaRonde F J , Woodgett J R , et al. 2008. Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide. Bioorg Med Chem 16, 5277–84.
Verhoeff N P , Wilson A A , Takeshita S , et al. 2004. In-vivo imaging of alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 12, 584–95.
Villemagne V L , Horti A , Scheffel U , et al. 1997. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. J Nucl Med 38, 1737–41.
Volkow N D , Ding Y S , Fowler J S , et al. 1995. A new PET ligand for the dopamine transporter: Studies in the human brain. J Nucl Med 36, 2162–8.
Volkow N D , Fowler J S , Gatley S J , et al. 1996. PET evaluation of the dopamine system of the human brain. J Nucl Med 37, 1242–56.
Volkow N D , Wang G J , Fowler J S , et al. 1994. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16, 255–62.
Wagner N H Jr, Burns H D , Dannals R F , et al. 1983. Imaging dopamine receptors in the human brain by positron tomography. Science 221, 1264–6.
Weissman M M , Bland R C , Canino G J , et al. 1996. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276, 293–9.
Willeit M , Ginovart N , Kapur S , et al. 2006. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO. Biol Psychiatry 59, 389–94.
Willeit M , Praschak-Rieder N , Neumeister A , et al. 2000. [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47, 482–9.
Willeit M , Stastny J , Pirker W , et al. 2001. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry 50, 8–12.
Wilson A A , Garcia A , Parkes J , et al. 2008. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35, 305–14.
Wilson A A , Ginovart N , Hussey D , Meyer J and Houle S. 2002. In vitro and in vivo characterisation of [11C]-DASB: A probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol 29, 509–15.
Wong D F , Tauscher J and Grunder G. 2009. The role of imaging in proof of concept for CNS drug discovery and development. Neuropsychopharmacology 34, 187–203.
Wong D F , Wagner N H Jr, Dannals R F , et al. 1984. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226, 1393–6.
Xiang L , Szebeni K , Szebeni A , et al. 2008. Dopamine receptor gene expression in human amygdaloid nuclei: Elevated D4 receptor mRNA in major depression. Brain Res 1207, 214–24.
Yasuno F , Ota M , Kosaka J , et al. 2008. Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. Biol Psychiatry 64, 835–41.
Yasuno F , Sanabria S M , Burns D , et al. 2007. PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: Assessment of reference tissue models and their test–retest reproducibility. Synapse 61, 242–51.
Yatham L N , Liddle P F , Dennie J , et al. 1999. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry 56, 705–11.
Yatham L N , Liddle P F , Lam R W , et al. 2002b. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry 159, 1718–23.
Yatham L N , Liddle P F , Shiah I S , et al. 2000. Brain serotonin 2 receptors in major depression: A positron emission tomography study. Arch Gen Psychiatry 57, 850–8.
Yatham L N , Liddle P F , Shiah I S , et al. 2002a. PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: Effects of treatment with divalproex sodium. Am J Psychiatry 159, 768–74.
Yu Y W , Tsai S J , Chen T J , Lin C H and Hong C J. 2002. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7, 1115–9.
Zarate C A Jr, Singh J and Manji H K. 2006. Cellular plasticity cascades: Targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59, 1006–20.
Zoghbi S S , Baldwin R M , Seibyl J P , et al. 1992. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. Int J Radiat Applic Instrum – Part B, Nucl Med Biol 19, 881–8.
Zubieta J K , Ketter T A , Bueller J A , et al. 2003. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 60, 1145–53.
Zubieta J K , Smith Y R , Bueller J A , et al. 2001a. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (New York, NY) 293, 311–5.
Zubieta J K , Taylor S F , Huguelet P , Koeppe R A , Kilbourn M R and Frey K A. 2001b. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry 49, 110–6.

Reference Title: References

Reference Type: reference-list

Behrens T E , Berg H J , Jbabdi S , et al. 2007. Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? Neuroimage 34, 144–55.
Calhoun V , Adali T , Liu J , et al. 2006. A feature-based approach to combine functional MRI, structural MRI and EEG brain imaging data. Conf Proc IEEE Eng Med Biol Soc 1, 3672–5.
Cho R Y , Ford J M , Krystal J H , et al. 2005. Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia. Schizophr Bull 31, 865–9.
Craddock R C , Holtzheimer P E , Hu X P , et al. 2009. Disease state prediction from resting state functional connectivity. Magn Reson Med 62, 1619–28.
Farrow T F , Whitford T J , Williams L M , et al. 2005. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58, 713–23.
Fu C H , Mourao-Miranda J , Costafreda S G , et al. 2008. Pattern classification of sad facial processing: Toward the development of neurobiological markers in depression. Biol Psychiatry 63, 656–62.
Jack C R Jr, Bernstein M A , Fox N C , et al. 2008. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27, 685–91.
James G A , Kelley M E , Craddock R C , et al. 2009. Exploratory structural equation modeling of resting-state fMRI: Applicability of group models to individual subjects. Neuroimage 45, 778–87.
Koob G F and Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97–129.
Lozano A M , Mayberg H S , Giacobbe P , et al. 2008. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64, 461–7.
Mayberg H S. 2003. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65, 193–207.
Mayberg H S , Lozano A M , Voon V , et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–60.
McEwen B S. 1998. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 840, 33–44.
Phillips M L , Drevets W C , Rauch S L , et al. 2003. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54, 515–28.
Robinson R G , Starr L B , Kubos K L , et al. 1983. A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation. Stroke 14, 736–41.
Seminowicz D A , Mayberg H S , McIntosh A R , et al. 2004. Limbic–frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 22, 409–18.
Sheline Y I , Gado M H , Kraemer H C , et al. 2003. Untreated depression and hippocampal volume loss. Am J Psychiatry 160, 1516–8.

Reference Title: References

Reference Type: reference-list

Abe O , Yamasue H , Kasai K , et al. 2006. Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism. Psychiatry Res Neuroimag 146, 231–42.
Araki T , Kasai K , Yamasue H , et al. 2005. Association between lower P300 amplitude and smaller anterior cingulated cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack. NeuroImage 25, 43–50.
Bonne O , Brandes D , Gilboa A , et al. 2001. Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am J Psychiatry 158, 1248–51.
Bonne O , Vythilingam M , Inagaki M , et al. 2008. Reduced posterior hippocampal volume in posttraumatic stress disorder. J Clin Psychiatry 69, 1087–91.
Bossini L , Tavanti M , Calossi S , et al. 2008. Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatric Res 42, 752–62.
Bremner J A , Narayan M , Anderson E R. 2000. Hippocampal volume reduction in major depression. Am J Psychiatry 157, 115–27.
Bremner J A , Randall P , Scott T M , et al. 1995. MRI-based measurements of hippocampal volume in combat-related posttraumatic stress disorder. Am J Psychiatry 152, 973–8.
Bremner J D , Randall P , Vermetten E , et al. 1997. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse – A preliminary report. Biol Psychiatry 41, 23–32.
Bremner J D , Vythilingam M , Vermetten E , et al. 2003. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 160, 924–32.
Canive J M , Lewine J D , Orrison W W , et al. 1997. MRI reveals gross structural abnormalities in PTSD. Ann N Y Acad Sci 821, 512–5.
Carrion V G , Weems C F , Eliez S , et al. 2001. Attenuation of frontal asymmetry in pediatric posttraumatic stress disorder. Biol Psychiatry 50, 943–51.
Carrion V G , Weems C F and Reiss A L. 2007. Stress predicts brain changes in children: A pilot longitudinal study on youth stress, posttraumatic stress disorder, and the hippocampus. Pediatrics 119, 509–16.
Chen S , Xia W , Li L , et al. 2006. Gray matter density reduction in the insula in fire survivors with posttraumatic stress disorder: A voxel-based morphometric study. Psychiatry Res Neuroimag 146, 65–72.
Corbo V , Clément M H , Armony J L , et al. 2005. Size versus shape differences: Contrasting voxel-based and volumetric analyses of the anterior cingulate cortex in individuals with acute posttraumatic stress disorder. Biol Psychiatry 58, 119–24.
Crusio W E , Schwegler H and Van Abeelen J H F. 1989. Behavioral responses to novelty and structural variation of the hippocampus in mice. II. Multivariate genetic analysis. Behav Brain Res 32, 81–8.
De Bellis M D , Hall J , Boring A M , et al. 2001. A pilot longitudinal study of hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry 50, 305–09.
De Bellis M D and Keshavan M S. 2003. Sex differences in brain maturation in maltreatment-related pediatric posttraumatic stress disorder. Neurosci Biobehav Rev 27, 103–17.
De Bellis M D , Keshavan M S , Clark D B , et al. 1999. Developmental traumatology part II: Brain development. Biol Psychiatry 45, 1271–84.
De Bellis M D , Keshavan M S , Frustaci K , et al. 2002b. Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biol Psychiatry 51, 544–52.
De Bellis M D , Keshavan M S , Shifflett H , et al. 2002a. Brain structures in pediatric maltreatment-related posttraumatic stress disorder: A sociodemographically matched study. Biol Psychiatry 52, 1066–78.
De Bellis M D and Kuchibhatla M. 2006. Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry 60, 697–703.
Emdad R , Bonekamp D , Sondergaard H P , et al. 2006. Morphometric and psychometric comparisons between non-substance-abusing patients with posttraumatic stress disorder and normal controls. Psychother Psychosom 75, 122–32.
Fennema-Notestine C , Stein M B , Kennedy C M , et al. 2002. Brain morphometry in female victims of intimate partner violence with and without posttraumatic stress disorder. Biol Psychiatry 51, 1089–101.
Freeman T W , Cardwell D , Karson C N and Komoroski R A. 1998. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 40, 66–71.
Freeman T , Kimbrell T , Booe L , et al. 2006. Evidence of resilience: Neuroimaging in former prisoners of war. Psychiatry Res Neuroimag 146, 59–64.
Geuze E , Westenberg H G M , Heinecke A , et al. 2008. Thinner prefrontal cortex in veterans with posttraumatic stress disorder. NeuroImage 41, 675–81.
Gilbertson M W , Shenton M E , Ciszewski A , et al. 2002. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neurosci 5, 1242–7.
Golier J A , Yehuda R , DeSanti S , et al. 2005. Absence of hippocampal volume differences in survivors of the Nazi Holocaust with and without posttraumatic stress disorder. Psychiatry Res Neuroimag 139, 53–64.
Gould E , McEwen B S , Tanapat P , et al. 1997. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17, 2492–8.
Gurvits T V , Shenton M E , Hokama H , et al. 1996. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 40, 1091–9.
Hakamata Y , Matsuoka Y , Inagaki M , et al. 2007. Structure of orbitofrontal cortex and its longitudinal course in cancer-related post-traumatic stress disorder. Neurosci Res 59, 383–9.
Ham B J , Chey J , Yoon S J , et al. 2007. Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: A proton magnetic resonance spectroscopy study. Eur J Neurosci 25, 324–9.
Hedges D W , Allen A , Tate D F , et al. 2003. Reduced hippocampal volume in alcohol and substance naïve Vietnam combat veterans with posttraumatic stress disorder. Cognit Behav Neurol 16, 219–24.
Herry C , Ciocchi S , Senn V , et al. 2008. Switching on and off fear by distinct neuronal circuits. Nature 454, 589–90.
Hull A M. 2002. Neuroimaging findings in post-traumatic stress disorder. Br J Psychiatry 181, 102–10.
Jackowski A P , Douglas-Palumberi H , Jackowski M , et al. 2008. Corpus callosum in maltreated children with posttraumatic stress disorder: A diffusion tensor imaging study. Psychiatry Res Neuroimag 162, 256–61.
Jatzko A , Rothenhöfer S , Schmitt A , et al. 2006. Hippocampal volume in chronic posttraumatic stress disorder (PTSD): MRI study using two different evaluation methods. J Affect Disord 94, 121–6.
Karl A , Schaefer M , Malta L S , et al. 2006. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 30, 1004–31.
Kasai K , Yamasue H , Gilbertson M W , et al. 2008. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol Psychiatry 63, 550–6.
Kim M J , Lyoo I K , Kim S J , et al. 2005. Disrupted white matter tract integrity of anterior cingulate in trauma survivors. Neuroreport 16, 1049–53.
Kim S J , Jeong D U , Sim M E , et al. 2006. Asymmetrically altered integrity of cingulum bundle in posttraumatic stress disorder. Neuropsychobiology 54, 120–5.
Kitayama N , Brummer M , Hertz L , et al. 2007. Morphologic alterations in the corpus callosum in abuse-related posttraumatic stress disorder: A preliminary study. J Nerv Mental Disord 195, 1027–9.
Kitayama N , Quinn S and Bremner J D. 2006. Smaller volume of anterior cingulate cortex in abuse-related posttraumatic stress disorder. J Affect Disord 90, 171–4.
Kitayama N , Vaccarino V , Kutner M , et al. 2005. Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: A meta-analysis. J Affect Disord 88, 79–86.
Laakso M P , Vaurio O , Savolainen L , et al. 2000. A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism. Behav Brain Res 109, 177–86.
Letizia B , Maricla T , Sara C , et al. 2008. Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatric Res 42, 752–62.
Levitt J J , Chen Q C , May F S , et al. 2006. Volume of cerebellar vermis in monozygotic twins discordant for combat exposure: Lack of relationship to posttraumatic stress disorder. Psychiatry Res Neuroimag 148, 143–9.
Li L , Chen S , Liu J , et al. 2006. Magnetic resonance imaging and magnetic resonance spectroscopy study of deficits in hippocampal structure in fire victims with recent-onset posttraumatic stress disorder. Can J Psychiatry 51, 431–7.
Lindauer R J L , Vlieger E J , Jalink M , et al. 2004. Smaller hippocampal volume in Dutch police officers with posttraumatic stress disorder. Biol Psychiatry 56, 356–63.
Mahmutyazicioğlu K , Konuk N , Ozdemir H , et al. 2005. Evaluation of the hippocampus and the anterior cingulate gyrus by proton MR spectroscopy in patients with post-traumatic stress disorder. Diagn Interven Radiol 11, 125–9.
Maren, S. 2005. Building and burying fear memories in the brain. Neuroscientist 11, 89–99.
Margarinos A M , McEwen B S , Flugge G and Fuchs E. 1996. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 16, 3534–40.
Matsuoka Y , Yamawaki S , Inagaki M , et al. 2003. A volumetric study of amygdala in cancer survivors with instrusive recollections. Biol Psychiatry 54, 736–43.
May F S , Chen Q C , Gilbertson M W , et al. 2004. Cavum septum pellucidum in monozygotic twins discordant for combat exposure: Relationship to posttraumatic stress disorder. Biol Psychiatry 55, 656–8.
McEwen B S. 1995. Stressful experience, brain, and emotions: developmental, genetic, and hormonal influences. In Gazzaniga M S (ed.) The Cognitive Neurosciences. Cambridge, MA: MIT Press, pp. 1117–35.
Mohanakrishnan Menon P , Nasrallah H A , Lyons J A , et al. 2003. Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry Res Neuroimag 123, 101–08.
Mohanakrishnan Menon P , Nasrallah H A , Reeves R R and Ali J A. 2004. Hippocampal dysfunction in gulf war syndrome: A proton MR spectroscopy study. Brain Res 1009, 189–94.
Myslobodsky M S , Glicksohn J , Singer J , et al. 1995. Changes of brain anatomy in patients with posttraumatic stress disorder: A pilot magnetic resonance imaging study. Psychiatry Res 58, 259–64.
Nakano T , Wenner M , Inagaki M , et al. 2002. Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors. Am J Psychiatry 159, 2087–93.
Pavić L , Gregurek R , Radoš M , et al. 2007. Smaller right hippocampus in war veterans with posttraumatic stress disorder. Psychiatry Res Neuroimag 154, 191–8.
Pederson C L , Maurer S H , Kaminski P L , et al. 2004. Hippocampal volume and memory performance in a community-based sample of women with posttraumatic stress disorder secondary to child abuse. J Traumat Stress 17, 37–40.
Pitman R K , Shin L M and Rauch S L. 2001. Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. J Clin Psychiatry 62, 47–54.
Rauch S L , Shin L M and Phelps E A. 2006. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research – Past, present, and future. Biol Psychiatry 60, 376–82.
Rauch S L , Shin L M , Segal E , et al. 2003. Selectively reduced regional cortical volumes in post-traumatic stress disorder. NeuroReport 14, 913–6.
Richert K A , Carrion V G , Karchemskiy A and Reiss A L. 2006. Regional differences of the prefrontal cortex in pediatric PTSD: An MRI study. Depress Anxiety 23, 17–25.
Sapolsky R M , Uno H , Rebert C S and Finch C E. 1990. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10, 2897–902.
Schuff N , Neylan T C , Fox-Bosetti S , et al. 2008. Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res 162, 147–57.
Schuff N , Neylan T C , Lenoci M A , et al. 2001. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 50, 952–9.
Schwegler H and Lipp H P. 1983. Hereditary covariations of neuronal circuitry and behavior: Correlations between the proportions of hippocampal synaptic fields in the regio inferior and two-way avoidance in mice and rats. Behav Brain Res 7, 1–38.
Shin L M , Shin P S , Heckers S , et al. 2004. Hippocampal function in posttraumatic stress disorder. Hippocampus 14, 292–300.
Smith M A , Makino S , Kvetnansky R and Post R M. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotorphin-3 mRNAs in the hippocampus. J Neurosci 15, 1768–77.
Smith M E. 2005. Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: A meta-analysis of structural MRI studies. Hippocampus 15, 798–807.
Stein M B , Koverola C , Hanna C , et al. 1997. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 27, 951–9.
Thomas L A and De Bellis M D. 2004. Pituitary volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry 55, 752–8.
Tupler L A and De Bellis M D. 2006. Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder. Biol Psychiatry 59, 523–9.
Villarreal G , Hamilton D A , Graham D P , et al. 2004. Reduced area of the corpus callosum in posttraumatic stress disorder. Psychiatry Res Neuroimag 131, 227–35.
Villarreal G , Hamilton D A , Petropoulos H , et al. 2002a. Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder. Biol Psychiatry 52, 119–25.
Villarreal G , Petropoulos H , Hamilton D A , et al. 2002b. Proton magnetic resonance spectroscopy of the hippocampus and occipital white matter in PTSD: Preliminary results. Can J Psychiatry 47, 666–70.
Vythilingam M , Luckenbaugh D A , Lam T , et al. 2005. Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder. Psychiatry Res Neuroimag 139, 89–99.
Wignall E L , Dickson J M , Vaughn P , et al. 2004. Smaller hippocampal volume in patients with recent-onset posttraumatic stress disorder. Biol Psychiatry 56, 832–6.
Winter H and Irle E. 2004. Hippocampal volume in adult burn patients with and without posttraumatic stress disorder. Am J Psychiatry 16, 2194–200.
Woodward S H , Kaloupek D G , Streeter C C , et al. 2006a. Hippocampal volume, PTSD, and alcoholism in combat veterans. Am J Psychiatry 163, 674–81.
Woodward S H , Kaloupek D G , Streeter C C , et al. 2006b. Decreased anterior cingulate volume in combat-related PTSD. Biol Psychiatry 59, 582–7.
Woon F L and Hedges D W. 2008. Hippocampal and amygdala volumes in children and adults with childhood maltreatment-related posttraumatic stress disorder: A meta-analysis. Hippocampus 18, 729–36.
Uno H , Tarara R , Else J G , et al. 1989. Hippocampal damage associated with prolonged and fetal stress in primates. J Neurosci 9, 1705–11.
Yamasue H , Kasai K , Iwanami A , et al. 2003. Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci 100, 9039–43.
Yehuda R , Golier J A , Tischler L , et al. 2007. Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: Relation to risk and resilience factors. J Psychiatric Res 41, 435–45.

Reference Title: References

Reference Type: reference-list

APA. 2000. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text-Revision. Washington, DC: American Psychiatric Press.
Armony J L , Corbo V , Clement M H and Brunet A. 2005. Amygdala response in patients with acute PTSD to masked and unmasked emotional facial expressions. Am J Psychiatry 162, 1961–3.
Astur R S , St Germain S A , Tolin D , Ford J , Russell D and Stevens M. 2006. Hippocampus function predicts severity of post-traumatic stress disorder. Cyberpsychol Behav 9, 234–40.
Binder E B , Bradley R G , Liu W , et al. 2008. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291–305.
Bishop S , Duncan J , Brett M and Lawrence A D. 2004. Prefrontal cortical function and anxiety: Controlling attention to threat-related stimuli. Nat Neurosci 7, 184–8.
Bonne O , Gilboa A , Louzoun Y , et al. 2003. Resting regional cerebral perfusion in recent posttraumatic stress disorder. Biol Psychiatry 54, 1077–86.
Breiter H C , Etcoff N L , Whalen P J , et al. 1996. Response and habituation of the human amygdala during visual processing of facial expression. Neuron 17, 875–87.
Bremner J D , Innis R B , Ng C K , et al. 1997. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 54, 246–54.
Bremner J D , Narayan M , Staib L H , Southwick S M , McGlashan T and Charney D S. 1999a. Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry 156, 1787–95.
Bremner J D , Randall P , Scott T M , et al. 1995. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 152, 973–81.
Bremner J D , Staib L H , Kaloupek D , Southwick S M , Soufer R and Charney D S. 1999b. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: A positron emission tomography study. Biol Psychiatry 45, 806–16.
Bremner J D , Vermetten E , Schmahl C , et al. 2005. Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychol Med 35, 791–806.
Bremner J D , Vermetten E , Vythilingam M , et al. 2004 Neural correlates of the classic color and emotional stroop in women with abuse-related posttraumatic stress disorder. Biol Psychiatry 55, 612–20.
Bremner J D , Vythilingam M , Vermetten E , et al. 2003a. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 160, 924–32.
Bremner J D , Vythilingam M , Vermetten E , et al. 2003b. Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry 53, 879–89.
Britton J C , Phan K L , Taylor S F , Fig L M and Liberzon I. 2005. Corticolimbic blood flow in posttraumatic stress disorder during script-driven imagery. Biol Psychiatry 57, 832–40.
Bryant R A , Felmingham K L , Kemp A H , et al. 2005. Neural networks of information processing in posttraumatic stress disorder: A functional magnetic resonance imaging study. Biol Psychiatry 58, 111–8.
Bryant R A , Felmingham K , Kemp A , Das P , Hughes G , Peduto A and Williams L. 2008a. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med 38, 555–61.
Bryant R A , Kemp A H , Felmingham K L , et al. 2008b. Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: An fMRI study. Hum Brain Mapp 29, 517–23.
Carrion V G , Garrett A , Menon V , Weems C F and Reiss A L. 2008. Posttraumatic stress symptoms and brain function during a response-inhibition task: An fMRI study in youth. Depress Anxiety 25, 514–26.
Chung Y A , Kim S H , Chung S K , et al. 2006. Alterations in cerebral perfusion in posttraumatic stress disorder patients without re-exposure to accident-related stimuli. Clin Neurophysiol 117, 637–42.
Corcoran K A and Maren S. 2001. Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. J Neurosci 21, 1720–6.
Davis M and Whalen P J. 2001. The amygdala: Vigilance and emotion. Mol Psychiatry 6, 13–34.
Dickie E W , Brunet A , Akerib V and Armony J L. 2008. An fMRI investigation of memory encoding in PTSD: Influence of symptom severity. Neuropsychologia 46, 1522–31.
Dolcos F , LaBar K S and Cabeza R. 2004. Interaction between the amygdala and the medial temporal lobe memory system predicts better memory for emotional events. Neuron 42, 855–63.
Driessen M , Beblo T , Mertens M , et al. 2004. Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder. Biol Psychiatry 55, 603–11.
Eichenbaum H. 2000. A cortical–hippocampal system for declarative memory. Nat Rev Neurosci 1, 41–50.
Elzinga B M and Bremner J D. 2002. Are the neural substrates of memory the final common pathway in posttraumatic stress disorder (PTSD)? J Affect Disord 70, 1–17.
Felmingham K , Kemp A , Williams L , et al. 2007. Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress disorder. Psychol Sci 18, 127–9.
Fernandez M , Pissiota A , Frans O , von Knorring L , Fischer H and Fredrikson M. 2001. Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: A positron emission tomography provocation study. Neurosci Lett 297, 101–04.
Francati V , Vermetten E and Bremner J D. 2007. Functional neuroimaging studies in posttraumatic stress disorder: Review of current methods and findings. Depress Anxiety 24, 202–18.
Frewen P , Lane R D , Neufeld R W , Densmore M , Stevens T and Lanius R. 2008. Neural correlates of levels of emotional awareness during trauma script-imagery in posttraumatic stress disorder. Psychosom Med 70, 27–31.
Geuze E , Vermetten E , Ruf M , de Kloet C S and Westenberg H G. 2008. Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder. J Psychiatr Res 42, 659–69.
Gilboa A , Shalev A Y , Laor L , et al. 2004. Functional connectivity of the prefrontal cortex and the amygdala in posttraumatic stress disorder. Biol Psychiatry 55, 263–72.
Gurvits T V , Shenton M E , Hokama H , et al. 1996. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 40, 1091–9.
Hamner M B , Lorberbaum J P and George M S. 1999. Potential role of the anterior cingulate cortex in PTSD: Review and hypothesis. Depress Anxiety 9, 1–14.
Hendler T , Rotshtein P , Yeshurun Y , et al. 2003. Sensing the invisible: Differential sensitivity of visual cortex and amygdala to traumatic context. Neuroimage 19, 587–600.
Hopper J W , Frewen P A , van der Kolk B A and Lanius R A. 2007. Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: Symptom dimensions and emotion dysregulation in responses to script-driven trauma imagery. J Trauma Stress 20, 713–25.
Hou C , Liu J , Wang K , et al. 2007. Brain responses to symptom provocation and trauma-related short-term memory recall in coal mining accident survivors with acute severe PTSD. Brain Res 1144, 165–74.
Karl A , Schaefer M , Malta L S , Dorfel D , Rohleder N and Werner A. 2006. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 30, 1004–31.
Kim M J , Chey J , Chung A , et al. 2008. Diminished rostral anterior cingulate activity in response to threat-related events in posttraumatic stress disorder. J Psychiatr Res 42, 268–77.
Koenen K C , Saxe G , Purcell S , et al. 2005. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry 10, 1058–9.
Lang P J , Levin D N , Miller G A and Kozak M J. 1983. Fear behavior, fear imagery, and the psychophysiology of emotion: The problem of affective response integration. J Abnorm Psychol 92, 276–306.
Lanius R , Williamson P , Boksman K , et al. 2002. Brain activation during script-driven imagery induced dissociative responses in PTSD: A functional magnetic resonance imaging investigation. Biol Psychiatry 52, 305.
Lanius R A , Bluhm R , Lanius U and Pain C. 2006. A review of neuroimaging studies in PTSD: Heterogeneity of response to symptom provocation. J Psychiatr Res 40, 709–29.
Lanius R A , Williamson P C , Bluhm R L , et al. 2005. Functional connectivity of dissociative responses in posttraumatic stress disorder: A functional magnetic resonance imaging investigation. Biol Psychiatry 57, 873–84.
Lanius R A , Williamson P C , Densmore M , et al. 2001. Neural correlates of traumatic memories in posttraumatic stress disorder: A functional MRI investigation. Am J Psychiatry 158, 1920–2.
Lanius R A , Williamson P C , Hopper J , et al. 2003. Recall of emotional states in posttraumatic stress disorder: An fMRI investigation. Biol Psychiatry 53, 204–10.
Lansing K , Amen D G , Hanks C and Rudy L. 2005. High-resolution brain SPECT imaging and eye movement desensitization and reprocessing in police officers with PTSD. J Neuropsychiatry Clin Neurosci 17, 526–32.
Layton B and Krikorian R. 2002. Memory mechanisms in posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 14, 254–61.
LeDoux J E. 2000. Emotion circuits in the brain. Annu Rev Neurosci 23, 155–84.
Lee H J , Lee M S , Kang R H , et al. 2005. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 21, 135–9.
Levin P , Lazrove S. and van der Kolk B. 1999. What psychological testing and neuroimaging tell us about the treatment of Posttraumatic Stress Disorder by Eye Movement Desensitization and Reprocessing. J Anxiety Disord 13, 159–72.
Liberzon I , Taylor S F , Amdur R , et al. 1999. Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 45, 817–26.
Lindauer R J , Booij J , Habraken J B , et al. 2004. Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder. Biol Psychiatry 56, 853–61.
Maren S and Holt W. 2000. The hippocampus and contextual memory retrieval in Pavlovian conditioning. Behav Brain Res 110, 97–108.
McGaugh J L. 2004. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27, 1–28.
Milad M R and Quirk G J. 2002. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420, 70–4.
Mirzaei S , Knoll P , Keck A , et al. 2001. Regional cerebral blood flow in patients suffering from post-traumatic stress disorder. Neuropsychobiology 43, 260–4.
Molina M E , Isoardi R , Prado M N and Bentolila S. 2010. Basal cerebral glucose distribution in long-term post-traumatic stress disorder. World J Biol Psychiatry 11 , 493–501.
Moores K A , Clark C R , McFarlane A C , Brown G C , Puce A and Taylor D J. 2008. Abnormal recruitment of working memory updating networks during maintenance of trauma-neutral information in post-traumatic stress disorder. Psychiatry Res 163, 156–70.
Morey R A , Dolcos F , Petty C M , et al. 2008. The role of trauma-related distractors on neural systems for working memory and emotion processing in posttraumatic stress disorder. J Psychiatr Res 43, 809–17.
Morgan M A , Romanski L M and LeDoux J E. 1993. Extinction of emotional learning: Contribution of medial prefrontal cortex. Neurosci Lett 163, 109–13.
Orr S P , Metzger L J , Lasko N B , et al. 2000. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J Abnorm Psychol 109, 290–8.
Osuch E A , Benson B , Geraci M , et al. 2001. Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder. Biol Psychiatry 50, 246–53.
Osuch E A , Willis M W , Bluhm R , Ursano R J and Drevets W C. 2008. Neurophysiological responses to traumatic reminders in the acute aftermath of serious motor vehicle collisions using [15O]-H2O positron emission tomography. Biol Psychiatry 64, 327–35.
Pavic L , Gregurek R , Petrovic R , et al. 2003. Alterations in brain activation in posttraumatic stress disorder patients with severe hyperarousal symptoms and impulsive aggressiveness. Eur Arch Psychiatry Clin Neurosci 253, 80–3.
Peres J F , Newberg A B , Mercante J P , et al. 2007. Cerebral blood flow changes during retrieval of traumatic memories before and after psychotherapy: A SPECT study. Psychol Med 37, 1481–91.
Phan K L , Britton J C , Taylor S F , Fig L M and Liberzon I. 2006. Corticolimbic blood flow during nontraumatic emotional processing in posttraumatic stress disorder. Arch Gen Psychiatry 63, 184–92.
Piefke M , Pestinger M , Arin T , et al. 2007. The neurofunctional mechanisms of traumatic and non-traumatic memory in patients with acute PTSD following accident trauma. Neurocase 13, 342–57.
Pissiota A , Frans O , Fernandez M , von Knorring L , Fischer H and Fredrikson M. 2002. Neurofunctional correlates of posttraumatic stress disorder: A PET symptom provocation study. Eur Arch Psychiatry Clin Neurosci 252, 68–75.
Pitman R K , Orr S P , Forgue D F , de Jong J B and Claiborn J M. 1987. Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans. Arch Gen Psychiatry 44, 970–5.
Protopopescu X , Pan H , Tuescher O , et al. 2005. Differential time courses and specificity of amygdala activity in posttraumatic stress disorder subjects and normal control subjects. Biol Psychiatry 57, 464–73.
Quirk G J , Russo G K , Barron J L and Lebron K. 2000. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci 20, 6225–31.
Rauch S L , Shin L M and Phelps E A. 2006. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research – Past, present, and future. Biol Psychiatry 60, 376–82.
Rauch S L , Shin L M , Segal E , et al. 2003. Selectively reduced regional cortical volumes in post-traumatic stress disorder. Neuroreport 14, 913–6.
Rauch S L , Shin L M , Whalen P J and Pitman R K. 1998. Neuroimaging and the neuroanatomy of PTSD. CNS Spectrums 3 (Suppl 2), 30–41.
Rauch S L , van der Kolk B A , Fisler R E , et al. 1996. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 53, 380–7.
Rauch S L , Whalen P J , Shin L M , et al. 2000. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: A functional MRI study. Biol Psychiatry 47, 769–76.
Reiman E M , Lane R D , Ahern G L , et al. 1997. Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry 154, 918–25.
Sachinvala N , Kling A , Suffin S , Lake R and Cohen M. 2000. Increased regional cerebral perfusion by 99mTc hexamethyl propylene amine oxime single photon emission computed tomography in post-traumatic stress disorder. Mil Med 165, 473–9.
Sailer U , Robinson S , Fischmeister F P , et al. 2008. Altered reward processing in the nucleus accumbens and mesial prefrontal cortex of patients with posttraumatic stress disorder. Neuropsychologia 46, 2836–44.
Sanders M , Wiltgen B and Fanselow M. 2003. The place of the hippocampus in fear conditioing. Eur J Pharmacol 463, 217–23.
Seedat S , Warwick J , van Heerden B , et al. 2004. Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor. J Affect Disord 80, 45–53.
Semple W E , Goyer P F , McCormick R , et al. 2000. Higher brain blood flow at amygdala and lower frontal cortex blood flow in PTSD patients with comorbid cocaine and alcohol abuse compared with normals. Psychiatry 63, 65–74.
Shin L M , Bush G , Whalen P J , et al. 2007. Dorsal anterior cingulate function in posttraumatic stress disorder. J Trauma Stress 20, 701–12.
Shin L M , Kosslyn S M , McNally R J , et al. 1997. Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry 54, 233–41.
Shin L M , Lasko N B , Macklin M L , et al. 2009. Resting metabolic activity in the cingulate cortex and vulnerability to posttraumatic stress disorder. Arch Gen Psychiatry 66, 1099–107.
Shin L M , McNally R J , Kosslyn S M , et al. 1999. Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: A PET investigation. Am J Psychiatry 156, 575–84.
Shin L M , Orr S P , Carson M A , et al. 2004a. Regional cerebral blood flow in amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry 61, 168–76.
Shin L M , Shin P S , Heckers S , et al. 2004b. Hippocampal function in posttraumatic stress disorder. Hippocampus 14, 292–300.
Shin L M , Whalen P J , Pitman R K , et al. 2001. An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biol Psychiatry 50, 932–42.
Shin L M , Wright C I , Cannistraro P A , et al. 2005. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 62, 273–81.
Thomaes K , Dorrepaal E , Draijer N P , et al. 2009. Increased activation of the left hippocampus region in Complex PTSD during encoding and recognition of emotional words: A pilot study. Psychiatry Res 171, 44–53.
Vermetten E , Schmahl C , Southwick S M and Bremner J D. 2007. Positron tomographic emission study of olfactory induced emotional recall in veterans with and without combat-related posttraumatic stress disorder. Psychopharmacol Bull 40, 8–30.
Werner N S , Meindl T , Engel R R , et al. 2009. Hippocampal function during associative learning in patients with posttraumatic stress disorder. J Psychiatr Res 43, 309–18.
Whalen P J. 1998. Fear, vigilance, and ambiguity: Initial neuroimaging studies of the human amygdala. Curr Dir Psychol Sci 6, 178–88.
Whalen P J , Bush G , McNally R J , et al. 1998. The emotional counting Stroop paradigm: A functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry 44, 1219–28.
Whalley M G , Rugg M D , Smith A P , Dolan R J and Brewin C R. 2009. Incidental retrieval of emotional contexts in post-traumatic stress disorder and depression: An fMRI study. Brain Cogn 69, 98–107.
Williams L M , Kemp A H , Felmingham K , et al. 2006. Trauma modulates amygdala and medial prefrontal responses to consciously attended fear. Neuroimage 29, 347–57.
Woodward S H , Kaloupek D G , Streeter C C , Martinez C , Schaer M and Eliez S. 2006. Decreased anterior cingulate volume in combat-related PTSD. Biol Psychiatry 59, 582–7.
Yamasue H , Kasai K , Iwanami A , et al. 2003. Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A 100, 9039–43.
Yang P , Wu M T , Hsu C C and Ker J H. 2004. Evidence of early neurobiological alternations in adolescents with posttraumatic stress disorder: A functional MRI study. Neurosci Lett 370, 13–8.
Zubieta J K , Chinitz J A , Lombardi U , Fig L M , Cameron O G and Liberzon I. 1999. Medial frontal cortex involvement in PTSD symptoms: A SPECT study. J Psychiatr Res 33, 259–64.

Reference Title: References

Reference Type: reference-list

Bonne O , Bain E , Neumeister A , et al. 2005. No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. Am J Psychiatry 162, 383–5.
Bremner J D . 2002. Does Stress Damage the Brain? Understanding Trauma-Related Disorders from a Mind–Body Perspective. New York, NY: W.W. Norton.
Bremner J D . 2004. Does stress damage the brain: Understanding trauma related disorders from a mind body perspective. Dir Psychiatry 24, 167–76.
Bremner J D . 2005. Brain Imaging Handbook. New York, NY: W.W. Norton.
Bremner J D . 2007. Functional neuroimaging in posttraumatic stress disorder. Exp Rev Neurotherapy 7, 393–405.
Bremner J D , Elzinga B , Schmahl C and Vermetten E . 2008. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 167, 171–86.
Bremner J D , Innis R B , White T , et al. 2000. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 47, 96–106.
Czermak C , Staley J K , Kasserman S , et al. 2008. beta2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder. Int J Neuropsychopharmacol 11, 419–24.
Davis M . 1992. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15, 353–75.
De Bellis M D , Keshavan M S , Spencer S and Hall J . 2000. N-acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. Am J Psychiatry 157, 1175–7.
Francati V , Vermetten E and Bremner J D . 2007. Functional neuroimaging studies in posttraumatic stress disorder: Review of current methods and findings. Depress Anxiety 24, 202–18.
Freeman T , Kimbrell T , Booe L , et al. 2006. Evidence of resilience: Neuroimaging in former prisoners of war. Psychiatry Res 146, 59–64.
Freeman T W , Cardwell D , Karson C N and Komoroski R A . 1998. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 40, 66–71.
Fujita M , Southwick S M , Denucci C C , et al. 2004. Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder. Biol Psychiatry 56, 95–100.
Geuze E , van Berckel B N , Lammertsma A A , et al. 2008. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 13, 74–83, 73.
Gould E , Tanapat P , McEwen B S , Flugge G and Fuchs E . 1998. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 95, 3168–71.
Kimbrell T , Leulf C , Cardwell D , Komoroski R A and Freeman T W . 2005. Relationship of in vivo medial temporal lobe magnetic resonance spectroscopy to documented combat exposure in veterans with chronic posttraumatic stress disorder. Psychiatry Res 140, 91–4.
Li L , Chen S , Liu J , Zhang J , He Z and Lin X . 2006. Magnetic resonance imaging and magnetic resonance spectroscopy study of deficits in hippocampal structure in fire victims with recent-onset posttraumatic stress disorder. Can J Psychiatry 51, 431–7.
Liberzon I , Taylor S F , Phan K L , et al. 2007. Altered central micro-opioid receptor binding after psychological trauma. Biol Psychiatry 61, 1030–8.
Lim M K , Suh C H , Kim H J , et al. 2003. Fire-related post-traumatic stress disorder: Brain 1H-MR spectroscopic findings. Korean J Radiol 4, 79–84.
Magarinos A M , McEwen B S , Flugge G and Fluchs E . 1996. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 16, 3534–40.
Mahmutyazicioglu K , Konuk N , Ozdemir H , Atasoy N , Atik L and Gundogdu S . 2005. Evaluation of the hippocampus and the anterior cingulate gyrus by proton MR spectroscopy in patients with post-traumatic stress disorder. Diagn Interv Radiol 11, 125–9.
McEwen B S , Angulo J , Cameron H , et al. 1992. Paradoxical effects of adrenal steroids on the brain: Protection versus degeneration. Biol Psychiatry 31, 177–99.
Milad M R and Quirk G J . 2002. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420, 70–3.
Milad M R , Rauch S L , Pitman R K and Quirk G J . 2006. Fear extinction in rats: Implications for human brain imaging and anxiety disorders. Biol Psychol 73, 61–71.
Mohanakrishnan Menon P , Nasrallah H A , Lyons J A , Scott M F and Liberto V . 2003. Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry Res 123, 101–08.
Morgan C A , Romanski L M and LeDoux J E. 1993. Extinction of emotional learning: Contribution of medial prefrontal cortex. Neurosci Lett 163, 109–13.
Nibuya M , Morinobu S and Duman R S . 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15, 7539–47.
Pitman R K . 2001. Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. J Clin Psychiatry 62, 47–54.
Radley J J , Sisti H M , Hao J , et al. 2004. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125, 1–6.
Sapolsky R M . 1996. Why stress is bad for your brain. Science 273, 749–50.
Sapolsky R M , Uno H , Rebert C S and Finch C E . 1990. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10, 2897–902.
Schuff N , Marmar C R , Weiss D S , et al. 1997. Reduced hippocampal volume and N-acetyl aspartate in posttraumatic stress disorder. Ann N Y Acad Sci 821, 516–20.
Schuff N , Neylan T C , Fox-Bosetti S , et al. 2008. Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res 162, 147–57.
Schuff N , Neylan T C , Lenoci M A , et al. 2001. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 50, 952–9.
Seedat S , Videen J S , Kennedy C M and Stein M B . 2005. Single voxel proton magnetic resonance spectroscopy in women with and without intimate partner violence-related posttraumatic stress disorder. Psychiatry Res 139, 249–58.
Vermetten E and Bremner J D. 2002a. Circuits and systems in stress. I. Preclinical studies. Depress Anxiety 15, 126–47.
Vermetten E and Bremner J D. 2002b. Circuits and systems in stress. II. Applications to neurobiology and treatment of PTSD. Depress Anxiety 16, 14–38.
Villarreal G , Hamilton D A , Petropoulos H , et al. 2002. Reduced hippocampal volume and total white matter in posttraumatic stress disorder. Biol Psychiatry 52, 119–25.

Reference Title: References

Reference Type: reference-list

Alexander G E , Crutcher M D and DeLong M R . 1990. Basal ganglia–thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res 85, 119–46.
Alexander G E , DeLong M R and Strick P L. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9, 357–81.
Aouizerate B , Guehl D , Cuny E , et al. 2004. Pathophysiology of obsessive–compulsive disorder: A necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 72, 195–221.
Atmaca M , Yildirim B H , Ozdemir B H , Aydin B A , Tezcan A E and Ozler A S. 2006. Volumetric MRI assessment of brain regions in patients with refractory obsessive–compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30, 1051–7.
Atmaca M , Yildirim H , Ozdemir H , et al. 2008. Hippocampus and amygdalar volumes in patients with refractory obsessive–compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32, 1283–6.
Atmaca M , Yildirim H , Ozdemir H , Tezcan E and Poyraz A K. 2007. Volumetric MRI study of key brain regions implicated in obsessive–compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31, 46–52.
Atmaca M , Yildirim H , Ozler S , Koc M , Kara B and Sec S. 2009. Smaller pituitary volume in adult patients with obsessive–compulsive disorder. Psychiatry Clin Neurosci 63, 516–20.
Aylward E H , Harris G J , Hoehn-Saric R , Barta P E , Machlin S R and Pearlson G D . 1996. Normal caudate nucleus in obsessive–compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 53, 577–84.
Barbas H . 1992. Architecture and cortical connections of the prefrontal cortex in the rhesus monkey. Adv Neurol 57, 91–115.
Baxter L R Jr, Saxena S , Brody A L , et al. 1996. Brain mediation of obsessive–compulsive disorder symptoms: Evidence from functional brain imaging studies in the human and nonhuman primate. Semin Clin Neuropsychiatry 1, 32–47.
Burdick K E , Robinson D G , Malhotra A K and Szeszko P R . 2008. Neurocognitive profile analysis in obsessive–compulsive disorder. J Int Neuropsychol Soc 14, 640–5.
Bush G , Luu P and Posner M I. 2000. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4, 215–22.
Cannistraro P A , Makris N , Howard J D , et al. 2007. A diffusion tensor imaging study of white matter in obsessive–compulsive disorder. Depress Anxiety 24, 440–6.
Carmona S , Bassas N , Rovira M , et al. 2007. Pediatric OCD structural brain deficits in conflict monitoring circuits: A voxel-based morphometry study. Neurosci Lett 421, 218–23.
Chamberlain S R , Blackwell A D , Fineberg N A , Robbins T W and Sahakian B J. 2005. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 29, 399–419.
Choi J S , Kang D H , Kim J J , et al. 2004. Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive–compulsive disorder. J Psychiatr Res 38, 193–9.
Christian C J , Lencz T , Robinson D G , et al. 2008. Gray matter structural alterations in obsessive–compulsive disorder: Relationship to neuropsychological functions. Psychiatry Res 164, 123–31.
Delgado M R. 2007. Reward-related responses in the human striatum. Ann NY Acad Sci 1104, 70–88. Epub 2007 Mar 7.
Duran F L , Hoexter M Q , Valente A A Jr, Miguel E C and Busatto G F . 2009. Association between symptom severity and internal capsule volume in obsessive–compulsive disorder. Neurosci Lett 452, 68–71. Epub 2009 Jan 9.
Fitzgerald K D , Welsh R C , Gehring W J , et al. 2005. Error related hyperactivity of the anterior cingulate cortex in obsessive–compulsive disorder. Biol Psychiatry 57, 287–94.
Garber H J , Ananth J V , Chiu L C , Griswold V J and Oldendorf W H. 1989. Nuclear magnetic resonance study of obsessive–compulsive disorder. Am J Psychiatry 146, 1001–05.
Giedd J N , Rapoport J L , Garvey M A , Perlmutter S and Swedo S E. 2000. MRI assessment of children with obsessive–compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 157, 281–3.
Gilbert A R , Mataix-Cols D , Almeida J R , et al. 2008. Brain structure and symptom dimension relationships in obsessive–compulsive disorder: A voxel-based morphometry study. J Affect Disord 109, 117–26.
Gilbert A R , Moore G J , Keshavan M S , et al. 2000. Decrease in thalamic volumes of pediatric patients with obsessive–compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 57, 449–56.
Grachev I D , Breiter H C , Rauch S L , et al. 1998. Structural abnormalities of frontal neocortex in obsessive–compulsive disorder. Arch Gen Psychiatry 55, 181–2.
Graybiel A M . 2000. The basal ganglia. Curr Biol 10, R509–11.
Graybiel A M and Rauch S L . 2000. Toward a neurobiology of obsessive–compulsive disorder. Neuron 28, 343–7.
Greenberg B D , Malone D A , Friehs G M , et al. 2006. Three-year outcomes in deep brain stimulation for highly resistant obsessive–compulsive disorder. Neuropsychopharmacology 31, 2384–93.
Hong S B , Shin Y W , Kim S H , et al. 2007. Hippocampal shape deformity analysis in obsessive–compulsive disorder. Eur Arch Psychiatry Clin Neurosci 257, 185–90.
Hornak J , Bramham J , Rolls E T , et al. 2003. Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain 126, 1691–712. Epub 2003 Jun 4.
Jenike M A , Breiter H C , Baer L , et al. 1996. Cerebral structural abnormalities in obsessive–compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 53, 625–32.
Jones E G . 2002. Thalamic organization and function after Cajal. Prog Brain Res 136, 333–57.
Jung M H , Huh M J , Kang D H , et al. 2009. Volumetric differences in the pituitary between drug-naive and medicated male patients with obsessive–compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 33, 605–09.
Kang D H , Kim J J , Choi J S , et al. 2004. Volumetric investigation of the frontal–subcortical circuitry in patients with obsessive–compulsive disorder. J Neuropsychiatry Clin Neurosci 16, 342–9.
Kellner C H , Jolley R R , Holgate R C , et al. 1991. Brain MRI in obsessive–compulsive disorder. Psychiatry Res 36, 45–9.
Kim J J , Lee M C , Kim J , et al. 2001. Grey matter in obsessive–compulsive disorder: Statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry 179, 330–4.
Kwon J S , Shin Y W , Kim C W , et al. 2003. Similarity and disparity of obsessive–compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus–amygdala complex. J Neurol Neurosurg Psychiatry 74, 962–4.
Lazaro L , Bargalló N , Castro-Fornieles J , et al. 2009. Brain changes in children and adolescents with obsessive–compulsive disorder before and after treatment: A voxel-based morphometric MRI study. Psychiatry Res 172, 140–6. Epub 2009 Mar 24.
Luxenberg J S , Swedo S E , Flament M F , Friedland R P , Rapoport J and Rapoport S I . 1988. Neuroanatomical abnormalities in obsessive–compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry 145, 1089–93.
MacMaster F P , Russell A , Mirza Y , et al. 2006. Pituitary volume in pediatric obsessive–compulsive disorder. Biol Psychiatry 59, 252–7.
Maltby N , Tolin D F , Worhunsky P , O'Keefe T M and Kiehl K A. 2005. Dysfunctional action monitoring hyperactivates frontal–striatal circuits in obsessive–compulsive disorder: An event-related fMRI study. Neuroimage 24, 495–503.
Menzies L , Chamberlain S R , Laird A R , Thelen S M , Sahakian B J and Bullmore E T . 2008a. Integrating evidence from neuroimaging and neuropsychological studies of obsessive–compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32, 525–49.
Menzies L , Williams G B , Chamberlain S R , et al. 2008b. White matter abnormalities in patients with obsessive–compulsive disorder and their first-degree relatives. Am J Psychiatry 165, 1308–15. Epub 2008 Jun 2.
Modell J G , Mountz J M , Curtis G C and Greden J F . 1989. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive compulsive disorder. J Neuropsychiatry Clin Neurosci 1, 27–36.
Murray C J L and Lopez A D. 1996. The Global Burden of Disease. Boston, MA: Harvard School of Public Health.
Nakamae T , Narumoto J , Shibata K , et al. 2008. Alteration of fractional anisotropy and apparent diffusion coefficient in obsessive–compulsive disorder: A diffusion tensor imaging study. Prog Neuropsychopharmacol Biol Psychiatry 32, 1221–6. Epub 2008 Mar 25.
Narayan V M , Narr K L , Phillips O R , Thompson P M , Toga A W and Szeszko P R. 2008. Greater regional cortical gray matter thickness in obsessive–compulsive disorder. Neuroreport 19, 1551–5.
Packard M G and Knowlton B J. 2002. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 25, 563–93.
Peterson B S , Leckman J F , Tucker D , et al. 2000. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive–compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry 57, 364–72.
Phillips M L , Marks I M , Senior C , et al. 2000. A differential neural response in obsessive–compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med 30, 1037–50.
Pujol J , Soriano-Mas C , Alonso P , et al. 2004. Mapping structural brain alterations in obsessive–compulsive disorder. Arch Gen Psychiatry 61, 720–30.
Rauch S L and Jenike M A. 1993. Neurobiological models of obsessive–compulsive disorder. Psychosomatics 34, 20–32.
Rauch S L , Wedig M M , Wright C I , et al. 2007. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive–compulsive disorder. Biol Psychiatry 61, 330–6.
Riffkin J , Yucel M , Maruff P , et al. 2005. Manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive–compulsive disorder: Comparison with healthy controls and patients with schizophrenia. Psychiatry Res 138, 99–113.
Robbins T W and Everitt B J . 1992. Functions of dopamine in the dorsal and ventral striatum. Sem Neurosci 4, 119–27.
Robinson D , Wu H , Munne R A , et al. 1995. Reduced caudate nucleus volume in obsessive–compulsive disorder. Arch Gen Psychiatry 52, 393–8.
Rolls E T . 2004. The functions of the orbitofrontal cortex. Brain Cogn 55, 11–29.
Rosenberg D R , Benazon N R , Gilbert A , Sullivan A and Moore G J . 2001. Thalamic volume in pediatric obsessive–compulsive disorder patients before and after cognitive behavioral therapy. Biol Psychiatry 50, 312.
Rosenberg D and Keshavan M . 1998. Toward a neurodevelopmental model of obsessive–compulsive disorder. Biol Psychiatry 43, 623–40.
Rosenberg D R , Keshavan M S , Dick E L , Bagwell W W , MacMaster F P and Birmaher B. 1997a. Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 21, 1269–83.
Rosenberg D R , Keshavan M S , O'Hearn K , et al. 1997b. Frontostriatal measurement in treatment-naive children with obsessive compulsive disorder. Arch Gen Psychiatry 54, 824–30.
Rotge J Y , Guehl D , Dilharreguy B , et al. 2009a. Meta-analysis of brain volume changes in obsessive–compulsive disorder. Biol Psychiatry 65, 75–83.
Rotge J Y , Dilharreguy B , Aouizerate B , et al. 2009b. Inverse relationship between thalamic and orbitofrontal volumes in obsessive–compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 33, 682–7. Epub 2009 Mar 21.
Saito Y , Nobuhara K , Okugawa G , et al. 2008. Corpus callosum in patients with obsessive–compulsive disorder: Diffusion-tensor imaging study. Radiology 246, 536–42. Epub 2008 Jan 7.
Saxena S , Bota R G and Brody A L . 2001. Brain–behavior relationships in obsessive–compulsive disorder. Semin Clin Neuropsychiatry 6, 82–101.
Saxena S , Brody A L , Schwartz J M and Baxter L R . 1998. Neuroimaging and frontal-subcortical circuitry in obsessive–compulsive disorder. Br J Psychiatry Suppl 35, 26–37.
Scarone S , Colombo C , Livian S , et al. 1992. Increased right caudate nucleus size in obsessive–compulsive disorder: Detection with magnetic resonance imaging. Psychiatry Res 45, 115–21.
Schwartz J M . 1998. Neuroanatomical aspects of cognitive–behavioural therapy response in obsessive compulsive disorder. An evolving perspective on brain and behaviour. Br J Psychiatry Suppl 35, 38–44.
Shin Y W , Yoo S Y , Lee J K , et al. 2007. Cortical thinning in obsessive compulsive disorder. Hum Brain Mapp 28, 1128–35.
Stein D J , Coetzer R , Lee M , Davids B and Bouwer C . 1997. Magnetic resonance brain imaging in women with obsessive–compulsive disorder and trichotillomania. Psychiatry Res 74, 177–82.
Stein D J , Hollander E , Chan S , et al. 1993. Computed tomography and neurological soft signs in obsessive–compulsive disorder. Psychiatry Res 50, 143–50.
Stewart S E , Geller D A , Jenike M , et al. 2004. Long-term outcome of pediatric obsessive–compulsive disorder: A meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 110, 4–13.
Stewart S E , Platko J , Fagerness J , et al. 2007. A genetic family-based association study of OLIG2 in obsessive–compulsive disorder. Arch Gen Psychiatry 64, 209–14.
Szeszko P R , Ardekani B A , Ashtari M , et al. 2005. White matter abnormalities in obsessive–compulsive disorder: A diffusion tensor imaging study. Arch Gen Psychiatry 62, 782–90.
Szeszko P R , Christian C , Macmaster F , et al. 2008. Gray matter structural alterations in psychotropic drug-naïve pediatric obsessive–compulsive disorder: An optimized voxel-based morphometry study. Am J Psychiatry 165, 1299–307.
Szeszko P R , MacMillan S , McMeniman M , et al. 2004a. Amygdala volume reductions in pediatric patients with obsessive–compulsive disorder treated with paroxetine: Preliminary findings. Neuropsychopharmacology 29, 826–32.
Szeszko P R , MacMillan S , McMeniman M , et al. 2004b. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive–compulsive disorder. Am J Psychiatry 161, 1049–56.
Szeszko P R , Robinson D , Alvir J M , et al. 1999. Orbital frontal and amygdala volume reductions in obsessive–compulsive disorder. Arch Gen Psychiatry 56, 913–9.
Ursu S , Stenger V A , Shear M K , Jones M R and Carter C S. 2003. Overactive action monitoring in obsessive–compulsive disorder: Evidence from functional magnetic resonance imaging. Psychol Sci 14, 347–53.
Valente A A Jr, Miguel E C , Castro C C , et al. 2005. Regional gray matter abnormalities in obsessive–compulsive disorder: A voxel-based morphometry study. Biol Psychiatry 58, 479–87.
Van den Heuvel O A , Remijnse P L , Mataix-Cols D , et al. 2009. The major symptom dimensions of obsessive–compulsive disorder are mediated by partially distinct neural systems. Brain 132, 853–68. Epub 2008 Oct 24.
Van den Heuvel O A , Veltman D J , Groenewegen H J , et al. 2005. Frontal–striatal dysfunction during planning in obsessive–compulsive disorder. Arch Gen Psychiatry 62, 301–09.
Van der Wee N J , Ramsey N F , Jansma J M , et al. 2003. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage 20, 2271–80.
Vogt B A , Finch D M and Olson C R . 1992. Functional heterogeneity in cingulate cortex: The anterior executive and posterior evaluative regions. Cereb Cortex 2, 435–43.
Vogt B A , Nimchinsky E A , Vogt L J and Hof P R . 1995. Human cingulate cortex: Surface features, flat maps, and cytoarchitecture. J Comp Neurol 359, 490–506.
Yoo S Y , Jang J H , Shin Y W , et al. 2007. White matter abnormalities in drug-naïve patients with obsessive–compulsive disorder: A diffusion tensor study before and after citalopram treatment. Acta Psychiatr Scand 116, 211–9.

Reference Title: References

Reference Type: reference-list

Adler C M , McDonough-Ryan P , Sax K W , Holland S K , Arndt S and Strakowski S M . 2000. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res 34, 317–24.
Alonso P , Menchon J M , Mataix-Cols D , et al. 2004. Perceived parental rearing style in obsessive–compulsive disorder: Relation to symptom dimensions. Psychiatry Res 127, 267–78.
An S K , Mataix-Cols D , Lawrence N S , et al. 2009. To discard or not to discard: the neural basis of hoarding symptoms in obsessive–compulsive disorder. Mol Psychiatry 14, 318–31.
Andreasen N C , Paradiso S and O'Leary D S . 1998. “Cognitive dysmetria” as an integrative theory of schizophrenia: A dysfunction in cortical–subcortical–cerebellar circuitry? Schizophr Bull 24, 203–18.
Bannon S , Gonsalvez C J , Croft R J and Boyce P M . 2002. Response inhibition deficits in obsessive–compulsive disorder. Psychiatry Res 110, 165–74.
Bannon S , Gonsalvez C J , Croft R J and Boyce P M . 2006. Executive functions in obsessive–compulsive disorder: State or trait deficits? Aust N Z J Psychiatry 40, 1031–8.
Baxter L R Jr, Schwartz J M , Bergman K S , et al. 1992. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive–compulsive disorder. Arch Gen Psychiatry 49, 681–9.
Benkelfat C , Nordahl T E , Semple W E , King A C , Murphy D L and Cohen R M . 1990. Local cerebral glucose metabolic rates in obsessive–compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry 47, 840–8.
Bolton D , Raven P , Madronal-Luque R and Marks I M . 2000. Neurological and neuropsychological signs in obsessive compulsive disorder: Interaction with behavioural treatment. Behav Res Ther 38, 695–708.
Boulougouris V , Dalley J W and Robbins T W . 2007. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res 179, 219–28.
Breiter H C and Rauch S L . 1996. Functional MRI and the study of OCD: From symptom provocation to cognitive–behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 4, S127–38.
Cannistraro P A , Wright C I , Wedig M M , et al. 2004. Amygdala responses to human faces in obsessive–compulsive disorder. Biol Psychiatry 56, 916–20.
Cath D C , van Grootheest D S , Willemsen G , van Oppen P and Boomsma D I . 2008. Environmental factors in obsessive–compulsive behavior: Evidence from discordant and concordant monozygotic twins. Behav Genet 38, 108–20.
Chamberlain S R , Blackwell A D , Fineberg N A , Robbins T W and Sahakian B J . 2005. The neuropsychology of obsessive compulsive disorder: The importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 29, 399–419.
Chamberlain S R , Fineberg N A , Blackwell A D , Robbins T W and Sahakian B J . 2006. Motor inhibition and cognitive flexibility in obsessive–compulsive disorder and trichotillomania. Am J Psychiatry 163, 1282–4.
Chamberlain S R , Fineberg N A , Menzies L A , et al. 2007. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive–compulsive disorder. Am J Psychiatry 164, 335–8.
Chamberlain S R , Menzies L , Hampshire A , et al. 2008. Orbitofrontal dysfunction in patients with obsessive–compulsive disorder and their unaffected relatives. Science 321, 421–2.
Corcoran K M , Woody S R and Tolin D F . 2008. Recognition of facial expressions in obsessive–compulsive disorder. J Anxiety Disord 22, 56–66.
Critchley H D , Wiens S , Rotshtein P , Ohman A and Dolan R J . 2004. Neural systems supporting interoceptive awareness. Nat Neurosci 7, 189–95.
Deckersbach T , Savage C R , Curran T , et al. 2002. A study of parallel implicit and explicit information processing in patients with obsessive–compulsive disorder. Am J Psychiatry 159, 1780–2.
Delorme R , Gousse V , Roy I , et al. 2007. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive–compulsive disorder. Eur Psychiatry 22, 32–8.
den Braber A , Ent D , Blokland G A , et al. 2008. An fMRI study in monozygotic twins discordant for obsessive–compulsive symptoms. Biol Psychol 79, 91–102.
Dias R , Robbins T W and Roberts A C . 1996. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380, 69–72.
Enright S J and Beech A R . 1993. Reduced cognitive inhibition in obsessive–compulsive disorder. Br J Clin Psychol 32, 67–74.
Fitzgerald K D , Welsh R C , Gehring W J , et al. 2005. Error-related hyperactivity of the anterior cingulate cortex in obsessive–compulsive disorder. Biol Psychiatry 57, 287–94.
Gehring W J , Coles M G , Meyer D E and Donchin E . 1995. A brain potential manifestation of error-related processing. Electroencephalogr Clin Neurophysiol Suppl 44, 261–72.
Gehring W J , Himle J and Nisenson L G . 2000. Action-monitoring dysfunction in obsessive–compulsive disorder. Psychol Sci 11, 1–6.
Gu B M , Park J Y , Kang D H , et al. 2008. Neural correlates of cognitive inflexibility during task-switching in obsessive–compulsive disorder. Brain 131, 155–64.
Hornak J , O'Doherty J , Bramham J , et al. 2004. Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci 16, 463–78.
Inouye E . 1965. Similar and dissimilar manifestations of obsessive–compulsive neuroses in monozygotic twins. Am J Psychiatry 121, 1171–5.
Johannes S , Wieringa B M , Nager W , et al. 2001. Discrepant target detection and action monitoring in obsessive–compulsive disorder. Psychiatry Res 108, 101–10.
Jung W H , Gu B M , Kang D H , et al. 2009. BOLD response during visual perception of biological motion in obsessive–compulsive disorder: An fMRI study using the dynamic point-light animation paradigm. Eur Arch Psychiatry Clin Neurosci 259, 46–54.
Kang D H , Kwon J S , Kim J J , et al. 2003. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive–compulsive disorder. Acta Psychiatr Scand 107, 291–7.
Karno M , Golding J M , Sorenson S B and Burnam M A . 1988. The epidemiology of obsessive–compulsive disorder in five US communities. Arch Gen Psychiatry 45, 1094–9.
Kiehl K A , Liddle P F and Hopfinger J B . 2000. Error processing and the rostral anterior cingulate: An event-related fMRI study. Psychophysiology 37, 216–23.
Kim J , Doop M L , Blake R and Park S . 2005. Impaired visual recognition of biological motion in schizophrenia. Schizophr Res 77, 299–307.
Kim M S , Park S J , Shin M S and Kwon J S . 2002. Neuropsychological profile in patients with obsessive–compulsive disorder over a period of 4-month treatment. J Psychiatr Res 36, 257–65.
Lawrence N S , An S K , Mataix-Cols D , Ruths F , Speckens A and Phillips M L . 2007. Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychiatry 61, 1072–80.
Lazaro L , Caldu X , Junque C , et al. 2008. Cerebral activation in children and adolescents with obsessive–compulsive disorder before and after treatment: A functional MRI study. J Psychiatr Res 42, 1051–9.
Maltby N , Tolin D F , Worhunsky P , O'Keefe T M and Kiehl K A . 2005. Dysfunctional action monitoring hyperactivates frontal–striatal circuits in obsessive–compulsive disorder: An event-related fMRI study. Neuroimage 24, 495–503.
Mataix-Cols D , Alonso P , Pifarre J , Menchon J M and Vallejo J . 2002. Neuropsychological performance in medicated vs. unmedicated patients with obsessive–compulsive disorder. Psychiatry Res 109, 255–64.
Mataix-Cols D , Wooderson S , Lawrence N , Brammer M J , Speckens A and Phillips M L . 2004. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive–compulsive disorder. Arch Gen Psychiatry 61, 564–76.
Menon V , Adleman N E , White C D , Glover G H and Reiss A L . 2001. Error-related brain activation during a Go/NoGo response inhibition task. Hum Brain Mapp 12, 131–43.
Menzies L , Achard S , Chamberlain S R , et al. 2007. Neurocognitive endophenotypes of obsessive–compulsive disorder. Brain 130, 3223–36.
Menzies L , Chamberlain S R , Laird A R , Thelen S M , Sahakian B J and Bullmore E T . 2008. Integrating evidence from neuroimaging and neuropsychological studies of obsessive–compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32, 525–49.
Miguel E C , Leckman J F , Rauch S , et al. 2005. Obsessive–compulsive disorder phenotypes: Implications for genetic studies. Mol Psychiatry 10, 258–75.
Miyata A , Matsunaga H , Kiriike N , Iwasaki Y , Takei Y and Yamagami S . 1998. Event-related potentials in patients with obsessive–compulsive disorder. Psychiatry Clin Neurosci 52, 513–8.
Morault P M , Bourgeois M , Laville J , Bensch C and Paty J . 1997. Psychophysiological and clinical value of event-related potentials in obsessive–compulsive disorder. Biol Psychiatry 42, 46–56.
Nabeyama M , Nakagawa A , Yoshiura T , et al. 2008. Functional MRI study of brain activation alterations in patients with obsessive–compulsive disorder after symptom improvement. Psychiatry Res 163, 236–47.
Nakao T , Nakagawa A , Yoshiura T , et al. 2005a. A functional MRI comparison of patients with obsessive–compulsive disorder and normal controls during a Chinese character Stroop task. Psychiatry Res 139, 101–14.
Nakao T , Nakagawa A , Yoshiura T , et al. 2005b. Brain activation of patients with obsessive–compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study. Biol Psychiatry 57, 901–10.
Nestadt G , Samuels J , Riddle M , et al. 2000. A family study of obsessive–compulsive disorder. Arch Gen Psychiatry 57, 358–63.
Nielen M M and Den Boer J A . 2003. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: Evidence for persistent cognitive deficits. Psychol Med 33, 917–25.
Parker H A , McNally R J , Nakayama K and Wilhelm S . 2004. No disgust recognition deficit in obsessive–compulsive disorder. J Behav Ther Exp Psychiatry 35, 183–92.
Pauls D L , Alsobrook J P 2nd, Goodman W , Rasmussen S and Leckman J F . 1995. A family study of obsessive–compulsive disorder. Am J Psychiatry 152, 76–84.
Penades R , Catalan R , Rubia K , Andres S , Salamero M and Gasto C . 2007. Impaired response inhibition in obsessive compulsive disorder. Eur Psychiatry 22, 404–10.
Phillips M L , Marks I M , Senior C , et al. 2000. A differential neural response in obsessive–compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med 30, 1037–50.
Phillips M L , Young A W , Scott S K , et al. 1998. Neural responses to facial and vocal expressions of fear and disgust. Proc Biol Sci 265, 1809–17.
Phillips M L , Young A W , Senior C , et al. 1997. A specific neural substrate for perceiving facial expressions of disgust. Nature 389, 495–8.
Pitman R K . 1987. A cybernetic model of obsessive–compulsive psychopathology. Compr Psychiatry 28, 334–43.
Purcell R , Maruff P , Kyrios M and Pantelis C . 1998a. Cognitive deficits in obsessive–compulsive disorder on tests of frontal–striatal function. Biol Psychiatry 43, 348–57.
Purcell R , Maruff P , Kyrios M and Pantelis C . 1998b. Neuropsychological deficits in obsessive–compulsive disorder: A comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 55, 415–23.
Rauch S L . 2003. Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurg Clin N Am 14, 213–23, vii–viii.
Rauch S L , Savage C R , Alpert N M , et al. 1997a. Probing striatal function in obsessive–compulsive disorder: A PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci 9, 568–73.
Rauch S L , Wedig M M , Wright C I , et al. 2007. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive–compulsive disorder. Biol Psychiatry 61, 330–6.
Rauch S L , Whalen P J , Savage C R , et al. 1997b. Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapp 5, 124–32.
Rauch S L , Whalen P J , Shin L M , et al. 2000. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: A functional MRI study. Biol Psychiatry 47, 769–76.
Remijnse P L , Nielen M M , van Balkom A J , et al. 2006. Reduced orbitofrontal–striatal activity on a reversal learning task in obsessive–compulsive disorder. Arch Gen Psychiatry 63, 1225–36.
Rosenberg D R and Keshavan M S . 1998. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive–compulsive disorder. Biol Psychiatry 43, 623–40.
Roth R M , Saykin A J , Flashman L A , Pixley H S , West J D and Mamourian A C . 2007. Event-related functional magnetic resonance imaging of response inhibition in obsessive–compulsive disorder. Biol Psychiatry 62, 901–09.
Rubin R T , Ananth J , Villanueva-Meyer J , Trajmar P G and Mena I . 1995. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive–compulsive disorder before and during treatment. Biol Psychiatry 38, 429–37.
Sanavio E . 1988. Obsessions and compulsions: The Padua Inventory. Behav Res Ther 26, 169–77.
Sanz M , Molina V , Martin-Loeches M , Calcedo A and Rubia F J . 2001. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive–compulsive disorder patients. Psychiatry Res 101, 75–81.
Saxena S , Brody A L , Ho M L , et al. 2002. Differential cerebral metabolic changes with paroxetine treatment of obsessive–compulsive disorder vs major depression. Arch Gen Psychiatry 59, 250–61.
Saxena S , Brody A L , Maidment K M , et al. 1999. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive–compulsive disorder. Neuropsychopharmacology 21, 683–93.
Saxena S , Brody A L , Schwartz J M and Baxter L R . 1998. Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder. Br J Psychiatry 35(Suppl), 26–37.
Saxena S and Rauch S L . 2000. Functional neuroimaging and the neuroanatomy of obsessive–compulsive disorder. Psychiatr Clin North Am 23, 563–86.
Schienle A , Schafer A , Stark R , Walter B and Vaitl D . 2005. Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiol 57, 69–77.
Schmahmann J D and Pandya D N . 1997. The cerebrocerebellar system. Int Rev Neurobiol 41, 31–60.
Shapira N A , Liu Y , He A G , et al. 2003. Brain activation by disgust-inducing pictures in obsessive–compulsive disorder. Biol Psychiatry 54, 751–6.
Sheline Y I , Barch D M , Donnelly J M , Ollinger J M , Snyder A Z and Mintun M A . 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry 50, 651–8.
Sprengelmeyer R , Rausch M , Eysel U T and Przuntek H . 1998. Neural structures associated with recognition of facial expressions of basic emotions. Proc Biol Sci 265, 1927–31.
Sprengelmeyer R , Young A W , Pundt I , et al. 1997. Disgust implicated in obsessive–compulsive disorder. Proc Biol Sci 264, 1767–73.
Stein D J and Ludik J . 2000. A neural network of obsessive–compulsive disorder: Modelling cognitive disinhibition and neurotransmitter dysfunction. Med Hypotheses 55, 168–76.
Stevens A A , Skudlarski P , Gatenby J C and Gore J C . 2000. Event-related fMRI of auditory and visual oddball tasks. Magn Reson Imaging 18, 495–502.
Swedo S E , Pietrini P , Leonard H L , et al. 1992. Cerebral glucose metabolism in childhood-onset obsessive–compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49, 690–4.
Tolin D F , Kiehl K A , Worhunsky P , Book G A and Maltby N . 2009. An exploratory study of the neural mechanisms of decision making in compulsive hoarding. Psychol Med 39, 325–36.
Towey J , Bruder G , Tenke C , et al. 1993. Event-related potential and clinical correlates of neurodysfunction in obsessive–compulsive disorder. Psychiatry Res 49, 167–81.
Ursu S , Stenger V A , Shear M K , Jones M R and Carter C S . 2003. Overactive action monitoring in obsessive–compulsive disorder: Evidence from functional magnetic resonance imaging. Psychol Sci 14, 347–53.
van den Heuvel O A , Veltman D J , Groenewegen H J , et al. 2005. Frontal–striatal dysfunction during planning in obsessive–compulsive disorder. Arch Gen Psychiatry 62, 301–09.
van der Wee N J , Ramsey N F , Jansma J M , et al. 2003. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage 20, 2271–80.
van der Wee N J , Ramsey N F , van Megen H J , Denys D , Westenberg H G and Kahn R S . 2007. Spatial working memory in obsessive–compulsive disorder improves with clinical response: A functional MRI study. Eur Neuropsychopharmacol 17, 16–23.
van Oppen P and Arntz A . 1994. Cognitive therapy for obsessive–compulsive disorder. Behav Res Ther 32, 79–87.
Veale D M , Sahakian B J , Owen A M and Marks I M . 1996. Specific cognitive deficits in tests sensitive to frontal lobe dysfunction in obsessive–compulsive disorder. Psychol Med 26, 1261–9.

Reference Title: References

Reference Type: reference-list

Adams K H , Hansen E S , Pinborg L H , et al. 2005. Patients with obsessive–compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int. J. Neuropsychopharmacol 8, 391–401.
Becquet D , Faudon M and Hery F. 1990. In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: Involvement of GABA neurons. Brain Res 519, 82–8.
Benmansour S , Owens W A , Cecchi M , Morilak D A and Frazer A. 2002. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22, 6766–72.
Bloch M H , Landeros-Weisenberger A , Kelmendi B , Coric V , Bracken M B and Leckman J F. 2006. A systematic review: Antipsychotic augmentation with treatment refractory obsessive–compulsive disorder. Mol Psychiatry 11, 622–32.
Booij J , de Jong J , de Bruin K , Knol R J J , de Win M M and van Eck-Smit B L F. 2007. Quantification of striatal dopamine transporters with [123I] beta-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: A double-blind, placebo-controlled, crossover study in healthy controls. J Nucl Med 48, 359–66.
Denys D. 2006. Pharmacotherapy of obsessive–compulsive disorder and obsessive–compulsive spectrum disorders. Psychiatr Clin North Am 29, 553–84, xi.
Denys D , Klompmakers A A and Westenberg H G. 2004. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology (Berl) 176, 195–203.
Dewey S L , Smith G S , Logan J , et al. 1995. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 15, 821–9.
Fineberg N A , Gale T M and Sivakumaran T. 2006. A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol 20, 97–103.
Fletcher P J , Korth K M and Chambers J W. 1999. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward. Psychopharmacology (Berl) 147, 291–9.
Fowler J S , Wang G J , Volkow N D , et al. 1999. PET studies of the effect of the antidepressant drugs nefazodone or paroxetine on [11C]raclopride binding in human brain. Clin Positron Imaging 2, 205–09.
Fullana M A , Mataix-Cols D , Caspi A , et al. 2009. Obsessions and compulsions in the community: Prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry 166, 329–36.
Gray J A and Roth B L. 2001. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res Bull 56, 441–51.
Hasselbalch S G , Hansen E S , Jacobsen T B , Pinborg L H , Lønborg J H and Bolwig T G . 2007. Reduced midbrain-pons serotonin transporter binding in patients with obsessive–compulsive disorder. Acta Psychiatr Scand 115, 388–94.
Hesse S , Muller U , Lincke T , et al. 2005. Serotonin and dopamine transporter imaging in patients with obsessive–compulsive disorder. Psychiatry Res 140, 63–72.
Kapur S and Remington G. 1996. Serotonin–dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153, 466–76.
Kim C H , Cheon K A , Koo M S , et al. 2007. Dopamine transporter density in the basal ganglia in obsessive–compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors. Neuropsychobiology 55, 156–62.
Kim C H , Koo M S , Cheon K A , Ryu Y H , Lee J D , Lee H S . 2003. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive–compulsive disorder. Eur J Nucl Med Mol Imaging 30, 1637–43.
Koch S , Perry K W , Nelson D L , Conway R G , Threlkeld P G and Bymaster F P. 2002. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: An in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27, 949–59.
Laruelle M , Baldwin R M , Malison R T , et al. 1993. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse 13, 295–309.
Laruelle M , Wallace E , Seibyl J P , et al. 1994. Graphical, kinetic, and equilibrium analyses of in vivo [123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 14, 982–94.
Malison R T , Price L H , Berman R , et al. 1998. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2bcarbomethoxy-3b-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44, 1090–8.
Menzies L , Chamberlain S R , Laird A R , Thelen S M , Sahakian B J and Bullmore E T . 2008. Integrating evidence from neuroimaging and neuropsychological studies of obsessive compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32, 525–49.
Moore G J , MacMaster F P , Stewart C and Rosenberg D R . 1998. Case study: Caudate glutamatergic changes with paroxetine therapy for paediatric obsessive–compulsive disorder. J Am Acad Child Adolesc Psychiatry 37, 663–7.
Moresco R M , Pietra L , Henin M , et al. 2007. Fluvoxamine treatment and D2 receptors: A PET study on OCD drug-naïve patients. Neuropsychopharmacology 32, 197–205.
Olver J S , O'Keefe G , Jones G R , et al. 2009. Dopamine D(1) receptor binding in the striatum of patients with obsessive–compulsive disorder. J Affect Disord 114, 321–6.
Olvera-Cortés M E , Anguiano-Rodríguez P , López-Vázquez M A and Alfaro J M . 2008. Serotonin/dopamine interaction in learning. Prog Brain Res 172, 567–602.
Perani D , Garibotto V , Gorini A , et al. 2008. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naïve obsessive–compulsive disorder. Neuroimage 42, 306–14.
Pfund Z , Chugani D C , Juhasz C , et al. 2000. Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. J Cerebr Blood Flow Metab 20, 871–8.
Pirker W , Asenbaum S , Hauk M , et al. 2000. Imaging serotonin and dopamine transporters with 123I-β-CIT SPECT: Binding kinetics and effects of normal aging. J Nucl Med 41, 36–44.
Pogarell O , Hamann C , Popperl G , et al. 2003. Elevated brain serotonin transporter availability in patients with obsessive–compulsive disorder. Biol Psychiatry 54, 1406–13.
Pogarell O , Poepperl G , Mulert C , et al. 2005. SERT and DAT availabilities under citalopram treatment in obsessive–compulsive disorder (OCD). Eur Neuropsychopharmacol 15, 521–4.
Reimold M , Smolka M N , Zimmer A , et al. 2007. Reduced availability of serotonin transporters in obsessive–compulsive disorder correlates with symptom severity – A [11C]DASB PET study. J Neural Transm 114, 1603–09.
Rosario-Campos M C , Leckman J F , Mercadante M T , et al. 2001. Adults with early-onset obsessive–compulsive disorder. Am J Psychiatry 158, 1899–903.
Rosenberg D R , MacMaster F P , Keshavan M S , Fitzgerald K D and Stewart C M . 2000. Decrease in caudate glutamatergic concentrations in paediatric obsessive–compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39, 1096–103.
Rosenberg D R , Mirza Y , Russell A , et al. 2004. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 43, 1146–53.
Ruscio A M , Stein D J , Chiu W T and Kessler R C . 2010. The epidemiology of obsessive–compulsive disorder in the National Comorbidity Survey Replication Mol Psychiatry 15, 53–63.
Saiz P A , Garcia-Portilla M P , Arango C , et al. 2008. Association study between obsessive–compulsive disorder and serotonergic candidate genes. Prog Neuropsychopharmacol Biol Psychiatry 32, 765–70.
Saxena S and Rauch S L. 2000. Functional neuroimaging and the neuroanatomy of obsessive–compulsive disorder. Psychiatr Clin North Am 23, 563–86.
Schneier F R , Liebowitz M R , Abi-Dargham A , Zea-Ponce Y , Lin S H and Laruelle M . 2000. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 157, 457–9.
Schneier F R , Martinez D , Abi-Dargham A , et al. 2008. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 25, 1–7.
Schultz W. 1998. Predictive reward signal of dopamine neurons. J Neurophysiol 80, 1–27.
Simpson H B , Lombardo I , Slifstein M , et al. 2003. Serotonin transporters in obsessive–compulsive disorder: A positron emission tomography study with [11C]McN 5652. Biol Psychiatry 54, 1414–21.
Smith G S , Dewey S L , Brodie J D , et al. 1997. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Am J Psychiatry 154, 490–6.
Soomro G M , Altman D , Rajagopal S and Oakley-Browne M. 2008. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 1, CD001765.
Starck G , Ljungberg M , Nilsson M , et al. 2008. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. J Neural Transm 115, 1051–62.
Stengler-Wenzke K , Müller U , Angermeyer M C , Sabri O and Hesse S. 2004. Reduced serotonin transporter availability in obsessive–compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci 254, 252–5.
Stengler-Wenzke K , Müller U , Barthel H , Angermeyer M C , Sabri O and Hesse S . 2006. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive–compulsive disorder. Neuropsychobiology 53, 40–5.
Van der Wee N J , Stevens H , Hardeman J A , et al. 2004. Enhanced dopamine transporter density in psychotropic-naïve patients with obsessive–compulsive disorder shown by [123I]{beta}-CIT SPECT. Am J Psychiatry 161, 2201–06.
Whiteside S P , Port J D , Deacon B J and Abramowitz J S. 2006. A magnetic resonance spectroscopy investigation of obsessive–compulsive disorder and anxiety. Psychiatry Res. 146, 137–47.
Wong D F , Brašic J R , Singer H S , et al. 2008. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette Syndrome: Clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33, 1239–51.
Yücel M , Wood S J , Wellard R M , et al. 2008. Anterior cingulate glutamate–glutamine levels predict symptom severity in women with obsessive–compulsive disorder. Aust N Z J Psychiatry 42, 467–77.
Zhou F M , Liang Y , Salas R , Zhang L , De Biasi M and Dani J A . 2005. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46, 65–74.
Zitterl W , Aigner M , Stompe T , et al. 2007. [123I]-beta-CIT SPECT imaging shows reduced thalamus–hypothalamus serotonin transporter availability in 24 drugfree obsessive–compulsive checkers. Neuropsychopharmacology 32, 1661–8.
Zitterl W , Aigner M , Stompe T , et al. 2008. Changes in thalamus–hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive–compulsive disorder. Neuropsychopharmacology 33, 3126–34.

Reference Title: References

Reference Type: reference-list

Asami T , Hayano F , Nakamura M , et al. 2008. Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry Clin Neurosci 62, 322–30.
Ashburner J and Friston K J . 2000. Voxel-based morphometry – the methods. Neuroimage 11, 805–21.
Basser P J . 1995. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 8, 333–44.
Boshuisen M L , Ter Horst G J , Paans A M , Reinders A A and den Boer J A. 2002. rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry 52, 126–35.
Bystritsky A , Pontillo D , Powers M , Sabb F W , Craske M G and Bookheimer S Y . 2001. Functional MRI changes during panic anticipation and imagery exposure. Neuroreport 21, 3953–7.
Cammarota M , Bevilaqua L R , Vianna M R , Medina J H and Izquierdo I . 2007. The extinction of conditioned fear: structural and molecular basis and therapeutic use. Rev Bras Psiquiatr 29, 80–5.
Cannistraro P A and Rauch S L . 2003. Neural circuitry of anxiety: Evidence from structural and functional neuroimaging studies. Psychopharmacol Bull 37, 8–25.
Chaves C , Trzesniak C , Derenusson G N , et al. Submitted. Late-onset social anxiety disorder after traumatic brain injury.
Crippa J A S , Busatto G and McGuire P K. 2004a. Neuroimagem. In Hetem L A B , Graeff F G (Eds). Transtornos de Ansiedade. São Paulo (SP): Atheneu, pp. 133–67.
Crippa J A , Uchida R , Busatto G F , et al. 2004b. The size and prevalence of the cavum septum pellucidum are normal in subjects with panic disorder. Braz J Med Biol Res 37, 371–4.
Crippa J A S , Zuardi A W , Busatto Filho, G , et al. 2008. Grey matter correlates of cognitive measures of the simulated public speaking test in social anxiety spectrum: a voxel-based study. In 16th European Congress of Psychiatry, 2008, Nice, France. Eur Psychiatry, 23[Abstract].
Dantendorfer K , Prayer D , Kramer J , et al. 1996. High frequency of EEG and MRI brain abnormalities in panic disorder. Psychiatry Res 68, 41–53.
De Bellis M D , Casey B J , Dahl R E , et al. 2000. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry 48, 51–7.
De Bellis M D , Keshavan M S , Shifflett H , et al. 2002. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry 51, 553–62.
Deakin J W F and Graeff F G. 1991. 5-HT and mechanisms of defence. J Psychopharmacol 5, 305–15.
Ferrari M C , Busatto G F , McGuire P K and Crippa J A . 2008. Structural magnetic resonance imaging in anxiety disorders: An update of research findings. Rev Bras Psiquiatr 30, 251–64.
Fontaine R , Breton G , Déry R , Fontaine S and Elie R . 1990. Temporal lobe abnormalities in panic disorder: An MRI study. Biol Psychiatry 27, 304–10.
Freire R C , Lopes F L , Valença A M , et al. 2008. Panic disorder respiratory subtype: A comparison between responses to hyperventilation and CO2 challenge tests. Psychiatry Res 157, 307–10.
Frodl T , Jäger M , Smajstrlova I , et al. 2008. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: A 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 33, 423–30.
Good C D , Johnsrude I S , Ashburner J , Henson R N , Friston K J and Frackowiak R S . 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21–36.
Gorman J M , Kent J M , Sullivan G M and Coplan J D . 2000. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157, 493–505.
Gray J A and McNaughton N. 2000. The Neuropsychology of Anxiety. An Enquiry into the Functions of the Septo-Hippocampal System. 2nd ed. Oxford: Oxford University Press.
Gross-Isseroff R , Kushnir T , Hermesh H , Marom S , Weizman A and Manor D. 2009. Alteration learning in social anxiety disorder: An fMRI study. World J Biol Psychiatry 19, 1–5.
Guru Raj A K , Pratap R C , Jayakumar R and Ariffin W A . 1998. Clinical features and associated radiological abnormalities in 54 patients with cavum septi pellucidi. Med J Malaysia 53, 251–6.
Han D H , Renshaw P F , Dager S R , et al. 2008. Altered cingulate white matter connectivity in panic disorder patients. J Psychiatr Res 42, 399–407.
Hulshoff Pol H E , Schnack H G , Mandl R C , et al. 2001. Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58, 1118–25.
Javanmard M , Shlik J , Kennedy S H , Vaccarino F J , Houle S and Bradwejn J . 1999. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: A comparison of two time points. Biol Psychiatry 45, 872–82.
Jetty P V , Charney D S and Goddard A W . 2001. Neurobiology of generalized anxiety disorder. Psychiatr Clin North Am 24, 75–97.
Lepola U , Nousiainen U , Puranen M , Riekkinen P and Rimón R . 1990. EEG and CT findings in patients with panic disorder. Biol Psychiatry 28, 721–7.
Maddock R J , Buonocore M H , Copeland L E and Richards A L . 2009. Elevated brain lactate responses to neural activation in panic disorder: A dynamic 1H-MRS study. Mol Psychiatry 14, 537–45.
Massana G , Serra-Grabulosa J M , Salgado-Pineda P , et al. 2003a. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage 19, 80–90.
Massana G , Serra-Grabulosa J M , Salgado-Pineda P , et al. 2003b. Parahippocampal gray matter density in panic disorder: A voxel-based morphometric study. Am J Psychiatry 160, 566–8.
Mathew S J and Ho S . 2006. Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry 67 (Suppl 12), 9–13.
Menzies L , Chamberlain S R , Laird S M , Thelen S M , Sahakian B J and Bullmore E T . 2008. Integrating evidence from neuroimaging and neuropsychological studies of obsessive–compulsive disorder. Neurosci Biobehav Rev 32, 525–49.
Milham M P , Nugent A C , Drevets W C , et al. 2005. Selective reduction in amygdala volume in pediatric anxiety disorders: A voxel-based morphometry investigation. Biol Psychiatry 57, 961–6.
Ontiveros A , Fontaine R , Breton G , Elie R , Fontaine S and Dery R. 1989. Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging. J Neuropsychiatry Clin Neurosci 1, 404–08.
Paulus M P . 2008. The role of neuroimaging for the diagnosis and treatment of anxiety disorders. Depress Anxiety 25, 348–56.
Paulus M P and Stein M B . 2006. An insular view of anxiety. Biol Psychiatry 60, 383–7.
Phan K L , Orlichenko A , Boyd E , et al. 2009. Preliminary evidence of white matter abnormality in the uncinate fasciculus in generalized social anxiety disorder. Biol Psychiatry 66, 691–4.
Potts N L , Davidson J R , Krishnan K R and Doraiswamy P M . 1994. Magnetic resonance imaging in social phobia. Psychiatry Res 52, 35–42.
Protopopescu X , Pan H , Tuescher O , et al. 2006. Increased brainstem volume in panic disorder: A voxel-based morphometric study. Neuroreport 17, 361–3.
Rauch S L and Shin L M. 2002. Structural and functional imaging of anxiety and stress disorders. In Davis K L , Dennis Charney D and Coyle J T (Eds). Neuropsychopharmacology. The Fifth Generation of Progress. Baltimore, MD: Lippincott Williams and Wilkins, pp. 953–66.
Shenton M E , Dickey C C , Frumin M and McCarley R W . 2001. A review of MRI findings in schizophrenia. Schizophr Res 49, 1–52.
Takahashi T , Wood S J , Yung A R , et al. 2009. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry 66, 366–76.
Trzesniak C , Araújo D , Crippa J A S. 2008. Magnetic resonance spectroscopy in anxiety disorders. Acta Neuropsychiatr 20, 56–71.
Uchida R R , Del-Ben C M , Busatto G F , et al. 2008b. Regional gray matter abnormalities in panic disorder: A voxel-based morphometry study. Psychiatry Res 163, 21–9.
Uchida R R , Del-Ben C M , Santos A C , et al. 2003. Decreased volume of left temporal lobe in panic patients measured through magnetic resonance imaging. Braz J Med Biol Res 36, 925–9.
Uhde T W and Kellner C H . 1987. Cerebral ventricular size in panic disorder. J Affect Disord 12, 175–8.
Vythilingam M , Anderson E R , Goddard A , et al. 2000. Temporal lobe volume in panic disorder – a quantitative magnetic resonance imaging study. Psychiatry Res 99, 75–82.
Wurthmann C , Bogerts B , Gregor J , Baumann B , Effenberger O and Döhring W . 1997. Frontal CSF enlargement in panic disorder: A qualitative CT-scan study. Psychiatry Res 76, 83–7.
Yoo H K , Kim M J , Kim S J , et al. 2005. Putaminal gray matter volume decrease in panic disorder: An optimized voxel-based morphometry study. Eur J Neurosci 22, 2089–94.

Reference Title: References

Reference Type: reference-list

Alonso J and Lepine J P . 2007. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry 68 (Suppl 2), 3–9.
American PsychiatricAssociation . 2000. Diagnostic and Statistical Manual of Mental Disorders —Text Revision (4th edition). Philadelphia, PA: APA.
Butler T , Pan H , Tuescher O , et al. 2007. Human fear-related motor neurocircuitry. Neuroscience 150, 1–7.
Bystritsky A , Pontillo D , Powers M , Sabb F W , Craske M G and Bookheimer S Y . 2001. Functional MRI changes during panic anticipation and imagery exposure. Neuroreport 12, 3953–7.
Canli T and Lesch K P . 2007. Long story short: The serotonin transporter in emotion regulation and social cognition. Nat Neurosci 10, 1103–09.
Chechko N , Wehrle R , Erhardt A , Holsboer F , Czisch M and Samann P G . 2009. Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder. PLoS One 4, e5537, 1–11.
Damsa C , Kosel M and Moussally J . 2009. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry 22, 96–110.
Del-Ben C M and Graeff F G . 2009. Panic disorder: Is the PAG involved? Neural Plast 2009, 108135, 1–9.
Delgado M R , Nearing K I , Ledoux J E and Phelps E A . 2008. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 59, 829–38.
Dieler A C , Samann P G , Leicht G , et al. 2008. Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): New insights into the functional networks underlying panic attacks as induced by CCK-4. Curr Pharm Des 14, 3492–507.
Domschke K , Braun M , Ohrmann P , et al. 2006. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9, 349–55.
Domschke K , Ohrmann P , Braun M , et al. 2008. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163, 13–20.
Engel K , Bandelow B , Gruber O and Wedekind D . 2009. Neuroimaging in anxiety disorders. J Neural Transm 116, 703–16.
Eser D , Leicht G , Lutz J , et al. 2009. Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. Hum Brain Mapp 30, 511–22.
Etkin A, Egner T , Peraza D M , Kandel E R and Hirsch J . 2006. Resolving emotional conflict: A role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 51, 871–82.
Etkin A and Wager T D . 2007. Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164, 1476–88.
Gorman J M , Kent J M , Sullivan G M and Coplan J D . 2000. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157, 493–505.
Graeff F G and Del-Ben C M . 2008. Neurobiology of panic disorder: From animal models to brain neuroimaging. Neurosci Biobehav Rev 32, 1326–35.
Kessler R C , Berglund P , Demler O , Jin R , Merikangas K R and Walters E E . 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62, 593–602.
Maddock R J , Buonocore M H , Kile S J and Garrett A S . 2003. Brain regions showing increased activation by threat-related words in panic disorder. Neuroreport 14, 325–8.
Meyer-Lindenberg A and Weinberger D R . 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7, 818–27.
Pfleiderer B , Zinkirciran S , Arolt V , Heindel W , Deckert J , Domschke K . 2007. fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J Biol Psychiatry 8, 269–72.
Phelps E A , O'Connor K J , Gatenby J C , Gore J C , Grillon C and Davis M . 2001. Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci 4, 437–41.
Pillay S S , Gruber S A , Rogowska J , Simpson N and Yurgelun-Todd D A . 2006. fMRI of fearful facial affect recognition in panic disorder: The cingulate gyrus–amygdala connection. J Affect Disord 94, 173–81.
Pillay S S , Rogowska J , Gruber S A , Simpson N and Yurgelun-Todd D A . 2007. Recognition of happy facial affect in panic disorder: An fMRI study. J Anxiety Disord 21, 381–93.
Protopopescu X , Pan H , Tuescher O , et al. 2006. Increased brainstem volume in panic disorder: A voxel-based morphometric study. Neuroreport 17, 361–3.
Rauch S L , Shin L M and Wright C I . 2003. Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci 985, 389–410.
Schunck T , Erb G , Mathis A , et al. 2006. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage 31, 1197–208.
Silbersweig D A and Stern E . 1997. Symptom localization in neuropsychiatry. A functional neuroimaging approach. Ann N Y Acad Sci 835, 410–20.
Simmons A , Matthews S C , Paulus M P and Stein M B . 2008. Intolerance of uncertainty correlates with insula activation during affective ambiguity. Neurosci Lett 430, 92–7.
Stern E and Silbersweig D A . 2001. Advances in functional neuroimaging methodology for the study of brain systems underlying human neuropsychological function and dysfunction. J Clin Exp Neuropsychol 23, 3–18.
Tuescher O , Protopopescu X , Pan H , et al. in press. Differential activation of the subgenual cingulate and brainstem in Panic Disorder and PTSD.
Thomas K M , Drevets W C , Dahl R E , et al. 2001. Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 58, 1057–63.
van den Heuvel O A , Veltman D J , Groenewegen H J , et al. 2005. Disorder-specific neuroanatomical correlates of attentional bias in obsessive–compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry 62, 922–33.
Whalen P J . 2007. The uncertainty of it all. Trends Cogn Sci 11, 499–500.
Wiest G , Lehner-Baumgartner E and Baumgartner C . 2006. Panic attacks in an individual with bilateral selective lesions of the amygdala. Arch Neurol 63, 1798–801.

Reference Title: References

Reference Type: reference-list

Abadie P , Boulenger J P , Benali K , Barre L , Zarifian E and Baron J C . 1999. Relationships between trait and state anxiety and the central benzodiazepine receptor: A PET study. Eur J Neurosci 11, 1470–8.
Atack J R . 2005. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Exp Opin Investig Drugs 14, 601–18.
Blair K , Shaywitz J , Smith B W , et al. 2008. Response to emotional expressions in generalized social phobia and generalized anxiety disorder: Evidence for separate disorders. Am J Psychiatry 165, 1193–202.
Bonne O , Bain E , Neumeister A , et al. 2005. No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. Am J Psychiatry 162, 383–5.
Bremner J D , Innis R B , Southwick S M , Staib L , Zoghbi S and Charney D S . 2000a. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 157, 1120–6.
Bremner J D , Innis R B , White T , et al. 2000b. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 47, 96–106.
Briones-Aranda A , Rocha L and Picazo O . 2005. Influence of forced swimming stress on 5-HT1A receptors and serotonin levels in mouse brain. Prog Neuropsychopharmacology Biol Psychiatry 29, 275–81.
Cameron O G , Huang G C , Nichols T , et al. 2007. Reduced gamma-aminobutyric acid(A)–benzodiazepine binding sites in insular cortex of individuals with panic disorder. Arch Gen Psychiatry 64, 793–800.
Caspi A , Sugden K , Moffitt T E , et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (New York, N.Y.) 301, 386–9.
Coplan J D , Mathew S J , Mao X , et al. 2006. Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: Relationship to IQ and early trauma. Psychiatry Res 147, 27–39.
de Win M M , Habraken J B , Reneman L , van den Brink W , den Heeten G J and Booij J . 2005. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: A double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology 30, 996–1005.
Domschke K , Deckert J , O'Donovan M C and Glatt S J . 2007. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet Part B Neuropsychiatric Genet 144B, 667–73.
Etkin A and Wager T D . 2007. Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164, 1476–88.
Fox N A , Nichols K E , Henderson H A , et al. 2005. Evidence for a gene–environment interaction in predicting behavioral inhibition in middle childhood. Psychol Sci 16, 921–6.
Fujita M , Southwick S M , Denucci C C , et al. 2004. Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder. Biol Psychiatry 56, 95–100.
Geuze E , van Berckel B N , Lammertsma A A , et al. 2008. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 13, 74–83, 3.
Goddard A W , Mason G F , Almai A , et al. 2001. Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Arch Gen Psychiatry 58, 556–61.
Goddard A W , Mason G F , Appel M , et al. 2004. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 161, 2186–93.
Graeff F G . 2004. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28, 239–59.
Graeff F G . 2002. On serotonin and experimental anxiety. Psychopharmacology 163, 467–76.
Gross C , Zhuang X , Stark K , et al. 2002. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396–400.
Hariri A R , Drabant E M , Munoz K E , et al. 2005. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 62, 146–52.
Hasler G , Nugent A C , Carlson P J , Carson R E , Geraci M and Drevets W C . 2008. Altered cerebral gamma-aminobutyric acid type A–benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 65, 1166–75.
Hasler G , van der Veen J W , Geraci M , Shen J , Pine D and Drevets W C . 2009. Prefrontal cortical gamma-aminobutyric acid levels in panic disorder determined by proton magnetic resonance spectroscopy. Biol Psychiatry 65, 273–5.
Kalueff A V and Nutt D J . 2007. Role of GABA in anxiety and depression. Depress Anxiety 24, 495–517.
Kaschka W , Feistel H and Ebert D . 1995. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J Psychiatric Res 29, 427–34.
Kent J M , Coplan J D , Lombardo I , et al. 2002a. Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: A positron emission tomography study with 11C McN 5652. Psychopharmacology 164, 341–8.
Kent J M , Mathew S J and Gorman J M . 2002b. Molecular targets in the treatment of anxiety. Biol Psychiatry 52, 1008–30.
Klemenhagen K C , Gordon J A , David D J , Hen R and Gross C T . 2006. Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology 31, 101–11.
Kuikka J T , Pitkanen A , Lepola U , et al. 1995. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun 16, 273–80.
Kusserow H , Davies B , Hortnagl H , et al. 2004. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res Mol Brain Res 129, 104–16.
Lanzenberger R R , Mitterhauser M , Spindelegger C , et al. 2007. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61, 1081–9.
LeDoux J E . 2000. Emotion circuits in the brain. Annu Rev Neurosci 23, 155–84.
Lemonde S , Turecki G , Bakish D , et al. 2003. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23, 8788–99.
Lesch K P , Bengel D , Heils A , et al. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (New York, N.Y.) 274, 1527–31.
Malizia A L , Cunningham V J , Bell C J , Liddle P F , Jones T and Nutt D J . 1998. Decreased brain GABA(A)–benzodiazepine receptor binding in panic disorder: Preliminary results from a quantitative PET study. Arch Gen Psychiatry 55, 715–20.
Maron E , Kuikka J T , Ulst K , Tiihonen J , Vasar V and Shlik J . 2004. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci 254, 392–6.
Mathew S J , Coplan J D and Gorman J M . 2001. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 158, 1558–67.
Mathew S J , Mao X , Coplan J D , et al. 2004. Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: A proton magnetic resonance spectroscopic imaging study. Am J Psychiatry 161, 1119–21.
Mathew S J , Price R B , Mao X , et al. 2008. Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder. Biol Psychiatry 63, 891–8.
McClure E B , Monk C S , Nelson E E , et al. 2007. Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry 64, 97–106.
Monk C S , Nelson E E , McClure E B , et al. 2006. Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry 163, 1091–7.
Monk C S , Telzer E H , Mogg K , et al. 2008. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry 65, 568–76.
Morris H V , Dawson G R , Reynolds D S , Atack J R and Stephens D N . 2006. Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur J Neurosci 23, 2495–504.
Morrow B A , Elsworth J D , Rasmusson A M and Roth R H . 1999. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 92, 553–64.
Neumeister A , Bain E , Nugent A C , et al. 2004a. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24, 589–91.
Neumeister A , Nugent A C , Waldeck T , et al. 2004b. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 61, 765–73.
Nutt D J and Malizia A L . 2001. New insights into the role of the GABA(A)–benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179, 390–6.
Ongur D , Ferry A T and Price J L . 2003. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 460, 425–49.
Paulus M P and Stein M B . 2006. An insular view of anxiety. Biol Psychiatry 60, 383–7.
Phan K L , Fitzgerald D A , Nathan P J and Tancer M E . 2006. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 59, 424–9.
Phan K L , Wager T , Taylor S F and Liberzon I . 2002. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16, 331–48.
Pollack M H , Jensen J E , Simon N M , Kaufman R E and Renshaw P F . 2008. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry 32, 739–43.
Quirk G J , Garcia R and Gonzalez-Lima F . 2006. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 60, 337–43.
Rauch S L , Shin L M and Phelps E A . 2006. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research – Past, present, and future. Biol Psychiatry 60, 376–82.
Schlegel S , Steinert H , Bockisch A , Hahn K , Schloesser R and Benkert O . 1994. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci 244, 49–51.
Schneier F R , Liebowitz M R , Abi-Dargham A , Zea-Ponce Y , Lin S H and Laruelle M . 2000. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 157, 457–9.
Schneier F R , Martinez D , Abi-Dargham A , et al. 2008. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: Preliminary findings. Depress Anxiety 25, 1–7.
Shin L M , Orr S P , Carson M A , et al. 2004. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry 61, 168–76.
Shin L M , Wright C I , Cannistraro P A , et al. 2005. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psych 62, 273–81.
Smith T A . 2001. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: Significance to clinical syndromes and their treatment. Br J Biomed Sci 58, 111–21.
Stein M B , Goldin P R , Sareen J , Zorrilla L T and Brown G G . 2002. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59, 1027–34.
Straube T , Mentzel H J and Miltner W H . 2006. Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia. Biol Psychiatry 59, 162–70.
Sullivan G M , Oquendo M A , Simpson N , Van Heertum R L , Mann J J and Parsey R V . 2005. Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety. Biol Psychiatry 58, 947–54.
Tiihonen J , Kuikka J , Bergstrom K , Lepola U , Koponen H and Leinonen E . 1997a. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154, 239–42.
Tiihonen J , Kuikka J , Rasanen P , et al. 1997b. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: A fractal analysis. Mol Psychiatry 2, 463–71.
Vaiva G , Thomas P , Ducrocq F , et al. 2004. Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol Psychiatry 55, 250–4.
van den Heuvel O A , Veltman D J , Groenewegen H J , et al. 2005. Disorder-specific neuroanatomical correlates of attentional bias in obsessive–compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry 62, 922–33.
van der Wee N J , van Veen J F , Stevens H , van Vliet I M , van Rijk P P and Westenberg H G . 2008. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med 49, 757–63.
Ventura R , Cabib S and Puglisi-Allegra S . 2002. Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral “despair” in a mouse model of depression. Neuroscience 115, 999–1007.
Zhang W , Connor K M and Davidson J R . 2005. Levetiracetam in social phobia: A placebo controlled pilot study. J Psychopharmacol (Oxford, England) 19, 551–3.

Reference Title: Suggested reading

Reference Type: further-reading

Baxter L R Jr, Phelps M E , Mazziotta J C , Guze B H , Schwartz J M and Selin C E. 1987. Local cerebral glucose metabolic rates in obsessive–compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 44, 211–8.
Bush G , Luu P and Posner M I . 2000. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4, 215–22.
Cannistraro P A , Wright C I , Wedig M M , et al. 2004. Amygdala responses to human faces in obsessive–compulsive disorder. Biol Psychiatry 56, 916–20.
Davis M , Ressler K , Rothbaum B O and Richardson R . 2006. Effects of d-cycloserine on extinction: Translation from preclinical to clinical work. Biol Psychiatry 60, 369–75.
Evans K C , Dougherty D D , Pollack M H and Rauch S L . 2006. Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry 18, 33–42.
Haber S N and Brucker J L . 2009. Cognitive and limbic circuits that are affected by deep brain stimulation. Front Biosci 14, 1823–34.
Hariri A R , Drabant E M and Weinberger D R . 2006. Imaging genetics: Perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 59, 888–97.
Isacson O and Kordower J H . 2008. Future of cell and gene therapies for Parkinson's disease. Ann Neurol 64 (Suppl 2): S122–38.
Kringelbach M L and Rolls E T . 2004. The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology. Prog Neurobiol 72, 341–72.
Paulus M P and Stein M B . 2006. An insular view of anxiety. Biol Psychiatry 60, 383–7.
Rauch S L , Shin L M and Wright C I . 2003. Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci 985, 389–410.
Rauch S L , Shin L M and Phelps E A . 2006. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research – Past, present, and future. Biol Psychiatry 60, 376–82.
Reiman E M . 1988. The quest to establish the neural substrates of anxiety. Psychiatr Clin North Am 11, 295–307.
Schwartz C E , Wright C I , Shin L M , Kagan J and Rauch S L . 2003. Inhibited and uninhibited infants “grown up”: Adult amygdalar response to novelty. Science 300, 1952–3.
Sowell E R , Peterson B S , Thompson P M , Welcome S E , Henkenius A L and Toga A W . 2003. Mapping cortical change across the human life span. Nat Neurosci 6, 309–15.

Reference Title: References

Reference Type: reference-list

Aganj I , Sapiro G , Parikshak N , Madsen S K and Thompson P M . 2009. Measurement of cortical thickness from MRI by minimum line integrals on soft-classified tissue. Hum Brain Mapp 30, 3188–99.
Apostolova L G , Akopyan G G , Partiali N , et al. 2007a. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 24, 91–7.
Apostolova L G , Beyer M K , Green A E , et al. 2010d. Hippocampal, caudate and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 25, 687–8.
Apostolova L G , Dinov I D , Dutton R A , et al. 2006a. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 129, 2867–73.
Apostolova L G , Dutton R A , Dinov I D et al. 2006b. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63, 693–9.
Apostolova L G , Lu P , Rogers S , et al. 2008. 3D mapping of language networks in clinical and pre-clinical Alzheimer's disease. Brain Lang 104, 33–41.
Apostolova L G , Lu P H , Rogers S , et al. 2006c. 3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 20, 224–31.
Apostolova L G , Mosconi L , Thompson P M , et al. 2010a. Subregional hippocampal atrophy predicts future decline to Alzheimer's dementia in cognitively normal subjects. Neurobiol Aging 31, 1077–1088.
Apostolova L G , Steiner C A , Akopyan G G , et al. 2007b. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol 64, 1489–95.
Apostolova L G and Thompson P M . 2007. Brain mapping as a tool to study neurodegeneration. Neurotherapeutics 4, 387–400.
Apostolova L G and Thompson P M . 2008. Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia 46, 1597–612.
Apostolova L G , Thompson P M , Green A E , et al. 2010b. 3D comparison of low, intermediate and advanced hippocampal atrophy in MCI. Brain 31, 786–97.
Apostolova L G , Thompson P M , Rogers S A , et al. 2010c. Surface feature-guided mapping of longitudinal FDG-PET changes in nondemented elderly. Mol Imag Biol 12, 218–24.
Ashburner J . 2007. A fast diffeomorphic image registration algorithm. Neuroimage 38, 95–113.
Ashburner J and Friston K J . 2000. Voxel-based morphometry – The methods. Neuroimage 11, 805–21.
Ashburner J and Friston K J . 2005. Unified segmentation. Neuroimage 26, 839–51.
Bakkour A , Morris J C and Dickerson B C. 2009. The cortical signature of prodromal AD. Regional thinning predicts mild AD dementia. Neurology 72, 1048–55.
Ballmaier M , O'Brien J T , Burton E J , et al. 2004. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: Diagnosis and gender effects. Neuroimage 23, 325–35.
Bearden C E , Thompson P M , Dalwani M , et al. 2007. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62, 7–16.
Bookstein F L . 2001. “Voxel-based morphometry” should not be used with imperfectly registered images. Neuroimage 14, 1454–62.
Braak H and Braak E . 1991. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82, 239–59.
Braskie M N , Klunder A D , Hayashi K M , et al. 2010. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging Nov 10. 31, 1669–78.
Carmichael O T , Aizenstein H A , Davis S W , et al. 2005. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 27, 979–90.
Carmichael O T , Kuller L H , Lopez O L , et al. 2007. Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol Aging 28, 389–97.
Chiang M C , Dutton R A , Hayashi K M , et al. 2007. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 34, 44–60.
Chou Y , Lepore N , Avedissian C , et al. 2009. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage 46, 394–410.
Chou Y , Lepore N , Zubicaray G I, et al. 2007. Automated 3D mapping and shape analysis of the lateral ventricles via fluid registration of multiple surface-based atlases. Proceedings of the 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro. Arlington, VA: IEEE Press, 1288–91.
Chou Y , Lepore N , de Zubicaray G I, et al. 2008a. Automated ventricular mappping with multi-atlas fluid image allignment reveals genetic effects in Alzheimer's disease. Neuroimage 40, 615–30.
Chou Y Y , Lepore N , de Zubicaray G I , et al. 2008b. Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease. Neuroimage 40, 615–30.
Christensen G E , Rabbitt R D and Miller M I . 1996. Deformable templates using large deformation kinematics. IEEE Trans Image Process 5, 1435–47.
Chupin M , Mukuna-Bantumbakulu A R , Hasboun D , et al. 2007. Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: Method and validation on controls and patients with Alzheimer's disease. Neuroimage 34, 996–1019.
Crum W R , Scahill R I and Fox N C . 2001. Automated hippocampal segmentation by regional fluid registration of serial MRI: Validation and application in Alzheimer's disease. Neuroimage 13, 847–55.
Csernansky J G , Wang L , Joshi S , et al. 2000. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 55, 1636–43.
Csernansky J G , Wang L , Swank J , et al. 2005. Preclinical detection of Alzheimer's disease: Hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25, 783–92.
Cummings J L , Doody R and Clark C . 2007. Disease-modifying therapies for Alzheimer disease: Challenges to early intervention. Neurology 69, 1622–34.
de Leon M J , Mosconi L , Blennow K , et al. 2007. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci 1097, 114–45.
de Toledo-Morrell L , Dickerson B , Sullivan M P , Spanovic C , Wilson R and Bennett D A . 2000. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 10, 136–42.
Dickerson B C , Bakkour A , Salat D H , et al. 2009. The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19, 497–510.
Dickerson B C and Sperling R A . 2008. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies. Neuropsychologia 46, 1624–35.
Dubois B and Albert M L . 2004. Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurology 3, 246–8.
Dubois B , Feldman H H , Jacova C , et al. 2007. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734–46.
Durrleman S , Pennec X , Trouve A , Thompson P and Ayache N . 2008. Inferring brain variability from diffeomorphic deformations of currents: An integrative approach. Med Image Anal 12, 626–37.
Duyckaerts C and Dickson D W . 2003. Neuropathology of Alzheimer's disease. In Dickson D W (Ed.) Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: ISN Neuropath Press, pp. 47–65.
Fischl B , Salat D H , Busa E , et al. 2002. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–55.
Fischl B , Salat D H , van der Kouwe A J , et al. 2004. Sequence-independent segmentation of magnetic resonance images. Neuroimage 23 (Suppl 1), S69–84.
Fox N C , Warrington E K and Rossor M N . 1999. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 353, 2125.
Freund Y and Shapire R . 1997. A decision-theoretic generalization of online learning and an application to boosting. J Comp Sys Sci 55, 119–39.
Frisoni G B , Pievani M , Testa C , et al. 2007. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 130, 720–30.
Gogtay N , Giedd J N , Lusk L , et al. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101, 8174–9.
Golland P , Grimson W E , Shenton M E and Kikinis R . 2005. Detection and analysis of statistical differences in anatomical shape. Med Image Anal 9, 69–86.
Grundman M , Jack C R Jr, Petersen R C , et al. 2003. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci 20, 241–8.
Hammers A , Heckemann R , Koepp M J , et al. 2007. Automatic detection and quantification of hippocampal atrophy on MRI in temporal lobe epilepsy: A proof-of-principle study. Neuroimage 36, 38–47.
Haroutunian V , Perl D P , Purohit D P , et al. 1998. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 55, 1185–91.
Hebert L E , Scherr P A , Bienias J L , Bennett D A and Evans D A . 2003. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60, 1119–22.
Hogan R E , Mark K E , Wang L , Joshi S , Miller M I and Bucholz R D. 2000. Mesial temporal sclerosis and temporal lobe epilepsy: MR imaging deformation-based segmentation of the hippocampus in five patients. Radiology 216, 291–7.
Hua X , Leow A D , Parikshak N , et al. 2008. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects. Neuroimage 43, 458–69.
Jack C R Jr, Bernstein M A , Fox N C , et al. 2008. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27, 685–91.
Jack C R Jr, Shiung M M , Gunter J L , et al. 2004. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591–600.
Joshi A A , Shattuck D W , Thompson P M and Leahy R M . 2007. Surface-constrained volumetric brain registration using harmonic mappings. IEEE Trans Med Imaging 26, 1657–69.
Klein A , Andersson J , Ardekani B A , et al. 2009. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46, 786–802.
Lao Z , Shen D , Jawad A , et al. 2006. Automated segmentation of white matter lesions in 3D brain MRI images, using multivariate pattern classification. In Proceedings of the 3rd IEEE International Symposium on Biomedical Imaging. Arlington, VA, IEEE Press, pp. 307–10.
Leow A , Yu C L , Lee S J , et al. 2005. Brain structural mapping using a novel hybrid implicit/explicit framework based on the level-set method. Neuroimage 24, 910–27.
Leow A D , Yanovsky I , Parikshak N , et al. 2009. Alzheimer's Neuroimaging Initiative: A one-year follow-up study correlating degenerative rates, biomarkers and cognition. Neuroimage 45, 645–55.
Lepore N , Brun C , Chou Y Y , et al. 2008. Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging 27, 129–41.
Lerch J P , Pruessner J C , Zijdenbos A , et al. 2005. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex 15, 995–1001.
Lerch J P , Pruessner J , Zijdenbos A P , et al. 2008. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol Aging 29, 23–30.
Lin J J , Salamon N , Lee A D , et al. 2007. Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex 17, 2007–18.
Liu L M , Wang Y L , Thompson P M and Chan T F . 2008. Optimized conformal parameterization of cortical surfaces using shape based matching of landmark curves. Medical Image Computing and Computer Assisted Intervention, Lecture Notes in Computer Science, 494–502.
Lu L H , Dapretto M , O'Hare E D , et al. 2009. Experience mediates brain function–brain structure correlates in children. J Neurosci Feb 24. [Epub ahead of print].
Michie P T , Budd T W , Fulham W R , et al. 2008. The potential for new understandings of normal and abnormal cognition by integration of neuroimaging and behavioral data: not an exercise bringing coals to Newcastle. Brain Imag Behav published online, December 2008.
Morra J H , Tu Z , Apostolova L G , Green A , Toga A W and Thompson P M . 2010. Comparison of Adaboost and Support Vector Machines for detecting Alzheimer's disease through automated hippocampal segmentation. IEEE Trans Med Imaging 29, 30–43.
Morra J H , Tu Z , Apostolova L G , et al. 2008a. Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage 43, 59–68.
Morra J H , Tu Z , Apostolova L G , et al. 2009a. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Hum Brain Mapp 30, 2766–88.
Morra J H , Tu Z , Apostolova L G , et al. 2009b. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 30, 2766–88.
Morra J H , Tu Z , Apostolova L G , et al. 2009c. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 45 (1 Suppl), S3–15.
Morra J H , Tu Z , Apostolova L G , Green A E , Toga A W and Thompson P M . 2008b. Automatic subcortical segmentation using a contextual model. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 11, 194–201.
Morra J H , Tu Z , Toga A W and Thompson P M . 2009d. Machine learning for brain image segmentation. In Gonzalez F and Romero E (Eds.) Biomedical Image Analysis and Machine Learning Technologies. Available from: http://ebook30.com/internet/internet/199031/biomedical-image-analysis-and-machine-learning-technologies-applications-and-techniques-premier-reference-source.html
Perelman G . 2002. The entropy formula for the Ricci flow and its geometric applications. arXiv:math.DG/0211159 2002.
Petersen R C . 2007. Mild cognitive impairment. Contin Lifelong Learning Neurol 13, 13–36.
Petersen R C , Doody R , Kurz A , et al. 2001. Current concepts in mild cognitive impairment. Arch Neurol 58, 1985–92.
Petersen R C , Thomas R G , Grundman M , et al. 2005. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352, 2379–88.
Pohl K M , Kikinis R and Wells W M . 2007. Active mean fields: Solving the mean field approximation in the level set framework. Inf Process Med Imaging 20, 26–37.
Powell S , Magnotta V A , Johnson H , Jammalamadaka V K , Pierson R and Andreasen N C . 2008. Registration and machine learning-based automated segmentation of subcortical and cerebellar brain structures. Neuroimage 39, 238–47.
Price J L and Morris J C . 1999. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann Neurol 45, 358–68.
Raji C A , Ho A J , Parikshak N , et al. 2009. Tensor Based Morphometry of body mass index, insulin and type II diabetes effects on brain structure in the Cardiovascular Health Cognition study. PNAS submitted.
Rasser P E , Johnston P , Lagopoulos J , et al. 2005. Functional MRI BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage 26, 941–51.
Reisberg B , Franssen E H , Hasan S M , et al. 1999. Retrogenesis: Clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Eur Arch Psychiatry Clin Neurosci 249 (Suppl 3), 28–36.
Salloway S , Ferris S , Kluger A , et al. 2004. Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial. Neurology 63, 651–7.
Schuff N , Woerner N , Boreta L , et al. 2009. Progression of hippocampal decline in Alzheimer's disease and mild cognitive impairmant in relation to ApoE status and CSF biomarkers: An MRI study of ADNI. Brain 132, 1067–77.
Shattuck D W , Sandor-Leahy S R , Schaper K A , Rottenberg D A and Leahy R M . 2001. Magnetic resonance image tissue classification using a partial volume model. Neuroimage 13, 856–76.
Shen D , Moffat S , Resnick S M and Davatzikos C . 2002. Measuring size and shape of the hippocampus in MR images using a deformable shape model. Neuroimage 15, 422–34.
Shi Y , Thompson P M , Dinov I , Osher S and Toga A W . 2007a. Direct cortical mapping via solving partial differential equations on implicit surfaces. Med Image Anal 11, 207–23.
Shi Y , Tu Z , Reiss A L , et al. 2007b. Joint sulci detection using graphical models and boosted priors. Inf Process Med Imaging 20, 98–109.
Singh V , Chertkow H , Lerch J P , Evans A C , Dorr A E and Kabani N J . 2006. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 129, 2885–93.
Sowell E R , Kan E , Yoshii J , et al. 2008. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 11, 637–9.
Sowell E R , Peterson B S , Kan E , et al. 2007. Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex 17, 1550–60.
Sowell E R , Peterson B S , Thompson P M , Welcome S E , Henkenius A L and Toga A W . 2003a. Mapping cortical change across the human life span. Nat Neurosci 6, 309–15.
Sowell E R , Thompson P M , Welcome S E , Henkenius A L , Toga A W and Peterson B S . 2003b. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362, 1699–707.
Thacker N . 2003. Tutorial: A critical analysis of VBM. Available at: http://www.tina-vision.net/docs/memos/2003-011.pdf. Last updated 08/28/05. Accessed 03/17/07 2003.
Thal L J , Carta A , Doody R , et al. 1997. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 11 (Suppl 3), 46–9.
Thompson P M and Apostolova L G . 2007. Computational anatomical methods as applied to ageing and dementia. Br J Radiol 80 (Spec No 2), S78–91.
Thompson P M , Bartzokis G , Hayashi K M , et al. 2009. Time-lapse mapping reveals different disease trajectories in schizophrenia depending on antipsychotic treatment. Cereb Cortex 19, 1107–23.
Thompson P M , Dutton R A , Hayashi K M , et al. 2005a. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A 102, 15 647–52.
Thompson P M , Giedd J N , Woods R P , MacDonald D , Evans A C and Toga A W . 2000. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 404, 190–3.
Thompson P M , Hayashi K M , de Zubicaray G , et al. 2003. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23, 994–1005.
Thompson P M , Hayashi K M , De Zubicaray G I , et al. 2004a. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22, 1754–66.
Thompson P M , Hayashi K M , Simon S L , et al. 2004b. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24, 6028–36.
Thompson P M , Hayashi K M , Sowell E R , et al. 2004c. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 (Suppl 1), S2–18.
Thompson P M , Lee A D , Dutton R A , et al. 2005b. Abnormal cortical complexity and thickness profiles mapped in Williams syndrome. J Neurosci 25, 4146–58.
Thompson P M , Mega M S , Woods R P , et al. 2001. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 11, 1–16.
Viola P and Jones M . 2004. Robust real-time face detection. Int J Comp Vision 57, 137–54.
von Economo C . 1929. The Cytoarchitectonics of the Human Cerebral Cortex. London: Oxford Medical Publications.
Wang Y L , Chiang M C and Thompson P M. 2005. Automated Surface Matching Using Mutual Information Applied to Reimann Surface Structures. MICCAI. Palm Springs, CA., Berlin: Springer, pp. 666–74.
Wang Y L , Gu X , Chan T F , Thompson P M and Yau S T . 2008. Brain mapping with the Ricci flow conformal parametrization and multivariate statistics on deformation tensors. MICCAI Workshop on Mathematical Foundations of Computational Anatomy (MFCA), 13 May 2008.
Wells W M III, Grimson W E L , Kikinis R and Jolesz F A. 1996. Adaptive segmentation of MRI data. Med Imag IEEE Trans 15, 429–42.
Wimo A , Jonsson L and Winblad B . 2006. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord 21, 175–81.
Wright I C , McGuire P K , Poline J B , et al. 1995. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage 2, 244–52.
Yanovsky I , Leow A D , Osher S J and Thompson P M . 2009. Asymmetric and symmetric unbiased image registration: Statistical assessment of performance. Med Image Anal 13, 679–700.
Yushkevich P A , Piven J , Hazlett H C , et al. 2006. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 31, 1116–28.

Reference Title: References

Reference Type: reference-list

Aizenstein H J , Nebes R D , Saxton J A , et al. 2008. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65, 1509–17.
Allen G , Barnard H , McColl R , Hester A L , Fields J A and Weiner M F . 2007. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol 64, 1482–7.
Almkvist O , Axelman K , Basun H et al. 2003. Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: A model of mild cognitive impairment. Acta Neurol Scand Suppl 179, 77–82.
Alzheimer's Association . 2008. Alzheimer's disease facts and figures. Alzheimer's Dementia 4, 110–33.
Arnaiz E , Jelic V , Almkvist O , et al. 2001. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 12, 851–5.
Bäckman L , Andersson J L , Nyberg L , Winblad B , Nordberg A and Almkvist O . 1999. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 52, 1861–70.
Bacskai B J , Frosch M P , Freeman S H , et al. 2007. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: A case report. Arch Neurol 64, 431–4.
Bai F , Zhang Z , Watson D R , et al. 2009. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment. Biol Psychiatry 65, 951–8.
Bartrés-Faz D , Serra-Grabulosa J M , Sun F T , et al. 2008. Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE epsilon4 allele. Neurobiol Aging 29, 1644–53.
Bassett S S , Yousem D M , Cristinzio C , et al. 2006. Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain 129, 1229–39.
Basun H , Bogdanovic N , Ingelsson M , et al. 2008. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 65, 499–505.
Becker J T , Mintun M A , Aleva K , Wiseman M B , Nichols T and Dekosky S T . 1996a. Alterations in functional neuroanatomical connectivity in Alzheimer's disease. Positron emission tomography of auditory verbal short-term memory. Ann N Y Acad Sci 777, 239–42.
Becker J T , Mintun M A , Aleva K , Wiseman M B , Nichols T and Dekosky S T . 1996b. Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology 46, 692–700.
Bentley P , Driver J and Dolan R J 2008. Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Brain 131, 409–24.
Bokde A L , Lopez-Bayo P , Meindl T , et al. 2006. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment Brain 129, 1113–24.
Bondi M W , Houston W S , Eyler L T and Brown G G . 2005. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer's disease. Neurology 64, 501–8.
Bookheimer S Y , Strojwas M H , Cohen M S , et al. 2000. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343, 450–6.
Borghesani P R , Johnson L C , Shelton A L , et al. 2008. Altered medial temporal lobe responses during visuospatial encoding in healthy APOEε4 carriers. Neurobiol Aging 29, 981–91.
Bosscher L and Scheltens P H . 2001. MRI of the Temporal Lobe. Evidence-Based Dementia. Oxford: Blackwell.
Bradley K M , O'sullivan V T , Soper N D , et al. 2002. Cerebral perfusion SPECT correlated with Braak pathological stage in Alzheimer's disease. Brain 125, 1772–81.
Buckner R L , Snyder A Z , Sanders A L , Raichle M E and Morris J C . 2000. Functional brain imaging of young, nondemented, and demented older adults. J Cogn Neurosci 12 (Suppl. 2), 24–34.
Burggren A C , Small G W , Sabb F W and Bookheimer S . 2002. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry 10, 44–51.
Caselli R J , Chen K , Lee W , Alexander G E and Reiman E M . 2008. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. Arch Neurol 65, 1231–6.
Celone K A , Calhoun V D , Dickerson B C , et al. 2006. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. J Neurosci 26, 10 222–31.
Chételat G , Desgranges B , De La Sayette V , et al. 2003. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 126, 1995–67.
Chételat G , Eustache F , Viader F , et al. 2005. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment Neurocase 11, 14–25.
Craig-Schapiro R , Fagan A M and Holtzman D M . 2009. Biomarkers of Alzheimer's disease. Neurobiol Dis 35, 128–40.
D'Esposito M , Deouell L Y and Gazzaley A . 2003. Alterations in the BOLD fMRI signal with ageing and disease: A challenge for neuroimaging. Nat Rev Neurosci 4, 863–72.
De Leon M , Golomb J , George A E , et al. 1993. The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation. Am J Neuroradiol 13, 897–906.
De Leon M J , Convit A , Wolf O T , et al. 2001. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A 98, 10 966–71.
De Leon M J , George A E , Stylopoulos L A , Smith G and Miller D C . 1989. Early marker for Alzheimer's disease: The atrophic hippocampus. Lancet 2, 672–3.
Desgranges B , Baron J C , De La Sayette V , et al. 1998. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 121, 611–31.
Desikan R S , Fischl B , Cabral H J , et al. 2008. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 71, 819–25.
Devanand D P , Habeck C G , Tabert M H , et al. 2006. PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology 31, 1327–34.
Dickerson B C , Bakkour A , Salat D H , et al. 2007a. The cortical signature of Alzheimer's disease (AD): A high throughput in vivo MRI-based quantitative biomarker. In Massachusetts Alzheimer's Disease Research Center 20th Annual Scientific Poster Symposium, Boston, MA.
Dickerson B C , Miller S L , Greve D N , et al. 2007b. Prefrontal–hippocampal–fusiform activity during encoding predicts intraindividual differences in free recall ability: An event-related functional–anatomic MRI study. Hippocampus 17, 1060–70.
Dickerson B C , Salat D H , Bates J F , et al. 2004. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 56, 27–35.
Dickerson B C , Salat D H , Greve D N , et al. 2005. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65, 404–11.
Dickerson B C and Sperling R A . 2005. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRX 2, 348–60.
Drzezga A , Grimmer T , Riemenschneider M , et al. 2005. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med 46, 1625–32.
Filbey F M , Slack K J , Sunderland T P and Cohen R M . 2006. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 17, 1585–90.
Fleisher A S , Houston W S , Eyler L T , et al. 2005. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol 62, 1881–8.
Forsberg A , Engler H , Almkvist O , et al. 2008. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29, 1456–65.
Fox N C , Kennedy A M , Harvey R J , et al. 1997. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 120, 491–501.
Fox N C , Warrington E K , Stevens J M and Rossor M N . 1996. Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation. Ann N Y Acad Sci 777, 226–32.
Goekoop R , Scheltens P , Barkhof F and Rombouts S A . 2006. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation – A pharmacological fMRI study. Brain 129, 141–57.
Grady C L , Furey M L , Pietrini P , Horwitz B and Rapoport S I . 2001. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain 124, 739–56.
Grady C L , Mcintosh A R , Beig S , Keightley M L , Burlan H and Black S E . 2003. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci 23, 986–93.
Graham J E , Rockwood K , Beattie B L , et al. 1997. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349, 1793–6.
Greicius M D , Srivastava G , Reiss A L and Menon V . 2004. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci U S A 101, 4637–42.
Grön G , Brandenburg I , Wunderlich A P and Riepe M W . 2006. Inhibition of hippocampal function in mild cognitive impairment: Targeting the cholinergic hypothesis. Neurobiol Aging 27, 78–87.
Grossman M , Koenig P , Glosser G , et al. 2003. Neural basis for semantic memory difficulty in Alzheimer's disease: An fMRI study. Brain 126, 292–311.
Guye M , Bartolomei F and Ranjeva J P . 2008. Imaging structural and functional connectivity: Towards a unified definition of human brain organization? Curr Opin Neurol 21, 393–403.
Han S D , Houston W S , Jak A J , et al. 2007. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging 28, 238–47.
He Y , Wang L , Zang Y , et al. 2007. Regional coherence changes in the early stages of Alzheimer's disease: A combined structural and resting-state functional MRI study. Neuroimage 35, 488–500.
Higuchi M , Arai H , Nakagawa T , et al. 1997. Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease. Neuroreport 8, 2639–43.
Hirao K , Ohnishi T , Matsuda H , et al. 2006. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography. Nucl Med Commun 27, 151–6.
Hoffman J M , Welsh-Bohmer K A , Hanson M , et al. 2000. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 41, 1920–8.
Høgh P , Knudsen G M , Kjaer K H , Jørgensen O S , Paulson O B and Waldemar G . 2001. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: Impact of the epsilon4 allele on regional cerebral blood flow. J Geriatr Psychiatry Neurol 14, 42–51.
Horwitz B , Grady C L , Schlageter N L , Duara R and Rapoport S I . 1987. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res 407, 294–306.
Ikonomovic M D , Klunk W E , Ambrahamson E E , et al. 2008. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131, 1630–45.
Jack C R , Petersen R C , Xu Y C , et al. 1999. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397–403.
Jack C R J , Petersen R C , Xu Y C , et al. 1997. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 49, 786–94.
Johnson K A , Jones K , Holman B L , et al. 1998. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50, 1563–71.
Johnson K A , Lopera F , Jones K , et al. 2001. Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology 56, 1545–51.
Johnson K A , Moran E K , Becker J A , Blacker D , Fischman A J and Albert M S . 2007a. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry 78, 240–7.
Johnson S C , Baxter L C , Susskind-Wilder L , Connor D J , Sabbagh M N and Caselli R J . 2004. Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia 42, 980–99.
Johnson S C , Ries M L , Hess T M , et al. 2007b. Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults. Arch Gen Psychiatry 64, 1163–71.
Johnson S C , Saykin A J , Baxter L C , et al. 2000. The relationship between fMRI activation and cerebral atrophy: Comparison of normal aging and Alzheimer disease. Neuroimage 11, 179–87.
Johnson S C , Schmitz T W , Asthana S , Gluck M A and Myers C . 2008. Associative learning over trials activates the hippocampus in healthy elderly but not mild cognitive impairment. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 15, 129–45.
Johnson S C , Schmitz T W , Moritz C H , et al. 2006a. Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiol Aging 27, 1604–12.
Johnson S C , Schmitz T W , Trivedi M A , et al. 2006b. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci 26, 6069–76.
Julin P , Almkvist O , Basun H , et al. 1998. Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation. Alzheimer Dis Assoc Disord 12, 49–53.
Julin P , Lindqvist J , Svensson L , Slomka P and Wahlund L O . 1997. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease. J Nucl Med 38, 914–9.
Kato T , Knopman D S and Liu H . 2001. Dissociation of regional activation in mild AD during visual encoding: A functional MRI study. Neurology 57, 812–6.
Kemppainen N M , Aalto S , Wilson I A , et al. 2007. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 68, 1603–06.
Kessler J , Herholz K , Grond M and Heiss W D . 1991. Impaired metabolic activation in Alzheimer's disease: A PET study during continuous visual recognition. Neuropsychologia 29, 229–43.
Kircher T T , Erb M , Grodd W and Leube D T . 2005. Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: Preliminary findings from a pharmaco-fMRI study. Am J Geriatr Psychiatry 13, 1006–13.
Klunk W E , Engler H , Nordberg A , et al. 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306–19.
Klunk W E and Mathis C A . 2008. The future of amyloid-beta imaging: A tale of radionuclides and tracer proliferation. Curr Opin Neurol 21, 683–7.
Kogure D , Matsuda H , Ohnishi T , et al. 2000. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 41, 1155–62.
Koivunen J , Pirttilä T , Kemppainen N , et al. 2008. PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dementia Geriatr Cogn Disord 26, 378–83.
Langbaum J B , Chen K , Lee W , et al. 2009. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 45, 1107–16.
Lee K U , Lee J S , Kim K W , et al. 2003. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients. J Neuropsychiatry Clin Neurosci 15, 78–83.
Lehtovirta M , Kuikka J , Helisalmi S , et al. 1998. Longitudinal SPECT study in Alzheimer's disease: Relation to apolipoprotein E polymorphism. J Neurol Neurosurg Psychiatry 64, 742–6.
Lehtovirta M , Soininen H , Laakso M P , et al. 1996. SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E epsilon 4 allele. J Neurol Neurosurg Psychiatry 60, 644–9.
Lekeu F , Van Der Linden M , Chicherio C , et al. 2003. Brain correlates of performance in a free/cued recall task with semantic encoding in Alzheimer disease. Alzheimer Dis Assoc Disord 17, 35–45.
Levy R . 1994. Aging-associated cognitive decline. Int Psychogeriatr 6, 63–8.
Li S J , Li Z , Wu G , Zhang M J , Franczak M and Antuono P G . 2002. Alzheimer Disease: Evaluation of a functional MR imaging index as a marker. Radiology 225, 253–9.
Lind J , Ingvar M , Persson J , et al. 2006a. Parietal cortex activation predicts memory decline in apolipoprotein E-epsilon4 carriers. Neuroreport 17, 1683–6.
Lind J , Persson J , Ingvar M , et al. 2006b. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 129, 1240–8.
Lipton A M , McColl R , Cullum C M , et al. 2003. Differential activation on fMRI of monozygotic twins discordant for AD. Neurology 60, 1713–6.
Machulda M M , Ward H A , Borowski B , et al. 2003. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61, 500–6.
Masdeu J C , Zubieta J L and Arbizu J . 2005. Neuroimaging as a marker of the onset and progression of Alzheimer's disease. J Neurol Sci 236, 55–64.
Matsuda H . 2001. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 15, 85–92.
Matsuda H , Kitayama N , Ohnishi T , et al. 2002. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 43, 304–11.
Maxim V , Sendur L , Fadili J , et al. 2005. Fractional Gaussian noise, functional MRI and Alzheimer's disease. Neuroimage 25, 141–58.
Mielke R , Zerres K , Uhlhaas S , Kessler J and Heiss W D . 1998. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease. Neurosci Lett 254, 49–52.
Minoshima S , Giordani B , Berent S , Frey K A , Foster N L and Kuhl D E . 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42, 85–94.
Mintun M A , Larossa G N , Sheline Y I , et al. 2006. [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446–52.
Mondadori C R , De Quervain D J , Buchmann A , et al. 2007. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cerebral Cortex 17, 1934–47.
Mormino E C , Kluth J T , Madison C M , et al. 2009. Episodic memory loss is related to hippocampal-mediated {beta}-amyloid deposition in elderly subjects. Brain 132, 1310–23.
Morris J C . 2006. Mild cognitive impairment is early-stage Alzheimer disease: Time to revise diagnostic criteria. Arch Neurol 63, 15–6.
Mosconi L , Brys M , Switalski R , et al. 2007. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104, 19 067–72.
Mosconi L , De Santi S , Brys M , et al. 2008. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 63, 609–18.
Mosconi L , Herholz K , Prohovnik I , et al. 2005. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: Implications for brain reserve. J Neurol Neurosurg Psychiatry 76, 15–23.
Mosconi L , Nacmias B , Sorbi S , et al. 2004a. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75, 370–6.
Mosconi L , Perani D , Sorbi S , et al. 2004b. MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET. Neurology 63, 2332–40.
Mosconi L , Sorbi S , De Leon M J , et al. 2006. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 47, 1778–86.
Mosconi L , Sorbi S , Nacmias B , et al. 2004c. Age and ApoE genotype interaction in Alzheimer's disease: An FDG-PET study. Psychiatry Res 130, 141–51.
Moulin C J , Laine M , Rinne J O , Kaasinen V S , Hiltunen J and Kangasmäki A . 2007. Brain function during multi-trial learning in mild cognitive impairment: A PET activation study. Brain Res 1136, 132–41.
Nestor P G , Fryer T D , Smielewski P and Hodges J R . 2003a. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 54, 343–51.
Nestor P G , Fryer T D , Ikeda M and Hodges J R . 2003b. Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). Eur J Neurosci 18, 2663–7.
Nishi H , Sawamoto N , Namiki C , et al. 2010. Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment. J Neuroimaging 20, 29–36.
Nobili F , Salmaso D , Morbelli S , et al. 2008. Principal component analysis of FDG PET in amnestic MCI. Eur J Nucl Med Mol Imaging 35, 2191–202.
Ohnishi T , Hoshi H , Nagamachi S , et al. 1995. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 36, 1163–9.
Ott B R , Heindel W C , Tan Z and Noto R B . 2000. Lateralized cortical perfusion in women with Alzheimer's disease. J Gender-Spec Med 3, 29–35.
Pariente J , Cole S , Henson R , et al. 2005. Alzheimer's patients engage an alternative network during a memory task. Ann Neurol 58, 870–9.
Perneczky R , Hartmann J , Grimmer T , Drzezga A and Kurz A . 2007. Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J Geriatr Psychiatry Neurol 20, 84–8.
Persson J , Lind J , Larsson A , et al. 2008. Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia 46, 1679–87.
Petersen R C . 2007. Mild cognitive impairment: Current research and clinical implications. Semin Neurol 27, 22–31.
Petersen R C , Smith G E , Waring S C , Ivnik R J , Tangalos E G and Kokmen E . 1999. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303–08.
Petrella J R , Lustig C , Bucher L A , Jha A P and Doraiswamy P M . 2002. Prefrontal activation patterns in subjects at risk for Alzheimer disease. Am J Geriatr Psychiatry 10, 112–3.
Petrella J R , Prince S E , Krishnan S , Husn H , Kelley L and Doraiswamy P M . 2009. Effects of donepezil on cortical activation in mild cognitive impairment: A pilot double-blind placebo-controlled trial using functional MR imaging. Am J Neuroradiol 30, 411–6.
Petrella J R , Wang L , Krishnan S , et al. 2007. Cortical deactivation in mild cognitive impairment: High-field-strength functional MR imaging. Radiology 245, 224–35.
Pike K E , Savage G , Villemagne V L , et al. 2007. Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain 130, 2837–44.
Rapoport S I . 1997. Discriminant analysis of brain imaging data identifies subjects with early Alzheimer's disease. Int Psychogeriatr 9 (Suppl. 1), 229–35.
Reiman E M , Caselli R J , Chen K , Alexander G E , Bandy D and Frost J . 2001. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A 98, 3334–9.
Reiman E M , Caselli R J , Yun L S , et al. 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334, 752–8.
Reiman E M , Chen K , Alexander G E , et al. 2004. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A 101, 284–9.
Reiman E M , Chen K , Alexander G E , et al. 2005. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 102, 8299–302.
Rimajova M , Lenzo N P , Wu J S , et al. 2008. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population. J Alzheimer's Dis 13, 137–46.
Risacher S L , Saykin A J , West J D , et al. 2009. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6, 347–61.
Rombouts S A , Barkhof F , Veltman D J , et al. 2000. Functional MR imaging in Alzheimer's disease during memory encoding. Am J Neuroradiol 21, 1869–75.
Rombouts S A and Scheltens P . 2005. Functional connectivity in elderly controls and AD patients using resting-state fMRI: A pilot study. Curr Alzheimer Res 2, 115–6.
Rossor M , Kennedy A M and Frackowiak R S . 1996. Clinical and neuroimaging features of familial Alzheimer's disease. Ann N Y Acad Sci 777, 49–56.
Rossor M , Newman S , Frackowiak R S , Lantos P and Kennedy A M . 1993. Alzheimer's disease families with amyloid precursor protein mutations. Ann N Y Acad Sci 695, 198–202.
Sakamoto S , Ishii K , Sasaki M , et al. 2002. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci 200, 27–32.
Sakamoto S , Matsuda H , Asada T , et al. 2003. Apolipoprotein E genotype and early Alzheimer's disease: A longitudinal SPECT study. J Neuroimag 13, 113–23.
Saykin A J , Wishart H A , Rabin L A , et al. 2004. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127, 1574–83.
Saykin A J , Wishart H A , Rabin L A , et al. 2006. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67, 834–42.
Scarmeas N , Anderson K E , Hilton J , et al. 2004a. APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology 63, 913–5.
Scarmeas N , Habeck C , Anderson K E , et al. 2004b. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the E4 allele). Am J Geriatr Psychiatry 12, 596–605.
Scarmeas N , Habeck C , Hilton J , et al. 2005. APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry 76, 1440–4.
Scarmeas N and Stern Y . 2006. Imaging studies and APOE genotype in persons at risk for Alzheimer's disease. Curr Psychiatry Rep 8, 11–7.
Scheltens P , Launer L J , Barkhof F , Weinstein H C and Jonker C . 1997. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population. Alzheimer Dis Assoc Disord 11, 63–70.
Schröder J , Buchsbaum M S , Shihabuddin L , et al. 2001. Patterns of cortical activity and memory performance in Alzheimer's disease. Biol Psychiatry 49, 426–36.
Seo S W , Cho S S , Park A , Chin J and Na D L . 2009. Subcortical vascular versus amnestic mild cognitive impairment: Comparison of cerebral glucose metabolism. J Neuroimag 19, 213–9.
Shulman G L , Fiez J A , Corbetta M , et al. 1997. Common blood flow changes across visual tasks: II. Decreases in cerebral cortex. J Cogn Neurosci 9, 648–63.
Silverman D H . 2004. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: Comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 45, 594–607.
Small B J , Mazziotta J C , Collins M T , et al. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. J Am Med Assoc 273, 942–7.
Small G W , Komo S , La Rue A , et al. 1996. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann N Y Acad Sci 802, 70–8.
Small G W , Okonek A , Mandelkern M A , et al. 1994. Age-associated memory loss: Initial neuropsychological and cerebral metabolic findings of a longitudinal study. Int Psychogeriatr 6, 23–44.
Small S A , Perera G M , Delapaz R , Mayeux R and Stern Y . 1999. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 45, 466–72.
Small S A , Tsai W Y , De La Paz R , Mayeux R and Stern C E . 2002. Imaging hippocampal function across the human life span: Is memory decline normal or not? Ann Neurol 51, 290–5.
Small S A , Wu E X , Bartsch D , et al. 2000. Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice. Neuron 28, 653–4.
Smith C D , Andersen A H , Kryscio R J , et al. 1999. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53, 1391–6.
Smith C D , Andersen A H , Kryscio R J , et al. 2002. Women at risk for AD show increased parietal activation during a fluency task. Neurology 58, 1197–202.
Smith C D , Kryscio R J , Schmitt F A , et al. 2005. Longitudinal functional alterations in asymptomatic women at risk for Alzheimer's disease. J Neuroimag 15, 271–7.
Sorg C , Riedl V , Mühlau M , et al. 2007. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 104, 18 760–5.
Sperling R A , Bates J F , Chua E F , et al. 2003. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 74, 44–50.
Supekar K , Menon V , Rubin D , Musen M and Greicius M D . 2008. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput Biol 4, e1000100.
Thompson P M , Hayashi K M , De Zubicaray G , et al. 2003. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23, 994–1005.
Trivedi M A , Murphy C M , Goetz C , et al. 2008a. fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults. Dementia Geriatr Cogn Disord 26, 123–37.
Trivedi M A , Schmitz T W , Ries M L , et al. 2006. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: A cross-sectional study. BMC Med 4, 1.
Trivedi M A , Schmitz T W , Ries M L , et al. 2008b. fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: Risk factors for Alzheimer's disease. Neuropsychologia 46, 1667–78.
Van Dyck C H , Gelernter J , Macavoy M G , et al. 1998. Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease. Arch Neurol 55, 1460–6.
Visser P J , Scheltens P , Verhey F R , et al. 1999. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 246, 477–85.
Wahlund L , Basun H , Almkvist O , et al. 1999. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dementia Geriatr Cogn Disord 10, 526–33.
Wang K , Jiang T , Liang M , et al. 2006a. Discriminative analysis of early Alzheimer's disease based on two intrinsically anti-correlated networks with resting-state fMRI. Med Image Comput ComputAssist Interv 9, 340–7.
Wang K , Liang M , Wang L , et al. 2007. Altered functional connectivity in early Alzheimer's disease: A resting-state fMRI study. Hum Brain Mapp 28, 967–78.
Wang L , Zang Y , He Y , et al. 2006b. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage 31, 496–504.
Wang P J , Saykin A J , Flashman L A , et al. 2006c. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiol Aging 27, 1613–7.
Waragai M , Mizumura S , Yamada T and Matsuda H . 2008. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy z-score imaging system analysis. Dementia Geriatr Cogn Disord 26, 547–55.
Weiner M W . 2009. Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease. J Nutr Health Aging 13, 332.
Wierenga C E and Bondi M W . 2007. Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease. Neuropsychol Rev 17, 127–43.
Winblad B , Palmer K , Kivipelto M , et al. 2004. Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Int Med 256, 240–6.
Wishart H A , Saykin A J , Rabin L A , et al. 2006. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry 163, 1603–10.
Wolf H , Jelic V , Gertz H J , Nordberg A , Julin P and Wahlund L O . 2003. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl 179, 52–76.
Wolk D A , Price J C , Saxton J A , et al. 2009. Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 65, 557–68.
Woodard J L , Grafton S T , Votaw J R , Green R C , Dobraski M E and Hoffman J M . 1998. Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease. Neuropsychology 12, 491–504.
Xu G , Mclaren D G , Ries M L , et al. 2008. The influence of parental history of Alzheimer's disease and apolipoprotein E {varepsilon}4 on the BOLD signal during recognition memory. Brain 132, 383–91.
Yassa M A , Verduzco G , Cristinzio C and Bassett S S . 2008. Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease. Neurology 70, 1898–904.
Zhou Y , Dougherty J H J , Hubner K F , Bai B , Cannon R L and Hutson R K . 2008. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment Alzheimer's Dementia 4, 265–70.

Reference Title: References

Reference Type: reference-list

Ackl N , Ising M , Schreiber Y A , Atiya M , Sonntag A and Auer D P . 2005. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 384, 23–8.
Adalsteinsson E , Sullivan E V , Kleinhans N , Spielman D M and Pfefferbaum A . 2000. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 355, 1696–7.
Birken D L and Oldendorf W H . 1989. N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13, 23–31.
Bitsch A , Bruhn H , Vougioukas V , et al. 1999. Inflammatory CNS demyelination: Histopathologic correlation with in vivo quantitative proton MR spectroscopy. Am J Neuroradiol 20, 1619–27.
Blakely R D and Coyle J T . 1988. The neurobiology of N-acetylaspartylglutamate. Int Rev Neurobiol 30, 39–100.
Braak H and Braak E . 1998. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl 53, 127–40.
Brand A , Richter-Landsberg C and Leibfritz D . 1993. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15, 289–98.
Capizzano A A , Schuff N , Amend D L , et al. 2000. Subcortical ischemic vascular dementia: Assessment with quantitative MR imaging and 1H MR spectroscopy. Am J Neuroradiol 21, 621–30.
Catani M , Cherubini A , Howard R , et al. 2001. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 12, 2315–7.
Chantal S , Braun C M , Bouchard R W , Labelle M and Boulanger Y . 2004. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 1003, 26–35.
Chao L L , Mueller S G , Buckley S T , et al. 2010. Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. Neurobiol Aging 31, 368–77.
Chao L L , Schuff N , Kramer J H , et al. 2005. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology 64, 282–9.
Dixon R M , Bradley K M , Budge M M , Styles P and Smith A D . 2002. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 125, 2332–41.
Engelborghs S and De Deyn P P . 1997. The neurochemistry of Alzheimer's disease. Acta Neurol Belg 97, 67–84.
Ernst T , Chang L , Melchor R and Mehringer C M . 1997. Frontotemporal dementia and early Alzheimer disease: Differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203, 829–36.
Fernandez A , Garcia-Segura J M , Ortiz T , et al. 2005. Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: A combination of techniques that may contribute to the diagnosis of Alzheimer's disease. Dement Geriatr Cogn Disord 20, 169–77.
Ferri C P , Prince M , Brayne C , et al. 2005. Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112–7.
Forsberg A , Engler H , Almkvist O , et al. 2008. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29, 1456–65.
Glanville N T , Byers D M , Cook H W , Spence M W and Palmer F B . 1989. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1004, 169–79.
Glodzik L , King K G , Gonen O , Liu S , De Santi S and de Leon M J . 2008. Memantine decreases hippocampal glutamate levels: A magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry 32, 1005–12.
Guimaraes A R , Schwartz P , Prakash M R , et al. 1995. Quantitative in vivo 1H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain. Neuroscience 69, 1095–101.
Jessen F , Block W , Traber F , et al. 2001. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 57, 930–2.
Kadir A , Almkvist O , Wall A , Langstrom B and Nordberg A . 2006. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology (Berl) 188, 509–20.
Kaiser L G , Young K , Meyerhoff D J , Mueller S G and Matson G B . 2008. A detailed analysis of localized J-difference GABA editing: theoretical and experimental study at 4 T. NMR Biomed 21, 22–32.
Kantarci K , Jack C R, Jr., Xu Y C , Campeau N G , O'Brien P C , Smith G E , et al. 2000. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000; 55: 210–7.
Kantarci K , Knopman D S , Dickson D W , et al. 2008. Alzheimer disease: Postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 248, 210–20.
Kantarci K , Smith G E , Ivnik R J , et al. 2002. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 8, 934–42.
Kantarci K , Weigand S D , Petersen R C , et al. 2007. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 28, 1330–9.
Kemppainen N M , Aalto S , Wilson I A , et al. 2007. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 68, 1603–06.
Kepe V , Barrio J R , Huang S C , et al. 2006. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci USA 103, 702–07.
Klein J . 2000. Membrane breakdown in acute and chronic neurodegeneration: Focus on choline-containing phospholipids. J Neural Transm 107, 1027–63.
Klunk W E , Panchalingam K , Moossy J , McClure R J and Pettegrew J W . 1992. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 42, 1578–85.
Koller K J , Zaczek R and Coyle J T . 1984. N-acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 43, 1136–42.
Krishnan K R , Charles H C , Doraiswamy P M , et al. 2003. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 160, 2003–11.
Kuhl D E , Koeppe R A , Minoshima S , et al. 1999. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52, 691–9.
Lin A P , Shic F , Enriquez C and Ross B D . 2003. Reduced glutamate neurotransmission in patients with Alzheimer's disease – an in vivo (13)C magnetic resonance spectroscopy study. Magma 16, 29–42.
Metastasio A , Rinaldi P , Tarducci R , et al. 2006. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. Neurobiol Aging 27, 926–32.
Meyerhoff D J , MacKay S , Constans J M , et al. 1994. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 36, 40–7.
Mihara M , Hattori N , Abe K , Sakoda S and Sawada T . 2006. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex. Neuroreport 17, 413–6.
Moats R A , Ernst T , Shonk T K and Ross B D . 1994. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32, 110–5.
Nordberg A . 1993. Clinical studies in Alzheimer patients with positron emission tomography. Behav Brain Res 57, 215–24.
Nordberg A , Hartvig P , Lilja A , et al. 1990. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm Park Dis Dement Sect 2, 215–24.
Nordberg A , Lundqvist H , Hartvig P , Lilja A and Langstrom B . 1995. Kinetic analysis of regional (S)(–)11C-nicotine binding in normal and Alzheimer brains – In vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9, 21–7.
Olson B L , Holshouser B A , Britt W 3rd, et al. 2008. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Dis Assoc Disord 22, 269–77.
Panza F , D'Introno A , Colacicco A M , et al. 2005. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 13, 633–44.
Parnetti L , Lowenthal D T , Presciutti O , et al. 1996. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 44, 133–8.
Parnetti L , Tarducci R , Presciutti O , et al. 1997. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Mech Ageing Dev 97, 9–14.
Petersen R C , Smith G E , Waring S C , Ivnik R J , Tangalos E G and Kokmen E . 1999. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303–08.
Pfefferbaum A , Adalsteinsson E , Spielman D , Sullivan E V and Lim K O . 1999. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry 56, 185–92.
Price J C , Klunk W E , Lopresti B J , et al. 2005. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 25, 1528–47.
Rose S E , de Zubicaray G I , Wang D , et al. 1999. A 1H MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 17, 291–9.
Ross B , Lin A , Harris K , Bhattacharya P and Schweinsburg B . 2003. Clinical experience with 13C MRS in vivo. NMR Biomed 16, 358–69.
Schuff N , Amend D , Ezekiel F , et al. 1997. Changes of hippocampal N-acetylaspartate and volume in Alzheimer's disease: A proton MR spectroscopic imaging and MRI study. Neurology 49, 1513–21.
Schuff N , Capizzano A A , Du A T , et al. 2003. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology 61, 358–64.
Schuff N , Capizzano A A , Du A T , et al. 2002. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 58, 928–35.
Schuff N , Ezekiel F , Gamst A C , et al. 2001. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45, 899–907.
Shinotoh H , Fukushi K , Nagatsuka S , et al. 2003. The amygdala and Alzheimer's disease: Positron emission tomographic study of the cholinergic system. Ann N Y Acad Sci 985, 411–9.
Shonk T K , Moats R A , Gifford P , et al. 1995. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195, 65–72.
Siger M , Schuff N , Zhu X , Miller B L and Weiner M W . 2009. Regional myo-inositol concentration in mild cognitive impairment using 1H magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 23, 57–62.
Simmons M L , Frondoza C G and Coyle J T . 1991. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37–45.
Tedeschi G , Bertolino A , Lundbom N , et al. 1996. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 47, 696–704.
Truchot L , Costes S N , Zimmer L , et al. 2007. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment. Neurology 69, 1012–7.
Urenjak J , Williams S R , Gadian D G and Noble M . 1993. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13, 981–9.
Wyper D J , Brown D , Patterson J , et al. 1993. Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease. Eur J Nucl Med 20, 379–86.
Zhu X , Schuff N , Kornak J , et al. 2006. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 20, 77–85.

Reference Title: References

Reference Type: reference-list

Aarsland D , Andersen K , Larsen J P , et al. 2001. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56, 730–6.
Albin R L , Young A B and Penney J B. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12, 366–75.
Alexander G E , DeLong, M R , and Strick P L. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9, 357–81.
Asanuma K , Tang C , Ma Y , et al. 2006. Network modulation in the treatment of Parkinson's disease. Brain 129, 2667–78.
Bergson C , Mrzljak L , Smiley J F , Pappy M , Levenson R , and Goldman-Rakic P S. 1995. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15, 7821–36.
Bernheimer H , Birkmayer W , Hornykiewicz O , Jellinger K , and Seitelberger F. 1973. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J Neurol Sci 20, 415–55.
Bestmann S , Baudewig J , Siebner H R , Rothwell J C and Frahm J. 2004. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci 19, 1950–62.
Black K J , Hershey T , Hartlein J M , Carl J L and Perlmutter J S. 2005. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology 30, 590–601.
Boecker H , Dagher A , Ceballos-Baumann A O , et al. 1998. Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET. J Neurophysiol 79, 1070–80.
Bohnen N I , Kaufer D I , Ivanco L S , et al. 2003. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study. Arch Neurol 60, 1745–8.
Braak H , Del Tredici K , Rüb U , de Vos R A , Jansen Steur E N and Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24, 197–211.
Brown J W and Braver T S. 2005. Learned predictions of error likelihood in the anterior cingulate cortex. Science 307, 1118–21.
Brück A , Portin R , Lindell A , et al. 2001. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 311, 81–4.
Buhmann C , Binkofski F , Klein C , et al. 2005. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: A human model for presymptomatic parkinsonism. Brain 128, 2281–90.
Buhmann C , Glauche V , Sturenburg H J , Oechsner M , Weiller C and Buchel C. 2003. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126, 451–61.
Burton E J , McKeith I G , Burn D J , Williams E D and O'Brien J T. 2004. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127, 791–800.
Camicioli R , Moore M M , Kinney A , Corbridge E , Glassberg K and Kaye J A. 2003. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18, 784–90.
Ceballos-Baumann A O , Boecker H , Bartenstein P , et al. 1999. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: Enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 56, 997–1003.
Cheesman A L , Barker R A , Lewis S J , Robbins T W , Owen A M and Brooks D J. 2005. Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry 76, 1204–10.
Cools R. 2006. Dopaminergic modulation of cognitive function – implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 30, 1–23.
Cools R , Barker R A , Sahakian B J and Robbins T W. 2001a. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 124, 2503–12.
Cools R , Barker R A , Sahakian B J and Robbins T W. 2001b. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11, 1136–43.
Cools R , Barker R A , Sahakian B J and Robbins T W. 2003. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41, 1431–41.
Cools R , Clark L , Owen A M and Robbins T W. 2002a. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 22, 4563–7.
Cools R , Lewis S J , Clark L , Barker R A and Robbins T W. 2007. L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 32, 180–9.
Cools R , Stefanova E , Barker R A , Robbins T W and Owen A M. 2002b. Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain 125, 584–94.
Cooper J R , Bloom F E and Roth R H. 2003. The Biochemical Basis of Neuropharmacology. 8th Ed. Oxford: Oxford University Press.
Dagher A and Nagano-Saito A. 2007. Functional and anatomical magnetic resonance imaging in Parkinson's disease. Mol Imaging Biol 9, 234–42.
Dagher A , Owen A M , Boecker H and Brooks D J. 1999. Mapping the network for planning: A correlational PET activation study with the Tower of London task. Brain 122, 1973–87.
Dagher A , Owen A M , Boecker H and Brooks D J. 2001. The role of the striatum and hippocampus in planning: A PET activation study in Parkinson's disease. Brain 124, 1020–32.
de la Fuente-Fernández R and Calne D B. 1996. What do Lewy bodies tell us about dementia and parkinsonism? In Perry R H , McKeith I G , Perry E K (Eds.). Dementia with Lewy Bodies. New York, NY: Cambridge University Press, pp. 287–301.
de Lau L M L and Breteler M M B. 2006. Epidemiology of Parkinson's disease. Lancet Neurol 5, 525–35.
Del Tredici K , Rüb U , De Vos R A , Bohl J R and Braak H. 2002. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61, 413–26.
Dirnberger G , Frith C D and Jahanshahi M. 2005. Executive dysfunction in Parkinson's disease is associated with altered pallidal–frontal processing. Neuroimage 25, 588–99.
Dubois B and Pillon B. 1997. Cognitive deficits in Parkinson's disease. J Neurol 244, 2–8.
Edison P , Rowe C C , Rinne J O , et al. 2008. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79, 1331–8.
Evans A H , Pavese N , Lawrence A D , et al. 2006. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59, 852–8.
Fearnley J M and Lees A J. 1991. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283–301.
Fera F , Nicoletti G , Cerasa A , et al. 2007. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain Res Bull 74, 75–83.
Foster E R , Black K J , Antenor-Dorsey J A , Perlmutter J S and Hershey T. 2008. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain Cogn 67, 1–10.
Frank M J , Seeberger L C and O'Reilly R C. 2004. By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science 306, 1940–3.
Fukuda M , Mentis M , Ghilardi M F , et al. 2001. Functional correlates of pallidal stimulation for Parkinson's disease. Ann Neurol 49, 155–64.
Gibb W R and Lees A J. 1988. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51, 745–52.
Gibb W R , Luthert P J , Janota I and Lantos P L. 1989. Cortical Lewy body dementia: Clinical features and classification. J Neurol Neurosurg Psychiatry 52, 185–92.
Gomperts S N , Rentz D M , Moran E , et al. 2008. Imaging amyloid deposition in Lewy body diseases. Neurology 71, 903–10.
Goodwin F K , Murphy D L , Brodie H K and Bunney W E Jr. 1971. Levodopa: Alterations in behavior. Clin Pharmacol Ther 12, 383–96.
Gotham A M , Brown R G and Marsden C D. 1986. Levodopa treatment may benefit or impair “frontal” function in Parkinson's disease. Lancet 2, 970–1.
Gotham A M , Brown R G and Marsden C D. 1988. “Frontal” cognitive function in patients with Parkinson's disease “on” and “off” levodopa. Brain 111, 299–321.
Grafton S T , Waters C , Sutton J , Lew M F and Couldwell W. 1995. Pallidotomy increases activity of motor association cortex in Parkinson's disease: A positron emission tomographic study. Ann Neurol 37, 776–83.
Grahn J A , Parkinson J A and Owen A M. 2008. The cognitive functions of the caudate nucleus. Prog Neurobiol 86, 141–55.
Haslinger B , Erhard P , Kämpfe N , et al. 2001. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124, 558–70.
Hilker R , Thomas A V , Klein J C , et al. 2005. Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways. Neurology 65, 1716–22.
Huang C , Mattis P , Tang C , Perrine K , Carbon M and Eidelberg D. 2007. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 34, 714–23.
Jahanshahi M , Jenkins I H , Brown R G , Marsden C D , Passingham R E and Brooks D J. 1995. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118, 913–33.
Javoy-Agid F and Agid Y. 1980. Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 30, 1326–30.
Jenkins I H , Fernandez W , Playford E D , et al. 1992. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32, 749–57.
Kaasinen V , Nurmi E , Bergman J , et al. 2001. Personality traits and brain dopaminergic function in Parkinson's disease. Proc Natl Acad Sci USA 98, 13 272–7.
Kimberg D and D'Esposito M. 2003. Cognitive effects of the dopamine agonist pergolide. Neuropsychologia 41, 1020–7.
Kish S J , Shannak K and Hornykiewicz O. 1988. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318, 876–80.
Kish S J , Shannak K , Rajput A , Deck J H and Hornykiewicz O. 1992. Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease. J Neurochem 58, 642–8.
Knowlton B J , Mangels J A and Squire L R. 1996. A neostriatal habit learning system in humans. Science 273, 1399–402.
Knutson B , Taylor J , Kaufman M , Peterson R and Glover, G. 2005. Distributed neural representation of expected value. J Neurosci 25, 4806–12.
Kosaka K and Iseki E. 1996. Dementia with Lewy bodies. Curr Opin Neurol 9, 271–5.
Kulisevsky J , Avila A , Barbanoj M , et al. 1996. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 119, 2121–32.
Lange K W , Robbins T W , Marsden C D , James M , Owen A M and Paul G M. 1992. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 107, 394–404.
Lawrence A D , Evans A H and Lees A J. 2003. Compulsive use of dopamine replacement therapy in Parkinson's disease: Reward systems gone awry? Lancet Neurol 2, 595–604.
Lehéricy S , Ducros M , Van de Moortele P F , et al. 2004. Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann Neurol 55, 522–9.
Lewis S J , Dove A , Robbins T W , Barker R A and Owen A M. 2003. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23, 6351–6.
Lewis S J , Dove A , Robbins T W , Barker R A and Owen A M. 2004. Striatal contributions to working memory: A functional magnetic resonance imaging study in humans. Eur J Neurosci 19, 755–60.
Lewis S J , Slabosz A , Robbins T W , Barker R A and Owen A M. 2005. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 43, 823–32.
Limousin P , Greene J , Pollak P , Rothwell J , Benabid A L and Frackowiak R. 1997. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 42, 283–91.
Marié R M , Barré L , Dupuy B , Viader F , Defer G and Baron J C. 1999. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260, 77–80.
Mattay V S , Tessitore A , Callicott J H , et al. 2002. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51, 156–64.
Mehta M A , Sahakian B J , McKenna P J and Robbins T W. 1999. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl) 146, 162–74.
Mehta M A , Swainson R , Ogilvie A D , Sahakian J and Robbins T W. 2001. Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers. Psychopharmacology (Berl) 159, 10–20.
Middleton F A and Strick P L. 2000. Basal ganglia and cerebellar loops: Motor and cognitive circuits. Brain Res Brain Res Rev 31, 236–50.
Mink J W. 1996. The basal ganglia: Focused selection and inhibition of competing motor programs. Prog Neurobiol 50, 381–425.
Minoshima S , Foster N L , Sima A A , Frey K A , Albin R L and Kuhl D E. 2001. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50, 358–65.
Monchi O , Petrides M , Doyon J , Postuma R B , Worsley K and Dagher A. 2004. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 24, 702–10.
Monchi O , Petrides M , Mejia-Constain B and Strafella A P. 2007. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 130, 233–44.
Monchi O , Petrides M , Petre V , Worsley K and Dagher A. 2001. Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related fMRI. J Neurosci 21, 7733–41.
Nagano-Saito A , Washimi Y , Arahata Y , et al. 2004. Visual hallucination in Parkinson's disease with FDG PET. Mov Disord 19, 801–06.
Nagano-Saito A , Washimi Y , Arahata Y , et al. 2005. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64, 224–9.
Nandhagopal R , McKeown M J and Stoessl A J. 2008. Functional imaging in Parkinson's disease. Neurology 70, 1478–88.
Nausieda P A. 1985. Sinemet “abusers”. Clin Neuropharmacol 8, 318–27.
Obeso J A , Rodríguez-Oroz M C , Rodríguez M , et al. 2000. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23, S8–19.
Owen A M. 1997. The functional organization of working memory processes within human lateral frontal cortex: The contribution of functional neuroimaging. Eur J Neurosci 9, 1329–39.
Owen A M , Beksinska M , James M , et al. 1993a. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 31, 627–44.
Owen A M , Doyon J , Dagher A , Sadikot A and Evans A C. 1998. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 121, 949–65.
Owen A M , James M , Leigh P N , et al. 1992. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115, 1727–51.
Owen A M , Roberts A C , Hodges J R , Summers B A , Polkey C E and Robbins T W. 1993b. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116, 1159–75.
Peters S , Suchan B , Rusin J , et al. 2003. Apomorphine reduces BOLD signal in fMRI during voluntary movement in Parkinsonian patients. Neuroreport 14, 809–12.
Playford E D , Jenkins I H , Passingham R E , Nutt J , Frackowiak R S and Brooks D J. 1992. Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study. Ann Neurol 32, 151–61.
Postuma R B and Dagher A. 2006. Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. Cereb Cortex 16, 1508–21.
Rascol O , Sabatini U , Chollet F , et al. 1992. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 49, 144–8.
Remy P , Doder M , Lees A , Turjanski N and Brooks D. 2005. Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain 128, 1314–22.
Rinne J O , Rummukainen J , Paljärvi L and Rinne U K. 1989. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26, 47–50.
Rowe J , Stephan K E , Friston K , Frackowiak R , Lees A and Passingham R. 2002. Attention to action in Parkinson's disease: Impaired effective connectivity among frontal cortical regions. Brain 125, 276–89.
Sabatini U , Boulanouar K , Fabre N , et al. 2000. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 123, 394–403.
Samuel M , Ceballos-Baumann A O , Blin J , et al. 1997a. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 120, 963–76.
Samuel M , Ceballos-Baumann A O , Turjanski N , et al. 1997b. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements. An H2O PET study. Brain 120, 1301–13.
Sawaguchi T. 2000. The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism Relat Disord 7, 9–19.
Scatton B , Javoy-Agid F , Rouquier L , Dubois B and Agid Y. 1983. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275, 321–8.
Schott B H , Niehaus L , Wittmann B C , et al. 2007. Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing. Brain 130, 2412–24.
Schrag A , Jahanshahi M and Quinn N. 2000. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69, 308–12.
Schultz W. 2002. Getting formal with dopamine and reward. Neuron 36, 241–63.
Sohn M H , Ursu S , Anderson J R , Stenger V A and Carter C S. 2000. The role of prefrontal cortex and posterior parietal cortex in task switching. Proc Natl Acad Sci USA 97, 13 448–53.
Strafella A P , Dagher A and Sadikot A. 2003. Cerebral blood flow changes induced by subthalamic stimulation in Parkinson's disease. Neurology 60, 1039–42.
Strafella A P , Paus T , Barrett J and Dagher A. 2001. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 21, RC157.
Strafella A P , Paus T , Fraraccio M and Dagher A. 2003. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 126, 2609–15.
Summerfield C , Junqué C , Tolosa E , et al. 2005. Structural brain changes in Parkinson disease with dementia: A voxel-based morphometry study. Arch Neurol 62, 281–5.
Swainson R , Rogers R D , Sahakian B J , Summers B A , Polkey C E and Robbins T W. 2000. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication. Neuropsychologia 38, 596–612.
Tricomi E M , Delgado M R and Fiez J A. 2004. Modulation of caudate activity by action contingency. Neuron 41, 281–92.
Vogel H P and Schiffter R. 1983. Hypersexuality – A complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatria 16, 107–10.
Weintraub D , Moberg P J , Duda J E , Katz I R and Stern M B. 2004. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 52, 784–8.
Williams G V and Goldman-Rakic P S. 1995. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376, 572–5.
Woods S P and Tröster A I. 2003. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Int Neuropsychol Soc 9, 17–24.
Yeterian E H and Pandya D N. 1991. Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys. J Comp Neurol 312, 43–67.

Reference Title: References

Reference Type: reference-list

Aarsland D , Litvan I , Salmon D , et al. 2003. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 74, 1215–20.
Amador-Ortiz C and Dickson D W . 2008. Neuropathology of hippocampal sclerosis. Handb Clin Neurol 89, 569–72.
Apaydin H , Ahlskog J E , Parisi J E , et al. 2002. Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Arch Neurol 59, 102–12.
Ash S , Moore P , Vesely L , et al. 2009. Non-fluent speech in frontotemporal lobar degeneration. J Neuroling 22, 370–83.
Asmuth J , Zhang H , Vesely L , et al. 2008. DTI analysis of white matter deficits in frontotemporal lobar dementia. Neurology 70, A452.
Ballard C , Ziabreva I , Perry R , et al. 2006. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67, 1931–4.
Ballmaier M , O'Brien J T , Burton E J , et al. 2004. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects. Neuroimage 23, 325–35.
Barber R , Ballard C , McKeith I G , et al. 2000. MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology 54, 1304–9.
Beck J , Rohrer J D , Campbell T , et al. 2008. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 131, 706–20.
Bersano A , Del Bo R , Lamperti C , et al. 2007. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol Aging 30, 752–8.
Beyer M K , Larsen J P , Aasrland D , et al. 2007. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69, 747–54.
Bian H , Van Swieten J C , Leight S , et al. 2008. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70, 1827–35.
Blin J , Vidailhet M J , Pillon B , et al. 1992. Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 7, 348–54.
Boeve B F , Lang A E , Litvan I , et al. 2003. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54 (Suppl 5), S15–9.
Bonelli S B , Ransmayr G , Steffelbauer M , et al. 2004. L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology 63, 376–8.
Borroni B , Brambati S M , Agosti C , et al. 2007. Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol 64, 246–51.
Boxer A L , Geschwind M D , Belfor N , et al. 2006. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 63, 81–6.
Bright P , Moss H E , Stamatakis E A , et al. 2008. Longitudinal studies of semantic dementia: The relationship between structural and functional changes over time. Neuropsychologia 46, 2177–88.
Burn D J , Rowan E N , Minett T , et al. 2003. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord 18, 884–9.
Burton E J , Karas G , Paling S M , et al. 2002. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 17, 618–30.
Burton E J , McKeith I G , Burn D J , et al. 2004. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127, 791–800.
Buxbaum L J , Kyle K , Grossman M , et al. 2007. Left inferior parietal representations for skilled hand-object interactions: Evidence from stroke and corticobasal degeneration. Cortex 43, 411–23.
Caselli R J , Jack C R Jr, Petersen R C , et al. 1992. Asymmetric cortical degenerative syndromes: Clinical and radiologic correlations. Neurology 42, 1462–8.
Chang J L , Lomen-Hoerth C , Murphy C J , et al. 2005. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 65, 75–80.
Chao L L , Schuff N , Clevenger E M , et al. 2007. Patterns of white matter atrophy in frontotemporal lobar degeneration. Arch Neurol 64, 1619–24.
Chow T W , Binns M A , Freedman M , et al. 2008. Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Dis Assoc Disord 22, 327–35.
Chui H C , Zarow C , Mack W J , et al. 2006. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 60, 677–87.
Clark D G , Charuvastra A , Miller B L , et al. 2005. Fluent versus nonfluent primary progressive aphasia: A comparison of clinical and functional neuroimaging features. Brain Lang 94, 54–60.
Colloby S J , O'Brien J T , Fenwick J D , et al. 2004. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 23, 956–66.
Colloby S J , Pakrasi S , Firbank M J , et al. 2006. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R, R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage 33, 423–9.
Colloby S J , Williams E D , Burn D J , et al. 2005. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging 32, 1176–85.
Colosimo C , Hughes A J , Kilford L , et al. 2003. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 74, 852–6.
Cooke A , DeVita C , Gee J , et al. 2003. Neural basis for sentence comprehension deficits in frontotemporal dementia. Brain Lang 85, 211–21.
Davatzikos C , Resnick S M , Wu X , et al. 2008. Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage 41, 1220–7.
Davies R R , Halliday G M , Xuereb J H , et al. 2008. The neural basis of semantic memory: Evidence from semantic dementia. Neurobiol Aging 30, 2043–52.
DeCarli C , Massaro J , Harvey D , et al. 2005. Measures of brain morphology and infarction in the Framingham heart study: Establishing what is normal. Neurobiol Aging 26, 491–510.
Delano-Wood L , Abeles N , Sacco J M , et al. 2008. Regional white matter pathology in mild cognitive impairment: Differential influence of lesion type on neuropsychological functioning. Stroke 39, 794–9.
Desgranges B , Matuszewski V , Poilino P , et al. 2007. Anatomical and functional alterations in semantic dementia: A voxel-based MRI and PET study. Neurobiol Aging 28, 1904–13.
Dickson D W . 2001. Neuropathology of Pick's disease. Neurology 56 (11 Suppl 4), S16–20.
Dickson D W . 2008. Neuropathology of progressive supranuclear palsy. Handb Clin Neurol 89, 487–91.
Dickson D W , Bergeron C , Chin S S , et al. 2002. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61, 935–46.
Donnemiller E , Heilmann J , Wenning G K , et al. 1997. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24, 320–5.
Downes J J , Priestley N M , Doran M , et al. 1998. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease. Behav Neurol 11, 173–83.
Drzezga A , Grimmer T , Henriksen G , et al. 2008. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage 39, 619–33.
Eckert T , Barnes A , Dhawan V , et al. 2005. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26, 912–21.
Eerola J , Tienari P J , Kaakkola S , et al. 2005. How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry 76, 1211–6.
Eidelberg D , Dhawan V , Moeller J R , et al. 1991. The metabolic landscape of cortico-basal ganglionic degeneration: Regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 54, 856–62.
Englund E . 1998. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 9 (Suppl 1), 6–12.
Englund E . 2002. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 13 (Suppl 2), 11–5.
Fagan A M , Mintun M A , Mach R H , et al. 2006. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59, 512–9.
Fein G , Di Sclafani V , Tanabe J , et al. 2000. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55, 1626–35.
Firbank M J , Burn D J , McKeith I G , et al. 2005. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. Int J Geriatr Psychiatry 20, 776–82.
Firbank M J , Colloby S J , Burn D J , et al. 2003. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20, 1309–19.
Forman M S , Farmer J , Johnson J K , et al. 2006a. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59, 952–62.
Forman M S , Mackenzie I R , Cairns N J , et al. 2006b. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 65, 571–81.
Foster N L , Heidebrink J L , Clark C M , et al. 2007. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130, 2616–35.
Fulbright R K , Hoffmann C , Leed H , et al. 2008. MR imaging of familial Creutzfeldt-Jakob disease: A blinded and controlled study. Am J Neuroradiol 29, 1638–43.
Garrard P and Hodges J R . 2000. Semantic dementia: Clinical, radiological and pathological perspectives. J Neurol 247, 409–22.
Geschwind M D , Tan K M , Lennon V A , et al. 2008. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt–Jakob disease. Arch Neurol 65, 1341–6.
Geser F , Winton M J , Kwong L K , et al. 2008. Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115, 133–45.
Gold G , Giannakopoulos P , Herrmann F R , et al. 2007. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 130, 2830–6.
Gorno-Tempini M L , Brambati S M , Ginex V , et al. 2008. The logopenic/phonological variant of primary progressive aphasia. Neurology 71, 1227–34.
Gorno-Tempini M L , Dronkers N F , Rankin K P , et al. 2004. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55, 335–46.
Gouw A A , van der Flier W M , Fazekas F , et al. 2008. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study. Stroke 39, 1414–20.
Groschel K , Hauser T K , Luft A , et al. 2004. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 21, 714–24.
Grossman M , Alsop D , Detre J A , et al. 2001. Perfusion fMRI using arterial spin labeling in Alzheimer's disease and frontotemporal dementia: Correlations with language. Brain Lang 79, 94–5.
Grossman M , Cooke A , DeVita C , et al. 2002. Sentence processing strategies in healthy seniors with poor comprehension: An fMRI study. Brain Lang 80, 296–313.
Grossman M , D'Esposito M , Hughes E , et al. 1996a. Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration. Neurology 47, 183–9.
Grossman M , McMillan C , Moore P , et al. 2004. What's in a name: Voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 127, 628–49.
Grossman M , Mickanin J , Onishi K , et al. 1996b. Progressive nonfluent aphasia: language, cognitive, and PET measures contrasted to probable Alzheimer's disease. J Cogn Neurosci 8, 135–54.
Grossman M and Moore P . 2005. A longitudinal study of sentence comprehension difficulty in primary progressive aphasia. J Neurol Neurosurg Psychiatry 76, 644–9.
Grossman M , Payer F , Onishi K , et al. 1998. Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease. Neurology 50, 157–63.
Grossman M , Wood E M , Moore P , et al. 2007. TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol 64, 1449–54.
Grossman M , Xie S X , Libon D J , et al. 2008. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology 70, 2036–45.
Gydesen S , Brown J M , Brun A , et al. 2002. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59, 1585–94.
Halpern C , McMillan C , Moore P , et al. 2003. Calculation impairment in neurodegenerative diseases. J Neurol Sci 208, 31–8.
Halpern C H , Glosser G , Clark R , et al. 2004. Dissociation of numbers and objects in corticobasal degeneration and semantic dementia. Neurology 62, 1163–9.
Harding A J and Halliday G M . 2001. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102, 355–63.
Hashimoto M , Kitagaki H , Imamura T , et al. 1998. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study. Neurology 51, 357–62.
Higuchi M , Tashiro M , Arai H , et al. 2000. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 162, 247–56.
Hodges J R , Davies R R , Xuereb J H , et al. 2004. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56, 399–406.
Hu W T , Josephs K A , Ahlskog J E , et al. 2005. MRI correlates of alien leg-like phenomenon in corticobasal degeneration. Mov Disord 20, 870–3.
Hu W T , Josephs K A , Knopman D S , et al. 2008. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116, 215–20.
Hu W T , Murray J A , Greenaway M C , et al. 2006. Cognitive impairment and celiac disease. Arch Neurol 63, 1440–6.
Hu W T , Rippon G , Boeve F , et al. 2009a. Alzheimer disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 24, 1375–9.
Hu W T , Seelaar H , Josephs K A , et al. 2009b. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol 66, 1359–64.
Ishii K , Imamura T , Sasaki M , et al. 1998a. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 51, 125–30.
Ishii K , Sakamoto S , Sasaki M , et al. 1998b. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39, 1875–8.
Ishii K , Yamaji S , Kitagaki H , et al. 1999. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 53, 413–6.
Jellinger K A and Attems J . 2007. Neurofibrillary tangle-predominant dementia: Comparison with classical Alzheimer disease. Acta Neuropathol 113, 107–17.
Johnson J K , Head E , Kim R , et al. 1999. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56, 1233–9.
Josephs K A , Duffy J R , Strand E A , et al. 2006a. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129, 1385–98.
Josephs K A , Knopman D S , Whitwell J L , et al. 2005. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 65, 645–7.
Josephs K A , Petersen R C , Knopman D S , et al. 2006b. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66, 41–8.
Josephs K A , Tang-Wai D F , Edland S D , et al. 2004. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 61, 1881–4.
Josephs K A , Whitwell J L , Dickson D W , et al. 2008a. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 29, 280–9.
Josephs K A , Whitwell J L , Duffy J R , et al. 2008b. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology 70, 25–34.
Josephs K A , Whitwell J L , Knopman D S , et al. 2008c. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70, 1850–7.
Kandiah N , Tan K , Pan A B , et al. 2008. Creutzfeldt–Jakob disease: Which diffusion-weighted imaging abnormality is associated with periodic EEG complexes? J Neurol 255, 1411–4.
Kartsounis L D , Crellin R F , Crewes H , et al. 1991. Primary progressive non-fluent aphasia: A case study. Cortex 27, 121–9.
Kertesz A , McMonagle P , Blair M , et al. 2005. The evolution and pathology of frontotemporal dementia. Brain 128, 1996–2005.
Kim E J , Rabinovici G D , Seeley W W , et al. 2007. Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 78, 1375–8.
Kim Y J , Ichise M , Erami S S , et al. 2002. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 17, 303–12.
Kitagaki H , Hirono N , Ishii K , et al. 2000. Corticobasal degeneration: Evaluation of cortical atrophy by means of hemispheric surface display generated with MR images. Radiology 216, 31–8.
Knibb J A , Xuereb J H , Patterson K , et al. 2006. Clinical and pathological characterization of progressive aphasia. Ann Neurol 59, 156–65.
Knopman D S , Petersen R C , Edland S D , et al. 2004. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 62, 506–08.
Kokmen E , Beard C M , O'Brien P C , et al. 1993. Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960–1984). Neurology 43, 1887–92.
Kovari E , Gold G ., Herrmann F R , et al. 2007. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology 68, 927–31.
Krause S , Gohringer T , Walter M C , et al. 2007. Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein. Clin Neuropathol 26, 232–40.
Laakso M P , Partanen K , Riekkinen P , et al. 1996. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46, 678–81.
Laureys S , Salmon E , Garraux G , et al. 1999. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol 246, 1151–8.
Le Ber I , Camuzat A , Hannequin D , et al. 2008. Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain 131, 732–46.
Le Ber I , Martinez M , Campion D , et al. 2004. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: Phenotype and suggestive mapping of the DM3 locus to chromosome 15q21–24. Brain 127, 1979–92.
Libon D J , Price C C , Giovannetti T , et al. 2008. Linking MRI hyperintensities with patterns of neuropsychological impairment: Evidence for a threshold effect. Stroke 39, 806–13.
Lippa C F , Duda J E , Grossman M , et al. 2007. DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68, 812–9.
Listerud J , Anderson C , Moore P , et al. 2009. Neuropsychological patterns in MRI-defined subgroups of patients with degenerative dementia. J Int Neuropsychol Soc, 15, 459–70.
Litvan I , Bhatia K P , Burn D J , et al. 2003. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18, 467–86.
Lobotesis K , Fenwick J D , Phipps A , et al. 2001. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56, 643–9.
Lutte I , Laterre C , Bodart J M , et al. 2000. Contribution of PET studies in diagnosis of corticobasal degeneration. Eur Neurol 44, 12–21.
Martindale J , Geschwind M D , De Armond S , et al. 2003. Sporadic Creutzfeldt–Jakob disease mimicking variant Creutzfeldt–Jakob disease. Arch Neurol 60, 767–70.
Massimo L and Grossman M . 2008. Patient care and management of frontotemporal lobar degeneration. Am J Alzh Dis Other Dementias 23, 125–31.
McKeith I , O'Brien J , Walker Z , et al. 2007. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study. Lancet Neurol 6, 305–13.
McKeith I G , Dickson D W , Lowe J , et al. 2005. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65, 1863–72.
McKeith I G , Galasko D , Kosaka K , et al. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47, 1113–24.
McKhann G M , Albert M S , Grossman M , et al. 2001. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58, 1803–09.
McMurtray A M , Chen A K , Shapira J S , et al. 2006. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 66, 517–22.
McNeill R , Sare G M , Manoharan M , et al. 2007. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 78, 350–5.
Meissner B , Kallenberg K , Sanchez-Juanc P , et al. 2008. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt–Jakob disease. Am J Neuroradiol 29, 1519–24.
Mendez M F , Shapira J S , McMurtray A , et al. 2007. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol 64, 830–5.
Mesulam M , Wicklund A , Johnson N , et al. 2008. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63, 709–19.
Mielke M M , Rosenberg P B , Tschanz J , et al. 2007. Vascular factors predict rate of progression in Alzheimer disease. Neurology 69, 1850–8.
Minoshima S , Foster N L , Sima A A , et al. 2001. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50, 358–65.
Minoshima S , Giordani B , Berent S , et al. 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42, 85–94.
Mori H , Yagishita A , Takeda T , et al. 2007. Symmetric temporal abnormalities on MR imaging in amyotrophic lateral sclerosis with dementia. Am J Neuroradiol 28, 1511–6.
Mosconi L , Tsui W H , Herholz K , et al. 2008. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49, 390–8.
Mosimann U P , Rowan E N , Partington C E , et al. 2006. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. Am J Geriatr Psychiatry 14, 153–60.
Mukherjee O , Pastor P , Cairns N J , et al. 2006. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 60, 314–22.
Mummery C J , Patterson K , Price C J , et al. 2000. A voxel-based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory. Ann Neurol 47, 36–45.
Mungas D , Jagust W J , Reed B R , et al. 2001. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 57, 2229–35.
Murphy J M , Henry R G , Langmore S , et al. 2007. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 64, 530–4.
Murray R , Neumann M , Forman M S , et al. 2007. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68, 1274–83.
Neary D , Snowden J S , Gustafson L , et al. 1998. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546–54.
Nestor P J , Fryer T D , Hodges J R , et al. 2006. Declarative memory impairments in Alzheimer's disease and semantic dementia. Neuroimage 30, 1010–20.
Nestor P J , Graham N L , Fruer T D , et al. 2003. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 126, 2406–18.
Neumann M , Sampathu D M , Kwong L K , et al. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–3.
Newberg A B , Mozley P D , Sadek A H , et al. 2000. Regional cerebral distribution of [Tc-99m] hexylmethylpropylene amineoxine in patients with progressive aphasia. J Neuroimaging 10, 162–8.
Noe E , Marder K , Bell K L , et al. 2004. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 19, 60–7.
O'Brien J T , Colloby S , Fenwick J , et al. 2004. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 61, 919–25.
O'Brien J T , Firbank M J , Mosimann U P , et al. 2005. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res 139, 79–88.
Osaki Y , Morita Y , Fukumoto M , et al. 2005. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia. Mov Disord 20, 999–1005.
Parchi P , Castellani R , Capellari S , et al. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39, 767–78.
Peigneux P , Salmon E , Garraux G , et al. 2001. Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology 57, 1259–68.
Phukan J , Pender N P , Hardiman O , et al. 2007. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6, 994–1003.
Plotkin M , Amthauer H , Klaffke S , et al. 2005. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients. J Neural Transm 112, 677–92.
Price C C , Jefferson A L , Merino J G , et al. 2005. Subcortical vascular dementia: Integrating neuropsychological and neuroradiologic data. Neurology 65, 376–82.
Price T R , Manolio T A , Kronmal R A , et al. 1997. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 28, 1158–64.
Prusiner S B and Hsiao K K . 1994. Human prion diseases. Ann Neurol 35, 385–95.
Rabinovici G D , Furst A J , O'Neil J P , et al. 2007. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 68, 1205–12.
Rankin K P , Rosen H J , Kramer J H , et al. 2004. Right and left medial orbitofrontal volumes show an opposite relationship to agreeableness in FTD. Dement Geriatr Cogn Disord 17, 328–32.
Rhee J , Antiquena P , Grossman M , et al. 2001. Verb comprehension in frontotemporal degeneration: The role of grammatical, semantic and executive components. Neurocase 7, 173–84.
Riekkinen P Jr, Kejonen K , Laakso M P , et al. 1998. Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients. Neuroreport 9, 1507–11.
Rohrer J D , Warren J D , Omar R , et al. 2008. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 65, 506–13.
Roman G C , Tatemichi T K , Erkinjuntti T , et al. 1993. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250–60.
Rosen H J , Allison S C , Ogar J M , et al. 2006. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 67, 1752–6.
Rosen H J , Gorno-Tempini M L , Goldman W P , et al. 2002a. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58, 198–208.
Rosen H J , Perry R J , Murphy J , et al. 2002b. Emotion comprehension in the temporal variant of frontotemporal dementia. Brain 125, 2286–95.
Satoh K , Shirabe S , Tsujino A , et al. 2007. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt–Jakob disease. Dement Geriatr Cogn Disord 24, 207–12.
Schneider J A , Boyle P A , Arvanitakis Z , et al. 2007. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol 62, 59–66.
Seeley W W , Bauer A M , Miller B L , et al. 2005. The natural history of temporal variant frontotemporal dementia. Neurology 64, 1384–90.
Skibinski G , Parkinson N J , Brown J M , et al. 2005. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37, 806–08.
Snowden J , Neary D , Mann D , et al. 2007. Frontotemporal lobar degeneration: Clinical and pathological relationships. Acta Neuropathol 114, 31–8.
Snowdon D A , Greiner L H , Mortimer J A , et al. 1997. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813–7.
Soliveri P , Monza D , Paridi D , et al. 1999. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 53, 502–07.
Swartz R H , Stuss D T , Gao F , et al. 2008. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 39, 822–30.
Sze G , De Armond S J , Brandt-Zawadzki M , et al. 1986. Foci of MRI signal (pseudo lesions) anterior to the frontal horns: Histologic correlations of a normal finding. Am J Roentgenol 147, 331–7.
Talbot P R , Snowden J S , Lloyd J J , et al. 1995. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol 242, 579–86.
Tam C W , Burton E J , McKeith I G , et al. 2005. Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64, 861–5.
Tedeschi G , Litvan I , Bonavita S , et al. 1997. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 120, 1541–52.
Turner R S , Kenyon L C , Trojanowski J Q , et al. 1996. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol 39, 166–73.
van der Zee J , Urwin H , Engelborghs S , et al. 2008. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet 17, 313–22.
van Swieten J and Spillantini M G . 2007. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17, 63–73.
Vander Borght T , Minoshima S , Giordani B , et al. 1997. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med 38, 797–802.
Vermeer S E , Koudstaal P J , Oudkerk M , et al. 2002. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 33, 21–5.
Viassolo V , Previtali S C , Schiatti E , et al. 2008. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: Recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling. Clin Genet 74, 54–60.
Walker Z , Costa D C , Ince P , et al. 1999. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 354, 646–7.
Walker Z , Costa D C , Walker R W , et al. 2002. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 73, 134–40.
Watts G D , Thomasova D , Ramdeen S K , et al. 2007. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin Genet 72, 420–6.
Whitwell J L , Jack C R Jr, Kantacri K , et al. 2007a. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol 64, 371–6.
Whitwell J L , Jack C R Jr, Parisi J E , et al. 2007b. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 130, 1148–58.
Whitwell J L , Josephs K A , Rossor M N , et al. 2005. Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 62, 1402–08.
Whitwell J L , Warren J D , Josephs K A , et al. 2004. Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegener Dis 1, 225–30.
Whitwell J L , Weigand S D , Shiung M M , et al. 2007c. Focal atrophy in dementia with Lewy bodies on MRI: A distinct pattern from Alzheimer's disease. Brain 130, 708–19.
Will R G , Zeidler M , Stewart G E , et al. 2000. Diagnosis of new variant Creutzfeldt–Jakob disease. Ann Neurol 47, 575–82.
Woolley J D , Gorno-Tempini M L , Seeley W W , et al. 2007. Binge eating is associated with right orbitofrontal–insular–striatal atrophy in frontotemporal dementia. Neurology 69, 1424–33.
Yi H A , Moore P , Grossman M , et al. 2007. Reversal of the concreteness effect for verbs in patients with semantic dementia. Neuropsychology 21, 9–19.
Yong S W , Yoon J K , An Y S , et al. 2007. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol 14, 1357–62.
Zamboni G , Huey E D , Krueger F , et al. 2008. Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology 71, 736–42.
Zeidler M , Sellar R J , Collie D A , et al. 2000. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt–Jakob disease. Lancet 355, 1412–8.

Reference Title: References

Reference Type: reference-list

Apostolova L G , Mosconi L , Thompson P , et al. 2010. Subregional hippocampal atrophy predicts Alzheimer's dementia in cognitively normal subjects. Neurobiol Aging 31, 1077–88.
Barron S A , Jacobs L and Kinkel W. 1976. Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology 26, 1011–3.
Bobinski M , de Leon M J , Wegiel J , et al. 2000. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 95, 721–5.
Brys M , Pirraglia E , Rich K , et al. 2009. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging 30, 682–90.
de Leon M J. 2006. Hippocampal imaging in the early diagnosis of AD, 1988 to 2006. In Jucker M , Beyreuther K , Haass C , Nitsch R M and Christen Y (Eds.), Alzheimer: 100 Years and Beyond. Berlin: Springer.
de Leon M J , Ferris S H , Blau I , et al. 1979. Correlations between computerised tomographic changes and behavioral deficits in senile dementia. Lancet 20, 859–60.
de Leon M J , George A E , Stylopoulos L A , Smith G and Miller D C. 1989. Early marker for Alzheimer's disease: The atrophic hippocampus. Lancet 2, 672–3.
de Leon M J , McRae T , Tsai J R , et al. 1988. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 2, 391–2.
de Leon M J , Segal C Y , Tarshish C Y , et al. 2002. Longitudinal CSF tau load increases in mild cognitive impairment. Neurosci Lett 333, 183–6.
Friston K J , Holmes A P , Worsley K J , et al. 1995. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 2, 189–210.
George A E , de Leon M J , Gentes C I , et al. 1986a. Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies. Am J Neuroradiol 7, 561–6.
George A E , de Leon M J , Kalnin A , Rosner L , Goodgold A and Chase N. 1986b. Leukoencephalopathy in normal and pathologic aging: 2. MRI and brain lucencies. Am J Neuroradiol 7, 567–70.
Jack C R , Twomey C , Zinsmeister A , Sharbrough F , Petersen R and Cascino G. 1989. Anterior temporal lobes and hippocampal formations: Normative volumetric measurements from MR images in young adults. Radiology 172, 549–54.
Jack C R Jr, Shiung M M , Weigand S D , et al. 2005. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65, 1227–31.
Li Y , Rinne J O , Mosconi L , et al. 2008. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment and Alzheimer's disease. Eur J Nucl Med Mol Imag 35, 2169–81.
Luo F , Seifert T R , Edalji R , et al. 2008. Non-invasive characterization of [Beta]-Amyloid1–40 vasoactivity by functional magnetic resonance imaging in mice. Neuroscience 155, 263–9.
Poduslo J F , Wengenack T M , Curran G L , et al. 2002. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 11, 315–29.
Rusinek H , De Santi S , Frid D , et al. 2003. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 229, 691–6.
Sigurdsson E M , Wadghiri Y Z , Mosconi L , et al. 2008. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging 29, 836–47.
Sperling R A. 2007. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann NY Acad Sci 1097, 146–55.

Reference Title: References

Reference Type: reference-list

Adams R D and Victor M. 1989. Principles of Neurology (4th ed.). New York, NY: McGraw-Hill, Inc.
Agartz I , Momenan R , Rawlings R R , Kerich M J and Hommer D W. 1999. Hippocampal volume in patients with alcohol dependence. Arch Gen Psychiatry 56, 356–63.
Agartz I , Saaf J , Wahlund L O and Wetterberg L. 1991. T1 and T2 relaxation time estimates and brain measures during withdrawal in alcoholic men. Drug Alcohol Depend 29, 157–69.
Alvarez I , Gonzalo L M and Llor J. 1989. Effects of chronic alcoholism on the amygdaloid complex. A study in human and rats. Histol Histopathol 4, 183–92.
Amaral D G , Schumann C M and Nordahl C W. 2008. Neuroanatomy of autism. Trends Neurosci 31, 137–45.
American Psychiatric Association . 1994. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
Andersen B B. 2004. Reduction of Purkinje cell volume in cerebellum of alcoholics. Brain Res 1007, 10–8.
Andreasen N C , O'Leary D S , Cizadlo T , et al. 1996. Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal–thalamic–cerebellar circuitry. Proc Natl Acad Sci USA 93, 9985–90.
Antunez E , Estruch R , Cardenal C , Nicolas J M , Fernandez-Sola J and Urbano-Marquez A. 1998. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. Am J Roentgenol 171, 1131–7.
Ashburner J and Friston K J. 2000. Voxel-based morphometry – The methods. Neuroimage 11, 805–21.
Baker K G , Halliday G M , Kril J J and Harper C G. 1996. Chronic alcoholics without Wernicke–Korsakoff syndrome or cirrhosis do not lose serotonergic neurons in the dorsal raphe nucleus. Alcohol Clin Exp Res 20, 61–6.
Baker K G , Harding A J , Halliday G M , Kril J J and Harper C G. 1999. Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy. Neuroscience 91, 429–38.
Balldin J , Berggren U , Engel J and Eriksson M. 1994. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Alcohol Clin Exp Res 18, 822–5.
Basser P J. 1995. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 8, 333–44.
Beatty W W , Hames K A , Blanco C R , Nixon S J and Tivis L J. 1996. Visuospatial perception, construction and memory in alcoholism. J Stud Alcohol 57, 136–43.
Begleiter H and Porjesz B. 1999. What is inherited in the predisposition toward alcoholism? A proposed model. Alcohol Clin Exp Res 23, 1125–35.
Benegal V , Antony G , Venkatasubramanian G and Jayakumar P N. 2007. Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol 12, 122–32.
Beresford T P , Arciniegas D B , Alfers J , et al. 2006. Hippocampus volume loss due to chronic heavy drinking. Alcohol Clin Exp Res 30, 1866–70.
Bergman H , Borg S , Hindmarsh T , Idestrom C M and Mutzell S. 1980. Computed-tomography of the brain and neuropsychological assessement of alcoholic patients. Adv Exp Med Biol 126, 771–86.
Besson J A , Glen A I , Foreman E I , et al. 1981. Nuclear magnetic resonance observations in alcoholic cerebral disorder and the role of vasopressin. Lancet 2, 923–4.
Besson J A , Greentree S G , Foster M A and Rimmington J E. 1989. Effects of ethanol on the NMR characteristics of rat brain. Acute administration, dependency, and long-term effects. Br J Psychiatry 155, 818–21.
Bierut L J , Saccone N L , Rice J P , et al. 2002. Defining alcohol-related phenotypes in humans. The Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health 26, 208–13.
Bleich S , Degner D , Kropp S , Ruther E and Kornhuber J. 2000. Red wine, spirits, beer and serum homocysteine. Lancet 356, 512.
Bleich S , Sperling W , Degner D , et al. 2003. Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI study. Alcohol Alcohol 38, 40–4.
Bloomer C W , Langleben D D and Meyerhoff D J. 2004. Magnetic resonance detects brainstem changes in chronic, active heavy drinkers. Psychiatry Res 132, 209–18.
Brandt J , Butters N , Ryan C and Bayog R. 1983. Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry 40, 435–42.
Bruno S , Cercignani M and Ron M A. 2008. White matter abnormalities in bipolar disorder: A voxel-based diffusion tensor imaging study. Bipolar Disord 10, 460–8.
Butters N. 1981. The Wernicke–Korsakoff syndrome: A review of psychological, neuropathological and etiological factors. Curr Alcohol 8, 205–32.
Cardenas V A , Studholme C , Gazdzinski S , Durazzo T C and Meyerhoff D J. 2007. Deformation-based morphometry of brain changes in alcohol dependence and abstinence. Neuroimage 34, 879–87.
Cargiulo T. 2007. Understanding the health impact of alcohol dependence. Am J Health Syst Pharm 64, S5–11.
Carlen P L , Penn R D , Fornazzari L , Bennett J , Wilkinson D A and Wortzman G. 1986. Computerized tomographic scan assessment of alcoholic brain damage and its potential reversibility. Alcohol Clin Exp Res 10, 226–32.
Carlen P L and Wilkinson D A. 1987. Alcohol-induced brain damage: Confounding variables. Alcohol Alcohol Suppl 1, 37–41.
Carlen P L , Wilkinson D A , Wortzman G and Holgate R. 1984. Partially reversible cerebral atrophy and functional improvement in recently abstinent alcoholics. Can J Neurol Sci 11, 441–6.
Carlen P L , Wortzman G , Holgate R C , Wilkinson D A and Rankin J C. 1978. Reversible cerebral atrophy in recently abstinent chronic alcoholics measured by computed tomography scans. Science 200, 1076–8.
Casey B J , Getz S and Galvan A. 2008. The adolescent brain. Dev Rev 28, 62–77.
Cavanagh J B , Holton J L and Nolan C C. 1997. Selective damage to the cerebellar vermis in chronic alcoholism: A contribution from neurotoxicology to an old problem of selective vulnerability. Neuropathol Appl Neurobiol 23, 355–63.
Chanraud S , Martelli C , Delain F , et al. 2007. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 32, 429–38.
Chanraud S , Reynaud M , Wessa M , et al. 2008. Diffusion tensor tractography in mesencephalic bundles: Relation to mental flexibility in detoxified alcohol-dependent subjects. Neuropsychopharmacology 34, 1223–32.
Charness M E. 1993. Brain lesions in alcoholics. Alcohol Clin Exp Res 17, 2–11.
Chick J D , Smith M A , Engleman H M , et al. 1989. Magnetic resonance imaging of the brain in alcoholics: Cerebral atrophy, lifetime alcohol consumption, and cognitive deficits. Alcohol Clin Exp Res 13, 512–8.
Cisler R , Holder H D , Longabaugh R , Stout R L and Zweben A. 1998. Actual and estimated replication costs for alcohol treatment modalities: Case study from Project MATCH. J Stud Alcohol 59, 503–12.
Clark D B , Thatcher D L and Tapert S F. 2008. Alcohol, psychological dysregulation, and adolescent brain development. Alcohol Clin Exp Res 32, 375–85.
Coleman M. 2005. Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 6, 889–98.
Courville C. 1955. Effects of Alcohol on the Nervous System of Man. Los Angeles, CA: San Lucas Press.
Crews F T , Collins M A , Dlugos C , et al. 2004. Alcohol-induced neurodegeneration: When, where and why? Alcohol Clin Exp Res 28, 350–64.
De Bellis M D , Clark D B , Beers S R , et al. 2000. Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry 157, 737–44.
De Bellis M D , Narasimhan A , Thatcher D L , Keshavan M S , Soloff P and Clark D B. 2005. Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res 29, 1590–600.
Demir B , Ulug B , Lay Ergun E and Erbas B. 2002. Regional cerebral blood flow and neuropsychological functioning in early and late onset alcoholism. Psychiatry Res 115, 115–25.
Di Sclafani V , Ezekiel F , Meyerhoff D J , et al. 1995. Brain atrophy and cognitive function in older abstinent alcoholic men. Alcohol Clin Exp Res 19, 1121–6.
Dick D M and Foroud T. 2003. Candidate genes for alcohol dependence: A review of genetic evidence from human studies. Alcohol Clin Exp Res 27, 868–79.
Diener H C , Muller A , Thron A , Poremba M , Dichgans J and Rapp H. 1986. Correlation of clinical signs with CT findings in patients with cerebellar disease. J Neurol 233, 5–12.
Ding J , Eigenbrodt M L , Mosley T H Jr et al. 2004. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) study. Stroke 35, 16–21.
Durazzo T C , Cardenas V A , Studholme C , Weiner M W and Meyerhoff D J. 2007. Non-treatment-seeking heavy drinkers: effects of chronic cigarette smoking on brain structure. Drug Alcohol Depend 87, 76–82.
Durazzo T C , Gazdzinski S , Banys P and Meyerhoff D J. 2004. Cigarette smoking exacerbates chronic alcohol-induced brain damage: A preliminary metabolite imaging study. Alcohol Clin Exp Res 28, 1849–60.
Edenberg H J and Foroud T. 2006. The genetics of alcoholism: Identifying specific genes through family studies. Addict Biol 11, 386–96.
Estruch R , Nicolas J M , Salamero M , et al. 1997. Atrophy of the corpus callosum in chronic alcoholism. J Neurol Sci 146, 145–51.
Fein G , Bachman L , Fisher S and Davenport L. 1990. Cognitive impairments in abstinent alcoholics. West J Med 152, 531–7.
Fein G , Landman B , Tran H , et al. 2006. Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task. Neuroimage 32, 1465–71.
Ferrer I , Fabregues I , Pineda M , Gracia I and Ribalta T. 1984. A Golgi study of cerebellar atrophy in human chronic alcoholism. Neuropathol Appl Neurobiol 10, 245–53.
First M B , Spitzer R L , Gibbon M and Williams J B W. 1998. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) Version 2.0. New York, NY: Biometrics Research Department, New York State Psychiatric Institute.
Gaser C , Nenadic I , Buchsbaum B R , Hazlett E A and Buchsbaum M S. 2001. Deformation-based morphometry and its relation to conventional volumetry of brain lateral ventricles in MRI. Neuroimage 13, 1140–5.
Gazdzinski S , Durazzo T C and Meyerhoff D J. 2005a. Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependence. Drug Alcohol Depend 78, 263–73.
Gazdzinski S , Durazzo T C , Studholme C , Song E , Banys P and Meyerhoff D J. 2005b. Quantitative brain MRI in alcohol dependence: Preliminary evidence for effects of concurrent chronic cigarette smoking on regional brain volumes. Alcohol Clin Exp Res 29, 1484–95.
Gazdzinski S , Durazzo T C , Yeh P H , Hardin D , Banys P and Meyerhoff D J. 2008. Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res 162, 133–45.
Good C D , Johnsrude I S , Ashburner J , Henson R N , Friston K J and Frackowiak R S. 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21–36.
Haber S and McFarland N R. 2001. The place of the thalamus in frontal cortical–basal ganglia circuits. Neuroscientist 7, 315–24.
Harding A J , Wong A , Svoboda M , Kril J J and Halliday G M. 1997. Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus 7, 78–87.
Harper C. 1998. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 57, 101–10.
Harper C. 2007. The neurotoxicity of alcohol. Hum Exp Toxicol 26, 251–7.
Harper C G , Kril J J and Daly J M. 1987. The specific gravity of the brains of alcoholic and control patients: A pathological study. Br J Addict 82, 1349–54.
Harris G J , Jaffin S K , Hodge S M , et al. 2008. Frontal white matter and cingulum diffusion tensor imaging deficits in alcoholism. Alcohol Clin Exp Res 32, 1001–13.
Harris G J , Oscar-Berman M , Gansler A , et al. 1999. Hypoperfusion of the cerebellum and aging effects on cerebral cortex blood flow in abstinent alcoholics: A SPECT study. Alcohol Clin Exp Res 23, 1219–27.
Hasin D S , Stinson F S , Ogburn E and Grant B F. 2007. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64, 830–42.
Hayakawa K , Kumagai H , Suzuki Y , et al. 1992. MR imaging of chronic alcoholism. Acta Radiol 33, 201–06.
He J , Nixon K , Shetty A K and Crews F T. 2005. Chronic alcohol exposure reduces hippocampal neurogenesis and dendritic growth of newborn neurons. Eur J Neurosci 21, 2711–20.
He X , Sullivan E V , Stankovic R K , Harper C G and Pfefferbaum A. 2007. Interaction of thiamine deficiency and voluntary alcohol consumption disrupts rat corpus callosum ultrastructure. Neuropsychopharmacology 32, 2207–16.
Hill S Y , De Bellis M D , Keshavan M S , et al. 2001. Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. Biol Psychiatry 49, 894–905.
Hill S Y , Muddasani S , Prasad K , et al. 2007. Cerebellar volume in offspring from multiplex alcohol dependence families. Biol Psychiatry 61, 41–7.
Hommer D , Momenan R , Kaiser E and Rawlings R. 2001. Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 158, 198–204.
Hommer D , Momenan R , Rawlings R , et al. 1996. Decreased corpus callosum size among alcoholic women. Arch Neurol 53, 359–63.
Jang D P , Namkoong K , Kim J J , et al. 2007. The relationship between brain morphometry and neuropsychological performance in alcohol dependence. Neurosci Lett 428, 21–6.
Jensen G B and Pakkenberg B. 1993. Do alcoholics drink their neurons away? Lancet 342, 1201–04.
Jernigan T L , Butters N , Ditraglia G , et al. 1991. Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res 15, 418–27.
Jernigan T L , Zatz L M , Ahumada A J Jr, Pfefferbaum A , Tinklenberg J R and Moses J A Jr. 1982. CT measures of cerebrospinal fluid volume in alcoholics and normal volunteers. Psychiatry Res 7, 9–17.
Kamarajan C , Porjesz B , Jones K , et al. 2006. Event-related oscillations in offspring of alcoholics: Neurocognitive disinhibition as a risk for alcoholism. Biol Psychiatry 59, 625–34.
Kashem M A , Harper C and Matsumoto I. 2008. Differential protein expression in the corpus callosum (genu) of human alcoholics. Neurochem Int 53, 1–11.
Kessler R C , Nelson C B , McGonagle K A , Liu J , Swartz M and Blazer D G. 1996. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 17–30.
Kinkingnehun S , Sarazin M , Lehericy S , Guichart-Gomez E , Hergueta T and Dubois B. 2008. VBM anticipates the rate of progression of Alzheimer disease: A 3-year longitudinal study. Neurology 70, 2201–11.
Koob G F. 2008. A role for brain stress systems in addiction. Neuron 59, 11–34.
Korbo L. 1999. Glial cell loss in the hippocampus of alcoholics. Alcohol Clin Exp Res 23, 164–8.
Kril J J , Halliday G M , Svoboda M D and Cartwright H. 1997. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79, 983–98.
Kroft C L , Gescuk B , Woods B T , et al. 1991. Brain ventricular size in female alcoholics: An MRI study. Alcohol 8, 31–4.
Krystal J H , D'Souza D C , Gallinat J , et al. 2006. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res 10, 235–52.
Kurth C , Wegerer V , Reulbach U , et al. 2004. Analysis of hippocampal atrophy in alcoholic patients by a Kohonen feature map. Neuroreport 15, 367–71.
Laakso M P , Vaurio O , Savolainen L , et al. 2000. A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism. Behav Brain es 109, 177–86.
Langlais P J and Zhang S X. 1997. Cortical and subcortical white matter damage without Wernicke's encephalopathy after recovery from thiamine deficiency in the rat. Alcohol Clin Exp Res 21, 434–43.
Lindboe C F and Loberg E M. 1988. The frequency of brain lesions in alcoholics. Comparison between the 5-year periods 1975–1979 and 1983–1987. J Neurol Sci 88, 107–13.
Lipton S A , Kim W K , Choi Y B , et al. 1997. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 94, 5923–8.
Lishman W A. 1990. Alcohol and the brain. Br J Psychiatry 156, 635–44.
Lishman W A , Jacobson R R and Acker C. 1987. Brain damage in alcoholism: current concepts. Acta Med Scand Suppl 717, 5–17.
Liu R S , Lemieux L , Shorvon S D , Sisodiya S M and Duncan J S. 2000. Association between brain size and abstinence from alcohol. Lancet 355, 1969–70.
Maguire E A , Gadian D G , Johnsrude I S , et al. 2000. Navigation-related structural change in the hippocampi of taxi drivers. Proc Natl Acad Sci USA 97, 4398–403.
Makris N , Oscar-Berman M , Jaffin S K , et al. 2008. Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 64, 192–202.
Malhi G S and Lagopoulos J. 2008. Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand 117, 100–17.
Mander A J , Young A , Chick J D and Best J J. 1989. The relationship of cerebral atrophy and T1 in alcoholics: An MRI study. Drug Alcohol Depend 24, 57–9.
Mann K , Ackermann K , Croissant B , Mundle G , Nakovics H and Diehl A. 2005a. Neuroimaging of gender differences in alcohol dependence: Are women more vulnerable? Alcohol Clin Exp Res 29, 896–901.
Mann K , Mundle G , Langle G and Petersen D. 1993. The reversibility of alcoholic brain damage is not due to rehydration: A CT study. Addiction 88, 649–53.
Mann K , Schafer D R , Langle G , Ackermann K and Croissant B. 2005b. The long-term course of alcoholism, 5, 10 and 16 years after treatment. Addiction 100, 797–805.
Martin P R , Singleton C K and Hiller-Sturmhofel S. 2003. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health 27, 134–42.
Mathalon D H , Sullivan E V , Rawles J M and Pfefferbaum A. 1993. Correction for head size in brain-imaging measurements. Psychiatry Res 50, 121–39.
Mayfield R D , Harris R A and Schuckit M A. 2008. Genetic factors influencing alcohol dependence. Br J Pharmacol 154, 275–87.
McBride W J. 2002. Central nucleus of the amygdala and the effects of alcohol and alcohol-drinking behavior in rodents. Pharmacol Biochem Behav 71, 509–15.
McMullen P A , Saint-Cyr J A and Carlen P L. 1984. Morphological alterations in rat CA1 hippocampal pyramidal cell dendrites resulting from chronic ethanol consumption and withdrawal. J Comp Neurol 225, 111–8.
Mechelli A , Price C J , Friston K J and Ashburner J. 2005. Voxel-based morphometry of the human brain: Methods and applications. Curr Med Imaging Rev 1, 1–9.
Mechtcheriakov S , Brenneis C , Egger K , Koppelstaetter F , Schocke M and Marksteiner J. 2007. A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry 78, 610–4.
Medana I M and Esiri M M. 2003. Axonal damage: A key predictor of outcome in human CNS diseases. Brain 126, 515–30.
Melgaard B and Ahlgren P. 1986. Ataxia and cerebellar atrophy in chronic alcoholics. J Neurol 233, 13–5.
Miller W R , Meyers R J and Tonigan J S. 1999. Engaging the unmotivated in treatment for alcohol problems: A comparison of three strategies for intervention through family members. J Consult Clin Psychol 67, 688–97.
Mochizuki H , Masaki T , Matsushita S , et al. 2005. Cognitive impairment and diffuse white matter atrophy in alcoholics. Clin Neurophysiol 116, 223–8.
Mori S and Van Zijl P C. 2002. Fiber tracking: Principles and strategies – A technical review. NMR Biomed 15, 468–80.
Munro C A , Saxton J and Butters M A. 2000. The neuropsychological consequences of abstinence among older alcoholics: A cross-sectional study. Alcohol Clin Exp Res 24, 1510–6.
Muuronen A , Bergman H , Hindmarsh T and Telakivi T. 1989. Influence of improved drinking habits on brain atrophy and cognitive performance in alcoholic patients: A 5-year follow-up study. Alcohol Clin Exp Res 13, 137–41.
Nicolas J M , Catafau A M , Estruch R , et al. 1993. Regional cerebral blood flow-SPECT in chronic alcoholism: Relation to neuropsychological testing. J Nucl Med 34, 1452–9.
Nicolas J M , Estruch R , Salamero M , et al. 1997. Brain impairment in well-nourished chronic alcoholics is related to ethanol intake. Ann Neurol 41, 590–8.
Nixon K. 2006. Alcohol and adult neurogenesis: Roles in neurodegeneration and recovery in chronic alcoholism. Hippocampus 16, 287–95.
Nixon K and Crews F T. 2004. Temporally specific burst in cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol. J Neurosci 24, 9714–22.
Noel X , Paternot J , Van Der Linden M , et al. 2001. Correlation between inhibition, working memory and delimited frontal area blood flow measure by 99mTc-Bicisate SPECT in alcohol-dependent patients. Alcohol Alcohol 36, 556–63.
Oscar-Berman M and Marinkovic K. 2003. Alcoholism and the brain: An overview. Alcohol Res Health 27, 125–33.
Oscar-Berman M and Marinkovic K. 2007. Alcohol: Effects on neurobehavioral functions and the brain. Neuropsychol Rev 17, 239–57.
Oscar-Berman M and Schendan H E. 2000. Asymetries of brain function in alcoholism: Relationship to aging. In Obler L and Connor L T (Eds.) Neurobehavior of Language and Cognition: Studies of Normal Aging and Brain Damage. New York, NY: Kluwer Academic Publishers.
Papez J W. 1937. A proposed mechanism of emotion. Arch Neurol Psychiatry 28, 725–43.
Passingham R E , Stephan K E and Kotter R. 2002. The anatomical basis of functional localization in the cortex. Nat Rev Neurosci 3, 606–16.
Pearlson G D and Calhoun V. 2007. Structural and functional magnetic resonance imaging in psychiatric disorders. Can J Psychiatry 52, 158–66.
Pentney R J and Dlugos C A. 2000. Cerebellar Purkinje neurons with altered terminal dendritic segments are present in all lobules of the cerebellar vermis of ageing, ethanol-treated F344 rats. Alcohol Alcohol 35, 35–43.
Petrakis I L , Poling J , Levinson C , et al. 2006. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry 60, 777–83.
Pfefferbaum A , Adalsteinsson E , Bell R L and Sullivan E V. 2007. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: A longitudinal magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology 32, 1159–77.
Pfefferbaum A , Adalsteinsson E and Sullivan E V. 2005. Frontal circuitry degradation marks healthy adult aging: Evidence from diffusion tensor imaging. Neuroimage 26, 891–9.
Pfefferbaum A , Adalsteinsson E and Sullivan E V. 2006a. Dysmorphology and microstructural degradation of the corpus callosum: Interaction of age and alcoholism. Neurobiol Aging 27, 994–1009.
Pfefferbaum A , Adalsteinsson E and Sullivan E V. 2006b. Supratentorial profile of white matter microstructural integrity in recovering alcoholic men and women. Biol Psychiatry 59, 364–72.
Pfefferbaum A , Lim K O , Desmond J E and Sullivan E V. 1996. Thinning of the corpus callosum in older alcoholic men: A magnetic resonance imaging study. Alcohol Clin Exp Res 20, 752–7.
Pfefferbaum A , Lim K O , Zipursky R B , et al. 1992. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: A quantitative MRI study. Alcohol Clin Exp Res 16, 1078–89.
Pfefferbaum A , Rosenbloom M , Crusan K and Jernigan T L. 1988. Brain CT changes in alcoholics: Effects of age and alcohol consumption. Alcohol Clin Exp Res 12, 81–7.
Pfefferbaum A , Rosenbloom M , Deshmukh A and Sullivan E. 2001. Sex differences in the effects of alcohol on brain structure. Am J Psychiatry 158, 188–97.
Pfefferbaum A , Rosenbloom M , Serventi K L and Sullivan E V. 2002. Corpus callosum, pons, and cortical white matter in alcoholic women. Alcohol Clin Exp Res 26, 400–06.
Pfefferbaum A , Rosenbloom M J , Serventi K L and Sullivan E V. 2004. Brain volumes, RBC status, and hepatic function in alcoholics after 1 and 4 weeks of sobriety: Predictors of outcome. Am J Psychiatry 161, 1190–6.
Pfefferbaum A and Sullivan E V. 2002. Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage 15, 708–18.
Pfefferbaum A and Sullivan E V. 2005. Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: Evidence from diffusion tensor imaging. Neuropsychopharmacology 30, 423–32.
Pfefferbaum A , Sullivan E V , Hedehus M , Adalsteinsson E , Lim K O and Moseley M. 2000. In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin Exp Res 24, 1214–21.
Pfefferbaum A , Sullivan E V , Mathalon D H and Lim K O. 1997. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res 21, 521–9.
Pfefferbaum A , Sullivan E V , Mathalon D H , Shear P K , Rosenbloom M J and Lim K O. 1995. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 19, 1177–91.
Pfefferbaum A , Sullivan E V , Rosenbloom M J , Mathalon D H and Lim K O. 1998. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 55, 905–12.
Pfefferbaum A , Sullivan E V , Rosenbloom M J , Shear P K , Mathalon D H and Lim K O. 1993. Increase in brain cerebrospinal fluid volume is greater in older than in younger alcoholic patients: A replication study and CT/MRI comparison. Psychiatry Res 50, 257–74.
Pfefferbaum A , Zatz L M and Jernigan T L. 1986. Computer-interactive method for quantifying cerebrospinal fluid and tissue in brain CT scans: Effects of aging. J Comput Assist Tomogr 10, 571–8.
Phillips S C , Harper C G and Kril J. 1987. A quantitative histological study of the cerebellar vermis in alcoholic patients. Brain 110, 301–14.
Pitel A L , Beaunieux H , Witkowski T , et al. 2007. Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence. Alcohol Clin Exp Res 31, 1169–78.
Porjesz B and Rangaswamy M. 2007. Neurophysiological endophenotypes, CNS disinhibition, and risk for alcohol dependence and related disorders. Sci World J 7, 131–41.
Rakic P. 2002. Neurogenesis in adult primates. Prog Brain Res 138, 3–14.
Reed R J , Grant I and Rourke S B. 1992. Long-term abstinent alcoholics have normal memory. Alcohol Clin Exp Res 16, 677–83.
Regier D A , Farmer M E , Rae D S , et al. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264, 2511–8.
Ridler K , Veijola J M , Tanskanen P , et al. 2006. Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci USA 103, 15 651–6.
Riley J N and Walker D W. 1978. Morphological alterations in hippocampus after long-term alcohol consumption in mice. Science 201, 646–8.
Rohlfing T , Sullivan E V and Pfefferbaum A. 2006. Deformation-based brain morphometry to track the course of alcoholism: Differences between intra-subject and inter-subject analysis. Psychiatry Res 146, 157–70.
Ron M A , Acker W , Shaw G K and Lishman W A. 1982. Computerized tomography of the brain in chronic alcoholism: A survey and follow-up study. Brain 105, 497–514.
Rosenbloom M J and Pfefferbaum A . 2008. Magnetic resonance imaging of the living brain: Evidence for brain degeneration among alcoholics and recovery with abstinence. Alcohol Res Hlth 31, 362–76.
Rosenbloom M J , Pfefferbaum A and Sullivan E V. 2004. Recovery of short-term memory and psychomotor speed but not postural stability with long-term sobriety in alcoholic women. Neuropsychology 18, 589–97.
Rosenbloom M J , Rohlfing T , O'Reilly A W , Sassoon S A , Pfefferbaum A and Sullivan E V. 2007. Improvement in memory and static balance with abstinence in alcoholic men and women: Selective relations with change in brain structure. Psychiatry Res 155, 91–102.
Rourke S B and Grant I. 1999. The interactive effects of age and length of abstinence on the recovery of neuropsychological functioning in chronic male alcoholics: A 2-year follow-up study. J Int Neuropsychol Soc 5, 234–46.
Schmahmann J D. 2004. Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 16, 367–78.
Schmahmann J D and Pandya D N. 1997. Anatomic organization of the basilar pontine projections from prefrontal cortices in rhesus monkey. J Neurosci 17, 438–58.
Schottenbauer M A , Momenan R , Kerick M and Hommer D W. 2007. Relationships among aging, IQ, and intracranial volume in alcoholics and control subjects. Neuropsychology 21, 337–45.
Schroth G , Naegele T , Klose U , Mann K and Petersen D. 1988. Reversible brain shrinkage in abstinent alcoholics, measured by MRI. Neuroradiology 30, 385–9.
Schroth G , Remmes U and Schupmann A. 1985. Computed tomographic follow-up of brain volume fluctuations before and after alcohol withdrawal treatment. Rofo 142, 363–9.
Schuckit M A , Anthenelli R M , Bucholz K K , Hesselbrock V M and Tipp J. 1995. The time course of development of alcohol-related problems in men and women. J Stud Alcohol 56, 218–25.
Schuckit M A , Daeppen J B , Tipp J E , Hesselbrock M and Bucholz K K. 1998. The clinical course of alcohol-related problems in alcohol dependent and nonalcohol dependent drinking women and men. J Stud Alcohol 59, 581–90.
Schuckit M A , Danko G P and Smith T L. 2004. Patterns of drug-related disorders in a prospective study of men chosen for their family history of alcoholism. J Stud Alcohol 65, 613–20.
Schulte T , Pfefferbaum A and Sullivan E V. 2004. Parallel interhemispheric processing in aging and alcoholism: Relation to corpus callosum size. Neuropsychologia 42, 257–71.
Schulte T , Sullivan E V , Muller-Oehring E M , Adalsteinsson E and Pfefferbaum A. 2005. Corpus callosal microstructural integrity influences interhemispheric processing: A diffusion tensor imaging study. Cereb Cortex 15, 1384–92.
Shear P K , Jernigan T L and Butters N. 1994. Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res 18, 172–6.
Shear P K , Sullivan E V , Lane B and Pfefferbaum A. 1996. Mammillary body and cerebellar shrinkage in chronic alcoholics with and without amnesia. Alcohol Clin Exp Res 20, 1489–95.
Sheedy D , Lara A , Garrick T and Harper C. 1999. Size of mamillary bodies in health and disease: Useful measurements in neuroradiological diagnosis of Wernicke's encephalopathy. Alcohol Clin Exp Res 23, 1624–8.
Shimamura A P , Jernigan T L and Squire L R. 1988. Korsakoff's syndrome: Radiological (CT) findings and neuropsychological correlates. J Neurosci 8, 4400–10.
Smith M A , Chick J , Kean D M , et al. 1985. Brain water in chronic alcoholic patients measured by magnetic resonance imaging. Lancet 1, 1273–4.
Sowell E R , Thompson P M , Mattson S N , et al. 2001. Voxel-based morphometric analyses of the brain in children and adolescents prenatally exposed to alcohol. Neuroreport 12, 515–23.
Squire L R , Amaral D G and Press G A. 1990. Magnetic resonance imaging of the hippocampal formation and mammillary nuclei distinguish medial temporal lobe and diencephalic amnesia. J Neurosci 10, 3106–17.
Stafford J L , Albert M S , Naeser M A , Sandor T and Garvey A J. 1988. Age-related differences in computed tomographic scan measurements. Arch Neurol 45, 409–15.
Sullivan E V. 2003. Compromised pontocerebellar and cerebellothalamocortical systems: Speculations on their contributions to cognitive and motor impairment in nonamnesic alcoholism. Alcohol Clin Exp Res 27, 1409–19.
Sullivan E V , Deshmukh A , De Rosa E , Rosenbloom M J and Pfefferbaum A. 2005a. Striatal and forebrain nuclei volumes: Contribution to motor function and working memory deficits in alcoholism. Biol Psychiatry 57, 768–76.
Sullivan E V , Deshmukh A , Desmond J E , Lim K O and Pfefferbaum A. 2000a. Cerebellar volume decline in normal aging, alcoholism, and Korsakoff's syndrome: Relation to ataxia. Neuropsychology 14, 341–52.
Sullivan E V , Deshmukh A , Desmond J E , et al. 2000b. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch Gen Psychiatry 57, 894–902.
Sullivan E V , Harding A J , Pentney R , et al. 2003. Disruption of frontocerebellar circuitry and function in alcoholism. Alcohol Clin Exp Res 27, 301–09.
Sullivan E V , Lane B , Deshmukh A , et al. 1999. In vivo mammillary body volume deficits in amnesic and nonamnesic alcoholics. Alcohol Clin Exp Res 23, 1629–36.
Sullivan E V and Marsh L. 2003. Hippocampal volume deficits in alcoholic Korsakoff's syndrome. Neurology 61, 1716–9.
Sullivan E V , Marsh L , Mathalon D H , Lim K O and Pfefferbaum A. 1995. Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol Clin Exp Res 19, 110–22.
Sullivan E V , Marsh L , Mathalon D H , Lim K O and Pfefferbaum A. 1996. Relationship between alcohol withdrawal seizures and temporal lobe white matter volume deficits. Alcohol Clin Exp Res 20, 348–54.
Sullivan E V , Marsh L , and Pfefferbaum A. 2005b. Preservation of hippocampal volume throughout adulthood in healthy men and women. Neurobiol Aging 26, 1093–8.
Sullivan E V and Pfefferbaum A. 2001. Magnetic resonance relaxometry reveals central pontine abnormalities in clinically asymptomatic alcoholic men. Alcohol Clin Exp Res 25, 1206–12.
Sullivan E V and Pfefferbaum A. 2003. Diffusion tensor imaging in normal aging and neuropsychiatric disorders. Eur J Radiol 45, 244–55.
Sullivan E V and Pfefferbaum A. 2005. Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology (Berl) 180, 583–94.
Sullivan E V and Pfefferbaum A. (2009). Neuroimaging of the Wernicke Korsakoff Syndrome. Alcohol Alcohol 44, 155–65.
Sullivan E V , Rose J and Pfefferbaum A. 2006. Effect of vision, touch and stance on cerebellar vermian-related sway and tremor: A quantitative physiological and MRI study. Cereb Cortex 16, 1077–86.
Sullivan E V , Rosenbloom M J , Lim K O and Pfefferbaum A. 2000c. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: Relationships to changes in brain structure. Neuropsychology 14, 178–88.
Sullivan E V , Rosenbloom M J , and Pfefferbaum A. 2000d. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 24, 611–21.
Sullivan E V and Zahr N M. 2008. Neuroinflammation as a neurotoxic mechanism in alcoholism: Commentary on “Increased MCP-1 and microglia in various regions of human alcoholic brain”. Exp Neurol 213, 10–7.
Thomson A D. 2000. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke–Korsakoff syndrome. Alcohol Alcohol Suppl 35, 2–7.
To S E and Vega C P. 2006. Alcoholism and pathways to recovery: New survey results on views and treatment options. Med Gen Med 8, 2.
Torvik A , Lindboe C F and Rogde S. 1982. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci 56, 233–48.
Torvik A and Torp S. 1986. The prevalence of alcoholic cerebellar atrophy. A morphometric and histological study of an autopsy material. J Neurol Sci 75, 43–51.
Venkatasubramanian G , Anthony G , Reddy U S , Reddy V V , Jayakumar P N and Benegal V. 2007. Corpus callosum abnormalities associated with greater externalizing behaviors in subjects at high risk for alcohol dependence. Psychiatry Res 156, 209–15.
Victor M , Adams R D and Mancall E L. 1959. A restricted form of cerebellar degeneration occurring in alcohol patients. Arch Neurol 1, 577–688.
Victor M A , Adams R D and Collins G H. 1989. The Wernicke–Korsakoff syndrome. Philadelphia, PA: F.A. Davis Company.
Vornik L A and Brown E S. 2006. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry, 67 (Suppl 7), 24–30.
Walker D W , Barnes D E , Zornetzer S F , Hunter B E and Kubanis P. 1980. Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science 209, 711–3.
Wang G J , Volkow N D , Roque C T , et al. 1993. Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 186, 59–65.
Whitfield J B , Zhu G , Madden P A , Neale M C , Heath A C and Martin N G. 2004. The genetics of alcohol intake and of alcohol dependence. Alcohol Clin Exp Res 28, 1153–60.
Wilens T E and Upadhyaya H P. 2007. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry 68, e20.
Wilhelm J , Frieling H , Hillemacher T , Degner D , Kornhuber J and Bleich S. 2008. Hippocampal volume loss in patients with alcoholism is influenced by the consumed type of alcoholic beverage. Alcohol Alcohol 43, 296–9.
Wrase J , Makris N , Braus D F , et al. 2008. Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 165, 1179–84.
Yeh P H , Gazdzinski S , Durazzo T C , Sjostrand K and Meyerhoff D J. 2007. Hierarchical linear modeling (HLM) of longitudinal brain structural and cognitive changes in alcohol-dependent individuals during sobriety. Drug Alcohol Depend 91, 195–204.
Zipursky R B , Lim K C and Pfefferbaum A. 1989. MRI study of brain changes with short-term abstinence from alcohol. Alcohol Clin Exp Res 13, 664–6.

Reference Title: References

Reference Type: reference-list

American Psychiatric Association . 1994. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders – 4th Edition. Washington, DC: APA.
Beatty W W , Katzung V M , Moreland V J and Nixon S J. 1995. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 37, 247–53.
Berry J , Van Gorp W G , Herzberg D S , et al. 1993. Neuropsychological deficits in abstinent cocaine abusers: Preliminary findings after two weeks of abstinence. Drug Alcohol Depend 32, 231–7.
Blake J and Smith A. 1997. Effects of smoking and smoking deprivation on the articulatory loop of working memory. Hum Psychopharmacol 12, 259–64.
Block R I , O'Leary D S , Hichwa R D , et al. 2000. Cerebellar hypoactivity in frequent marijuana users. Neuroreport 11, 749–53.
Brody A L , Mandelkern M A , Olmstead R E , et al. 2007. Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry 62, 642–51.
Büttner A , Mall G , Penning R and Weis S. 2000. The neuropathology of heroin abuse. Foren Sci Int 113, 435–42.
Chang L and Chronicle E P. 2007. Functional imaging studies in cannabis users. The Neuroscientist 13, 422.
Chang L , Ernst T , Speck O , et al. 2002. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res Neuroimag 114, 65–79.
Chang L , Yakupov R , Cloak C and Ernst T. 2006. Marijuana use is associated with a reorganized visual–attention network and cerebellar hypoactivation. Brain 129, 1096.
Cowan R L. 2007. Neuroimaging research in human MDMA users: A review. Psychopharmacology 189, 539–56.
Daumann J , Fimm B , Willmes K , Thron A and Gouzoulis-Mayfrank E. 2003a. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: A functional magnetic resonance imaging (fMRI) study. Cogn Brain Res 16, 479–87.
Daumann J , Fischermann T , Heekeren K , Henke K , Thron A and Gouzoulis-Mayfrank E. 2005. Memory-related hippocampal dysfunction in poly-drug ecstasy (3, 4-methylenedioxymethamphetamine) users. Psychopharmacology 180, 607–11.
Daumann J , Fischermann T , Heekeren K , Thron A and Gouzoulis-Mayfrank E. 2004. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry 56, 349–55.
Daumann J , Schnitker R , Weidemann J , Schnell K , Thron A and Gouzoulis-Mayfrank E. 2003b. Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. Neuroreport 14, 1983.
David S P , Munafn M R , Johansen-Berg H , et al. 2005. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: A functional magnetic resonance imaging study. Biol Psychiatry 58, 488–94.
Davis P E , Liddiard H and McMillan T M. 2002. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend 67, 105–08.
Desmond J E , Chen S H A , DeRosa E , Pryor M R , Pfefferbaum A and Sullivan E V. 2003. Increased frontocerebellar activation in alcoholics during verbal working memory: An fMRI study. Neuroimage 19, 1510–20.
Due D L , Huettel S A , Hall W G and Rubin D C. 2002. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging. Am J Psychiatry 159, 954–60.
Forman S D , Dougherty G G , Casey B J , et al. 2004. Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biol Psychiatry 55, 531–7.
Franklin T R , Acton P D , Maldjian J A , et al. 2002. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 51, 134–42.
Fu L P , Bi G H , Zou Z T , et al. 2008. Impaired response inhibition function in abstinent heroin dependents: An fMRI study. Neurosci Lett 438, 322–6.
Gallinat J , Meisenzahl E , Jacobsen L K , et al. 2006. Smoking and structural brain deficits: A volumetric MR investigation. Eur J Neurosci 24, 1744–50.
Garavan H , Pankiewicz J , Bloom A , et al. 2000. Cue-induced cocaine craving: Neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157, 1789–98.
George M S , Anton R F , Bloomer C , et al. 2001. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry 58, 345–52.
Gilman J M and Hommer D W. 2008. Modulation of brain response to emotional images by alcohol cues in alcohol-dependent patients. Addiction Biol 13, 423–34.
Goldstein R Z , Tomasi D , Rajaram S , et al. 2007. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144, 1153–9.
Gruber S A and Yurgelun-Todd D A. 2005. Neuroimaging of marijuana smokers during inhibitory processing: A pilot investigation. Cogn Brain Res 23, 107–18.
Grüsser S M , Wrase J , Klein S , et al. 2004. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology 175, 296–302.
Heinz A , Wrase J , Kahnt T , et al. 2007. Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcohol Clin Exp Res 31, 1138–47.
Hester R and Garavan H. 2004. Executive dysfunction in cocaine addiction: Evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24, 11 017–22.
Jacobsen L K , Mencl W E , Constable R T , Westerveld M and Pugh K R. 2007a. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology 193, 557–66.
Jacobsen L K , Mencl W E , Pugh K R , Skudlarski P and Krystal J H. 2004a. Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: Possible relationship to neurotoxic effects. Psychopharmacology (Berl) 173, 383–90.
Jacobsen L K , Mencl W E , Westerveld M and Pugh K R. 2004b. Impact of cannabis use on brain function in adolescents. Ann N Y Acad Sci 1021, 384–90.
Jacobsen L K , Pugh K R , Constable R T , Westerveld M and Mencl W E. 2007b. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol Psychiatry 61, 31–40.
Jaffe J H , Cascella N G , Kumor K M and Sherer M A. 1989. Cocaine-induced cocaine craving. Psychopharmacology 97, 59–64.
Jager G , de Win M M L , van der Tweel I , et al. 2008. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: Results from an fMRI study. Neuropsychopharmacology 33, 247.
Jager G , Kahn R S , Van Den Brink W , Van Ree J M and Ramsey N F. 2006. Long-term effects of frequent cannabis use on working memory and attention: An fMRI study. Psychopharmacology 185, 358–68.
Jager G , Van Hell H H , De Win M M L , et al. 2007. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 17, 289–97.
Kanayama G , Rogowska J , Pope H G , Gruber S A and Yurgelun Todd D A. 2004. Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology 176, 239–47.
Kaufman J N , Ross T J , Stein E A and Garavan H. 2003. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci 23, 7839–43.
Kivisaari R , Kähkönen S , Puuskari V , Jokela O , Rapeli P and Autti T. 2004. Magnetic resonance imaging of severe, long-term, opiate-abuse patients without neurologic symptoms may show enlarged cerebrospinal spaces but no signs of brain pathology of vascular origin. Arch Med Res 35, 395–400.
Kosten T R , Scanley B E , Tucker K A , et al. 2006. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31, 644–50.
Langleben D D , Ruparel K , Elman I , et al. 2008. Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues. Am J Psychiatry 165, 390.
Lee J H , Lim Y , Wiederhold B K and Graham S J. 2005. A functional magnetic resonance imaging (fMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedb 30, 195–204.
Lee T M C , Zhou W , Luo X , Yuen K S L , Ruan X and Weng X. 2005. Neural activity associated with cognitive regulation in heroin users: A fMRI study. Neurosci Lett 382, 211–6.
Lundqvist T , Jonsson S and Warkentin S. 2001. Frontal lobe dysfunction in long-term cannabis users. Neurotoxicol Teratol 23, 437–43.
Matochik J A , Eldreth D A , Cadet J L and Bolla K I. 2005. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 77, 23–30.
McBride D , Barrett S P , Kelly J T , Aw A and Dagher A. 2006. Clinical research effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: An fMRI study. Neuropsychopharmacology 31, 2728–38.
McClernon F J , Hiott F B , Huettel S A and Rose J E. 2005. Abstinence-induced changes in self-report craving correlate with event-related fMRI responses to smoking cues. Neuropsychopharmacology 30, 1940.
McClernon F J , Kozink R V and Rose J E. 2007. Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology 33, 2148.
Medina K L , Hanson K L , Schweinsburg A D , Cohen-Zion M , Nagel B J and Tapert S F. 2007. Neuropsychological functioning in adolescent marijuana users: Subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc 13, 807–20.
Moeller F G , Steinberg J L , Dougherty D M , Narayana P A , Kramer L A and Renshaw P F. 2004. Functional MRI study of working memory in MDMA users. Psychopharmacology 177, 185–94.
Myrick H , Anton R F , Li X , et al. 2004. Differential brain activity in alcoholics and social drinkers to alcohol cues: Relationship to craving. Neuropsychopharmacology 29, 393–402.
Nestor L , Roberts G , Garavan H and Hester R. 2008. Deficits in learning and memory: Parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. Neuroimage 40, 1328–39.
Okuyemi K S , Powell J N , Savage C R , et al. 2006. Enhanced cue-elicited brain activation in African American compared with Caucasian smokers: An fMRI study. Addiction Biol 11, 97–106.
Padula C B , Schweinsburg A D and Tapert S F. 2007. Spatial working memory performance and fMRI activation interactions in abstinent adolescent marijuana users. Psychol Addict Behav 21, 478.
Paulus M P , Hozack N , Frank L , Brown G G and Schuckit M A. 2003. Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 53, 65–74.
Paulus M P , Hozack N E , Zauscher B E , et al. 2002. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26, 53–63.
Paulus M P , Tapert S F and Schuckit M A. 2005. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 62, 761–8.
Payer D E , Lieberman M D , Monterosso J R , Xu J , Fong T W and London E D. 2007. Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task. Drug Alcohol Depend 93, 93–102.
Pfefferbaum A , Desmond J E , Galloway C , Menon V , Glover G H and Sullivan E V. 2001. Reorganization of frontal systems used by alcoholics for spatial working memory: An fMRI study. Neuroimage 14, 7–20.
Pfefferbaum A , Sullivan E V , Mathalon D H and Lim K O. 1997. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res 21, 521–9.
Pillay S S , Rogowska J , Kanayama G , et al. 2008. Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol 16, 22.
Pillay S S , Rogowska J , Kanayama G , et al. 2004. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: An fMRI study. Drug Alcohol Depend 76, 261–71.
Pope H G and Yurgelun-Todd D. 1996. The residual cognitive effects of heavy marijuana use in college students. JAMA 275, 521–7.
Pope J H G , Gruber A J , Hudson J I , Huestis M A and Yurgelun-Todd D. 2001. Neuropsychological performance in long-term cannabis users. Am Med Assoc 58, 909–15.
Potter A S and Newhouse P A. 2008. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav 88, 407–17.
Quickfall J and Crockford D. 2006. Brain neuroimaging in cannabis use: A review. J Neuropsychiatry Clin Neurosci 18, 318.
Ray R , Loughead J , Wang Z , et al. 2008. Neuroimaging, genetics and the treatment of nicotine addiction. Behav Brain Res 193, 159–69.
Risinger R C , Salmeron B J , Ross T J , et al. 2005. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26, 1097–108.
Rose J S , Branchey M , Buydens-Branchey L , et al. 1996. Cerebral perfusion in early and late opiate withdrawal: A technetium-99m-HMPAO SPECT study. Psychiatry Res Neuroimag 67, 39–47.
Rosenbloom M J , Sullivan E V , Sassoon S A , et al. 2007. Alcoholism, HIV infection, and their comorbidity: Factors affecting self-rated health-related quality of life. J Stud Alcohol 68, 115–25.
Salloum J B , Ramchandani V A , Bodurka J , et al. 2007. Blunted rostral anterior cingulate response during a simplified decoding task of negative emotional facial expressions in alcoholic patients. Alcohol Clin Exp Res 31, 1490–504.
Schneider F , Habel U , Wagner M , et al. 2001. Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry 158, 1075–83.
Schweinsburg A D , Nagel B J , Schweinsburg B C , Park A , Theilmann R J and Tapert S F. 2008. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res Neuroimag 163, 40–51.
Scott J C , Woods S P , Matt G E , et al. 2007. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychol Rev 17, 275–97.
Sinha R , Lacadie C , Skudlarski P , et al. 2005. Neural activity associated with stress-induced cocaine craving: A functional magnetic resonance imaging study. Psychopharmacology (Berl) 183, 171–80.
Snyder F R , Davis F C and Henningfield J E. 1989. The tobacco withdrawal syndrome: Performance decrements assessed on a computerized test battery. Drug Alcohol Depend 23, 259–66.
Solowij N and Battisti R. 2008. The chronic effects of cannabis on memory in humans: A review. Curr Drug Abuse Rev 1, 81–98.
Solowij N , Michie P T and Fox A M. 1995. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37, 731–9.
Strickland T L. 1993. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. Am Neuropsych Assoc 5, 419–27.
Substance Abuse and Mental Health Services Administration (SAMHSA) . 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.
Swan G E and Lessov-Schlaggar C N. 2007. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 17, 259–73.
Tanner-Smith E E. 2006. Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service. Drug Alcohol Depend 83, 247–54.
Tapert S F , Brown G G , Baratta M V and Brown S A. 2004a. fMRI BOLD response to alcohol stimuli in alcohol dependent young women. Addict Behav 29, 33–50.
Tapert S F , Brown G G , Kindermann S , Cheung E H , Frank L R and Brown S A. 2001. fMRI measurement of brain dysfunction in alcohol-dependent young women. Alcohol Clin Exp Res 25, 236–45.
Tapert S F , Cheung E H , Brown G G , et al. 2003. Neural response to alcohol stimuli in adolescents with alcohol use disorder. Arch Gen Psychiatry 60, 727–35.
Tapert S F , Schweinsburg A D , Barlett V C , et al. 2004b. Blood oxygen level dependent response and spatial working memory in adolescents with alcohol use disorders. Alcohol Clin Exp Res 28, 1577–86.
Tapert S F , Schweinsburg A , Drummond S , et al. 2007. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology 194, 173–83.
Thompson P M , Hayashi K M , Simon S L , et al. 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24, 6028–36.
Toomey R , Lyons M J , Eisen S A , et al. 2003. A twin study of the neuropsychological consequences of stimulant abuse. Am Med Assoc 60, 303–10.
Volkow N D , Chang L , Wang G J , et al. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158, 377–82.
Volkow N D , Fowler J S , Wang G J , et al. 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14(2), 169–77.
Wexler B E , Gottschalk C H , Fulbright R K , et al. 2001. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 158, 86–95.
Wrase J , Grüsser S M , Klein S , et al. 2002. Development of alcohol-associated cues and cue-induced brain activation in alcoholics. Eur Psychiatry 17, 287–91.
Xiao Z , Lee T , Zhang J X , et al. 2006. Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues. Drug Alcohol Depend 83, 157–62.
Xu J , Mendrek A , Cohen M S , et al. 2005. Brain activity in cigarette smokers performing a working memory task: Effect of smoking abstinence. Biol Psychiatry 58, 143–50.
Xu J , Mendrek A , Cohen M S , et al. 2006. Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back Task: A preliminary study. Psychiatry Res Neuroimag 148, 103–09.
Xu J , Mendrek A , Cohen M S , et al. 2007. Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the stroop task. Neuropsychopharmacology 32, 1421–8.
Xu P , Jiang Y , Geng D , Wang Y and Lu G. 2008. A fMRI Study on Electroacupuncture Intervening Heroin Abstainers' Cognitive Attention. Paper presented at the 7th Asian-Pacific Conference on Medical and Biological Engineering, Beijing, China.
Yücel M , Lubman D I , Harrison B J , et al. 2007. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry 12, 691–702.
Yurgelun-Todd D , Gruber A J , Hanson R A , Baird A A , Renshaw P F and Pope H G Jr. 1999. Residual Effects of Marijuana Use: A fMRI Study. Paper presented at the Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting of the College on Problems of Drug Dependence, Bethesda, MD.
Zakzanis K K , Campbell Z and Jovanovski D. 2007. The neuropsychology of ecstasy (MDMA) use: A quantitative review. Hum Psychopharmacol 22, 427–35.

Reference Title: References

Reference Type: reference-list

Adams K M , Gilman S , Koeppe R A , et al. 1993. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res 17, 205–10.
Alhassoon O M , Dupont R M , Schweinsburg B C , Taylor M J , Patterson T L and Grant I. 2001. Regional cerebral blood flow in cocaine- versus methamphetamine-dependent patients with a history of alcoholism. Int J Neuropsychopharmacol 4, 105–12.
Alkondon M , Pereira E F , Eisenberg H M and Albuquerque E X. 2000. Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and disinhibition of neuronal networks. J Neurosci 20, 66–75.
Ariyannura P S , Madhavaraoa C N and Namboodiri A M A. 2008. N-acetylaspartate synthesis in the brain: Mitochondria vs. microsomes. Brain Res 1227, 34–41.
Arstad E , Gitto R , Chimirri A , et al. 2006. Closing in on the AMPA receptor: Synthesis and evaluation of 2-acetyl-1-(4'-chlorophenyl)-6-methoxy-7-[11C]methoxy-1,2,3,4-tetrahydroisoquinoline as a potential PET tracer. Bioorg Med Chem 14, 4712–7.
Behar K L and Ogino T. 1993. Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain. Magn Reson Med 30, 38–44.
Bendszus M , Weijers H G , Wiesbeck G , et al. 2001. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: Correlation with clinical and neuropsychological data. Am J Neuroradiol 22, 1926–32.
Biegon A , Gibbs A , Alvarado M , Ono M and Taylor S. 2007. In vitro and in vivo characterization of [3H]CNS-5161 – A use-dependent ligand for the N-methyl-d-aspartate receptor in rat brain. Synapse 61, 577–86.
Blusztajn J K , Liscovitch M and Richardson U I. 2008. Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc Natl Acad Sci USA 84, 5474–7.
Bossong M G , van Berckel B N , Boellaard R , et al. 2009. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34, 759–66.
Bostwick D G. 1981. Amphetamine induced cerebral vasculitis. Hum Pathol 12, 1031–3.
Braissant O , Henry H , Loup M , Eilers B and Bachmann C. 2001. Endogenous synthesis and transport of creatine in the rat brain: An in situ hybridization study. Mol Brain Res 86, 193–201.
Brockerhoff H and Ballou C E. 1962. On the metabolism of the brain phosphoinositide complex. J Biol Chem 237, 1764–8.
Brody A L , Mandelkern M A , Olmstead R E , et al. 2009. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 34, 282–9.
Brody A L , Olmstead R E , London E D , et al. 2004. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161, 1211–8.
Buchert R , Obrocki J , Thomasius R , et al. 2001. Long-term effects of “ecstasy” abuse on the human brain studied by FDG PET. Nucl Med Commun 22, 889–97.
Buchert R , Thomasius R , Wilke F , et al. 2004. A voxel-based PET investigation of the long-term effects of “ecstasy” consumption on brain serotonin transporters. Am J Psychiatry 161, 1181–9.
Burns H D , Van Laere K , Sanabria-Bohorquez S , et al. 2007. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A 104, 9800–05.
Cahill D W , Knipp H and Mosser J. 1981. Intracranial hemorrhage with amphetamine abuse. Neurology 31, 1058–9.
Cass W A. 1997. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther 280, 105–13.
Chakraborty G , Mekala P , Yahya D , Wu G and Ledeen R W. 2001. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 78. 736–45.
Chang L , Cloak C , Yakupov R and Ernst T. 2006. Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol 1, 65–76.
Chang L , Ernst T , Grob C S and Poland R E. 1999. Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users. J Magn Reson Imaging 10, 521–6.
Choi C , Coupland N J , Bhardwaj P P , Malykhin N , Gheorghiu D and Allen P S . 2006. Measurement of brain glutamate and glutamine by spectrally-selective refocusing at 3 Tesla. Magn Reson Med 55, 997–1005.
Commins D L and Seiden L S. 1986. Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex. Brain Res 365, 15–20.
Couey J J , Meredith R M , Spijker S , et al. 2007. Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron 54, 73–87.
Cowan R L. 2007. Neuroimaging research in human MDMA users: A review. Psychopharmacology (Berl) 189, 539–56.
Cowan R L , Bolo N R , Dietrich M , Haga E , Lukas S E and Renshaw P F. 2007. Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users. Psychiatry Res 155, 179–88.
Cowan R L , Joers J M and Dietrich M S. 2009. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: A 3 T magnetic resonance spectroscopy study. Pharmacol Biochem Behav 92, 105–10.
Dao-Castellana M H , Samson Y , Legault F , et al. 1998. Frontal dysfunction in neurologically normal chronic alcoholic subjects: Metabolic and neuropsychological findings. Psychol Med 28, 1039–48.
Daumann J , Fischermann T , Pilatus U , Thron A , Moeller-Hartmann W and Gouzoulis-Mayfrank E. 2004. Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. Neurosci Lett 362, 113–6.
Davison F D , Sweeney B J and Scaravilli F. 1996. Mitochondrial DNA levels in the brain of HIV-positive patients after zidovudine therapy. J Neurol 243, 648–51.
de Win M M , Jager G , Booij J , et al. 2008. Sustained effects of ecstasy on the human brain: A prospective neuroimaging study in novel users. Brain 131, 2936–45.
de Win M M , Reneman L , Reitsma J B , den Heeten G J , Booij J and van den Brink W. 2004. Mood disorders and serotonin transporter density in ecstasy users – The influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) 173, 376–82.
Eggan S M and Lewis D A. 2007. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis. Cerebral Cortex 17, 175–52.
Eisch A J , Gaffney M , Weihmuller F B , O'Dell S J and Marshall J F. 1992. Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res 598, 321–6.
Eisch A J , O'Dell S J and Marshall J F. 1996. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 22, 217–25.
Ellis G M Jr, Mann M A , Judson B A , Schramm N T and Tashchian A. 1985. Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Therap 38, 572–8.
Elsinga P H , Hatano K and Ishiwata K . 2006. PET tracers for imaging of the dopaminergic system. Curr Med Chem 13, 2139–53.
Ernst T , Chang L , Leonido-Yee M and Speck O. 2000. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 54, 1344–9.
Farfel G M and Seiden L S. 1995. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J Pharmacol Exp Ther 272, 868–75.
Fein G , Meyerhoff D J , Discalfani V , et al. 1994. 1H magnetic resonance spectroscopic imaging separates neuronal from glial changes in alcohol-related brain atrophy. In Lancaster F E (Ed.) Alcohol and Glial Cells. Bethesda, MD: National Institutes of Health, 27, 227–41.
Fleckenstein A E , Gibb J W and Hanson G R. 2000. Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol 406, 1–13.
Gao M , Kong D , Clearfield A and Zheng Q-H. 2006. Synthesis of carbon-11 and fluorine-18 labeled N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as new potential PET AMPA receptor ligands. Bioorg Med Chem Lett 16, 2229–33.
Gazdzinski S , Durazzo T C , Yeh P -H , Hardin D , Banys P and Meyerhoff D J. 2008. Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res 162, 133–45.
Gilman S , Adams K , Koeppe R A , et al. 1990. Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol 28, 775–85.
Glass M , Dragunow M and Faull R L. 1997. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77, 299–318.
Gouzoulis-Mayfrank E and Daumann J. 2006. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: How strong is the evidence for persistent brain damage? Addiction 101, 348–61.
Gray R , Rajan A S , Radcliffe K A , Yakehiro M and Dani J A. 1996. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713–6.
Greenwald M , Johanson C -E , Bueller J , et al. 2007. Buprenorphine duration of action: Mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biol Psychiatry 61, 101–10.
Greenwald M K , Johanson C-E , Moody D E , et al. 2003. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology 28, 2000–9.
Hamill T G , Lin L S , Hagmann W , et al. 2009. PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [(11)C]CB-119. Mol Imaging Biol 11, 246–52.
Haselhorst R , Dursteler-MacFarland K M , Scheffler K , et al. 2002. Frontocortical N-acetylaspartate reduction associated with long-term i.v. heroin use. Neurology 58, 305–07.
Henriksen G and Willoch F. 2008. Imaging of opioid receptors in the central nervous system. Brain 131, 1171–96.
Herkenham M , Lynn A B , Little M D , et al. 1990. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87, 1932–6.
Hermann D , Sartorius A , Welzel H , et al. 2007. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychiatry 61, 1281–9.
Hesse S , Barthel H , Schwarz J , Sabri O and Muller U. 2004. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev 28, 547–63. [Erratum, Neurosci Biobehav Rev, 2005, 29, 1119.]
Horti A G and Van Laere K. 2008. Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain. Curr Pharmaceut Des 14, 3363–83.
Hurd R , Sailasuta N , Srinivasan R , Vigneron D B , Pelletier D and Nelson S J. 2004. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 51, 435–40.
Iyo M , Namba H , Yanagisawa M , Hirai S , Yui N and Fukui S. 1997. Abnormal cerebral perfusion in chronic methamphetamine abusers: A study using 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry 21, 789–96.
Jagannathan N R , Desai N G , et al. 1996. Brain metabolite changes in alcoholism: An in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Res Imag 14, 553–7.
Johnson-Greene D , Adams K M , Gilman S , et al. 1997. Effects of abstinence and relapse upon neuropsychological function and cerebral glucose metabolism in severe chronic alcoholism. J Clin Exp Neuropsychol 19, 378–85.Kao C H, Wang S J and Yeh S H. 1994. Presentation of regional cerebral blood flow in amphetamine abusers by 99Tcm-HMPAO brain SPECT. Nucl Med Commun 15, 94–8.
Katsifis A and Kassiou M. 2004. Development of radioligands for in vivo imaging of GABA(A)-benzodiazepine receptors. Mini-Rev Med Chem 4, 909–21.
Kessler R C , Chiu W T , Demler O , Merikangas K R and Walters E E. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62, 617–27.
Kling M A , Carson R E , Borg L , et al. 2000. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts. J Pharmacol Exp Therap 295, 1070–6.
Koob G F and Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97–129.
Lambe E K , Picciotto M R and Aghajanian G K. 2003. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28, 216–25.
Larsen K E , Fon E A , Hastings T G , Edwards R H and Sulzer D. 2002. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 22, 8951–60.
Lindsey K P , Glaser S T and Gatley S J. 2005. Imaging of the brain cannabinoid system. Handb Exp Pharmacol 168, 425–43.
Lopez-Moreno J A , Gonzalez-Cuevas G , Moreno G and Navarro M. 2008. The pharmacology of the endocannabinoid system: Functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict Biol 13, 160–87.
Mansvelder H D , Keath J R and McGehee D S. 2002. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905–19.
Markus R P , Reno L A C , Zago W and Markus R P. 2004. Release of [(3)H]-L-glutamate by stimulation of nicotinic acetylcholine receptors in rat cerebellar slices. Neuroscience 124, 647–53.
Markus R P , Santos J M , Zago W and Reno L A C. 2003. Melatonin nocturnal surge modulates nicotinic receptors and nicotine-induced [3H]glutamate release in rat cerebellum slices. J Pharmacol Exp Therap 305, 525–30.
Martin P R , Gibbs S J , et al. 1995. Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics. Alcohol Clin Exp Res 19, 1078–82.
Mason G F , Petrakis I L , de Graaf R A , et al. 2006. Cortical GABA levels and the recovery from alcohol dependence: Preliminary evidence of modification by cigarette smoking. Biol Psychiatry 59, 85–93.
McCann U D , Szabo Z , Seckin E , et al. 2005. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 30, 1741–50.
McCann U D , Szabo Z , Vranesic M , et al. 2008. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/–)3,4-methylenedioxymethamphetamine (“ecstasy”) users: Relationship to cognitive performance. Psychopharmacology (Berl) 200, 439–50.
McGehee D S and Role L W. 1996. Presynaptic ionotropic receptors. Curr Opin Neurobiol 6, 342–9.
Michel V , Yuan Z , Ramsubir S and Bakovic M. 2006. Choline transport for phospholipid synthesis. Exp Biol Med 231, 490–504.
Moreno A , Ross B D , et al. 2001. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem 77, 347–50.
NIDA and NIAAA . 1998. The economic costs of alcohol and drug abuse in the United States – 1992. NIH Publication Number 98–4327.
Nordahl T E , Salo R , Possin K , et al. 2002. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: A preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 116, 43–52.
Obrocki J , Buchert R , Vaterlein O , Thomasius R , Beyer W and Schiemann T. 1999. Ecstasy – Long-term effects on the human central nervous system revealed by positron emission tomography. Br J Psychiatry 175, 186–8.
Pacheco M A and Jope R S. 1996. Phosphoinositide signaling in human brain. Progr Neurobiol 50, 255–73.
Parks M H , Dawant B M , Riddle W R , et al. 2002. Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res 26, 1368–80.
Patel T B and Clark J B. 1979. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184, 539–46.
Pfefferbaum A , Adalsteinsson E , Bell R L and Sullivan E V. 2007. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: A longitudinal magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology 32, 1159–77.
Phelps M E , Huang S C , Hoffman E J , Selin C , Sokoloff L and Kuhl D E. 1979. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: Validation of method. Ann Neurol 6, 371–88.
Pu C and Vorhees C V. 1995. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: An immunohistochemical study. Synapse 19, 97–104.
Radcliffe K A and Dani J A. 1998. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18, 7075–83.
Radcliffe K A , Fisher J L , Gray R and Dani J A. 1999. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann N Y Acad Sci 868, 591–610.
Reneman L , Booij J , Lavalaye J , et al. 2002b. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: A [123I]beta-CIT SPECT study – Preliminary report. Psychopharmacology (Berl) 159, 335–40.
Reneman L , Endert E , de Bruin K , et al. 2002a. The acute and chronic effects of MDMA (“ecstasy”) on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26, 387–96.
Reneman L , Majoie C B , Flick H and den Heeten G J. 2002c. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: Preliminary results. Am J Neuroradiol 23, 231–7.
Reneman L , Majoie C B , Schmand B , van den Brink W and den Heeten G J. 2001. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: Preliminary report. Biol Psychiatry 50, 550–4.
Rothman D L , Petroff O A , Behar K L and Mattson R H. 1993. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 90, 5662–6.
Ryan L J , Linder J C , Martone M E and Groves P M. 1990. Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res 518, 67–77.
SAMHSA . 2006. Results from the 2005. National Survey on Drug Use and Health: National Findings. NSDUM Series H-30. Rockville, MD, Office of Applied Studies.
SAMHSA . 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Series H-34. Rockville, MD, Office of Applied Studies.
Sanchez-Pernaute R , Wang J Q , Kuruppu D , et al. 2008. Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates. Neuroimage 42, 248–51.
Schweinsburg B C , Alhassoon O M , Taylor M J , et al. 2003. Effects of alcoholism and gender on brain metabolism. Am J Psychiatry 160, 1180–3.
Schweinsburg B C , Taylor M J , Alhassoon O M , et al. 2001. Chemical pathology in brain white matter of recently detoxified alcoholics: A 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 25, 924–34.
Schweinsburg B C , Taylor M J , Videen J S , et al. 2000. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: A preliminary MR spectroscopy study. Alcohol Clin Exp Res 24, 699–705.
Seitz D , Widmann U , Seeger U , et al. 1999. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics. Alcohol Clin Exp Res 23, 158–63.
Sekine Y , Minabe Y , Kawai M , et al. 2002. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study. Neuropsychopharmacology 27, 453–61.
Semple D M , Ebmeier K P , Glabus M F , O'Carroll R E and Johnstone E C. 1999. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (“ecstasy”) users. Br J Psychiatry 175, 63–9.
Sevy S , Smith G S , Ma Y , et al. 2008. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl) 197, 549–56.
Shi J , Zhao L-Y , Copersino M L , et al. 2008. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 579, 160–6.
Silver S M , Schroeder B M and Sterns R H. 2002. Brain uptake of myoinositol after exogenous administration. J Am Soc Nephrol 13, 1255–60.
Sokoloff L , Reivich M , Kennedy C , et al. 1977. The [14C]-deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28, 879–916.
Staley J K , Gottschalk C , Petrakis I L , et al. 2005. Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: Relationship to features of alcohol dependence and cigarette smoking. Arch Gen Psychiatry 62, 877–88.
Staley J K , Krishnan-Sarin S , Cosgrove K P , et al. 2006. Human tobacco smokers in early abstinence have higher levels of β2*nicotinic acetylcholine receptors than nonsmokers. J Neurosci 26, 8707–14.
Stephans S and Yamamoto B. 1996. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 72, 593–600.
Stone J M , Erlandsson K , Arstad E , et al. 2006. Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivo. Nucl Med Biol 33, 239–43.
Taylor M J , Alhassoon O M , Schweinsburg B C , Videen J S and Grant I. 2000. MR spectroscopy in HIV and stimulant dependence HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 6, 83–5.
Thomasius R , Petersen K , Buchert R , et al. 2003. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 167, 85–96.
Thomasius R , Zapletalova P , Petersen K , et al. 2006. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: The longitudinal perspective. J Psychopharmacol 20, 211–25.
Truckenmiller M E , Namboodiri M A , Brownstein M J and Neale J H. 1985. N-Acetylation of L-aspartate in the nervous system: Differential distribution of a specific enzyme. J Neurochem 45, 1658–62.
Volkow N D , Chang L , Wang G J , et al. 2001a. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21, 9414–8.
Volkow N D , Chang L , Wang G J , et al. 2001b. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry 158, 383–9.
Volkow N D , Chang L , Wang G J , et al. 2001c. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158, 377–82.
Volkow N D , Gillespie H , Mullani N , et al. 1991. Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: A study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose. Psychiatry Res 40, 69–78.
Volkow N D , Gillespie H , Mullani N , et al. 1996. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res Neuroimag 67, 29–38.
Volkow N D , Hitzemann R , Wang G J , et al. 1992. Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry 149, 1016–22.
Volkow N D , Hitzemann R , Wolf A P , et al. 1990. Acute effects of ethanol on regional brain glucose metabolism and transport. Psychiatry Res 35, 39–48.
Volkow N D , Wang G J , Hitzemann R , et al. 1994. Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 151, 178–83.
Voruganti L N , Slomka P , Zabel P , Mattar A and Awad A G. 2001. Cannabis induced dopamine release: An in-vivo SPECT study. Psychiatry Res 107, 173–7.
Wang G J , Volkow N D , Chang L , et al. 2004. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161, 242–8.
Wang J-Q , Tueckmantel W , Zhu A , Pellegrino D and Brownell A-L. 2007. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse 61, 951–61.
Wang G J , Volkow N D , Fowler J S , et al. 2003. Alcohol intoxication induces greater reductions in brain metabolism in male than in female subjects. Alcohol Clin Exp Res 27, 909–17.
Waterhouse R N , Slifstein M , Dumont F , et al. 2004. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor. Nucl Med Biol 31, 939–48.
Watkins S S , Koob G F and Markou A. 2000. Neural mechanisms underlying nicotine addiction: Acute positive reinforcement and withdrawal. Nicotine Tobacco Res 2, 19–37.
Wik G , Borg S , Sjogren I , et al. 1988. PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose. Acta Psychiatr Scand 78, 234–41.
Yamamoto H , Kitamura N , Lin X H , et al. 1999. Differential changes in glutamatergic transmission via N-methyl-d-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine. Int J Neuropsychopharmacol 2, 155–63.
Zahr N M , Mayer D , Vinco S , et al. 2009. In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage. Neuropsychopharmacology 34, 1427–42.
Zubieta J , Greenwald M K , Lombardi U , et al. 2000. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: A preliminary study. Neuropsychopharmacology 23, 326–34.
Zubieta J K , Gorelick D A , Stauffer R , Ravert H T , Dannals R F and Frost J J. 1996. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 2, 1225–9.

Reference Title: References

Reference Type: reference-list

Adolphs R. 2002. Recognizing emotion from facial expressions: Psychological and neurological mechanisms. Behav Cogn Neurosci Rev 1, 21–62.
Alvarez J A and Emory E . 2006. Executive function and the frontal lobes: A meta-analytic review. Neuropsychol Rev 16, 17–42.
Andreason P J , Altemus M , Zametkin A J , King A C , Lucinio J and Cohen R M . 1992. Regional cerebral glucose metabolism in bulimia nervosa. Am J Psychiatry 149, 1506–13.
Audenaert K , Van Laere K , Dumont F , et al. 2003. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. J Nucl Med 44, 163–9.
Bailer U F , Frank G K , Henry S E , et al. 2007a. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology 195, 315–24.
Bailer U F , Frank G K , Henry S E , et al. 2007b. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61, 1090–9.
Bailer U F , Frank G K , Henry S E , et al. 2005. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 62, 1032–41.
Bailer U F , Price J C , Meltzer C C , et al. 2004. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: Relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 29, 1143–55.
Barnes N M and Sharp T . 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083–152.
Besthorn C , Zerfass R , Geiger-Kabisch C , et al. 1997. Discrimination of Alzheimer's disease and normal aging by EEG data. Electroencephalogr Clin Neurophysiol 103, 241–8.
Borzekowski D L and Robinson T N . 2005. The remote, the mouse, and the no. 2 pencil: The household media environment and academic achievement among third grade students. Arch Pediatr Adolesc Med 159, 607–13.
Bradley S J , Taylor M J , Rovet J F , et al. 1997. Assessment of brain function in adolescent anorexia nervosa before and after weight gain. J Clin Exp Neuropsychol 19, 20–33.
Bruch H. 1962. Perceptual and conceptual disturbances in anorexia nervosa. Psychosom Med 24, 187–94.
Bulik C M , Sullivan P F , Fear J L and Joyce P R . 1997. Eating disorders and antecedent anxiety disorders: A controlled study. Acta Psychiatr Scand 96, 101–7.
Bush G , Vogt B A , Holmes J , et al. 2002. Dorsal anterior cingulate cortex: A role in reward-based decision making. Proc Natl Acad Sci USA 99, 523–8.
Carter C S , Braver T S , Barch D M , Botvinick M M , Noll D and Cohen J D . 1998. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 280, 747–9.
Castro-Fornieles J , Bargallo N , Lazaro L , et al. 2009. A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J Psychiatr Res 43, 331–40.
Castro-Fornieles J , Bargallo N , Lazaro L , et al. 2007. Adolescent anorexia nervosa: Cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy. J Psychiatr Res 41, 952–8.
Chau D T , Roth R M and Green A I . 2004. The neural circuitry of reward and its relevance to psychiatric disorders. Curr Psychiatry Rep 6, 391–9.
Chowdhury U , Gordon I , Lask B , Watkins B , Watt H and Christie D . 2003. Early-onset anorexia nervosa: Is there evidence of limbic system imbalance? Int J Eat Disord 33, 388–96.
Connan F , Murphy F , Connor S E , et al. 2006. Hippocampal volume and cognitive function in anorexia nervosa. Psychiatry Res 146, 117–25.
Craig A D . 2002. How do you feel? Interoception: The sense of the physiological condition of the body. Nat Rev Neurosci 3, 655–66.
Crisp A H , Fenton G W and Scotton L . 1967. The electroencephalogram in anorexia nervosa. Electroencephalogr Clin Neurophysiol 23, 490.
Critchley H D , Mathias C J and Dolan R J . 2002. Fear conditioning in humans: The influence of awareness and autonomic arousal on functional neuroanatomy. Neuron 33, 653–63.
Delvenne V , Goldman S , Biver F , De Maertalaer V , Wikler D , Damhaut P and Lotstra F . 1997a. Brain hypometabolism of glucose in low-weight depressed patients and in anorectic patients: A consequence of starvation? J Affect Disord 44, 69–77.
Delvenne V , Goldman S , De Maertelaer V , Simon Y , Luxen A and Lotstra F . 1996. Brain hypometabolism of glucose in anorexia nervosa: Normalization after weight gain. Biol Psychiatry 40, 761–8.
Delvenne V , Goldman S , De Maertelaer V , Wikler D , Damhaut P and Lotstra F . 1997b. Brain glucose metabolism in anorexia nervosa and affective disorders: Influence of weight loss or depressive symptomatology. Psychiatry Res 74, 83–92.
Delvenne V , Goldman S , Simon Y , De Maertelaer V and Lotstra F . 1997c. Brain hypometabolism of glucose in bulimia nervosa. Int J Eat Disord 21, 313–20.
Delvenne V , Lotstra F , Goldman S , et al. 1995. Brain hypometabolism of glucose in anorexia nervosa: A PET scan study. Biol Psychiatry 37, 161–9.
Devinsky O , Morrell M J and Vogt B A . 1995. Contributions of anterior cingulate cortex to behaviour. Brain 118, 279–306.
Dodin V and Nandrino J L . 2003. Cognitive processing of anorexic patients in recognition tasks: An event-related potentials study. Int J Eat Disord 33, 299–307.
Doraiswamy P M , Krishnan K R , Boyko O B , et al. 1991. Pituitary abnormalities in eating disorders: Further evidence from MRI studies. Progr Neuro-Psychopharmacol Biol Psychiatry 15, 351–6.
Drewnowski A , Bellisle F , Aimez P and Remy B . 1987. Taste and bulimia. Physiol Behav 41, 621–6.
Ellison Z , Foong J , Howard R , Bullmore E , Williams S and Treasure J . 1998. Functional anatomy of calorie fear in anorexia nervosa. Lancet 352, 1192.
Faris P L , Kim S W , Meller W H , et al. 2000. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial. Lancet 355, 792–7.
Frank G K , Bailer U F , Henry S E , et al. 2005. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11C]raclopride. Biol Psychiatry 58, 908–12.
Frank G K , Bailer U F , Meltzer C C , et al. 2007. Regional cerebral blood flow after recovery from anorexia or bulimia nervosa. Int J Eat Disord 40, 488–92.
Frank G K , Kaye W H , Greer P , Meltzer C C and Price J C . 2000. Regional cerebral blood flow after recovery from bulimia nervosa. Psychiatry Res 100, 31–9.
Frank G K , Kaye W H , Meltzer C C , et al. 2002. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 52, 896–906.
Frank G K , Wagner A , Achenbach S , et al. 2006. Altered brain activity in women recovered from bulimic-type eating disorders after a glucose challenge: A pilot study. Int J Eat Disord 39, 76–9.
Friederich H C , Uher R , Brooks S , et al. 2007. I'm not as slim as that girl: Neural bases of body shape self-comparison to media images. Neuroimage 37, 674–81.
Galusca B , Costes N , Zito N G , et al. 2008. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biol Psychiatry 64, 1009–13.
Ganong W. 2005. Review of Medical Physiology. New York, NY: The McGraw-Hill Companies, Inc.
Geliebter A , Ladell T , Logan M , et al. 2006. Responsivity to food stimuli in obese and lean binge eaters using functional MRI. Appetite 46, 31–5. [Erratum appears in Appetite, 2006; 46, 395. Note: Schweider, Tzipporah [corrected to Schneider, Tzipporah].]
Giordano G D , Renzetti P , Parodi R C , et al. 2001. Volume measurement with magnetic resonance imaging of hippocampus–amygdala formation in patients with anorexia nervosa. J Endocrinol Invest 24, 510–4.
Giummarra M J , Gibson S J , Georgiou-Karistianis N and Bradshaw J L . 2008. Mechanisms underlying embodiment, disembodiment and loss of embodiment. Neurosci Biobehav Rev 32, 143–60.
Goethals I , Vervaet M , Audenaert K , Jacobs F , Ham H and Van Heeringen C . 2007. Does regional brain perfusion correlate with eating disorder symptoms in anorexia and bulimia nervosa patients? J Psychiatr Res 41, 1005–11.
Golden N H , Ashtari M , Kohn M R , et al. 1996. Reversibility of cerebral ventricular enlargement in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. J Pediatr 128, 296–301.
Gordon C M , Dougherty D D , Fischman A J , et al. 2001. Neural substrates of anorexia nervosa: A behavioral challenge study with positron emission tomography. J Pediatr 139, 51–7.
Gordon I , Lask B , Bryant-Waugh R , Christie D and Timimi S . 1997. Childhood-onset anorexia nervosa: Towards identifying a biological substrate. Int J Eat Disord 22, 159–65.
Grunwald M , Weiss T , Assmann B , et al. 2004. Stable asymmetric interhemispheric theta power in patients with anorexia nervosa during haptic perception even after weight gain: A longitudinal study. J Clin Exp Neuropsychol 26, 608–20.
Gwirtsman H E , Kaye W H , George D T , Jimerson D C , Ebert M H and Gold P W . 1989. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia. Arch Gen Psychiatry 46, 61–9.
Hagman J O , Buchsbaum M S , Wu, J C , Rao S J , Reynolds C A and Blinder B J . 1990. Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography. J Affect Disord 19, 153–62.
Hentschel F , Besthorn C and Schmidt M H . 1997. Die fraktale Dimension als Bildbearbeitungsparameter im CT bei Anorexia nervosa vor und nach Therapie. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 25, 201–06.
Hentschel F , Schmidbauer M , Detzner U , Blanz B and Schmidt M H . 1995. Reversible Hirnvolumenanderungen bei der Anorexia nervosa. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 23, 104–12.
Hentschel J , Mockel R , Schlemmer H P , et al. 1999. 1H-MR-Spektroskopie bei Anorexia nervosa: charakteristische Unterschiede zwischen Patienten und gesunden Probanden. ROFO-Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden V 170, 284–9.
Hoffman G W , Ellinwood E H Jr, Rockwell W J , Herfkens R J , Nishita J K and Guthrie L F . 1989. Cerebral atrophy in bulimia. Biol Psychiatry 25, 894–902.
Husain M M , Black K J , Doraiswamy P M , et al. 1992. Subcortical brain anatomy in anorexia and bulimia. Biol Psychiatry 31, 735–8.
Jelic V , Shigeta M , Julin P , Almkvist O , Winblad B and Wahlund L O . 1996. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 7, 314–23.
Jimerson D C , Lesem M D , Kaye W H and Brewerton T D . 1992. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry, 49, 132–8.
Karhunen L J , Vanninen E J , Kuikka J T , Lappalainen R I , Tiihonen J and Uusitupa M I . 2000. Regional cerebral blood flow during exposure to food in obese binge eating women. Psychiatry Res 99, 29–42.
Katzman D K and Colangelo J J . 1996. Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. Hlth Law Canada 16, 110–4.
Katzman D K , Kaptein S , Kirsh C , et al. 1997. A longitudinal magnetic resonance imaging study of brain changes in adolescents with anorexia nervosa. Compr Psychiatry 38, 321–6.
Kaye W H , Bastiani A M and Moss H . 1995. Cognitive style of patients with anorexia nervosa and bulimia nervosa. Int J Eat Disord 18, 287–90.
Kaye W H , Frank G K and McConaha C . 1999. Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacology 21, 503–06.
Kaye W H , Frank G K , Meltzer C C , et al. 2001. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158, 1152–5.
Kaye W H , Klump K L , Frank G K and Strober M . 2000. Anorexia and bulimia nervosa. Annu Rev Med 51, 299–313.
Kelley A E . 2004. Ventral striatal control of appetitive motivation: Role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27, 765–76.
Kiehl K A , Liddle P F and Hopfinger J B . 2000. Error processing and the rostral anterior cingulate: An event-related fMRI study. Psychophysiology 37, 216–23.
Kingston K , Szmukler G , Andrewes D , Tress B and Desmond P . 1996. Neuropsychological and structural brain changes in anorexia nervosa before and after refeeding. Psychol Med 26, 15–28.
Kiriike N , Nishiwaki S , Nagata T , Inoue Y , Inoue K and Kawakita Y . 1990. Ventricular enlargement in normal weight bulimia. Acta Psychiatr Scand 82, 264–6.
Klem G H , Luders H O , Jasper H H and Elger C . 1999. The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 52, 3–6.
Kojima S , Nagai N , Nakabeppu Y , et al. 2005. Comparison of regional cerebral blood flow in patients with anorexia nervosa before and after weight gain. Psychiatry Res 140, 251–8.
Konarski J Z , McIntyre R S , Soczynska J K and Kennedy S H . 2007. Neuroimaging approaches in mood disorders: Technique and clinical implications. Ann Clin Psychiatry 19, 265–77.
Kornreich L , Shapira A , Horev G , Danziger Y , Tyano S and Mimouni M . 1991. CT and MR evaluation of the brain in patients with anorexia nervosa. Am J Neuroradiol 12, 1213–6.
Krieg J C , Backmund H and Pirke K M . 1987. Cranial computed tomography findings in bulimia. Acta Psychiatrica Scand 75, 144–9.
Krieg J C , Lauer C and Pirke K M . 1989. Structural brain abnormalities in patients with bulimia nervosa. Psychiatry Res 27, 39–48.
Kringelbach M L . 2004. Food for thought: Hedonic experience beyond homeostasis in the human brain. Neuroscience 126, 807–19.
Kuikka J T , Tammela L , Karhunen L , et al. 2001. Reduced serotonin transporter binding in binge eating women. Psychopharmacology 155, 310–4.
Kuo Y T , Parkinson J R , Chaudhri O B , et al. 2007. The temporal sequence of gut peptide CNS interactions tracked in vivo by magnetic resonance imaging. J Neurosci 27, 12 341–8.
Kuruoglu A C , Kapucu O , Atasever T , Arikan Z , Isik E and Unlu M . 1998. Technetium-99m-HMPAO brain SPECT in anorexia nervosa. J Nucl Med 39, 304–06.
Lacey J H , Crisp A H , Kalucy R S , Hartmann M K and Chien C N . 1975. Weight gain and the sleeping electroencephalogram: Study of 10 patients with anorexia nervosa. Br Med J 4, 556–8.
Laessle R G , Krieg J C , Fichter M M and Pirke K M . 1989. Cerebral atrophy and vigilance performance in patients with anorexia nervosa and bulimia nervosa. Neuropsychobiology 21, 187–91.
Lambe E K , Katzman D K , Mikulis D J , Kennedy S H and Zipursky R B . 1997. Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Arch Gen Psychiatry 54, 537–42.
Le D S , Pannacciulli N , Chen K , et al. 2007. Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss. Am J Clin Nutr 86, 573–9.
Ledoux J. 2003. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23, 727–38.
Lee A L , Ogle W O and Sapolsky R M . 2002. Stress and depression: Possible links to neuron death in the hippocampus. Bipolar Disord 4, 117–28.
Leonard B E . 1994. Serotonin receptors – Where are they going? Int Clin Psychopharmacol 9 (Suppl 1), 7–17.
Lundgren J D , Newberg A B , Allison K C , Wintering N A , Ploessl K and Stunkard A J . 2008. 123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: A preliminary report. Psychiatry Res 162, 214–20.
Martin F. 1955. Pathological neurological and psychiatric aspects of some deficiency manifestations with digestive and neuro-endocrine disorders. II. Studies of the changes in the central nervous system in two cases of anorexia (so-called anorexia nervosa) in young girls. Helv Med Acta 22, 522–9.
Matsumoto R , Kitabayashi Y , Narumoto J , et al. 2006. Regional cerebral blood flow changes associated with interoceptive awareness in the recovery process of anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 30, 1265–70.
McCormick L M , Keel P K , Brumm M C , et al. 2008. Implications of starvation-induced change in right dorsal anterior cingulate volume in anorexia nervosa. Int J Eat Disord 41, 602–10.
Mockel R , Schlemmer H P , Guckel F , et al. 1999. 1H-MR-Spektroskopie bei Anorexia nervosa: reversible zerebrale Metabolitenanderungen. ROFO-Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden V 170, 371–7.
Moretti D V , Babiloni C , Binetti G , et al. 2004. Individual analysis of EEG frequency and band power in mild Alzheimer's disease. Clin Neurophysiol 115, 299–308.
Muhlau M , Gaser C , Ilg R , et al. 2007. Gray matter decrease of the anterior cingulate cortex in anorexia nervosa. Am J Psychiatry 164, 1850–7.
Naruo T , Nakabeppu Y , Sagiyama K , et al. 2000. Characteristic regional cerebral blood flow patterns in anorexia nervosa patients with binge/purge behavior. Am J Psychiatry 157, 1520–2.
Nozoe S , Naruo T , Nakabeppu Y , et al. 1993. Changes in regional cerebral blood flow in patients with anorexia nervosa detected through single photon emission tomography imaging. Biol Psychiatry 34, 578–80.
Nozoe S , Naruo T , Yonekura R , et al. 1995. Comparison of regional cerebral blood flow in patients with eating disorders. Brain Res Bull 36, 251–5.
Ohman A , Carlsson K , Lundqvist D and Ingvar M . 2007. On the unconscious subcortical origin of human fear. Physiol Behav 92, 180–5.
Phan K L , Wager T , Taylor S F and Liberzon I . 2002. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16, 331–48.
Pieters G L , De Bruijn E R , Maas Y , et al. 2007. Action monitoring and perfectionism in anorexia nervosa. Brain Cogn 63, 42–50.
Pollatos O , Herbert B M , Schandry R and Gramann K . 2008. Impaired central processing of emotional faces in anorexia nervosa. Psychosom Med 70, 701–08.
Puri B K , Lewis H J , Saeed N and Davey N J . 1999. Volumetric change of the lateral ventricles in the human brain following glucose loading. Exp Physiol 84, 223–6.
Rastam M , Bjure J , Vestergren E , et al. 2001. Regional cerebral blood flow in weight-restored anorexia nervosa: A preliminary study. Dev Med Child Neurol 43, 239–42.
Redgrave G W , Bakker A , Bello N T , et al. 2008. Differential brain activation in anorexia nervosa to Fat and Thin words during a Stroop task. Neuroreport 19, 1181–5.
Richmond B J , Liu Z and Shidara M . 2003. Neuroscience. Predicting future rewards. Science 301, 189–80.
Rodriguez G , Babiloni C , Brugnolo A , et al. 2007. Cortical sources of awake scalp EEG in eating disorders. Clin Neurophysiol 118, 1213–22.
Rolls E T , Sienkiewicz Z J and Yaxley S . 1989. Hunger modulates the responses to gustatory stimuli of single neurons in the caudolateral orbitofrontal cortex of the macaque monkey. Eur J Neurosci 1, 53–60.
Roser W , Bubl R , Buergin D , Seelig J , Radue E W and Rost B . 1999. Metabolic changes in the brain of patients with anorexia and bulimia nervosa as detected by proton magnetic resonance spectroscopy. Int J Eat Disord 26, 119–36.
Rost B , Roser W , Bubl R , Radue E W and Buergin D . 1999. MRS of the brain in patients with anorexia or bulimia nervosa. Hosp Med (London) 60, 474–6.
Rzanny R , Freesmeyer D , Reichenbach J R , et al. 2003. 31P-MRS des Hirns bei Anorexia nervosa: Charakteristische Unterschiede in den Spektren von Patienten und gesunden Vergleichspersonen. ROFO-Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden V 175, 75–82.
Sachdev P , Mondraty N , Wen W , et al. 2008. Brains of anorexia nervosa patients process self-images differently from non-self-images: An fMRI study. Neuropsychologia 46, 2161–8.
Santel S , Baving L , Krauel K , et al. 2006. Hunger and satiety in anorexia nervosa: fMRI during cognitive processing of food pictures. Brain Res 1114, 138–48.
Schienle A , Schafer A , Hermann A and Vaitl D . 2009. Binge-eating disorder: Reward sensitivity and brain activation to images of food. Biol Psychiatry 65, 654–61.
Schlemmer H P , Mockel R , Marcus A , et al. 1998. Proton magnetic resonance spectroscopy in acute, juvenile anorexia nervosa. Psychiatry Res 82, 171–9.
Seeger G , Braus D F , Ruf M , Goldberger U and Schmidt M H . 2002. Body image distortion reveals amygdala activation in patients with anorexia nervosa – A functional magnetic resonance imaging study. Neurosci Lett 326, 25–8.
Shirao N , Okamoto Y , Mantani T , et al. 2005. Gender differences in brain activity generated by unpleasant word stimuli concerning body image: An fMRI study. Br J Psychiatry 186, 48–53.
Shirao N , Okamoto Y , Okada G , Okamoto Y and Yamawaki S . 2003. Temporomesial activation in young females associated with unpleasant words concerning body image. Neuropsychobiology 48, 136–42.
Soloff P H , Meltzer C C , Becker C , Greer P J , Kelly T M and Constantine D . 2003. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 123, 153–63.
Steiger H and Bruce K R . 2007. Phenotypes, endophenotypes, and genotypes in bulimia spectrum eating disorders. Can J Psychiatry 52, 220–7.
Steiger H , Young S N , Kin N M , et al. 2001. Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31, 85–95.
Stephan E , Pardo J V , Faris P L , et al. 2003. Functional neuroimaging of gastric distention. J Gastrointest Surg 7, 740–9.
Svirko E and Hawton K . 2007. Self-injurious behavior and eating disorders: The extent and nature of the association. Suicide Life Threat Behav 37, 409–21.
Swayze V W 2nd, Andersen A , Arndt S , et al. 1996. Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid. Psychol Med 26, 381–90.
Takano A , Shiga T , Kitagawa N , et al. 2001. Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT. Psychiatry Res 107, 45–50.
Tammela L I , Rissanen A , Kuikka J T , et al. 2003. Treatment improves serotonin transporter binding and reduces binge eating. Psychopharmacology 170, 89–93.
Task Force On DSM-IV . 1994. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision), Washington DC:, American Psychiatric Press.
Tauscher J , Pirker W , Willeit M , et al. 2001. [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49, 326–32.
Tiihonen J , Keski-Rahkonen A , Lopponen M , et al. 2004. Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 55, 871–3.
Uher R , Brammer M J , Murphy T , et al. 2003. Recovery and chronicity in anorexia nervosa: Brain activity associated with differential outcomes. Biol Psychiatry 54, 934–42.
Uher R , Murphy T , Friederich H C , et al. 2005. Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biol Psychiatry 58, 990–7.
Wagner A , Aizenstein H , Mazurkewicz L , et al. 2008. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology 33, 513–23.
Wagner A , Aizenstein H , Venkatraman V K , et al. 2007. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 164, 1842–9.
Wagner A , Greer P , Bailer U F , et al. 2006. Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa. Biol Psychiatry 59, 291–3.
Wagner A , Ruf M , Braus D F and Schmidt M H . 2003. Neuronal activity changes and body image distortion in anorexia nervosa. Neuroreport 14, 2193–7.
Wang G J , Volkow N D , Thanos P K and Fowler J S . 2004. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: A concept review. J Addict Dis 23, 39–53.
Whitwell J L , Sampson E L , Loy C T , et al. 2007. VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage 35, 207–13.
Woolley J D , Gorno-Tempini M L , Seeley W W , et al. 2007. Binge eating is associated with right orbitofrontal–insular–striatal atrophy in frontotemporal dementia. Neurology 69, 1424–33.
Yonezawa H , Otagaki Y , Miyake Y , Okamoto Y and Yamawaki S . 2008. No differences are seen in the regional cerebral blood flow in the restricting type of anorexia nervosa compared with the binge eating/purging type. Psychiatry Clin Neurosci 62, 26–33.

Reference Title: References

Reference Type: reference-list

Abizaid A , Liu Z W , Andrews Z B , et al. 2006. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116, 3229–39.
Adam T C and Epel E S . 2007. Stress, eating and the reward system. Physiol Behav 91, 449–58.
Ahima R S and Lazar M A . 2008. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22, 1023–31.
Ahima R S , Prabakaran D , Mantzoros C , et al. 1996. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–2.
American Psychiatric Association . 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychatric Association, 729–31.
Andreoli M , Tessari M , Pilla M , Valerio E , Hagan J J and Heidbreder C A . 2003. Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28, 1272–80.
Anthony K , Reed L J , Dunn J T , et al. 2006. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: The cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55, 2986–92.
Arias M , Crespo Iglesias J M , Perez J , Requena-Caballero I , Sesar-Ignacio A and Peleteiro-Fernandez M . 2002. Kleine–Levin syndrome: Contribution of brain SPECT in diagnosis. Rev Neurol 35, 531–3.
Aronne L J and Thornton-Jones Z D . 2007. New targets for obesity pharmacotherapy. Clin Pharmacol Ther 81, 748–52.
Avena N M , Rada P and Hoebel B G . 2008. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32, 20–39.
Avena N M , Rada P , Moise N and Hoebel B G . 2006. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience 139, 813–20.
Baicy K , London E D , Monterosso J , et al. 2007. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A 104, 18 276–9.
Baldo B A and Kelley A E . 2007. Discrete neurochemical coding of distinguishable motivational processes: Insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 191, 439–59.
Banks W A . 2008. The blood–brain barrier as a cause of obesity. Curr Pharm Des 14, 1606–14.
Batterham R L , Cohen M A , Ellis S M , et al. 2003. Inhibition of food intake in obese subjects by peptide YY3–36. N Engl J Med 349, 941–8.
Batterham R L , Ffytche D H , Rosenthal J M , et al. 2007. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450, 106–09.
Berridge K C and Robinson T E . 1998. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Rev 28, 309–69.
Berthoud H R . 2008. Vagal and hormonal gut–brain communication: From satiation to satisfaction. Neurogastroenterol Motil 20 (Suppl 1), 64–72.
Bessesen D H . 2008. Update on obesity. J Clin Endocrinol Metab 93, 2027–34.
Bina K G and Cincotta A H . 2000. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71, 68–78.
Blackburn J R , Phillips A G , Jakubovic A and Fibiger H C . 1989. Dopamine and preparatory behavior: II. A neurochemical analysis. Behav Neurosci 103, 15–23.
Brewer J A and Potenza M N . 2008. The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochem Pharmacol 75, 63–75.
Brody S , Keller U , Degen L , Cox D J and Schachinger H . 2004. Selective processing of food words during insulin-induced hypoglycemia in healthy humans. Psychopharmacology (Berl) 173, 217–20.
Bruning J C , Gautam D , Burks D J , et al. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–5.
Burgmer R , Grigutsch K , Zipfel S , et al. 2005. The influence of eating behavior and eating pathology on weight loss after gastric restriction operations. Obes Surg 15, 684–91.
Burton P , Smit H J and Lightowler H J . 2007. The influence of restrained and external eating patterns on overeating. Appetite 49, 191–7.
Cameron J D , Goldfield G S , Cyr M J and Doucet E . 2008. The effects of prolonged caloric restriction leading to weight-loss on food hedonics and reinforcement. Physiol Behav 94, 474–80.
Capasso A , Petrella C and Milano W . 2009. Pharmacological profile of SSRIs and SNRIs in the treatment of eating disorders. Curr Clin Pharmacol 4, 78–83.
Carr K D . 2002. Augmentation of drug reward by chronic food restriction: Behavioral evidence and underlying mechanisms. Physiol Behav 76, 353–64.
Carr K D . 2007. Chronic food restriction: Enhancing effects on drug reward and striatal cell signaling. Physiol Behav 91, 459–72.
Catalano P M and Ehrenberg H M . 2006. The short- and long-term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynaecol 113, 1126–33.
Cervo L , Cocco A , Petrella C and Heidbreder C A . 2007. Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat. Int J Neuropsychopharmacol 10, 167–81.
Chechlacz M , Rotshtein P , Klamer S , et al. 2009. Diabetes dietary management alters responses to food pictures in brain regions associated with motivation and emotion: a functional magnetic resonance imaging study. Diabetologia 52, 524–33.
Chen P S , Yang Y K , Yeh T L , et al. 2008a. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers – A SPECT study. Neuroimage 40, 275–9.
Chen Y I , Ren J , Wang F N , et al. 2008b. Inhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw. Neurosci Lett 431, 231–5.
Colles S L , Dixon J B and O'Brien P E . 2008. Grazing and loss of control related to eating: Two high-risk factors following bariatric surgery. Obesity (Silver Spring) 16, 615–22.
Comings D E , Gade R , MacMurray J P , Muhleman D and Peters W R . 1996. Genetic variants of the human obesity (OB) gene: Association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry 1, 325–35.
Cooper S J and Al-Naser H A . 2006. Dopaminergic control of food choice: contrasting effects of SKF 38393 and quinpirole on high-palatability food preference in the rat. Neuropharmacology 50, 953–63.
Cox S M , Andrade A and Johnsrude I S . 2005. Learning to like: A role for human orbitofrontal cortex in conditioned reward. J Neurosci 25, 2733–40.
Craig A D . 2003. Interoception: The sense of the physiological condition of the body. Curr Opin Neurobiol 13, 500–05.
Cummings D E and Overduin J . 2007. Gastrointestinal regulation of food intake. J Clin Invest 117, 13–23.
Dalley J W , Cardinal R N and Robbins T W . 2004. Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates. Neurosci Biobehav Rev 28, 771–84.
Dallman M F , Pecoraro N , Akana S F , et al. 2003. Chronic stress and obesity: A new view of “comfort food”. Proc Natl Acad Sci U S A 100, 11 696–701.
Davis C , Levitan R D , Carter J , et al. 2008a. Personality and eating behaviors: A case-control study of binge eating disorder. Int J Eat Disord 41, 243–50.
Davis C , Levitan R D , Kaplan A S , et al. 2008b. Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 32, 620–8.
Davis C , Patte K , Levitan R , Reid C , Tweed S and Curtis C . 2007. From motivation to behaviour: A model of reward sensitivity, overeating, and food preferences in the risk profile for obesity. Appetite 48, 12–9.
Delamater A R . 2007. The role of the orbitofrontal cortex in sensory-specific encoding of associations in pavlovian and instrumental conditioning. Ann N Y Acad Sci 1121, 152–73.
Del Parigi A , Chen K , Salbe A D , et al. 2002. Tasting a liquid meal after a prolonged fast is associated with preferential activation of the left hemisphere. Neuroreport 13, 1141–5.
Del Parigi A , Chen K , Salbe A D , et al. 2004. Persistence of abnormal neural responses to a meal in postobese individuals. Int J Obes Relat Metab Disord 28, 370–7.
Del Parigi A , Chen K , Salbe A D , Reiman E M and Tataranni P A . 2005. Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast. Neuroimage, 24, 436–43.
Di Chiara G and Bassareo V . 2007. Reward system and addiction: What dopamine does and doesn't do. Curr Opin Pharmacol 7, 69–76.
Duong T , Yacoub E , Adriany G , Hu X , Ugurbil K and Kim S . 2003. Microvascular BOLD contribution at 4 and 7 T in the human brain: Gradient-echo and spin-echo fMRI with suppression of blood effects. Magn Res Med 49, 1019–27.
Dymek-Valentine M , Rienecke-Hoste R and Alverdy J . 2004. Assessment of binge eating disorder in morbidly obese patients evaluated for gastric bypass: SCID versus QEWP-R. Eat Weight Disord 9, 211–6.
Epstein L H , Temple J L , Neaderhiser B J , Salis R J , Erbe R W and Leddy J J . 2007. Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav Neurosci 121, 877–86.
Epstein L H , Wright S M , Paluch R A , et al. 2004. Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiol Behav 81, 511–7.
Erondu N , Addy C , Lu K , et al. 2007. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Obesity (Silver Spring) 15, 2027–42.
Fallon S , Shearman E , Sershen H and Lajtha A . 2007. Food reward-induced neurotransmitter changes in cognitive brain regions. Neurochem Res 32, 1772–82.
Farooqi I S , Bullmore E , Keogh J , Gillard J , O'Rahilly S and Fletcher P C . 2007. Leptin regulates striatal regions and human eating behavior. Science 317, 1355.
Fedoroff I , Polivy J and Herman C P . 2003. The specificity of restrained versus unrestrained eaters' responses to food cues: General desire to eat, or craving for the cued food? Appetite 41, 7–13.
Fenu S , Bassareo V and Di Chiara G . 2001. A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci 21, 6897–904.
Figlewicz D P , Bennett J L , Naleid A M , Davis C and Grimm J W . 2006. Intraventricular insulin and leptin decrease sucrose self-administration in rats. Physiol Behav 89, 611–6.
Fiorino D F , Coury A , Fibiger H C and Phillips A G . 1993. Electrical stimulation of reward sites in the ventral tegmental area increases dopamine transmission in the nucleus accumbens of the rat. Behav Brain Res 55, 131–41.
Frank G K , Oberndorfer T A , Simmons A N , et al. 2008. Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage 39, 1559–69.
Gadde K M , Franciscy D M , Wagner H R 2nd and Krishnan K R . 2003. Zonisamide for weight loss in obese adults: A randomized controlled trial. JAMA 289, 1820–5.
Gadde K M , Yonish G M , Foust M S and Wagner H R . 2007. Combination therapy of zonisamide and bupropion for weight reduction in obese women: A preliminary, randomized, open-label study. J Clin Psychiatry 68, 1226–9.
Gallagher M , McMahan R W and Schoenbaum G . 1999. Orbitofrontal cortex and representation of incentive value in associative learning. J Neurosci 19, 6610–4.
Gallou-Kabani C and Junien C . 2005. Nutritional epigenomics of metabolic syndrome: New perspective against the epidemic. Diabetes 54, 1899–906.
Geiger B M , Behr G G , Frank L E , et al. 2008. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. Faseb J 22, 2740–6.
Geliebter A , Ladell T , Logan M , Schneider T , Sharafi M and Hirsch J . 2006. Responsivity to food stimuli in obese and lean binge eaters using functional MRI. Appetite 46, 31–5.
Gilhooly C H , Das S K , Golden J K , et al. 2007. Food cravings and energy regulation: The characteristics of craved foods and their relationship with eating behaviors and weight change during 6 months of dietary energy restriction. Int J Obes (Lond) 31, 1849–58.
Goldfein J A , Walsh B T , Lachaussee J L , Kissileff H R and Devlin M J . 1993. Eating behavior in binge eating disorder. Int J Eat Disord 14, 427–31.
Goldstein R Z and Volkow N D . 2002. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159, 1642–52.
Grabenhorst F , Rolls E T and Bilderbeck A . 2008. How cognition modulates affective responses to taste and flavor: Top-down influences on the orbitofrontal and pregenual cingulate cortices. Cereb Cortex 18, 1549–59.
Grace A A , Floresco S B , Goto Y and Lodge D J . 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30, 220–7.
Grilo C M , Masheb R M and Wilson G T . 2006. Rapid response to treatment for binge eating disorder. J Consult Clin Psychol 74, 602–13.
Hainer V , Toplak H and Mitrakou A . 2008. Treatment modalities of obesity: What fits whom? Diabetes Care 31 (Suppl 2), S269–77.
Hajnal A and Norgren R . 2005. Taste pathways that mediate accumbens dopamine release by sapid sucrose. Physiol Behav 84, 363–9.
Hajnal A , Smith G P and Norgren R . 2004. Oral sucrose stimulation increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 286, R31–7.
Hamdi A , Porter J and Prasad C . 1992. Decreased striatal D2 dopamine receptors in obese Zucker rats: Changes during aging. Brain Res 589, 338–40.
Harrold J A and Halford J C . 2006. The hypothalamus and obesity. Recent Patents CNS Drug Discov 1, 305–14.
Heidbreder C A , Gardner E L , Xi Z X , et al. 2005. The role of central dopamine D3 receptors in drug addiction: A review of pharmacological evidence. Brain Res Brain Res Rev 49, 77–105.
Hocke C , Prante O , Salama I , et al. 2008. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor. Chem Med Chem 3, 788–93.
Hollander J A , Lu Q , Cameron M D , Kamenecka T M and Kenny P J . 2008. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 105, 19 480–5.
Huang X F , Yu Y , Zavitsanou K , Han M and Storlien L . 2005. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. Brain Res Mol Brain Res 135, 150–61.
Huang X F , Zavitsanou K , Huang X , et al. 2006. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res 175, 415–9.
Hurd Y L . 2006. Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. CNS Spectr 11, 855–62.
Huttunen J , Kahkonen S , Kaakkola S , Ahveninen J and Pekkonen E . 2003. Effects of an acute D2-dopaminergic blockade on the somatosensory cortical responses in healthy humans: Evidence from evoked magnetic fields. Neuroreport 14, 1609–12.
Jimerson D C , Lesem M D , Kaye W H and Brewerton T D . 1992. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49, 132–8.
Jonsson E G , Nothen M M , Grunhage F , et al. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4, 290–6.
Karhunen L J , Vanninen E J , Kuikka J T , Lappalainen R I , Tiihonen J and Uusitupa M I . 2000. Regional cerebral blood flow during exposure to food in obese binge eating women. Psychiatry Res 99, 29–42.
Karra E , Chandarana K and Batterham R L . 2009. The role of peptide YY in appetite regulation and obesity. J Physiol 587, 19–25.
Kelley A E , Baldo B A , Pratt W E and Will M J . 2005. Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward. Physiol Behav 86, 773–95.
Killgore W D , Young A D , Femia L A , Bogorodzki P , Rogowska J and Yurgelun-Todd D A . 2003. Cortical and limbic activation during viewing of high- versus low-calorie foods. Neuroimage 19, 1381–94.
Kim S G , Ashe J , Hendrich K , et al. 1993. Functional magnetic resonance imaging of motor cortex: Hemispheric asymmetry and handedness. Science 261, 615–7.
King B M . 2006. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav 87, 221–44.
Kiyatkin E A and Gratton A . 1994. Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res 652, 225–34.
Klein T A , Neumann J , Reuter M , Hennig J , Von Cramon D Y and Ullsperger M . 2007. Genetically determined differences in learning from errors. Science 318, 1642–5.
Kuikka J T , Tammela L , Karhunen L , et al. 2001. Reduced serotonin transporter binding in binge eating women. Psychopharmacology (Berl) 155, 310–4.
Kuo M F , Paulus W and Nitsche M A . 2008. Boosting focally-induced brain plasticity by dopamine. Cereb Cortex 18, 648–51.
Laruelle M , Gelernter J and Innis R B . 1998. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry 3, 261–5.
Leibowitz S F and Alexander J T . 1998. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44, 851–64.
Liang N C , Hajnal A and Norgren R . 2006. Sham feeding corn oil increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 291, R1236–9.
Liu Y , Gao J H , Liu H L and Fox P T . 2000. The temporal response of the brain after eating revealed by functional MRI. Nature 405, 1058–62.
Lustig R H . 2006. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab 2, 447–58.
Machado C J and Bachevalier J . 2007. The effects of selective amygdala, orbital frontal cortex or hippocampal formation lesions on reward assessment in nonhuman primates. Eur J Neurosci 25, 2885–904.
Malik S , McGlone F , Bedrossian D and Dagher A . 2008. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 7, 400–9.
Matsuda M , Liu Y , Mahankali S , et al. 1999. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 48, 1801–6.
McFarland K and Ettenberg A . 1998. Haloperidol does not affect motivational processes in an operant runway model of food-seeking behavior. Behav Neurosci 112, 630–5.
Meguid M M , Fetissov S O , Blaha V and Yang Z J . 2000. Dopamine and serotonin VMN release is related to feeding status in obese and lean Zucker rats. Neuroreport 11, 2069–72.
Menon R . 2002. Postacquisition suppression of large-vessel BOLD signals in high-resolution fMRI. Magn Res Med 47, 1–9.
Mietus-Snyder M L and Lustig R H . 2008. Childhood obesity: Adrift in the “limbic triangle”. Annu Rev Med 59, 147–62.
Missale C , Nash S R , Robinson S W , Jaber M and Caron M G . 1998. Dopamine receptors: From structure to function. Physiol Rev 78, 189–225.
Morrison C D . 2008. Leptin resistance and the response to positive energy balance. Physiol Behav 94, 660–3.
Morrison C D and Berthoud H R . 2007. Neurobiology of nutrition and obesity. Nutr Rev 65, 517–34.
Morton G J , Cummings D E , Baskin D G , Barsh G S and Schwartz M W . 2006. Central nervous system control of food intake and body weight. Nature 443, 289–95.
Mrzljak L , Bergson C , Pappy M , Huff R , Levenson R and Goldman-Rakic P S . 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381, 245–8.
Myers M G , Cowley M A and Munzberg H . 2008. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70, 537–56.
Naqvi N H , Rudrauf D , Damasio H and Bechara A . 2007. Damage to the insula disrupts addiction to cigarette smoking. Science 315, 531–4.
Narendran R , Slifstein M , Guillin O , et al. 2006. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse 60, 485–95.
Niego S H , Kofman M D , Weiss J J and Geliebter A . 2007. Binge eating in the bariatric surgery population: A review of the literature. Int J Eat Disord 40, 349–59.
Noble E P , Blum K , Ritchie T , Montgomery A and Sheridan P J . 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48, 648–54.
Noble E P , Noble R E , Ritchie T , et al. 1994. D2 dopamine receptor gene and obesity. Int J Eat Disord 15, 205–17.
Oak J N , Oldenhof J and Van Tol H H . 2000. The dopamine D(4) receptor: One decade of research. Eur J Pharmacol 405, 303–27.
Ogawa S , Lee T M , Kay A R and Tank D W . 1990. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87, 9868–72.
Ogawa S , Menon R S , Tank D W , et al. 1993. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 64, 803–12.
Ogden C L , Carroll M D , Curtin L R , et al. 2006. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295, 1549–55.
Ogden C L , Carroll M D and Flegal K M . 2008. High body mass index for age among US children and adolescents, 2003–2006. JAMA 299, 2401–5.
Ogden C L , Carroll M D , McDowell M A and Flegal K M . 2007a. Obesity among adults in the United States – No change since 2003–2004. NCHS Data Brief No 1. Hyattsville, MD: National Center for Health Statistics.
Ogden C L , Yanovski S Z , Carroll M D and Flegal K M . 2007b. The epidemiology of obesity. Gastroenterology 132, 2087–102.
Ogden J and Wardle J . 1990. Cognitive restraint and sensitivity to cues for hunger and satiety. Physiol Behav 47, 477–81.
Palmiter R D . 2007. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30, 375–81.
Palmiter R D . 2008. Dopamine signaling in the dorsal striatum is essential for motivated behaviors: Lessons from dopamine-deficient mice. Ann N Y Acad Sci 1129, 35–46.
Parkinson J R , Chaudhri O B , Kuo Y T , et al. 2009. Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI). Neuroimage 44, 1022–31.
Passamonti L , Rowe J B , Schwarzbauer C , Ewbank M P , Von Dem Hagen E and Calder A J . 2009. Personality predicts the brain's response to viewing appetizing foods: The neural basis of a risk factor for overeating. J Neurosci 29, 43–51.
Pelchat M L , Johnson A , Chan R , Valdez J and Ragland J D . 2004. Images of desire: Food-craving activation during fMRI. Neuroimage 23, 1486–93.
Peleg-Raibstein D , Pezze M A , Ferger B , et al. 2005. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-D-aspartate stimulation of the ventral hippocampus in rats. Neuroscience 132, 219–32.
Petrovich G D and Gallagher M . 2003. Amygdala subsystems and control of feeding behavior by learned cues. Ann N Y Acad Sci 985, 251–62.
Pfaffly J , Michaelides M , Wang G J , Pessin J E , Volkow N D and Thanos P K . 2010. Leptin increases striatal dopamine D2 receptor (D2R) binding in leptin-deficient obese (ob/ob) mice. Synapse 64, 503–10.
Pijl H . 2003. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a “thrifty” genotype underlying the metabolic syndrome? Eur J Pharmacol 480, 125–31.
Prante O , Tietze R , Hocke C , et al. 2008. Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: Discovery of an inverse agonist radioligand for PET. J Med Chem 51, 1800–10.
Rada P , Avena N M and Hoebel B G . 2005. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 134, 737–44.
Regard M and Landis T . 1997. “Gourmand syndrome”: Eating passion associated with right anterior lesions. Neurology 48, 1185–90.
Ren X , Zhou L , Terwilliger R , Newton S S and De Araujo I E . 2009. Sweet taste signaling functions as a hypothalamic glucose sensor. Front Integr Neurosci 3, 12.
Ritchie T and Noble E P . 2003. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28, 73–82.
Rivera A , Cuellar B , Giron F J , Grandy D K , De la Calle A and Moratalla R . 2002. Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 80, 219–29.
Robinson S , Rainwater A J , Hnasko T S and Palmiter R D . 2007. Viral restoration of dopamine signaling to the dorsal striatum restores instrumental conditioning to dopamine-deficient mice. Psychopharmacology (Berl) 191, 567–78.
Rolls E T . 2007. Sensory processing in the brain related to the control of food intake. Proc Nutr Soc 66, 96–112.
Rolls E T and McCabe, C . 2007. Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci 26, 1067–76.
Rosenbaum M , Goldsmith R , Bloomfield D , et al. 2005. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 115, 3579–86.
Rosenbaum M , Sy M , Pavlovich K , Leibel R L and Hirsch J . 2008. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest 118, 2583–91.
Ross M G and Desai M . 2005. Gestational programming: Population survival effects of drought and famine during pregnancy. Am J Physiol Regul Integr Comp Physiol 288, R25–33.
Rossini P M , Bassetti M A and Pasqualetti P . 1995. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism. Electroencephalogr Clin Neurophysiol 96, 236–47.
Rotte M , Baerecke C , Pottag G , et al. 2005. Insulin affects the neuronal response in the medial temporal lobe in humans. Neuroendocrinology 81, 49–55.
Sallet P C , Sallet J A , Dixon J B , et al. 2007. Eating behavior as a prognostic factor for weight loss after gastric bypass. Obes Surg 17, 445–51.
Schienle A , Schafer A , Hermann A and Vaitl D . 2009. Binge-eating disorder: Reward sensitivity and brain activation to images of food. Biol Psychiatry 65, 654–61.
Schultes B , Peters A , Kern W , et al. 2005. Processing of food stimuli is selectively enhanced during insulin-induced hypoglycemia in healthy men. Psychoneuroendocrinology 30, 496–504.
Schultz W . 2004. Neural coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioural ecology. Curr Opin Neurobiol 14, 139–47.
Schultz W , Apicella P and Ljungberg T . 1993. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13, 900–13.
Segal N L and Allison D B . 2002. Twins and virtual twins: Bases of relative body weight revisited. Int J Obes Relat Metab Disord 26, 437–41.
Self D W , Barnhart W J , Lehman D A and Nestler E J . 1996. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271, 1586–9.
Shimura T , Kamada Y and Yamamoto T . 2002. Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats. Behav Brain Res 134, 123–30.
Small D M , Jones-Gotman M and Dagher A . 2003. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 19, 1709–15.
Small D M and Prescott J . 2005. Odor/taste integration and the perception of flavor. Exp Brain Res 166, 345–57.
Smeets P A , De Graaf C , Stafleu A , Van Osch M J , Nievelstein R A and Van Der Grond J . 2006. Effect of satiety on brain activation during chocolate tasting in men and women. Am J Clin Nutr 83, 1297–305.
Smeets P A , De Graaf C , Stafleu A , Van Osch M J and Van Der Grond J . 2005. Functional MRI of human hypothalamic responses following glucose ingestion. Neuroimage 24, 363–8.
Smith G P . 2004. Accumbens dopamine mediates the rewarding effect of orosensory stimulation by sucrose. Appetite 43, 11–3.
Sotak B N , Hnasko T S , Robinson S , Kremer E J and Palmiter R D . 2005. Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding. Brain Res 1061, 88–96.
Spitz M R , Duphorne C M , Detry M A , et al. 2000. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev 9, 1017–20.
Staley J K , Malison R T and Innis R B . 1998. Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 44, 534–49.
Stenlof K , Rossner S , Vercruysse F , Kumar A , Fitchet M and Sjostrom L . 2007. Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab 9, 360–8.
Stice E , Spoor S , Bohon C and Small D M . 2008a. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322, 449–52.
Stice E , Spoor S , Bohon C , Veldhuizen M G and Small D M . 2008b. Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study. J Abnorm Psychol 117, 924–35.
Stunkard A J and Wadden T A . 1993. Obesity Theory and Therapy (2nd ed.). New York, NY: Raven Press.
Szczypka M S , Kwok K , Brot M D , et al. 2001. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 30, 819–28.
Tauscher J , Pirker W , Willeit M , et al. 2001. [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49, 326–32.
Thanos P K , Michaelides M , Gispert J D , et al. 2008a. Differences in response to food stimuli in a rat model of obesity: In-vivo assessment of brain glucose metabolism. Int J Obes (Lond) 32, 1171–9.
Thanos P K , Michaelides M , Ho C W , et al. 2008b. The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity. Pharmacol Biochem Behav 89, 499–507.
Thanos P K , Michaelides M , Piyis Y K , Wang G J and Volkow N D . 2008c. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography. Synapse 62, 50–61.
Tracy A L , Jarrard L E and Davidson T L . 2001. The hippocampus and motivation revisited: Appetite and activity. Behav Brain Res 127, 13–23.
Trevitt J T , Carlson B B , Nowend K and Salamone J D . 2001. Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology (Berl) 156, 32–41.
Tupala E , Hall H , Mantere T , Rasanen P , Sarkioja T and Tiihonen J . 2003. Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage 19, 145–55.
Turner R , Jezzard P , Wen H , et al. 1993. Functional mapping of the human visual cortex at 4 and 1.5 Tesla using deoxygenation contrast EPI. Magn Res Med 29, 277–9.
Ugurbil K , Hu X , Chen W , Zhu X , Kim S and Georgopoulos A . 1999. Functional mapping in the human brain using high magnetic fields. Phil Trans R Soc Lond B 354, 1195–213.
Volkow N D , Chang L , Wang G J , et al. 2001. Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158, 2015–21.
Volkow N D , Fowler J S , Wang G J , et al. 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14, 169–77.
Volkow N D , Wang G J , Begleiter H , et al. 2006. High levels of dopamine D2 receptors in unaffected members of alcoholic families: Possible protective factors. Arch Gen Psychiatry 63, 999–1008.
Volkow N D , Wang G J , Fowler J S , et al. 2002. “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 44, 175–80.
Volkow N D , Wang G J , Fowler J S and Telang F . 2008a. Overlapping neuronal circuits in addiction and obesity: Evidence of systems pathology. Phil Trans R Soc Lond B Biol Sci 363, 3191–200.
Volkow N D , Wang G J , Telang F , et al. 2009. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) 17, 60–5.
Volkow N D , Wang G J , Telang F , et al. 2007. Profound decreases in dopamine release in striatum in detoxified alcoholics: Possible orbitofrontal involvement. J Neurosci 27, 12 700–06.
Volkow N D , Wang G J , Telang F , et al. 2008b. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors. Neuroimage 42, 1537–43.
Volkow N D and Wise R A . 2005. How can drug addiction help us understand obesity? Nat Neurosci 8, 555–60.
Wagner A , Aizenstein H , Mazurkewicz L , et al. 2008. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology 33, 513–23.
Wang G J , Tomasi D , Backus W , et al. 2008. Gastric distention activates satiety circuitry in the human brain. Neuroimage 39, 1824–31.
Wang G J , Volkow N D , Felder C , et al. 2002. Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport 13, 1151–5.
Wang G J , Volkow N D , Logan J , et al. 2001. Brain dopamine and obesity. Lancet 357, 354–7.
Wang G J , Volkow N D , Telang F , et al. 2004. Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage 21, 1790–7.
Wang G J , Volkow N D , Telang F , et al. 2009. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci U S A 106, 1249–54.
Wang G J , Yang J , Volkow N D , et al. 2006. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A 103, 15 641–5.
Watanabe M , Cromwell H C , Tremblay L , Hollerman J R , Hikosaka K and Schultz W . 2001. Behavioral reactions reflecting differential reward expectations in monkeys. Exp Brain Res 140, 511–8.
Weingarten H P . 1983. Conditioned cues elicit feeding in sated rats: A role for learning in meal initiation. Science 220, 431–3.
Will M J , Franzblau E B and Kelley A E . 2003. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 23, 2882–8.
Will M J , Pratt W E and Kelley A E . 2006. Pharmacological characterization of high-fat feeding induced by opioid stimulation of the ventral striatum. Physiol Behav 89, 226–34.
Wise R A . 2006. Role of brain dopamine in food reward and reinforcement. Phil Trans R Soc Lond B Biol Sci 361, 1149–58.
Wise R A , Murray A and Bozarth M A . 1990. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology (Berl) 100, 355–60.
Wolnerhanssen B K , Peters T , Kern B , et al. 2008. Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: Results of a prospective study of 380 patients. Surg Obes Relat Dis 4, 500–06.
Woolley J D , Lee B S and Fields H L . 2006. Nucleus accumbens opioids regulate flavor-based preferences in food consumption. Neuroscience 143, 309–17.
Wren A M . 2008. Gut and hormones and obesity. Front Horm Res 36, 165–81.
Yanovski S Z , Nelson J E , Dubbert B K and Spitzer R L . 1993. Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 150, 1472–9.
Yeomans M R and Gray R W . 1997. Effects of naltrexone on food intake and changes in subjective appetite during eating: Evidence for opioid involvement in the appetizer effect. Physiol Behav 62, 15–21.
Zhang Y , Proenca R , Maffei M , Barone M , Leopold L and Friedman J M . 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–32.
Zink C F , Pagnoni G , Martin M E , Dhamala M and Berns G S . 2003. Human striatal response to salient nonrewarding stimuli. J Neurosci 23, 8092–7.
Zipursky R B , Meyer J H and Verhoeff N P . 2007. PET and SPECT imaging in psychiatric disorders. Can J Psychiatry 52, 146–57.

Reference Title: References

Reference Type: reference-list

Avena N M . 2007. Examining the addictive-like properties of binge eating using an animal model of sugar dependence. Exp Clin Psychopharmacol 15, 481–91.
Avena N M , Rada P and Hoebel B G . 2008. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32, 20–39.
Baicy K , London E D , Monterosso J , et al. 2007. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A 104, 18 276–9.
Bailer U F , Frank G K , Henry S E , et al. 2007a. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology (Berl) 195, 315–24.
Bailer U F , Frank G K , Henry S E , et al. 2007b. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61, 1090–9.
Bailer U F , Frank G K , Henry S E , et al. 2005. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 62, 1032–41.
Batterham R L , Ffytche D H , Rosenthal J M , et al. 2007. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450, 106–09.
Castro-Fornieles J , Bargallo N , Lazaro L , et al. 2009. A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J Psychiatr Res 43, 331–40.
Eddy K T , Dorer D J , Franko D L , Tahilani K , Thompson-Brenner H and Herzog D B. 2008. Diagnostic crossover in anorexia nervosa and bulimia nervosa: Implications for DSM-V. Am J Psychiatry 165, 245–50.
Ellison Z , Foong J , Howard R , Bullmore E , Williams S , and Treasure J . 1998. Functional anatomy of calorie fear in anorexia nervosa. Lancet 352, 1192.
Farooqi I S , Bullmore E , Keogh J , Gillard J , O'Rahilly S , and Fletcher P C . 2007. Leptin regulates striatal regions and human eating behavior. Science 317, 1355.
Frank G K , Bailer U F , Henry S E , et al. 2005. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [(11)C]raclopride. Biol Psychiatry 32, 755–61.
Frank G K , Oberndorfer T.A , Simmons A N , et al. 2008. Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage 39, 1559–69.
Frank G K , Wagner A , Achenbach S , et al. 2006. Altered brain activity in women recovered from bulimic-type eating disorders after a glucose challenge: A pilot study. Int J Eat Disord 39, 76–9.
Galusca B , Costes N , Zito N G , et al. 2008. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biol Psychiatry 64, 1009–13.
Geliebter A , Ladell T , Logan M , Schneider T , Sharafi M and Hirsch J . 2006. Responsivity to food stimuli in obese and lean binge eaters using functional MRI. Appetite 46, 31–5.
Gordon C M , Dougherty D D , Fischman A J , et al. 2001. Neural substrates of anorexia nervosa: A behavioral challenge study with positron emission tomography. J Pediatr 139, 51–7.
Hebebrand J and Remschmidt H . 1995. Anorexia nervosa viewed as an extreme weight condition: Genetic implications. Hum Genet 95, 1–11.
Hinton E C , Holland A J , Gellatly M S , et al. 2006. Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes (Lond) 30, 313–21.
Liu Y , Gao J H , Liu H L and Fox P T . 2000. The temporal response of the brain after eating revealed by functional MRI. Nature 405, 1058–62.
Malik S , McGlone F , Bedrossian D and Dagher A . 2008. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 7, 400–9.
Marsh R , Steinglass J E , Gerber A J , et al. 2009. Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry 66, 51–63.
Matsuda M , Liu Y . Mahankali S , et al. 1999. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 48, 1801–06.
McCormick L M , Keel P K , Brumm M C , et al. 2008. Implications of starvation-induced change in right dorsal anterior cingulate volume in anorexia nervosa. Int J Eat Disord 41, 602–10.
Naruo T , Nakabeppu Y , Sagiyama K , et al. 2000. Characteristic regional cerebral blood flow patterns in anorexia nervosa patients with binge/purge behavior. Am J Psychiatry 157, 1520–2.
Redgrave G W , Bakker A , Bello N T , et al. 2008. Differential brain activation in anorexia nervosa to Fat and Thin words during a Stroop task. Neuroreport 19, 1181–5.
Roberts M E , Tchanturia K , Stahl D , Southgate L and Treasure J . 2007. A systematic review and meta-analysis of set-shifting ability in eating disorders. Psychol Med 37, 1075–84.
Sachdev P , Mondraty N , Wen W and Gulliford K . 2008. Brains of anorexia nervosa patients process self-images differently from non-self-images: An fMRI study. Neuropsychologia 46, 2161–8.
Schienle A , Schafer A , Hermann A and Vaitl D . 2009. Binge-eating disorder: Reward sensitivity and brain activation to images of food. Biol Psychiatry 65, 654–61.
Seeger G , Braus D F , Ruf M , Goldberger U and Schmidt M H . 2002. Body image distortion reveals amygdala activation in patients with anorexia nervosa – A functional magnetic resonance imaging study. Neurosci Lett 326, 25–8.
Small D M , Jones-Gotman M and Dagher A . 2003. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 19, 1709–15.
Smeets P A , de G C , Stafleu A , van Osch M J and van der Grond J . 2005. Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr 82, 1011–6.
Uher R , Murphy T , Brammer M J , et al. 2004. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry 161, 1238–46.
Uher R , Murphy T , Friederich H C , et al. 2005. Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biol Psychiatry 58, 990–7.
Volkow N D , Wang G J , Fowler J S , et al. 2002. “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 44, 175–80.
Volkow N D , Wang G J , Fowler J S and Telang F . 2008. Overlapping neuronal circuits in addiction and obesity: Evidence of systems pathology. Phil Trans R Soc Lond B Biol Sci 363, 3191–200.
Volkow N D , Wang G J , Telang F , et al. 2009. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) 17, 60–5.
Wagner A , Aizenstein H , Mazurkewicz L , et al. 2008. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology 33, 513–23.
Wagner A , Aizenstein H , Venkatraman V K , et al. 2010. Altered striatal response to reward in bulimia nervosa after recovery. Int J Eat Disord 45, 289–94.
Wagner A , Aizenstein H , Venkatraman V K , et al. 2007. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 164, 1842–9.
Wagner A , Ruf M , Braus D F and Schmidt M H . 2003. Neuronal activity changes and body image distortion in anorexia nervosa. Neuroreport 14, 2193–7.
Wang G J , Tomasi D , Backus W , et al. 2008. Gastric distention activates satiety circuitry in the human brain. Neuroimage 39, 1824–31.
Wang G J , Volkow N D , Felder C , et al. 2002. Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport 13, 1151–5.
Wang G J Volkow N D , Logan J , et al. 2001. Brain dopamine and obesity. Lancet 357, 354–7.
Wentz E , Gillberg I C , Anckarsater H , Gillberg C and Rastam M . 2009. Adolescent-onset anorexia nervosa: 18-year outcome. Br J Psychiatry 194, 168–74.
Zastrow A , Kaiser S , Stippich C , et al. 2009. Neural correlates of impaired cognitive-behavioral flexibility in anorexia nervosa. Am J Psychiatry 166, 608–16.

Reference Title: References

Reference Type: reference-list

Abrahams B S and Geschwind D H. 2008. Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet 9, 341–55.
Adolphs R. 2003. Cognitive neuroscience of human social behaviour. Nat Rev Neurosci 4, 165–78.
Alexander A L , Lee J E , Lazar M , et al. 2007. Diffusion tensor imaging of the corpus callosum in Autism. Neuroimage 34, 61–73.
Allison T , Puce A , and McCarthy G. 2000. Social perception from visual cues: Role of the STS region. Trends Cogn Sci 4, 267–78.
Amaral D G and Price J L. 1984. Amygdalo-cortical projections in the monkey (Macaca fascicularis). J Comp Neurol 230, 465–96.
American Psychiatric Association . 2000. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). Washington, DC: American Psychiatric Association.
Anderson A K and Phelps E A. 2001. Lesions of the human amygdala impair enhanced perception of emotionally salient events. Nature 411, 305–09.
Armstrong D D. 2001. Rett syndrome neuropathology review 2000. Brain Dev 23 (Suppl 1), S72–6.
Ashwin C , Baron-Cohen S , Wheelwright S , O'Riordan M and Bullmore E T. 2007. Differential activation of the amygdala and the “social brain” during fearful face-processing in Asperger Syndrome. Neuropsychologia 45, 2–14.
Aylward E H , Minshew N J , Goldstein G , et al. 1999. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53, 2145–50.
Bailey A , Le Couteur A , Gottesman I , et al. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 25, 63–77.
Bailey A , Luthert P , Dean A , et al. 1998. A clinicopathological study of autism. Brain 121, 889–905.
Bailey A , Phillips W and Rutter M. 1996. Autism: Towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J Child Psychol Psychiatry All Discip 37, 89–126.
Banich M. 2004. Cognitive Neuroscience and Neuropsychology. Boston, MA: Houghton Mifflin,
Barlow H and Tripathy S P. 1997. Correspondence noise and signal pooling in the detection of coherent visual motion. J Neurosci 17, 7954–66.
Barnea-Goraly N , Kwon H , Menon V , Eliez S , Lotspeich L and Reiss A L. 2004. White matter structure in autism: Preliminary evidence from diffusion tensor imaging. Biol Psychiatry 55, 323–6.
Barnes C L and Pandya D N. 1992. Efferent cortical connections of multimodal cortex of the superior temporal sulcus in the rhesus monkey. J Comp Neurol 318, 222–44.
Baron-Cohen S , Ring H A , Wheelwright S , et al. 1999. Social intelligence in the normal and autistic brain: An fMRI study. Eur J Neurosci 11, 1891–8.
Baron-Cohen S , Ring H , Bullmore E , Wheelwright S , Ashwin C and Williams S. 2000. The amygdala theory of autism. Neurosci Biobehav Rev 24, 355–64.
Baron-Cohen S and Tager-Flusberg H. 2000. Understanding Other Minds: Perspectives from Developmental Cognitive Neuroscience. New York: Oxford University Press, p. 530.
Bauman M and Kemper T. 1994. The Neurobiology of Autism. Baltimore, MD: Johns Hopkins University Press.
Belmonte M K , Cook E H , Anderson G M , et al. 2004a. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol Psychiatry 9(7), 646–63.
Belmonte M K , Allen G , Beckel-Mitchener A , Boulanger L M , Carper R A and Webb S J. 2004b. Autism and abnormal development of brain connectivity. J Neurosci 24, 9228–31.
Bernier R , Dawson G , Webb S and Murias M. 2007. EEG mu rhythm and imitation impairments in individuals with autism spectrum disorder. Brain Cogn 64, 228–37.
Bertone A and Faubert J. 2006. Demonstrations of decreased sensitivity to complex motion information not enough to propose an autism-specific neural etiology. J Autism Devptl Disord 36, 55–64.
Bertone A , Mottron L , Jelenic P and Faubert J. 2003. Motion perception in autism: A “complex” issue. J Cogn Neurosci 15, 218–25.
Bigler E D , Mortensen S , Neeley E S , et al. 2007. Superior temporal gyrus, language function, and autism. Devptl Neuropsychol 31, 217–38.
Boddaert N , Chabane N , Gervais H , et al. 2004. Superior temporal sulcus anatomical abnormalities in childhood autism: A voxel-based morphometry MRI study. Neuroimage 23, 364–9.
Boddaert N , Belin P , Chabane N , et al. 2003. Perception of complex sounds: Abnormal pattern of cortical activation in autism. Am J Psychiatry 160, 2057–60.
Bucan M , Abrahams B S , Wang K , et al. 2009. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 5, e1000536.
Burmeister M , McInnis M G and Zöllner S. 2008. Psychiatric genetics: Progress amid controversy. Nat Rev Genet 9, 527–40.
Carr L , Iacoboni M , Dubeau M , Mazziotta J C and Lenzi G L. 2003. Neural mechanisms of empathy in humans: A relay from neural systems for imitation to limbic areas. Proc Natl Acad Sci U S A, 100, 5497–502.
Casanova M F , Buxhoeveden D P , Switala A E and Roy E. 2002. Minicolumnar pathology in autism. Neurology 58, 428–32.
Casanova M F , van Kooten I A J , Switala A E , et al. 2006. Minicolumnar abnormalities in autism. Acta Neuropathol 112, 287–303.
Castelli F , Happe F , Frith U and Frith C. 2000. Movement and mind: A functional imaging study of perception and interpretation of complex intentional movement patterns. Neuroimage 12, 314–25.
Castelli F , Frith C , Happé F and Frith U. 2002. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain 125, 1839–49.
Cherkassky V L , Kana R K , Keller T A and Just M A. 2006. Functional connectivity in a baseline resting-state network in autism. Neuroreport 17, 1687–90.
Chung M K , Dalton K M , Alexander A L and Davidson R J. 2004. Less white matter concentration in autism: 2D voxel-based morphometry. Neuroimage 23, 242–51.
Colle L , Baron-Cohen S , Wheelwright S and van der Lely H K J. 2008. Narrative discourse in adults with high-functioning autism or Asperger syndrome. J Autism Devptl Disord 38, 28–40.
Courchesne E , Karns C M , Davis H R , et al. 2001. Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology 57, 245–54.
Cowey A , Campana G , Walsh V and Vaina L M. 2006. The role of human extra-striate visual areas V5/MT and V2/V3 in the perception of the direction of global motion: A transcranial magnetic stimulation study. Exp Brain Res 171, 558–62.
Critchley H , Daly E , Bullmore E , et al. 2000. The functional neuroanatomy of social behaviour: Changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 123, 2203–12.
Dakin S and Frith U. 2005. Vagaries of visual perception in autism. Neuron 48, 497–507.
Dalton K M , Nacewicz B M , Alexander A L and Davidson R J. 2007. Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism. Biol Psychiatry 61, 512–20.
Dalton K M , Nacewicz B M , Johnstone T , et al. 2005. Gaze fixation and the neural circuitry of face processing in autism. Nat Neurosci 8, 519–26.
Dapretto M , Davies M S , Pfeifer J H , et al. 2006. Understanding emotions in others: Mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 9, 28–30.
Davatzikos C , Fan Y , Wu X , Shen D and Resnick S M. 2008. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging 29, 514–23.
Davidson R , Lewis D , Alloy L , et al. 2002. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 52, 478–502.
Dumoulin S , Bittar R , Kabani N , et al. 2000. A new anatomical landmark for reliable identification of human area V5/MT: A quantitative analysis of sulcal patterning. Cerebral Cortex 10, 454–63.
Egass B , Courchesne E and Saitoh O. 1995. Reduced size of corpus callosum in autism. Arch Neurol 52, 794–801.
Fan Y , Batmanghelich N , Clark C M and Davatzikos C. 2008. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 39, 1731–43.
Fletcher P , Happe F , Frith U , et al. 1995. Other minds in the brain: A functional imaging study of “theory of mind” in story comprehension. Cognition 57, 109–28.
Fogassi L , Ferrari P F , Gesierich B , Rozzi S , Chersi F and Rizzolatti G. 2005. Parietal lobe: From action organization to intention understanding. Science 308, 662–7.
Friston K , Buechel C , Fink G , Morris J , Rolls E and Dolan R. 1997. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 6, 218–29.
Frith C and Frith U. 2000. Understanding other minds: Perspectives from developmental cognitive neuroscience. In Baron-Cohen, S and Tager-Flusberg H (Eds.) Understanding Other Minds: Perspectives from Developmental Cognitive Neuroscience (2nd ed.). New York, NY: Oxford University Press, pp. 334–56.
Frith U. 1989. Autism: Explaining the Enigma. Oxford, UK: Basil Blackwell.
Gallagher H , Happe F , Brunswick N , Fletcher P , Frith U and Frith C. 2000. Reading the mind in cartoons and stories: An fMRI study of “theory of the mind” in verbal and nonverbal tasks. Neuropsychologia 38, 11–21.
Gallese V . 2006. Intentional attunement: A neurophysiological perspective on social cognition and its disruption in autism. Brain Res 1079, 15–24.
Gallese V , Fadiga L , Fogassi L and Rizzolatti G. 1996. Action recognition in the premotor cortex. Brain 119, 593–609.
Gallese V , Keysers C and Rizzolatti G. 2004. A unifying view of the basis of social cognition. Trends Cogn Sci 8, 396–403.
Geschwind D H. 2008. Autism: Many genes, common pathways? Cell 135, 391–5.
Geschwind D H , Sowinski J , Lord C , et al. 2001. The autism genetic resource exchange: A resource for the study of autism and related neuropsychiatric conditions. Am J Human Genet 69, 463–6.
Ghaziuddin M and Gerstein L. 1996. Pedantic speaking style differentiates Asperger syndrome from high-functioning autism. J Autism Devptl Disord 26, 585–95.
Glessner J T , Wang K , Cai G , et al. 2009. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459, 569–73.
Grelotti D , Gauthier I and Schultz R. 2002. Social interest and the development of cortical face specialization: What autism teaches us about face processing. Devptl Psychobiol 40, 213–25.
Grelotti D J , Klin A J , Gauthier I , et al. 2005. fMRI activation of the fusiform gyrus and amygdala to cartoon characters but not to faces in a boy with autism. Neuropsychologia 43, 373–85.
Groen W B , Zwiers M P , van der Gaag R and Buitelaar J K. 2008. The phenotype and neural correlates of language in autism: An integrative review. Neurosci Biobehav Rev 32, 1416–25.
Hadjikhani N , Joseph R M , Snyder J and Tager-Flusberg H. 2006. Anatomical differences in the mirror neuron system and social cognition network in autism. Cerebral Cortex 16, 1276–82.
Hadjikhani N , Joseph R M , Snyder J , and Tager-Flusberg H. 2007. Abnormal activation of the social brain during face perception in autism. Hum Brain Mapp 28, 441–9.
Hamilton A F D C , Brindley R M and Frith U. 2007. Imitation and action understanding in autistic spectrum disorders: How valid is the hypothesis of a deficit in the mirror neuron system? Neuropsychologia 45, 1859–68.
Happe F , Ehlers S , Fletcher P , et al. 1996. “Theory of mind” in the brain: Evidence from a PET scan study of Asperger syndrome. Neuroreport 8, 197–201.
Haxby J , Hoffman E and Gobbini M. 2000. The distributed human neural system for face perception. Trends Cogn Sci 4, 223–33.
Haxby J , Gobbini M , Furey M , Ishai A , Schouten J and Pietrini P. 2001. Distributed and overlapping representations of faces and objects in ventral temporal cortex. Science 293, 2425–30.
Haxby J , Hoffman E and Gobbini M. 2002. Human neural systems for face recognition and social communication. Biol Psychiatry 51, 59–67.
Hazlett H C , Poe M , Gerig G , et al. 2005. Magnetic resonance imaging and head circumference study of brain size in autism: Birth through age 2 years. Arch Gen Psychiatry 62, 1366–76.
Heider F and Simmel M. 1944. An experimental study of apparent behavior. Am J Psychol 57, 243–59.
Herbert M R , Harris G J , Adrien K T , et al. 2002. Abnormal asymmetry in language association cortex in autism. Ann Neurol 52, 588–96.
Herbert M R , Ziegler D A , Deutsch C K , et al. 2003. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain J Neurol 126, 1182–92.
Herbert M R , Ziegler D A , Makris N , et al. 2004. Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 55, 530–40.
Herrington J D , Baron-Cohen S , Wheelwright S J , et al. 2007. The role of MT+/V5 during biological motion perception in Asperger Syndrome: An fMRI study. Res Autism Spectr Disord 1, 14–27.
Herrington J , Nymberg C and Schultz R T . In preparation. Biological motion task performance predicts superior temporal sulcus activity.
Hickok G. 2009. Eight problems for the mirror neuron theory of action understanding in monkeys and humans. J Cogn Neurosci 21, 1229–43.
Hobson R P and Bishop M. 2003. The pathogenesis of autism: Insights from congenital blindness. Phil Trans R Soc Lond Series B Biol Sci 358, 335–44.
Horwitz B , Rumsey J M , Grady C L and Rapoport S I. 1988. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Arch Neurol 45, 749–55.
Howard M A , Cowell P E , Boucher J , et al. 2000. Convergent neuroanatomical and behavioural evidence of an amygdala hypothesis of autism. Neuroreport 11, 2931–5.
Hurley S and Chater N . 2005. Perspectives on Imitation: From Neuroscience to Social Science (Vol. 1). Cambridge, MA: MIT Press.
Jamain S , Quach H , Betancur C , et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34, 27–9.
Johansson G. 1973. Visual perception of biological motion and a model for its analysis. Percept Psychophys 14, 201–11.
Jones W , Carr K and Klin A . 2008. Absence of preferential looking to the eyes of approaching adults predicts level of social disability in 2-year-old toddlers with autism spectrum disorder. Arch Gen Psychiatry 65, 946–54.
Jorde L B , Hasstedt S J , Ritvo E R , et al. 1991. Complex segregation analysis of autism. Am J Human Genet 49, 932–8.
Jou R , Paterson S , Jackowski A , et al. 2007. Abnormalities in white matter structure in autism spectrum disorders detected by diffusion tensor imaging. Biol Psychiatry 61, 217S.
Juranek J , Filipek P A , Berenji G R , Modahl C , Osann K and Spence M A. 2006. Association between amygdala volume and anxiety level: Magnetic resonance imaging (MRI) study in autistic children. J Child Neurol 21, 1051–8.
Just M A , Cherkassky V L , Keller T A , Kana R K and Minshew N J. 2007. Functional and anatomical cortical underconnectivity in autism: Evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cerebral Cortex 17, 951–61.
Just M A , Cherkassky V L , Keller T A and Minshew N J. 2004. Cortical activation and synchronization during sentence comprehension in high-functioning autism: Evidence of underconnectivity. Brain J Neurol 127, 1811–21.
Kana R K , Keller T A , Cherkassky V L , Minshew N J and Just M A. 2006. Sentence comprehension in autism: Thinking in pictures with decreased functional connectivity. Brain J Neurol 129, 2484–93.
Kanner L. 1943. Autistic disturbances of affective contact. Nerv Child 2, 217–50.
Kanwisher N. 2000. Domain specificity in face perception. Nat Neurosci 3, 759–63.
Kanwisher N , McDermott J and Chun M. 1997. The fusiform face area: A module in human extrastriate cortex specialized for face perception. J Neurosci 17, 4302–11.
Keller T A , Kana R K and Just M A. 2007. A developmental study of the structural integrity of white matter in autism. Neuroreport 18, 23–7.
Kemper T L and Bauman M. 1998. Neuropathology of infantile autism. J Neuropathol Exp Neurol 57, 645–52.
Keysers C and Gazzola V. 2006. Towards a unifying neural theory of social cognition. Progr Brain Res 156, 379–401.
Kjelgaard M M and Tager-Flusberg H. 2001. An investigation of language impairment in autism: implications for genetic subgroups. Lang Cogn Proc 16, 287–308.
Klin A. 2000. Attributing social meaning to ambiguous visual stimuli in higher-functioning autism and Asperger syndrome: The Social Attribution Task. J Child Psychol Psychiatry All Disc 41, 831–46.
Klin A , Jones W , Schultz R , Volkmar F and Cohen D. 2002. Defining and quantifying the social phenotype in autism. Am J Psychiatry 159, 909–16.
Klin A , Lin D J , Gorrindo P , Ramsay G and Jones W. 2009. Two-year-olds with autism orient to non-social contingencies rather than biological motion. Nature 459, 257–61.
Kluver H and Bucy P. 1939. Preliminary analysis of functions of the temporal lobes in monkeys. Arch Neurol Psychiatry 42, 979–1000.
Koshino H , Carpenter P A , Minshew N J , Cherkassky V L , Keller T A and Just M A. 2005. Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 24, 810–21.
Lainhart J E . 2006. Advances in autism neuroimaging research for the clinician and geneticist. Am J Med Genet Part C Semin Med Genet, 142C, 33–9.
Lee J E , Bigler E D , Alexander A L , et al. 2007. Diffusion tensor imaging of white matter in the superior temporal gyrus and temporal stem in autism. Neurosci Lett 424, 127–32.
Liu J , Pearlson G , Windemuth A , Ruano G , Perrone-Bizzozero N I and Calhoun V. 2009. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum Brain Mapp 30, 241–55.
Lord C , Risi S , Lambrecht L , et al. 2000. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Devptl Disord 30, 205–23.
Lord C , Rutter M and Le Couteur A. 1994. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Devptl Disord 24, 659–85.
Milner A D. 2006. The Visual Brain in Action (2nd ed.). Oxford, UK: Oxford University Press.
Morris J , Friston K , Buchel C , et al. 1998a. A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain 121, 47–57.
Morris J , Ohman A and Dolan R. 1998b. Conscious and unconscious emotional learning in the human amygdala. Nature 393, 467–70.
Morris J , Ohman A and Dolan R. 1999. A subcortical pathway to the right amygdala mediating “unseen” fear. Proc Natl Acad Sci U S A 96, 1680–5.
Müller R A , Behen M E , Rothermel R D , et al. 1999. Brain mapping of language and auditory perception in high-functioning autistic adults: A PET study. J Autism Devptl Disord 29, 19–31.
Newsome W and Pare E. 1988. A selective impairment of motion perception following lesions of the middle temporal visual area (MT). J Neurosci 8, 2201–11.
Nieminen-von Wendt T , Metsähonkala L , Kulomäki T , et al. 2003. Changes in cerebral blood flow in Asperger syndrome during theory of mind tasks presented by the auditory route. Eur Child Adolesc Psychiatry 12, 178–89.
Nishitani N , Avikainen S and Hari R. 2004. Abnormal imitation-related cortical activation sequences in Asperger's syndrome. Ann Neurol 55, 558–62.
Norman K A , Polyn S M , Detre G J and Haxby J V. 2006. Beyond mind-reading: multi-voxel pattern analysis of fMRI data. Trends Cogn Sci 10, 424–30.
Oberman L M , Hubbard E M , McCleery J P , Altschuler E L , Ramachandran V S and Pineda J A. 2005. EEG evidence for mirror neuron dysfunction in autism spectrum disorders. Cogn Brain Res 24, 190–8.
Oram M W and Perrett D I. 1996. Integration of form and motion in the anterior superior temporal polysensory area (STPa) of the Macaque monkey. J Neurophysiol 76, 109–29.
O'Roak B J and State M W. 2008. Autism genetics: Strategies, challenges, and opportunities. Autism Res Off J Int Soc Autism Res 1, 4–17.
Pellicano E and Gibson L Y. 2008. Investigating the functional integrity of the dorsal visual pathway in autism and dyslexia. Neuropsychologia 46, 2593–6.
Pellicano E , Gibson L , Maybery M , Durkin K , and Badcock D R . 2005. Abnormal global processing along the dorsal visual pathway in autism: A possible mechanism for weak visuospatial coherence? Neuropsychologia 43, 1044–53.
Pelphrey K A , Morris J P , McCarthy G and Labar K S. 2007. Perception of dynamic changes in facial affect and identity in autism. Soc Cogn Affect Neurosci 2, 140–9.
Pelphrey K A , Viola R J and McCarthy G. 2004. When strangers pass: Processing of mutual and averted social gaze in the superior temporal sulcus. Psycholog Sci 15, 598–603.
Pinkham A E , Hopfinger J B , Pelphrey K A , Piven J and Penn D L. 2008. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res 99, 164–75.
Piven J , Arndt S , Bailey J , Havercamp S , Andreasen N C and Palmer P. 1995. An MRI study of brain size in autism. Am J Psychiatry 152, 1145–9.
Piven J , Palmer P , Jacobi D , Childress D and Arndt S. 1997. Broader autism phenotype: Evidence from a family history study of multiple-incidence autism families. Am J Psychiatry 154, 185–90.
Puce A , Allison T , Gore J C and McCarthy G. 1995. Face-sensitive regions in human extrastriate cortex studied by functional MRI. J Neurophysiol 74, 1192–9.
Puce A and Perrett D. 2003. Electrophysiology and brain imaging of biological motion. Phil Trans R Soc Lond Series B Biol Sci 358, 435–45.
Redcay E. 2008. The superior temporal sulcus performs a common function for social and speech perception: Implications for the emergence of autism. Neurosci Biobehav Rev 32, 123–42.
Redcay E and Courchesne E. 2005. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58, 1–9.
Ringo J L . 1991. Neuronal interconnection as a function of brain size. Brain Behav Evol 38, 1–6.
Robins D L , Hunyadi E and Schultz R T. 2009. Superior temporal activation in response to dynamic audio-visual emotional cues. Brain Cogn 69, 269–78.
Rogers S and Williams J G . 2006. Imitation and the Social Mind: Autism and Typical Development. New York, NY: Guilford Press.
Rutter M , Pickles A , Murray R and Eaves L. 2001. Testing hypotheses on specific environmental causal effects on behavior. Psychol Bull 127, 291–324.
Sasson N J , Turner-Brown L M , Holtzclaw T N , Lam K S L and Bodfish J W. 2008. Children with autism demonstrate circumscribed attention during passive viewing of complex social and nonsocial picture arrays. Autism Res 1, 31–42.
Schultz R T. 2005. Developmental deficits in social perception in autism: The role of the amygdala and fusiform face area. Int J Devptl Neurosci 23, 125–41.
Schultz R T , Gauthier I , Klin A , et al. 2000b. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 57, 331–40.
Schultz R T , Grelotti D , Klin A , et al. 2003. The role of the fusiform face area in social cognition: Implications for the pathobiology of autism. Phil Trans R Soc London B 358, 415–27.
Schultz R T , Grupe D W , Hunyadi E , Jones W , Wolf J M and Hoyt E . 2008. The Effect of Task Differences on FFA Activity in Autism Spectrum Disorders. Paper Presented at the International Meeting for Autism Research, London, UK, May 2008.
Schultz R T , Hunyadi E , Conners C and Pasley B . 2005. fMRI Study of Facial Expression Perception in Autism: The Amygdala, Fusiform Face Area and their Functional Connectivity. Paper presented at the annual meeting of the Organization for Human Brain Mapping, 12–16 June 2005.
Schultz R T and Robins D. 2005. Functional neuroimaging studies of autism spectrum disorders. In Volkmar F , Klin A (Eds.), Handbook of Autism and Pervasive Developmental Disorders (3rd ed.). New York, NY: John Wiley and Sons. pp. 515–22.
Schultz R T , Romanski L M and Tsatsanis K D. 2000a. Neurofunctional models of autistic disorder and Asperger syndrome: Clues from neuroimaging. In Klin A , Volkmar F , Sparrow S (Eds.), Asperger Syndrome. New York, NY: Guilford Press, pp. 172–209.
Sebat J. 2007. Major changes in our DNA lead to major changes in our thinking. Nat Genet 39 (7 Suppl), S3–5.
Seltzer B and Pandya D N. 1994. Parietal, temporal, and occipital projections to cortex of the superior temporal sulcus in the rhesus monkey: A retrograde tracer study. J Comp Neurol 343, 445–63.
Shah A and Frith U. 1983. An islet of ability in autistic children: A research note. J Child Psychol Psychiatry All Discip 24, 613–20.
Shah A and Frith U. 1993. Why do autistic individuals show superior performance on the block design task? J Child Psychol Psychiatry All Discip 34, 1351–64.
Stewart M E , Barnard L , Pearson J , Hasan R and O'Brien G. 2006. Presentation of depression in autism and Asperger syndrome: A review. Autism Int J Res Pract 10, 103–16.
Sukhodolsky D G , Scahill L , Gadow K D , et al. 2008. Parent-rated anxiety symptoms in children with pervasive developmental disorders: Frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol 36, 117–28.
Tager-Flusberg H , Paul R and Lord C. 2005. Language and communication in autism. In: Volkmar F , Klin A (Eds.) Handbook of Autism and Pervasive Developmental Disorders (3rd ed.). New York, NY: John Wiley and Sons, pp. 335–64.
Théoret H , Halligan E , Kobayashi M , Fregni F , Tager-Flusberg H and Pascual-Leone A. 2005. Impaired motor facilitation during action observation in individuals with autism spectrum disorder. Curr Biol 15, R84–5.
Thompson J C , Hardee J E , Panayiotou A , Crewther D and Puce A. 2007. Common and distinct brain activation to viewing dynamic sequences of face and hand movements. Neuroimage 37, 966–73.
Tranel D , Damasio A R and Damasio H. 1988. Intact recognition of facial expression, gender, and age in patients with impaired recognition of face identity. Neurology 38, 690–6.
Vanderwal T , Hunyadi E , Grupe D W , Connors C M and Schultz R T. 2008. Self, mother and abstract other: An fMRI study of reflective social processing. Neuroimage 41, 1437–46.
Verma R , Zacharaki E I , Ou Y , et al. 2008. Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images. Acad Radiol 15, 966–77.
Volkmar F R , Paul R , Klin A and Cohen D . 2005. Handbook of Autism and Pervasive Developmental Disorders, Vol. 1: Diagnosis, Development, Neurobiology, and Behavior. Hoboken, NJ: John Wiley and Sons.
Vuilleumier P , Richardson M P , Armony J L , Driver J and Dolan R J. 2004. Distant influences of amygdala lesion on visual cortical activation during emotional face processing. Nat Neurosci 7, 1271–8.
Wada Y and Yamamoto T. 2001. Selective impairment of facial recognition due to a haematoma restricted to the right fusiform and lateral occipital region. J Neurol Neurosurg Psychiatry 71, 254–7.
Wang K , Zhang H , Bucan M , et al. 2009. Common genetic variation in the intergenic region between CDH10 and CDH9 is associated with susceptibility to autism spectrum disorders. Nature 459, 528–33.
Williams J H G , Waiter G D , Gilchrist A , Perrett D I , Murray A D and Whiten A. 2006. Neural mechanisms of imitation and ‘mirror neuron’ functioning in autistic spectrum disorder. Neuropsychologia 44, 610–21.
Witelson S F. 1989. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain 112, 799–835.
Wolf J M , Tanaka J W , Klaiman C , et al. 2008. Specific impairment of face-processing abilities in children with autism spectrum disorder using the Let's Face It! skills battery. Autism Res 1, 329–40.
Zald D. 2003. The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Rev 41, 88–123.
Zilbovicius M , Meresse I , Chabane N , Brunelle F , Samson Y and Boddaert N. 2006. Autism, the superior temporal sulcus and social perception. Trends Neurosci 29, 359–66.

Reference Title: References

Reference Type: reference-list

Adolphs R . 2003. Cognitive neuroscience of human social behaviour. Nat Rev Neurosci 4, 165–78.
Aguirre G K , Zarahn E and D'Esposito M. 1998. Neural components of topographical representation. Proc Natl Acad Sci U S A 95, 839–46.
American Academy of Pediatrics . 2001. Health care supervision for children with Williams syndrome. Pediatrics 107, 1192–204.
Atkinson J . 2000. The Developing Visual Brain. Oxford, UK: Oxford University Press.
Atkinson J , Anker S , Braddick O , Nokes L , Mason A and Braddick F . 2001. Visual and visuospatial development in young children with Williams syndrome. Devptl Med Child Neurol 43, 330–7.
Atkinson J , Braddick O , Anker S , et al. 2003. Neurobiological models of visuospatial cognition in children with Williams syndrome: Measures of dorsal-stream and frontal function. Devptl Neuropsychol 23, 139–72.
Atkinson J , Braddick O , Rose F E , Searcy Y M , Wattam-Bell J and Bellugi U . 2006. Dorsal-stream motion processing deficits persist into adulthood in Williams syndrome. Neuropsychologia 44, 828–33.
Atkinson J , King J , Braddick O , Nokes L , Anker S and Braddick F . 1997. A specific deficit of dorsal stream function in Williams syndrome. Neuroreport 8 1919–22.
Bello A , Capirci O and Volterra V . 2004. Lexical production in children with Williams syndrome: Spontaneous use of gesture in a naming task. Neuropsychologia 42, 201–13.
Bellugi U , Adolphs R , Cassadi C and Chiles M . 1999. Towards the neural basis for hypersociability in a genetic syndrome. Neuroreport 10, 1653–7.
Bellugi U , Lichtenberger L , Jones W , Lai Z and St. George M . 2000. I. The neurocognitve profile of Williams syndrome: A complex pattern of strengths and weaknesses. J Cogn Neurosci 12 (Suppl 1), 7–29.
Bellugi U , Sabo H and Vaid V . 1988. Spatial defects in children with Williams syndrome. In Stiles-Davis J , Kritchevsky M , Bellugi U (Eds.), Spatial Cognition: Brain Bases and Development. Hillsdale, NJ: Lawrence Erlbaum Associates, pp. 273–98.
Bellugi U , Wang P and Jernigan T . 1994. Higher cortical functions: Evidence from specific genetically based syndromes of disorder. In Broman S , Graffman J (Eds.), Cognitive Deficits in Developmental Disorders: Implications for Brain Function. Hillsdale, NJ: Lawrence Erlbaum, pp. 23–56.
Beuren A J , Apitz J and Harmjanz D . 1962. Supravalvular aortic stenosis in association with mental retardation and a certain facial appearance. Circulation 26, 1235–40.
Bihrle A M , Bellugi U , Delis S and Marks S . 1989. Seeing the forest or the trees: Dissociation in visuospatial processing. Brain Cogn 11, 37–49.
Bishop K M , Goudreau G and O'Leary D D . 2000. Regulation of area identity in the mammalian neocortex by Emx2 and Pax6. Science 288, 344–9.
Blomberg S , Rosander M and Andersson G . 2006. Fears, hyperacusis and musicality in Williams syndrome. Res Devptl Disabil 27, 668–80.
Brock J . 2007. Language abilities in Williams syndrome: A critical review. Devpt Psychopathol 19, 97–127.
Campbell L E , Daly E , Toal F , et al. 2009. Brain structural differences associated with the behavioural phenotype in children with Williams syndrome. Brain Res 1258, 96–107.
Chapman C A , De Plessis A and Pober B R . 1996. Neurologic findings in children and adults with Williams syndrome. J Child Neurol 11, 63–5.
Cherniske E M , Carpenter T O , Klaiman C , et al. 2004. Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet 131A, 255–64.
Chiang M C , Reiss A L , Lee A D , et al. 2007. 3D pattern of brain abnormalities in Williams syndrome visualized using tensor-based morphometry. Neuroimage 36, 1096–109.
Danoff S K , Taylor H E , Blackshaw S and Desiderio S . 2004. TFII-I, a candidate gene for Williams syndrome cognitive profile: Parallels between regional expression in mouse brain and human phenotype. Neuroscience 123, 931–8.
Davachi L , Mitchell J P and Wagner A D . 2003. Multiple routes to memory: Distinct medial temporal lobe processes build item and source memories. Proc Natl Acad Sci U S A 100, 2157–62.
Deruelle C , Rondan C , Livet M O and Mancini J . 2003. Exploring face processing in Williams syndrome. Cogn Brain Behav 7, 157–72.
Deruelle C , Rondan C , Mancini J and Livet M O . 2006. Do children with Williams syndrome fail to process visual configural information? Res Devptl Disabil 27, 243–53.
Deruelle C , Schön D , Rondan C and Mancini J . 2005. Global and local music perception in children with Williams syndrome. Neuroreport 16, 631–4.
Donnai D and Karmiloff-Smith A . 2000. Williams syndrome: From genotype through to the cognitive phenotype. Am J Med Genet Semin Med Genet 97, 164–71.
Dykens E M . 2003. Anxiety, fears, and phobias in persons with Williams syndrome. Devptl Neuropsychol 23, 291–316.
Eckert M A , Galaburda A M , Karchemskiy A , et al. 2006a. Anomalous Sylvian fissure morphology in Williams syndrome. Neuroimage 33, 39–45.
Eckert M A , Hu D , Eliez S , et al. 2005. Evidence for superior parietal impairment in Williams syndrome. Neurology 64, 152–3.
Eckert M A , Tenforde A , Galaburda A M , et al. 2006b. To modulate or not to modulate: Differing results in uniquely shaped Williams syndrome brains. Neuroimage 32, 1001–07.
Einfield S , Tonge B and Florio T . 1997. Behavioral and emotional disturbance in individuals with Williams syndrome. Am J Mental Retard 102, 45–53.
Epstein R and Kanwisher N . 1998. A cortical representation of the local visual environment. Nature 392, 598–601.
Ewart A K , Morris C A , Atkinson D , et al. 1993. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet 5, 11–6.
Fagot J and Deruelle C . 1997. Processing of global and local visual information and hemispheric specialization in humans (Homo sapiens) and baboons (Papio papio). J Exp Psychol Hum Percept Perform 23, 429–42.
Faravelli F , D'Arrigo S , Bagnasco I , et al. 2003. Oligogyric microcephaly in a child with Williams syndrome. Am J Med Genet A 117, 169–71.
Farran E K and Jarrold C . 2003. Visuospatial cognition in Williams syndrome: Reviewing and accounting for the strengths and weaknesses in performance. Devptl Neuropsychol 23, 173–200.
Farran E K , Jarrold C and Gathercole S E . 2001. Block design performance in the Williams syndrome phenotype: A problem with mental imagery? J Child Psychol Psychiatry 42, 719–28.
Farran E K , Jarrold C and Gathercole S E . 2003. Divided attention, selective attention and drawing: processing preferences in Williams syndrome are dependent on the task administered. Neuropsychologia 41, 676–87.
Fidler D J , Hepburn S L , Most D E , Philofsky A and Rogers S J . 2007. Emotional responsivity in young children with Williams syndrome. Am J Mental Retard 112, 194–206.
Frangiskakis J M , Ewart A K , Morris C A , et al. 1996. LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 86, 59–69.
Frigerio E , Burt D M , Gagliardi C , et al. 2006. Is everybody always my friend? Perception of approachability in Williams syndrome. Neuropsychologia 44, 254–9.
Galaburda A M and Bellugi U . 2000. V. Multi-level analysis of cortical neuroanatomy in Williams syndrome. J Cogn Neurosci 12 (Suppl 1), 74–88.
Galaburda A M , Holinger D P , Bellugi U and Sherman G F . 2002. Williams syndrome: neuronal size and neuronal-packing density in primary visual cortex. Arch Neurol 59, 1461–7.
Galaburda A M , Schmitt J E , Atlas S W , Eliez S , Bellugi U and Reiss A L . 2001. Dorsal forebrain anomaly in Williams syndrome. Arch Neurol 58, 1865–9.
Galaburda A M , Wang P P , Bellugi U and Rossen M . 1994. Cytoarchitectonic anomalies in a genetically based disorder: Williams syndrome. Neuroreport 5, 753–7.
Gaser C , Luders E , Thompson P M , et al. 2006. Increased local gyrification mapped in Williams syndrome. Neuroimage 33, 46–54.
Gothelf D , Searcy Y M , Reilly J , et al. 2008. Association between cerebral shape and social use of language in Williams syndrome. Am J Med Genet 146, 2753–61.
Gosch A and Pankau R . 1994. Social–emotional and behavioral adjustment in children with Williams–Beuren syndrome. Am J Med Genet 52, 291–6.
Gosch A and Pankau R . 1997. Personality characteristics and behavioural problems in individuals of different ages with Williams syndrome. Devptl Med Child Neurol 39, 327–533.
Grill-Spector, K . 2003. The neural basis of object perception. Curr Opin Neurobiol 13, 159–66.
Gunn A , Cory E , Atkinson J , et al. 2002. Dorsal and ventral stream sensitivity in normal development and hemiplegia. Neuroreport 13, 843–7.
Haas B W , Mills D , Yam A , Hoeft F , Bellugi U and Reiss A . 2009. Genetic influences on sociability: Heightened amygdala reactivity and event-related responses to positive social stimuli in Williams syndrome. J Neurosci 29, 1132–49.
Hammond P , Hutton T J , Allanson J E , et al. 2005. Discriminating power of localized three-dimensional facial morphology. Am J Hum Genet 77, 999–1010.
Hansen P C , Stein J F , Orde S R , Winter J L and Talcott J B . 2001. Are dyslexics' visual deficits limited to measures of dorsal stream function? Neuroreport 12, 1527–30.
Hariri A R , Tessitore A , Mattay V S , Fera F and Weinberger D R . 2002. The amygdala response to emotional stimuli: A comparison of faces and scenes. Neuroimage 17, 317–23.
Haxby J V , Ungerleider L G , Clark V P , Schouten J L , Hoffman E A and Martin A . 1999. The effect of face inversion on activity in human neural systems for face and object perception. Neuron 22, 189–99.
Hoeft F , Barnea-Goraly N , Haas B W , et al. 2007. More is not always better: Increased fractional anisotropy of superior longitudinal fasciculus associated with poor visuospatial abilities in Williams syndrome. J Neurosci 27, 11 960–5.
Holinger D P , Bellugi U , Mills D L , et al. 2005. Relative sparing of primary auditory cortex in Williams syndrome. Brain Res 1037, 35–42.
Hoogenraad C C , Koekkoek B , Akhmanova A , et al. 2002. Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice. Nat Genet 32, 116–27.
Howlin P , Davies M and Udwin O . 1998. Cognitive functioning in adults with Williams syndrome. J Child Psychol Psychiatry 39, 183–9.
Jackowski A P and Schultz R T . 2005. Foreshortened dorsal extension of the central sulcus in Williams syndrome. Cortex 41, 282–90.
Jarrold C , Baddeley A D and Hewes A K . 1998. Verbal and nonverbal abilities in the Williams syndrome phenotype: Evidence for diverging developmental trajectories. J Child Psychol Psychiatry 39, 511–23.
Jernigan T L and Bellugi U . 1990. Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome. Arch Neurol 47, 529–33.
Jernigan T L , Bellugi U , Sowell E , Doherty S and Hesselink J R . 1993. Cerebral morphologic distinctions between Williams and Down syndromes. Arch Neurol 50, 186–91.
Jones W , Bellugi U , Lai Z , et al. 2000. Hypersociability in Williams syndrome. J Cogn Neurosci 12 (Suppl 1), 30–46.
Jones W , Hesselink J , Courschene E , et al. 2002. Cerebellar abnormalities in infants and toddlers with Williams syndrome. Devptl Med Child Neurol 44, 688–94.
Kanwisher N , McDermott J and Chun M M . 1997. The fusiform face area: A module in human extrastriate cortex specialized for face perception. J Neurosci 17, 4302–11.
Karmiloff-Smith A . 1998. Development itself is the key to understanding developmental disorders. Trends Cogn Sci 2, 389–98.
Karmiloff-Smith A , Brown J H , Grice S and Paterson S . 2003. Dethroning the myth: Cognitive dissociations and innate modularity in Williams syndrome. Devptl Neuropsychol 23, 227–42.
Karmiloff-Smith A , Klima E , Bellugi U , Grant J and Baron-Cohen S . 1995. Is there a social module? Language, face-processing and theory of mind in Williams syndrome. J Cogn Neurosci 7, 196–208.
Kimchi R . 1990. Children's perceptual organization of hierarchical visual patterns. Eur J Cogn Psychol 2, 133–49.
Kippenhan J S , Olsen R K , Mervis C B , et al. 2005. Genetic contributions to human gyrification: Sulcal morphometry in Williams syndrome. J Neurosci 25, 7840–6.
Klein-Tasman B P and Mervis C B . 2003. Distinctive personality characteristics of 8–9, and 10-year-olds with Williams syndrome. Devptl Neuropsychol 23, 269–90.
Kogan C S , Boutet I , Cornish K , et al. 2004. Differential impact of the FMR1 gene on visual processing in fragile X syndrome. Brain 127, 591–601.
Korenberg J R , Chen X N , Hirota H , et al. 2000. IV. Genome structure and cognitive map of Williams syndrome. J Cogn Neurosci 12 (Suppl 1), 89–107.
Korenberg J R , Dai L , Bellugi U , et al. 2008. Deletion of 7q11.23 Genes and Williams syndrome. In Epstein C J , Erickson R P , Wynshaw-Boris A (Eds.), Inborn Errors of Development (2nd ed.). New York, NY: Oxford University Press.
Ku M , Sokol S , Wu J , Tussie-Luna M , Roy A and Hata A . 2005. Positive, and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcripton factors. Mol Cell Biol 25, 7144–57.
Laing E , Butterworth G , Ansari D , et al. 2002. Atypical development of language and social communication in toddlers with Williams syndrome. Devptl Sci 5, 233–46.
Landau B , Hoffman J E and Kurz N . 2006. Object recognition with severe spatial deficits in Williams syndrome: Sparing and breakdown. Cognition 100, 483–510.
Lawler K A and Cowey A . 1986. The effects of pretectal and superior collicular lesions on binocular vision. Exp Brain Res 63, 402–08.
Levitin D J , Menon V , Schmitt J E , et al. 2003. Neural correlates of auditory perception in Williams syndrome: An fMRI study. Neuroimage 18, 74–82.
Levitin D J , Cole K , Chiles M , Lai Z , Lincoln A and Bellugi U. 2004. Characterizing the musical phenotype in individuals with Williams Syndrome. Child Neuropsychol 10, 223–47.
Levitin D J , Cole K , Lincoln A and Bellugi U . 2005. Aversion, awareness, and attraction: Investigating claims of hyperacusis in the Williams syndrome phenotype. J Child Psychol Psychiatry 46, 514–23.
Leyfer O T , Woodruff-Borden J , Klein-Tasman B P , Fricke J S and Mervis C B . 2006. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet Neuropsychiatr Genet 141, 615–22.
Logothetis N K . 1999. Vision: A window on consciousness. Sci Am 281, 69–75.
Lowery M C , Morris C A , Ewart A , et al. 1995. Strong correlation of elastin deletions, detected by FISH, with Williams syndrome. Am J Hum Genet 57, 49–53.
Luders E , Di Paola M , Tomaiuolo F , et al. 2007. Callosal morphology in Williams syndrome: A new evaluation of shape and thickness. Neuroreport 18, 203–07.
Marler J A , Elfenbein J L , Ryals B M , Urban Z and Netzloff M L . 2005. Sensorineural hearing loss in children and adults with Williams syndrome. Am J Medl Genet 138, 318–27.
Marenco S , Siuta M A , Kippenhan J S , et al. 2007. Genetic contributions to white matter architecture revealed by diffusion tensor imaging in Williams syndrome. Proc Natl Acad Sci U S A 104, 15 117–222.
Mervis C B and Klein-Tasman B P . 2000. Williams syndrome: Cognition, personality, and adaptive behaviour. Mental Retard Devptl Disabil Res Rev 6, 148–58.
Mervis C B , Morris C A , Bertrand J and Robinson B F . 1999. Williams syndrome: Findings from an integrated program of research. In Tager-Flusberg H (Ed.), Neurodevelopmental Disorders: Contributions to a New Framework from the Cognitive Neurosciences. Cambridge, MA: MIT Press, pp. 65–110.
Mervis C B , Morris C A , Klein-Tasman B P , et al. 2003a. Attentional characteristics of infants and toddlers with Williams syndrome during triadic interactions. Devptl Neuropsychol 23, 243–68.
Mervis C B , Robinson B , Bertrand J , Morris C A , Klein-Tasman B and Armstrong S . 2000. The Williams syndrome cognitive profile. Brain Cogn 44, 604–28.
Mervis C B , Robinson B F , Rowe M L , Becerra A M and Klein-Tasman B P . 2003b. Language abilities of individuals with Williams syndrome. Int Rev Res Mental Retard 27, 35–81.
Meyer-Lindenberg A , Hariri A R , Munoz K E , et al. 2005a. Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci 8, 991–3.
Meyer-Lindenberg A , Kohn P , Mervis C B , et al. 2004. Neural basis of genetically determined visuospatial construction deficit in Williams syndrome. Neuron 43, 623–31.
Meyer-Lindenberg A , Mervis C B and Berman K F . 2006. Neural mechanisms in Williams syndrome: A unique window to genetic influences on cognition and behaviour. Nat Neurosci 8, 991–3.
Meyer-Lindenberg A , Mervis C B , Sarpal D , et al. 2005b. Functional, structural, and metabolic abnormalities of the hippocampal formation in Williams syndrome. J Clin Invest 115, 1888–95.
Milner A D and Goodale M A . 1995. The Visual Brain in Action. Cambridge, UK: MIT Press.
Mobbs D , Eckert M A , Menon V , et al. 2007a. Reduced parietal and visual cortical activation during global processing in Williams syndrome. Devptl Med Child Neurol 49, 433–8.
Mobbs D , Eckert M A , Mills D , et al. 2007b. Frontostriatal dysfunction during response inhibition in Williams syndrome. Biol Psychiatry 62, 256–61.
Mobbs D , Garrett A S , Menon V , Rose F E , Bellugi U and Reiss A L . 2004. Anomalous brain activations during face and gaze processing in Williams syndrome. Neurology 62, 2070–6.
Morris C A . 2006. The dysmorphology, genetics, and natural history of Williams–Beuren syndrome. In Morris C A , Lenhoff H M , Wang P P (Eds.), Williams–Beuren Syndrome: Research, Evaluation and Treatment. Baltimore, MD: Johns Hopkins University Press, pp. 3–17.
Morris C A , Demsey S A , Leonard C O , Dilts C and Blackburn B L . 1988. Natural history of Williams syndrome: Physical characteristics. J Ped 113, 318–26.
Morris C A and Mervis C B . 2000. Williams syndrome and related disorders. Annu Rev Genom Hum Genet 1, 461–84.
Nakamura M , Watanabe K , Matsumoto A , et al. 2001. Williams syndrome and deficiency in visuospatial recognition. Devptl Med Child Neurol 43, 617–21.
Navon D . 1977. Forest before trees: The precedence of global features in visual perception. Cogn Psychol 9, 353–83.
Paul B M , Stiles J , Passarotti A , Bavar N and Bellugi U . 2002. Face and place processing in Williams syndrome: Evidence for a dorsal–ventral dissociation. Neuroreport 13, 1115–9.
Pennington B F , Filipek P A , Lefly D , et al. 2000. A twin MRI study of size variations in human brain. J Cogn Neurosci 12, 223–32.
Peoples R , Franke Y , Wang Y K , et al. 2000. A physical map, including a BAC/PAC clone contig, of the Williams–Beuren syndrome – Deletion region at 7q11.23. Am J Hum Genet 66, 47–68.
Pober B R and Filiano J J . 1995. Association of Chiari I malformation and Williams syndrome. Ped Neurol 12, 84–8.
Prather M D , Lavenex P , Mauldin-Jourdain M L , et al. 2001. Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions. Neuroscience 106, 653–8.
Ranganath C and D'Esposito M . 2001. Medial temporal lobe activity associated with active maintenance of novel information. Neuron 31, 865–73.
Reilly J , Losh M , Bellugi U and Wulfeck B . 2004. Frog, where are you? Narratives in children with specific language impairment, early focal brain injury, and Williams syndrome. Brain Lang 88, 229–47.
Reiss A L , Abrams M T , Singer H S , Ross J L and Denckla M B . 1996. Brain development, gender and IQ in children. A volumetric imaging study. Brain 119, 1763–74.
Reiss A L , Eckert M A , Rose F E , et al. 2004. An experiment of nature: Brain anatomy parallels cognition and behaviour in Williams Syndrome. J Neurosci 24, 5009–15.
Reiss A L , Eliez S , Schmitt J E , et al. 2000. IV. Neuroanatomy of Williams syndrome: A high-resolution MRI study. J Cogn Neurosci 12 (Suppl 1), 65–73.
Rondan C , Santos A , Mancini J , Livet M O and Deruelle C . 2008. Global and local processing in Williams syndrome: Drawing versus perceiving. Child Neuropsychol 14, 237–48.
Santos A , Milne D , Rosset D and Deruelle C . 2007a. Challenging symmetry on mental retardation: Evidence from Williams syndrome. In Heinz E B (Ed.), Mental Retardation Research Advances. New York, NY: Nova Science Publishers, pp. 147–74.
Santos A , Rondan C , Mancini J and Deruelle C . 2007b. Behavioural indexes of callosal functioning in Williams syndrome. J Neuropsychol 1, 189–200.
Sarpal D , Buchsbaum B R , Kohn P D , et al. (2008). A genetic model for understanding higher order visual processing: Functional interactions of the ventral visual stream in Williams syndrome. Cerebral Cortex 18, 2402–09.
Scheiber, B . 2000. Fulfilling Dreams – Book 1. A Handbook for Parents of Williams Syndrome Children. Clawson, MI: Williams Syndrome Association.
Schmitt J E , Eliez S , Bellugi U and Reiss A L . 2001a. Analysis of cerebral shape in Williams syndrome. Arch Neurol 58, 283–7.
Schmitt J E , Eliez S , Warsofsky I S , Bellugi U and Reiss A L . 2001b. Corpus callosum morphology of Williams syndrome: Relation to genetics and behaviour. Devptl Med Child Neurol 43, 155–9.
Schmitt J E , Watts K , Eliez S , Bellugi U , Galaburda A M and Reiss A L . 2002. Increased gyrification in Williams syndrome: Evidence using 3D MRI methods. Devptl Med Child Neurol 44, 292–5.
Schultz R T . 2005. Developmental deficits in social perception in autism: The role of the amygdala and fusiform face are. Int J Devptl Neurosci 23, 125–41.
Spencer J , O'Brien J , Riggs K , Braddick O , Atkinson J and Wattam-Bell J . 2000. Motion processing in autism: Evidence for a dorsal stream deficiency. Neuroreport 11, 2765–7.
Strømme P , Bjørnstad P G and Ramstad K . 2002. Prevalence estimation of Williams syndrome. J Child Neurol 17, 269–71.
Sukarova-Angelovska E , Piperkova K , Sredovska A , Ilieva G and Kocova M . 2007. Implementation of fluorescent in situ hybridization (FISH) as a method for detecting microdeletion syndromes – Our first experiments. Prilozi 28, 87–98.
Tager-Flusberg H , Plesa Skewerer D , Faja S and Joseph R M . 2003. People with Williams syndrome processes faces holistically. Cognition 89, 11–24.
Tager-Flusberg H and Sullivan K . 2000. A componential view of theory of mind: Evidence from Williams syndrome. Cognition 76, 59–90.
Thompson P M , Cannon T D , Narr K L , et al. 2001. Genetic influences on brain structure. Nat Neurosci 4, 1253–8.
Thompson P M , Lee A D , Dutton R A , et al. 2005. Abnormal cortical complexity and thickness profiles mapped in Williams syndrome. J Neurosci 25, 4146–58.
Tomaiuolo F , Di Paola M , Caravale B , Vicari S , Petrides M and Caltagirone C . 2002. Morphology and morphometry of the corpus callosum in Williams syndrome: A TI-weighted MRI study. Neuroreport 13, 2281–4.
Udwin O and Yule W . 1991. A cognitive and behavioural phenotype in Williams syndrome. J Clin Exp Neuropsychol 13, 232–44.
Udwin O , Yule W and Martin N . 1987. Cognitive abilities and behavioural characteristics of children with idiopathic infantile hypercalcaemia. J Child Psychol Psychiatry All Discipl 28, 297–309.
Ungerleider L and Mishkin M . 1982. Two cortical visual systems. In Ingle D J , Goodale M A , Mansfeld R J W (Eds.), Analyses of visual behaviour. Cambridge, MA: MIT Press, pp. 549–86.
Urbán Z , Helms C , Fekete G , et al. 1996. 7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am J Hum Genet 59, 958–62.
Van Essen D.C , Anderson C H and Felleman D J. 1992. Information processing in the primate visual system: An integrated systems perspective. Science 255, 419–23.
Van Essen D C , Dierker D , Snyder A Z , Raichle M E , Reiss A L and Korenberg J . 2006. Symmetry of cortical folding abnormalities in Williams syndrome revealed by surface-based analyses. J Neurosci 26, 5470–83.
VanLieshout C , DeMeyer R , Curfs L and Fryns J . 1998. Family contexts, parental behavior, and personality profiles of children and adolescents with Prader-Willi, Fragile-X, or Williams syndrome. J Child Psychol Psychiatry All Discipl 39, 699–710.
Vicari S , Brizzolara D , Carlesimo G A , Pezzini G and Volterra V . 1996. Memory abilities in children with Williams syndrome. Cortex 32, 502–14.
Wang P P and Bellugi U . 1994. Evidence from two genetic syndromes for a dissociation between verbal and visual–spatial short-term memory. J Child Exp Neuropsychol 162, 317–22.
Wang P P , Doherty S , Hesselink J R and Bellugi U . 1992. Callosal morphology concurs with neurobehavioral and neuropathological findings in two neurodevelopmental disorders. Arch Neurol 49, 407–11.
Wang P P , Doherty S , Rourke S B and Bellugi U . 1995. Unique profile of visuo-perceptual skills in a genetic syndrome. Brain Cogn 29, 54–65.
Wang P P , Hesselink J R , Jernigan T L , Doherty S and Bellugi U . 1992. Specific neurobehavioral profile of Williams' syndrome is associated with neocerebellar hemispheric preservation. Neurology 42, 1999–2002.
Wilke M , Sohn J H , Byars A W and Holland S K . 2003. Bright spots: Correlations of gray matter volume with IQ in a normal pediatric population. Neuroimage 20, 202–15.
Williams J C P , Barret-Boyes B G and Lowe J B . 1961. Supravalvular aortic stenosis. Circulation 24, 1311–8.
Zeki S . 2001. Localization and globalization in conscious vision. Annu Rev Neurosci 24, 57–86.
Zhao C , Aviles C , Abel R A , Almli C R , McQuillen P and Pleasure S J . 2005. Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval. Development 132, 2917–27.

Reference Title: References

Reference Type: reference-list

Church J A , Fair D A , Dosenbach N U F , et al. 2009. Control networks in pediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain 132, 225–38.
Dawson G , Munson G , Webb S J , Nalty T , Abbott R and Toth K . 2007. Rate of head growth decelerates and symptoms worsen in the second year of life in autism. Biol Psychiatry 61, 458–64.
Dosenbach N U , Fair D A , Cohen A L , Schlaggar B L and Petersen S E . 2008. A dual networks architecture of top-down control. Trends Cogn Sci 12, 99–105.
Kuschner E , Bodner K and Minshew N J . 2009. Local versus global approaches to reproducing the Rey Osterrieth complex figure by children, adolescents and adults with high functioning autism. Autism Res 2, 348–58.
Minshew N J , Goldstein G and Siegel D J . 1997 . Neuropsychologic functioning in autism: Profile of a complex information processing disorder. J Int Neuropsychol Soc 3, 303–16.
Minshew N J , Goldstein G , Muenz L R and Payton J B . 1992.Neuropsychological functioning in nonmentally retarded autistic individuals. J Clin Exp Neuropsychol 14, 749–61.
Raznahan A , Toro, R , Proitsi P , et al. 2009. A functional polymorphism of the brain derived neurotropic factor gene and cortical anatomy in autism spectrum disorder. J Neurodevelop Disord 1, 215–23.
Rogers S J . 2009. What are infant siblings teaching us about autism in infancy. Autism Res 2, 125–37.
Scott A A , Abraham B S , Alvarez-Retuerto A-I , et al. 2009. Genetic variation in CNTNAP2 modulates human frontal cortical connectivity. Abstract, Society for Neuroscience.
Volpe J J . 1998. Brain development unit. In Neurology of the newborn (5th ed.). Philadelphia, PA: Saunders-Elsevier, pp. 3–118.
Williams D L , Goldstein G and Minshew N J . 2006.Neuropsychologic functioning in children with autism: Further evidence for disordered complex information-processing. Child Neurol 12, 279–98.